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Abstract 
Background: Stroke is a leading cause of morbidity and mortality, the majority of stroke 
cases are first events, and therefore primary prevention is essential. Stroke risk and major 
risk factors, blood pressure (BP) and lipid profile, may be modified by diet. The associations 
of dietary magnesium and protein intake on these outcomes has been understudied in 
parallel in a single population and the relationship between diet, nutritional biomarkers 
and BP is lacking in older populations.  
Aim: To determine associations between dietary magnesium and protein intakes and 
biomarkers with BP, lipid profile and stroke risk. 
Methods: This cross-sectional study included 4,443 men and women, a representative sub-
sample of the EPIC-Norfolk cohort, aged 39-80 and 234 older men and women, aged 65-
79, from the NU-AGE study. Multiple regression analysis and cox-proportional hazards 
model were used to assess associations between dietary magnesium and protein intakes, 
with BP, lipids and stroke risk. Dietary and biomarkers of magnesium and protein were 
assessed in relation to BP in the NU-AGE cohort.  
Results: BP was significantly inversely associated with dietary magnesium in men, total and 
animal protein in women and plant protein (diastolic BP only) for both sexes. Inconsistent 
relationships were identified between lipid levels and dietary magnesium and protein 
intakes with discrepancies between sexes. Men with the lowest 10% of magnesium intake 
were at highest risk of stroke. There was no significant relationship with other dietary 
intakes and stroke risk. In the NU-AGE study serum magnesium was not correlated with BP 
in men or women, and urinary urea nitrogen was inversely correlated with diastolic BP in 
men only. 
Conclusions: Dietary intakes of magnesium and protein have the potential to modify stroke 
risk. A diet higher in plant foods such as wholegrains, green vegetables, nuts, and legumes 
and quality animal protein may be beneficial in preventing stroke.   
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1.0 General overview 
Stroke is the second leading cause of death worldwide, and is accountable for 10% of all-
cause mortality (2, 3). Stroke is defined by the World Health Organisation (WHO) as; 
neurological impairment of sudden onset, either focal or global, where symptoms persist 
for more than 24 hours or result in death within 24 hours of onset and are of presumed 
vascular origin. The recent trends in stroke incidence have been a decrease in incidence in 
high income countries and a significant increase in incidence in middle and low income 
countries (4). However, with the increasingly ageing population, and the higher incidence 
of stroke with advancing age, it will continue to be a condition that requires investigation 
and prevention.  
The majority of strokes, globally, are ischaemic, accounting for approximately 80% of all 
cases, whereby there is an occlusion of the blood supply to the brain primarily as a 
consequence of a blood clot (5). A further 15% of cerebrovascular events are classified as 
primary intracerebral haemorrhages which occur when an artery within the brain ruptures, 
the remaining 5% are subarachnoid haemorrhages and result when an artery on the surface 
of the brain ruptures (5). 
The risk of having a cerebrovascular event can be influenced by a number of factors some 
of which cannot be modified, including age, sex, genetics, and ethnicity (6). However, the 
majority of risk factors for stroke are modifiable, including; high blood pressure, 
hypercholesterolemia, atrial fibrillation, type II diabetes, physical inactivity and smoking 
which combined account for over 65% of first adverse events (7, 8). Some of these risk 
factors can be strongly influenced by dietary intakes of foods and nutrients, which is 
discussed in more detail in section 1.3.2 of this Chapter. 
Therefore, it may be possible to reduce the risk of stroke occurrence by prevention through 
lifestyle modification. Previous research has indicated that dietary intake, including 
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increased consumption of fruit and vegetables and other plant based foods, may have a 
major influence on stroke incidence or its risk factors, including blood pressure and 
abnormal lipid profile, with low fruit and vegetable consumption attributing to 
approximately 11% of strokes worldwide (9-13). 
Hypertension, defined as systolic blood pressure (SBP) >140 mmHg and diastolic blood 
pressure (DBP) >90 mmHg (14),  is one of the most important and modifiable risk factors of 
stroke. It may have a contributory role in up to 70% of all strokes in the UK (6, 15). A number 
of mechanisms may be involved in the role of hypertension on stroke incidence.  These 
include endothelial dysfunction, increased permeability of the blood-brain barrier and an 
increase in atherosclerotic plaque formation (16, 17). Likewise, abnormal lipid profile, 
another major potentially modifiable risk factor for stroke, can influence stroke risk via a 
number of possible mechanisms, which are yet to be fully elucidated. However it appears 
that increased risk may in part be due to atherogenic effects and clotting abnormalities 
(18). These mechanisms of action will be discussed in more detail later in this chapter.  
This chapter provides a narrative review of relevant literature related to stroke risk and risk 
factors for stroke based on keyword searches using MEDLINE (Ovid) and PubMed. 
Additional relevant articles were identified from article reference lists. 
Research has indicated that dietary habits can have an effect on blood pressure and serum 
lipid levels, for example substantial evidence supports a strong association between 
increased sodium intake and increased blood pressure and hypertension (19, 20). However,  
to date, research into the association between intakes of other dietary components 
including the impact of plant based foods, any food derived from plant material including 
fruit, vegetables, grains and their products such as bread, pasta, and their influence on 
blood pressure has provided less consistent findings (20-23).  
With regard to diet and serum lipid levels, the primary focus of research has been on dietary 
fatty acid intakes which influence lipid levels both positively and negatively depending on 
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the type of fat consumed (24-26). The consumption of polyunsaturated fatty acids (PUFA), 
omega-3 fats and plant-derived monounsaturated fatty acids (MUFA) affect serum lipid 
levels favourably, leading to increases in high density lipoprotein (HDL) and decreases in 
low density lipoprotein (LDL) (24). Whilst diets high in saturated fats may negatively 
influence lipid profile; including higher LDL and lower HDL levels. 
Most evidence surrounding plant based nutrients and cholesterol levels is related to the 
consumption of flavonoid rich foods including nuts, cocoa, wine, soy products and fruit 
beverages, with mixed findings  (27-30). There is some evidence to indicate a beneficial 
effect on serum LDL and total cholesterol levels from soy protein isolates and green tea, 
but no effect was illustrated on HDL levels (31-33). A number of studies have reported an 
increase in circulating HDL following the consumption of flavonoid rich fruit beverages 
including orange, cranberry and grape (13, 34-36). 
It is also not known, whether dietary intakes or biological markers of intakes are more 
highly correlated with differences in blood pressure, and thus may be more accurate 
predictors of change, particularly in older populations. 
Previous research has utilised a number of different methods of dietary assessment. These 
methods are described in more detail in the following section and their respective strengths 
and limitations are discussed.  
Bias and measurement error in dietary assessment methods 
The self-reported measurement of dietary intake is inherently prone to bias (37, 38). Bias 
can be introduced at any point of the study including during recruitment, data collection, 
analysis and interpretation but is broadly split into selection and information bias (38). 
Selection bias is related to the recruitment process and can occur if the recruited 
population has a different relationship with the exposure of interest than the general 
population they are sampled from. Information bias, which includes recall bias, is the result 
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of either random or systematic differences in how exposure and outcome are reported in 
the study sample. Bias in a study can ultimately result in drawing inaccurate conclusions.  
Self-reported measures include FFQs, 24hr recall and dietary records, with FFQ being the 
most commonly used due to its low relative cost, ease of administration and data entry 
(37). All the methods aim to determine the usual habitual diet of the individuals and study 
population.  Each method is prone to its own biases and mis-reporting. For example FFQs 
and 24hr recalls rely on memory; particularly so for FFQs which may be aiming to establish 
approximate consumption of food items over long periods of time. Dietary records aim to 
avoid this problem by being completed by the participant at the time, or soon after, eating. 
However, they are more burdensome for the volunteer and require a greater input during 
data entry by the research team. Another common difficulty for all methods is in reporting 
portion size accurately. FFQs and 24hr recalls are often based on standard portion sizes, 
images may be used to help participants to select the most appropriate portion but 
differences from actual intake will occur. Weighed food records may most precisely report 
portion size, however, it is not always possible for participants to weigh all food items, such 
as when eating away from the home. And as such, discrepancies in portion size consumed 
may also occur (37, 38).  
Measurement error can be systematic or random. Systematic error includes person-
specific, constant additive and intake-related bias, these types of systematic error rarely 
occur in isolation (37). Person-specific bias is related to particular characteristics of the 
individual which lead to over or under-reporting such as age, sex, or weight. An average of 
observed intake in this case would not give representation of true intake (as is the case 
with within-person error in random error). Constant additive error is consistent for all 
participants, but still leads to over or under estimation of intake (compared with true 
intake). Intake related bias on the other hand differs between individuals. For example 
there may be greater under-reporting in those with true higher intakes compared with 
individuals with true lower intakes. Random error includes within person error, which 
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includes day to day variability in intake or reporting of intake in relation to true intake. With 
sufficient repeats the average of intake can be representative of true intake, minus bias 
(37). 
FFQs are mostly influenced by systematic error, which is not reduced or influenced by 
repeats and averaging. Whereas 24hr recalls and food diaries are mostly affected by 
random error, which can be reduced with repeated measurements, although they may still 
be additionally affected by systematic error (39).  
There is not yet a method which reports true intake 100% accurately. However, gold 
standards, recovery biomarkers, are available for some nutrients, including total energy, 
protein intake and micronutrients such as sodium and potassium, which can be used to 
validate observed intakes from self-reported measurements. Recovery biomarkers are 
objective measurements which are directly related to nutrient intake in the general 
population. Validation studies, utilising a reference measurement such as a biomarker of 
intake, can be used to determine how well the dietary assessment method, observed 
intake, estimates true intake (37).  
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1.1 Stroke incidence and prevalence 
1.1.1 Global data and burden 
Cerebrovascular disease accounts for 8.6% and 11.0% of worldwide deaths for men and 
women respectively, equating to more than 5.5 million deaths annually (40). It is estimated 
that by 2020 global stroke burden will account for more than 61 million disability-adjusted 
life years (DALYs) (2). This in part is due to the increase in the proportion of the population 
aged over 45 years as the incidence of stroke increases significantly with age, and doubles 
each decade after 45 years (41-44). 
In the developed world the incidence of stroke is declining although, with the ageing 
population the crude number of strokes is increasing (2). In contrast in many developing 
countries the incidence of stroke is rapidly increasing as depicted in Figure 1.0 which 
illustrates worldwide mortality for both sexes from cerebrovascular disease. It is estimated 
that by 2030 stroke mortality in the developing world including Latin America, the Middle 
East and sub-Saharan Africa will have tripled (45).
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Figure 1.0 Global cerebrovascular mortality for men and women from 2004 (1) 
Chapter One  Introduction 
 
9 
 
1.1.2 Western population data 
In Europe, stroke is the second most common cause of death, accounting for 1.28 million 
deaths per year, which is approximately 11% and 18% of all deaths in men and women 
respectively (46). The incidence and mortality rate from stroke is greater in Central and 
Eastern parts of Europe compared with Northern, Southern and Western areas as depicted 
in Figures 1.1 and 1.2 for men and women respectively (47, 48). This largely correlates with 
the age of populations in the majority of European countries which is increasing and has 
been reflected in a 45% rise in stroke related hospital discharges since 1990 (47). The 
majority of strokes in Western populations, including Europe, are ischaemic, accounting for 
85% of all strokes (8).  
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Figure 1.1 Age-standardised stroke mortality, men aged 35-74, in 2001 (46) 
 
Figure 1.2 Age-standardised stroke mortality, women aged 35-74, in 2001 (46) 
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1.1.3 UK data 
Stroke is one of the three leading causes of mortality in the UK, accounting for 
approximately 9% of all deaths, and it is the primary cause of adult disability in the UK (8, 
47). Each year over 110,000 individuals experience a first stroke and a further 30,000 have 
a subsequent event (49). With an increasingly ageing population profile (Figure 1.3) the 
number of people experiencing a first stroke each year will be greater, raising the burden 
on the NHS. At present, stroke is estimated to cost the NHS a total of £8.9 billion per annum 
(p.a) (50). This is inclusive of diagnosis, inpatient and outpatient treatment, informal care 
and loss of productivity (50). 
 
 
Figure 1.3 Age structure of England and Wales, 2014 (population 57.3 million) and 2050 
(population 69.0 million) (51) 
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1.2 Stroke background 
1.2.1 Classification of stroke 
Stroke is a neurological impairment of sudden onset, either focal or global, where 
symptoms persist for more than 24 hours or result in death within 24 hours of onset and 
are of presumed vascular origin. Strokes are broadly classified as either ischaemic or 
haemorrhagic in origin. Ischaemic strokes result from the occlusion of an artery supplying 
part of the brain. This is the more common type of stroke accounting for 80-85% of all 
stroke cases. Ischaemic strokes can be either thrombotic, where a blood clot forms in situ 
in an artery supplying the brain, or embolic which is the result of a more mobile clot that 
has formed elsewhere in the body, often originating from cardiac or carotid arteries, and 
travels through the bloodstream and causes a blockage in a medium or small sized vessel. 
Haemorrhagic strokes, caused when an artery leading to or on the surface of the brain 
ruptures, account for a smaller proportion of stroke incidences. They can be further 
subdivided into intracerebral haemorrhage when a vessel within the brain ruptures and 
subarachnoid haemorrhage which leads to bleeding on the surface of the brain. 
Intracerebral haemorrhage leads to the release of blood into the brain, thus increasing the 
pressure which damages surrounding cells in addition to damage resulting from 
subsequent lack of oxygenated blood supply. Following subarachnoid haemorrhage blood 
accumulates between the skull and brain (the subarachnoid space) which damages 
surrounding cells. In addition leaked blood may also combine with cerebrospinal fluid, this 
can cause reduced circulation of cerebrospinal fluid which leads to further fluid build-up 
and additional increase in pressure. 
Transient ischaemic attack, is a short lived ischaemic event with symptoms typically lasting 
only a few minutes. In lay terms it is often referred to as a mini-stroke and frequently 
precludes a ‘full’ stroke. The present thesis does not cover this type of cerebrovascular 
event. 
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1.2.2 Stroke aetiology 
Atherosclerosis 
Atherosclerosis is the formation of plaques in arteries, which are comprised of a number of 
materials including fatty deposits, cholesterol and calcium ions (52). It is often referred to 
as hardening or furring of the arteries.  
Atherosclerosis begins with damage to the endothelium. A number of factors can lead to 
endothelium damage including mechanical force, bacterial and viral infections, 
hypertension, raised cholesterol, smoking, raised glucose and homocysteine levels (53). 
This initial damage then allows LDL to infiltrate the subendothelium where it is oxidised by 
macrophages (54). This stimulates the release of adhesion molecules, which attract 
additional monocytes and T lymphocytes to the site by acting as receptors. Monocytes 
migrate into the intima and transform to macrophages. Macrophages then ingest the 
previously oxidised LDL and develop into foam cells (54). On death the macrophages 
release stored lipid which then forms the basis of the lipid-core. T lymphocytes and foam 
cells form a fatty streak which is the beginnings of an atherosclerotic plaque (54). The 
plaque grows due to smooth muscle cell proliferation in addition to the localised 
accumulation of macrophages and foam cells. The plaque can be stabilised by the 
formation of a thick fibrous cap, however, if this cap degrades or is weakened the result is 
rupture and release of the tissue factor lipid core. When this comes into contact with blood, 
the clotting process begins (54). 
Atherosclerotic plaques can be a causal factor in strokes in one of two ways; they may lead 
to the occlusion of an artery leading to or within the brain or a plaque in a larger vessel in 
the body may rupture initiating the formation of blood clot which may then break off and 
travel to the brain and occlude the micro vessels (52). Early stages of atherosclerotic plaque 
formation can also influence stroke risk factors including blood pressure. As the build-up of 
plaque progresses the arteries narrow, this leads to an increase in pressure due in part to 
reduction in size but also in the reduced flexibility of the artery walls (52). 
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Thrombus and embolus 
A thrombus forms locally within a vessel, the formation of a thrombus can be initiated at 
the site of a ruptured atherosclerotic plaque or at any point where there is damage to the 
endothelium. An embolus is a mobile clot, and is usually a fraction of a thrombus (52).  
Cerebral aneurysm 
Cerebral aneurysms, restricted to vessels in the brain, usually form at branching points in 
arteries and result from pressure of blood flow. Over time the artery walls are weakened 
allowing for a ‘ballooning’ effect. A large aneurysm can exert pressure on surrounding brain 
or nervous tissues which may present with symptoms. However, most commonly 
symptoms are only present after an aneurysm has ruptured. 
1.2.3 Stroke treatment 
Treatment for each type of stroke differs as does the medical outcome, with a higher 
proportion of haemorrhagic strokes being fatal. 
Acute therapy 
It is important to identify and diagnose a stroke rapidly as delay in treatment leads to less 
favourable outcomes. The most widely used treatment for ischaemic strokes is 
thrombolysis using Alteplase, which is a tissue plasminogen activator (tPA). tPA catalayses 
the reaction leading to the conversion of plasminogen to plasmin. This then initiates 
fibrinolysis as the plasmin degrades fibrin which breaks down the clot. These fragments can 
be removed from the bloodstream by proteases or during filtration in the liver and kidneys 
(55).  The aim is to disperse the blood clot, allowing restoration of normal blood flow (56). 
This treatment is only recommended to be used where the onset of symptoms was less 
than 4.5 hours ago (56).  In addition anti-coagulants and/or aspirin may be given to reduce 
the likelihood of subsequent clots forming depending on the aetiopathology.  
Intracerebral haemorrhage may be treated with both medical and surgical interventions. 
In instances where the intracerebral haemorrhage is caused by hypertension, the most 
common cause in up to 60% of all cases, then medication to normalise blood pressure is 
given. After which action may be taken to reduce pressure including the use of surgery. 
Surgery may also be employed in the treatment of ischaemic strokes. Subarachnoid 
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haemorrhage, which are frequently caused by an aneurysm, often require emergency 
surgical procedures, in order to repair the damaged vessel and to drain the excess fluid 
which can otherwise cause cranial pressure (57).  
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1.3 Risk factors  
1.3.1 Non-modifiable 
Age 
Although a stroke can occur at any age, three quarters of all strokes occur in individuals 
aged over 65 years, making age the most important risk factor for stroke (43). In addition 
the incidence of stroke has been reported to double with each advancing decade after 45 
years (58). The effect of age can be attributed to the accumulative impact of ageing on the 
cardiovascular system, such as the formation of atherosclerotic plaques and changes to 
vascular structure, in addition to gradual rise in blood pressure (59, 60). 
Sex 
Despite the incidence of stroke being greater in men, albeit to a lesser extent than for 
cardiovascular disease, the overall prevalence of stroke is greater in women. This is in part 
due to their increased longevity and the associated exponential increase in stroke risk with 
age. In women the onset of menopause has been associated with increased risk of stroke, 
in part due to the effect of changes in hormonal balance on stroke risk factors, such as 
acceleration of atherosclerosis (61). In addition hormone replacement therapy (HRT) use 
has been indicated to increase the risk of stroke by up to 30%, however there is limited 
evidence as to whether risk is dose dependent or related to specific routes of 
administration (transdermal vs oral) (61-63). 
Genetics 
There is evidence to suggest that genetic predisposition may play a contributory role to an 
individual’s risk of stroke. A family history of stroke may increase risk by up to 75% (64). 
To date there is no one single gene associated with stroke risk. However, the genetic role 
in stroke is in relation to risk factors such as hereditary predisposition to high blood 
pressure (BP), diabetes and vascular abnormalities such as cerebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADSIL). CADSIL is a result 
of genetic mutation of the Notch 3 gene and causes migraine-like headaches, strokes and 
dementia (64).  
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1.3.2 Modifiable 
Blood pressure and stroke 
High blood pressure is the single most modifiable risk factor for stroke. There is an 
approximate fourfold increase in stroke risk in hypertensive individuals (SBP >140 and DBP 
>90 mmHg) compared with the normotensive population (65). It is acknowledged that even 
those with prehypertension, defined as SBP 120-139 mmHg and DBP 80-89 mmHg, are at 
increased risk of stroke (16, 66, 67). It has been identified that up to 40% of individuals fall 
into the prehypertensive category depending on sex, age and ethnicity (66, 68, 69). Often 
individuals in the prehypertensive stage progress to being hypertensive within 4 years, this 
is particularly the case for individuals aged over 65 (68).  Therefore reducing their blood 
pressure at this earlier prehypertensive stage may potentially decrease stroke risk. 
Evidence suggests that even a modest reduction of 1-3 mmHg in systolic blood pressure 
can lead to a 20-30% reduction in stroke risk and a 4 mmHg reduction in diastolic blood 
pressures equates to a 23% reduction (16, 70, 71). Hypertension increases the risk of stroke 
incidence via a number of mechanisms including, the promotion of atherosclerotic plaque 
formation. Over time this can lead to occlusion of blood vessels restricting blood flow (16). 
It also affects smooth muscle cells by inducing hypertrophy leading to narrowing of the 
arteries. 
There is a large body of research to support the benefits of lowering salt intake on blood 
pressure reduction (19, 20, 72).  Changes similar to this with other nutrients remain more 
controversial and therefore further research to elucidate the potential beneficial role 
between increased consumption of plant-based dietary components and a reduction in 
blood pressure is required. 
Abnormal lipid profile and stroke 
The relationship between total cholesterol and stroke risk is inconsistent, despite a 
significant amount of research being conducted in the field, the findings remain 
contradictory (6, 73-78). This may in part be due to total cholesterol (TC) being formed 
primarily from HDL cholesterol and LDL cholesterol which have opposing effects on stroke 
risk. Increased HDL concentration may infer a protective effect against stroke whilst the 
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converse is true of LDL (74, 77, 79). There is additional evidence to support different effects 
of serum cholesterol on stroke subtypes. Lower serum TC has been associated with an 
increased risk of haemorrhagic stroke incidence, whilst concentrations above 7.23 mmol/L 
have been associated with an increased risk of ischaemic stroke incidence (80). 
Where evidence is in support of increased total stroke incidence associated with higher TC 
concentration the association is weak or non-significant, and is more commonly related to 
younger populations aged ≤ 45 years (80-83). 
Diabetes and stroke 
Both type I and type II diabetes mellitus (DM) have been associated with an increased risk 
of stroke incidence, both total stroke and subtypes, and less favourable outcomes (78, 84-
87). A greater risk of incidence has been identified in those with insulin dependent DM and 
also in association with duration of disease. Therefore those diagnosed at younger ages 
have greater risk than individuals diagnosed later in life (85, 88). 
The increased risk of cerebrovascular events associated with DM may in part be due to co-
morbidities that also frequently occur in conjunction with DM including dyslipidaemia, and 
hypertension. Individuals with DM also commonly present with increased carotid intima-
media thickness, a significant independent predictor of stroke risk (86, 89) and enhanced 
incidence of atherosclerotic plaque formation (90).  
Hyperglycaemia associated with DM has been linked to endothelial dysfunction including 
inhibition of nitric oxide (NO) production which otherwise has a vasodilatory effect (90). In 
conjunction with this there is upregulation of vasodilators including endothelin-1 which is 
required for the activation of endothelin-A receptors located on vascular smooth muscle 
cell (90). 
Atrial fibrillation 
Atrial fibrillation (AF) is predominately associated with increases in ischaemic stroke risk, 
with approximately 1 in 6 stroke patients having AF (91). There is a five-fold increase in risk 
of stroke in patients with AF compared with the general population (92). The increase in 
risk may also be sex specific with women who had untreated AF having a 40-70% greater 
risk of having a stroke compared with males with AF (93). As with DM, AF is also associated 
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with more severe events and less favourable outcomes (91). The associated increase in risk 
with atrial fibrillation may in part be due to the increased likelihood of individuals also 
having further cardiovascular diseases including hypertension, coronary heart disease 
(CHD) and prior myocardial infarction (MI) (92). 
Smoking 
Cigarette smoking is one of the main modifiable risk factors for stroke along with high blood 
pressure. When compared with non-smokers, current smokers have twice the risk of stroke 
(94, 95). 
Former smoking remains a risk factor for stroke. Both the Nurses’ Health Study and 
Physicians Health Study indicated an increased risk associated with former smoking. 
However, this risk may return to baseline levels after 5 continuous years of cessation (96, 
97). Smoking may also indirectly increase the risk of stroke by influencing stroke risk factors 
including blood pressure. Long term smoking is linked to increased risk of developing 
hypertension (98, 99). Other mechanisms by which smoking can increase stroke risk include 
acceleration of atherosclerotic plaque formation as illustrated in animal models. There is 
also evidence that smoking leads to increased vascular stiffness, and has procoagulant 
affects including enhanced platelet aggregation and increased fibrinogen concentrations 
(58, 100, 101) 
Diet and stroke 
Dietary habits and intakes can have a significant impact on general health and wellbeing. 
Inappropriate consumption of a range of foods and nutrients has been associated with 
increased risk of developing a number of non-communicable diseases such as CVD and 
stroke. Table 1.0 adapted from Lim et al (102) illustrates the influence of certain dietary 
habits on global deaths. Additionally within the top ten risk factors attributing to burden of 
disease in Western Europe specifically were diets low in fruit, nuts and seeds, high sodium 
intakes and alcohol use (102). 
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Table 1.0 Global all-cause mortality (in millions) attributable to dietary risk factors (2010) 
Dietary risk factor Men Women 
Low fruit intake 2.84 2.06 
Low vegetable intake 1.02 0.78 
Low wholegrain intake 0.96 0.76 
Low nuts and seeds intake 1.39 1.08 
Low fibre 0.44 0.30 
Low calcium 0.08 0.05 
Low omega-3 fatty acids 0.79 0.60 
Low PUFA 0.31 0.22 
High red meat 0.02 0.02 
High processed meat 0.47 0.37 
High sugar-sweetened beverages 0.16 0.14 
High trans fatty acids 0.29 0.22 
High sodium 1.73 1.37 
Table adapted from Lim et al (102). 
In relation to stroke risk specifically, a number of studies have identified an inverse 
association between increased fruit and vegetable consumption and stroke risk in both 
male and female populations (103-107). It has been suggested that this is likely to be due 
to the high levels of beneficial constituents such as fibre, flavonoids, micronutrients and 
other phytochemicals that are found in plant based foods. These constituents exhibit a 
range of beneficial effects including increased oxygen scavenging – reducing oxidative 
stress, reduction and/or prevention of endothelial dysfunction, and reduction in blood 
pressure and improved lipoprotein profile (104, 108, 109).  It may also be that increased 
consumption of fruit and vegetables displaces the consumption other foods such as those 
high in saturated fat which is associated with increased risk of CVD. There is also evidence 
that a higher fruit and vegetable consumption is associated with other beneficial dietary 
and lifestyle habits such as lower prevalence of smoking, and increased physical activity. 
To date, research has produced equivocal results with regard to reducing stroke risk and 
dietary patterns. One study did however report an estimated risk reduction of 46% 
between the highest and lowest quartiles of serum vitamin C levels, used as a marker of 
high fruit and vegetable consumption (110, 111). Whilst others found that after adjusting 
for dietary vitamin C intake the association between fruit intake and stroke risk was non-
significant (112). For vegetable intake a similar effect was shown after adjustment for β-
Chapter One  Introduction 
 
21 
 
carotene intake (112). This may suggest that any potential protective effects are likely to 
be limited to specific plant foods or combinations of nutrients only when consumed in 
certain quantities (113). However, the characteristics of these studies’ cohorts are different 
which may in part account for this disparity in findings. Current UK government guidelines 
recommend the consumption of a minimum of five portions of fruit and vegetables per day 
as part of a healthy diet. High fruit and vegetable intake is estimated to reduce the risk of 
stroke by 26% in those consuming more than 5 servings of fruit and vegetables per day 
compared with individuals consuming less than 3 portions per day (104, 114-116).  
Diet and blood pressure and lipid profile 
Elevated blood pressure and the development of hypertension can be modified by diet 
because a number of dietary factors have been associated with the risk of hypertension 
including; salt, alcohol, saturated fat and high cholesterol (19). Other dietary components 
including; higher fruit and vegetable, protein, potassium, magnesium and calcium intakes 
may exert a beneficial effect on blood pressure (19, 20). 
Favourable lipid profile may be achievable by dietary modification. A number of dietary 
components have been implicated with influencing blood lipid profile including most 
commonly total fat intake and fat subtypes (saturated (SFA), MUFA and PUFA), alcohol 
intake and whole grain consumption.  
Dietary patterns 
The Dietary Approaches to Stop Hypertension (DASH) diet is the most widely known dietary 
strategy to reduce BP and prevent hypertension. It is characterised by high intake of fruit 
and vegetables, low-fat dairy products, whole-grain, nuts, fish and poultry whilst reducing 
total and saturated fat intakes, and limiting consumption of red meat and high sugar foods 
(including sweets and sugar-sweetened drinks) (72). This dietary pattern lead to significant 
reductions in BP in both normotensive and hypertensive populations (117).  Additionally 
reductions in LDL and TC have been reported in those consuming a DASH diet, however, a 
decrease in HDL levels was also noted (118). 
The Mediterranean diet, like the DASH diet, is rich in fruit and vegetables and cereal 
products but encourages higher fat intake in the form of MUFA, from nuts, olive oils and 
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seeds. It is also characterised by an overall low intake of meat and meat products, and 
moderate consumption of alcohol and dairy products. There is evidence that following this 
dietary pattern may reduce blood pressure. 
Those consuming a vegetarian diet have been reported to have lower blood pressure and 
LDL cholesterol levels compared with their non-vegetarian counterparts (119-121). This 
may be attributable to a combination of a number of factors, including the tendency for 
those on a vegetarian diet to have a lower body mass index (BMI) than those consuming a 
non-vegetarian diet. In addition a vegetarian diet is often associated with higher fruit and 
vegetable intakes than the omnivorous diet. Interventions involving following a vegetarian 
diet have also led to a decrease in TC as well as produced beneficial effects on LDL profile 
of participants in the intervention arm. Vegetarian diets are typically higher in a number of 
food groups and compounds which may exhibit beneficial effects on serum lipid profile. 
This includes higher intakes of fruit and vegetables, overall fibre intake, and greater 
consumption of nuts which has been shown to significantly reduce circulating total and LDL 
cholesterol levels (13). Vegetarian diets may also contain higher levels of soy protein and 
plant sterols which are present in small quantities in many of the previously mention foods. 
Mechanisms are likely to be a combination of factors rather than attributable to one 
specific component of the diets and may also relate to other lifestyle factors associated 
with more health conscious vegetarian diet. 
Fruit and vegetables 
Previous studies have investigated the effects of increased consumption of whole grains, 
fruit and vegetables (122-124). The specific mechanisms of effect are not well understood, 
and may in part be attributable to other components of these foods, including higher fibre, 
vitamin or mineral content, and typically lower fat contents. However, further research is 
required to elucidate the potential mechanistic effects. 
Previous studies investigating the effects of specific groups of fruit and vegetables and 
stroke risk have yielded inconclusive findings. A significant trend was reported with 
increased total fruit and vegetable intake and increased fruit intake, but not with increasing 
vegetable intake (125). There was a greater increase in number of portions of vegetables 
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than fruit across the quintiles (0.9-5.1 portions of vegetables compared with 0.4-3.1 
portions of fruit) (125). Therefore it is not necessarily that the effect of fruit is due to 
concurrent higher intakes of vegetables. This would suggest that there are additional 
benefits of fruit consumption, it may be that fruit is often consumed in the raw state unlike 
vegetables which are often cooked. Cooking can lead to degradation of beneficial 
compounds such as vitamins, which may explain the non-significant effect of higher 
vegetable intake, despite the number of portions being greater than that for fruit intake 
(126). 
A prospective study of 74,961 Swedish men and women, with 4,089 stroke cases, reported 
a RR of 0.87 (95% CI 0.79-0.97) for quintile 4 of total fruit and vegetables intake, which had 
a median intake of 5.2 portions of fruit and vegetables (125). This finding may be relevant 
in terms of UK government guidelines which recommend consumption of at least 5 portions 
of fruit and vegetables per day, which many people do not reach. 
Specific foods 
Specific foods such as consumption of fish, nuts or soy products may also benefit serum 
lipid profile. This could be due to a number of factors including their fatty acid composition, 
vitamin and mineral content, specific proteins and the presence of other beneficial 
constituents such as flavonoids in these foods (24). Specifically studies have indicated 
potential inverse associations between TC and LDL levels and the consumption of soy 
protein products. Research in relation to the potential impact on HDL and triglyceride (TG) 
levels has produced more inconsistent findings (27, 28, 127, 128). 
Plant stanols and sterols 
In the UK diet the main sources of plant sterols and stanols were cereals and bread, 
vegetables and vegetable fats (129). Average intakes in the Western diets are between 200-
400 mg/d, higher intakes are seen in those with predominantly plant based diets (130). 
Plant stanols and sterols help to reduce the absorption of cholesterol in the intestine, 
leading to decrease in circulating LDL and total cholesterol levels (131). They may also have 
additional beneficial effects including reducing inflammation, and coagulation and 
improved endothelial function.  
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Alcohol 
Moderate alcohol intake, estimated at 1-2 drinks/d, may be beneficial for both blood 
pressure and lipid profile, specifically HDL, compared with no alcohol consumption. 
However, high alcohol intakes are associated with increased blood pressure and overall 
increase in risk of CVD mortality (12, 22, 132, 133). Despite this, a systematic review by 
Brien et al (133) reported no significant associations either positive or negative between 
alcohol intake and TC, LDL or TG levels. The relationship with blood pressure is dose-
dependent above ≈2 drinks/d and independent of obesity, salt intake and age (72). The 
mechanisms of alcohol consumption and blood pressure are unclear. A number of potential 
mechanisms have been proposed including the effect of alcohol on; renin-angiotensin-
aldosterone axis which has a role in arterial vasoconstriction and maintaining extracellular 
fluid volume, heart rate variability, cortisol levels and fluctuations in ion levels including 
calcium (134, 135). Other explanations include a mild withdrawal effect due to overnight 
fast that is often prior to blood pressure measurements. There is evidence that this may 
even be the case in individuals who drink moderately but over a long period of time, and 
therefore not exclusively affecting those with heavy consumption (136). Alcohol 
consumption along with social class, education and physical activity status, may also be 
indicators of other dietary habits that influence blood pressure. 
Macronutrients 
What many of the above dietary patterns have in common is a high intake of fruit and 
vegetables. There is evidence that some specific macro and micronutrients may influence 
BP and lipid profile including fat intake, sodium, potassium and calcium.  
A number of macronutrients including carbohydrates, fibre, and fat intake have been well 
studied in relation to risk factors for stroke, BP and lipid levels (24, 72, 137, 138). For 
example a meta-analysis of placebo controlled RCTs increasing fibre intake suggests that 
an average 11.5 g/d increase in fibre intake was associated with lower SBP and DBP 
(approximately -1.13 and -1.26 mmHg respectively) (139). Twenty four trials were included 
in the meta-analysis, comprising a total of 1,404 men and women aged 23-63 years. The 
trials ranged in duration from 2-24 weeks and fibre dosage varied from 3.5 – 42.6 g/d, in a 
range of formats; soluble, insoluble, mixed and through dietary increase. In 8 of the trials 
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hypertensive participants were included (139). In relation to dietary fat intake, the type and 
amount of fat consumed is important for both BP and lipid levels (24). Blood pressure and 
lipid levels are adversely affected by high intakes of SFA. However, higher intakes of 
unsaturated fatty acids may be inversely associated with BP and beneficially influence lipid 
profile, decreasing LDL and TC and increasing HDL levels (25, 72, 138). 
Fibre consumption has been indicated to be a more accurate predictor of BP and plasma 
cholesterol levels than ‘other dietary components’ (139). 
Protein 
Increased dietary protein intakes, have previously been inversely associated with BP (140, 
141), however the influence of different sources of protein, and more specifically whether 
different amounts of dietary plant or animal protein has an effect on blood pressure has 
been less conclusively studied. 
In the UK, on average, protein intake accounts for between 14-16% of an adult’s daily 
energy intake (142).  The primary sources of protein are meat and meat products, 
attributing approximately 37% of daily protein intake. A further ~23% is obtained from 
cereal and cereal products, whilst milk and dairy products accounts for ~14% of daily 
protein intake (142).  
Previously, vegetarians eating largely plant protein have been shown to have lower BP than 
their omnivorous counterparts (143). However, this does not necessarily illustrate that it is 
the protein content of their diet that has beneficial effects, but it may be that the 
vegetarian diet is, in general, lower in total and saturated fat, and higher in fibre which as 
previously stated can both have a significant influence on risk factors for stroke, BP and 
lipid levels (25, 72, 138). In addition the vegetarian diet may also be indicative of other 
more healthful dietary and lifestyle factors (144). In addition to this, cultures where protein 
intake is primarily obtained from plant sources such as Asian populations, where ~47% of 
protein intake is from plant, tend to have lower BP than Western populations whose 
consumption of animal protein is greatly increased, with ~36% of protein from red meat 
sources and only ~33% from plant sources (145, 146).  
Chapter One  Introduction 
 
26 
 
Protein has a key role in satiety, and this may therefore also indirectly influence cholesterol 
levels, as weight loss can favourable influence lipid profile (147). Randomised controlled 
trials (RCTs) have also investigated the effects of high protein and low carbohydrate diets. 
Findings have indicated that plasma lipid levels can be modified by higher consumption of 
protein (148). They found that a diet higher in protein, in this instance beef protein, led to 
a reduction in plasma triglyceride levels after 2 weeks of intervention, compared to 
baseline measurements. This effect was independent of saturated fat intake. However, the 
saturated fat content of the diet appeared to influence plasma total, LDL and HDL 
cholesterol as greater reductions in total and LDL cholesterol were reported in those in the 
low saturated fat group (8% of energy intake, compared with 13% of energy intake). The 
consumption of the low saturated fat diet also led to a reduction in HDL concentrations. A 
smaller reduction was also shown in those consuming the higher saturated fat diet, which 
may reduce the potentially beneficial effects of reduction in total, LDL and triglyceride 
levels previously indicated. To further assess this, the ratio of HDL-LDL cholesterol could be 
calculated, as a higher ratio of HDL to LDL cholesterol may be beneficial for disease risk 
reduction.  
Mechanisms related to dietary protein intake, include regulation of blood pressure through 
changes in plasma amino acid concentrations. Higher circulating levels of cysteine, 
glutamate, arginine, leucine, taurine and tryptophan have been indicated to have potential 
BP lowering effects (149). This is thought to be through their influence on a number of 
metabolic processes including insulin resistance, oxidative stress, renin-angiotensin 
aldosterone system and renal function. The effects on renal function include influencing 
proximal sodium resorption and cell permeability. This in turn increases glomerular 
filtration rate via increased renal plasma flow (149).  Amino acids may also influence nitric 
oxide (NO) bioavailability. L-arginine is specifically associated with increasing production of 
NO, which reduces BP through its vasodilatory effects (149, 150). Soy protein has been 
associated with lower blood pressure; this is believed to be largely due to the presence of 
isoflavones and other beneficial compounds rather than the protein constituents. 
However, it is a good source of arginine, which, as previously detailed, influences NO and 
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BP (151). These relationships have also been highlighted in studies investigating the 
relationship of biomarkers of protein intake and BP. 
Micronutrients 
Calcium, potassium, sodium 
The literature surrounding dietary calcium intakes and cardiovascular disease and stroke 
risk has been inconsistent (152, 153). Wang et al (152) reported no significant association 
between dietary calcium intake and incident stroke in prospective studies but report a RR 
of 0.86 (95% CI 0.69-1.06) for pooled results, of 254,876 men and women from 8 studies, 
comparing the highest vs lowest dietary calcium intakes. The studies included participants 
from US, Finland and Japan with ages between 34-99 years (152). More recently Larsson et 
al (153) reviewed the relationship between dietary calcium intake and stroke risk 
specifically and noted a potential for dietary calcium to be inversely associated with stroke 
risk in populations with low calcium intake.  
There is also emerging evidence of a potential influence of the Ca:Mg ratio on overall 
mortality including specifically stroke risk (154). It has been suggested that the Ca:Mg ratio 
may also influence the effects of the two nutrients individually on stroke risk. This may be 
due to the way in which these nutrients antagonise each other, and the close routes of 
absorption they share. For example, recent work has highlighted that TRPM7, a magnesium 
ion transporter also has an affinity for calcium (155) although the majority of magnesium 
is absorbed in the small intestine and thus only small amounts via TRMP7 channel (156). 
These two ions may also compete for absorption in the intestine, with research suggesting 
a higher calcium intake reduces the absorption magnesium (157). Therefore the ratio of 
intake may be important.  
Dietary potassium intake has been inversely associated with stroke risk in a meta-analysis 
of over 240,000 men and women (including 7,066 incident strokes) (158). A higher 
potassium intake of 1064 mg/d was associated with a 21% decrease in stroke risk (P≤0.001). 
The UK dietary reference value (DRV) for adults (over 18 years) is 3,500 mg/d. This 
reduction in stroke risk may in part be due to the effects of dietary potassium intake on 
blood pressure (159) a key risk factor for stroke.  
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The mechanism of increased dietary salt adversely influencing blood pressure is linked to 
restrictions in the kidney’s ability to handle high dietary salt intakes, as humans have 
adapted evolutionary to be able to consume and excrete only <1g salt/d which is far less 
than the average consumption in the Western world (160).  
Magnesium 
Two recent meta-analyses have investigated the effects of dietary magnesium on stroke 
risk and a third on CVD risk (161-163). Both meta-analyses found a significant inverse 
association between dietary magnesium and stroke risk (161, 163). However, the study on 
CVD endpoints, rather than stroke specifically, found no significant association with diet 
but a significant inverse association with circulating magnesium and CVD risk (162). Dietary 
magnesium intake may influence stroke risk via effects on risk factors including blood 
pressure however, results are inconsistent (22, 164-166). In addition, the effect of dietary 
magnesium intake on lipid profile is a currently under-researched area (167-170). There 
has also been a distinct lack of studies conducted in European, and specifically UK 
populations, or those which concurrently assess the associations with risk factors and 
stroke risk in one population of men and women. Furthermore few studies have assessed 
the influence of biomarkers of magnesium, how they relate to dietary intake and stroke 
risk factors. 
Most recently Adebamowo et al (171) investigated the associations of intakes of 
magnesium, potassium and calcium on stroke risk in two Nurses’ Health Study cohorts. The 
women in cohort I were aged 30-55 years and in cohort II 25-42 years at baseline. Follow-
up was 30 years and 22 years for cohorts I and II respectively, with a total of 3,780 incident 
stroke cases reported. The two cohorts were pooled for analyses. The authors sought to 
investigate the relationship of these nutrients individually and as a combined score with 
stroke risk. After adjusting for a number of relevant confounding factors which included, 
age, calendar year, total energy intake, BMI, parental history of heart disease ≤60 years, 
alcohol intake, physical activity, smoking, HRT use, oral contraceptive, menopausal status, 
aspirin use, multivitamin, hypertension, hypercholesterolemia, DM baseline, and thiazide 
use the RR for total stroke between extreme quintiles of total magnesium was 0.87 (95% 
CI 0.78-0.97) P trend = 0.007. However, this was attenuated with the addition of potassium 
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and calcium intakes to the model; RR 0.93 (95% CI 0.79-1.08) P trend = 0.69 for total stroke 
and total magnesium intake. A stronger association was seen between dietary magnesium 
and total stroke, RR 0.81 (95% CI 0.73-0.90) P trend = 0.001 before adjustment for 
potassium and calcium. After additional adjustment for calcium and potassium the RR of 
extreme quintiles of dietary magnesium intake and total stroke was 0.82 (95% CI 0.69-0.97) 
P trend = 0.08. They also investigated the relationship of a mineral score combining mineral 
intakes of magnesium, potassium and calcium. This was achieved by assigning each quintile 
of each mineral a point, 1 for the lowest quintile through to 5 for the highest quintile, and 
summing the total score. The score ranged between 3 and 15 points. Pooled analysis of the 
two cohorts indicated a significant trend toward lower stroke risk with higher intakes of 
these three minerals P trend = 0.003 across quintiles of the score. A RR of 0.81 (95% CI 0.72-
0.91) was reported between the extreme quintiles after adjustment for the confounding 
variables previously mentioned. 
Research gaps 
It is therefore evident that there are dietary components, including intakes of plant-based 
foods, which need to be further explored in terms of associations with stroke risk and risk 
factors, including blood pressure and lipid profile. Large scale population studies are a 
useful way to assess these potential associations between diet and biomarkers and stroke 
risk and risk factors 
There have been inconsistent findings in relation to blood pressure (22, 164-166) and lipid 
profile, two risk factors for stroke, with dietary magnesium intake (167-170). There is more 
evidence to support an association between dietary total protein intake and blood pressure 
(140, 141) but less in relation to lipid profile (172, 173). In addition the association of 
different types of protein, animal and plant based, is an understudied area, particularly in 
relation to lipid levels. Some work has been conducted investigating the differences in 
association of types of protein with blood pressure, but these have not been conducted in 
UK population and the protein sources of the diet differ between countries (123, 124, 141, 
174). 
Chapter One  Introduction 
 
30 
 
For stroke risk recent work suggests an inverse association between stroke risk and dietary 
magnesium intake, and there is less evidence in relation to protein intake (175-177). These 
studies have often not focused on European, and specifically UK populations. In addition 
previous studies have not concurrently assessed the associations of magnesium and 
protein with risk factors and stroke risk in one population of men and women. Few studies 
have sought to assess the influence of biomarkers of magnesium and protein, and how they 
relate to dietary intake and BP in older populations. 
In addition research into the composition and contribution of foods and food sources to 
protein intake in the UK diet is limited and there has been a lack of previous research into 
how different sub-types of protein, plant and animal based, contribute to total protein 
intake and if they differ between men and women (178).  
This thesis aims to address these gaps in the current literature.  
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1.4 Aims and objectives 
The overall aim of this thesis is to elucidate a gap in the current literature around the 
associations between plant-based nutrients and their associations with major modifiable 
stroke risk factors as well as risk of stroke. More specifically two areas were identified that 
are currently understudied, specifically in the UK population. The first was the influence of 
dietary magnesium intake and dietary protein intake on major stroke risk factors, blood 
pressure and lipid profile, and stroke risk. And the second was the use of biomarkers of 
magnesium and protein and their relationship to dietary intakes and blood pressure.  
Hypothesis: increased dietary magnesium intake will be associated with reduced stroke risk 
and lower blood pressure and beneficial lipid profile compared with lowest intakes. With 
regard to proteins, I hypothesised that a higher plant:animal protein ratio would have 
beneficial effects for stroke risk and risk factors. In terms of biomarkers it is hypothesised 
that urinary urea will correlate well with dietary protein intake, and have a similar 
relationship with blood pressure. Serum magnesium may correlate less strongly with 
dietary intake than protein and urinary urea, but may be related to blood pressure.
Research questions this thesis aims to answer are: 
1. What is the relationship between dietary magnesium intake and stroke risk factors, 
blood pressure and serum lipid levels and the risk of stroke in middle and older aged 
men and women? 
2. What are the main contributing sources of dietary protein intake, and how do the 
subtypes of protein (animal, plant and ratio of plant:animal) and food group sources 
of protein differ between men and women? 
3. What are the relationships between dietary protein intake, including that from 
different types (animal and plant) and stroke risk factors, blood pressure and serum 
lipid levels and the risk of stroke in middle and older aged men and women? 
4. How do biomarkers of magnesium and protein intake compare with dietary 
reported intakes in relation to blood pressure in older men and women? 
5. What are the implications of the findings of this thesis for public health nutrition 
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The relationship between dietary intakes of magnesium and protein with stroke risk factors 
and risk of stroke (questions 1 and 3) was determined through statistical analyses of a case-
cohort of 4,443 men and women aged 39-80 years part of EPIC-Norfolk. The results are 
presented in the following chapters; Chapter Three – The influence of dietary magnesium 
intake on stroke risk and risk factors and Chapter Five – The influence of dietary protein 
intake on stroke risk and risk factors.  
The main contributing sources to dietary protein intake and how subtypes of protein and 
food sources differ across intakes and between men and women was determined across 
quintiles of intake using linear regression to assess trends. The results are presented in 
Chapter Four – Dietary protein intake and contribution of food sources. 
The correlations between biomarkers of magnesium and protein intake and dietary intakes 
of these nutrients were assessed to identify which method was most strongly related to 
blood pressure (question 4).  A cohort of 234 older men and women, aged 65-79 years, in 
the New dietary strategies addressing the specific needs of elderly population for an 
healthy ageing in Europe (NU-AGE) study was analysed. The results are presented in 
Chapter Six – Associations between dietary intakes and biomarkers of magnesium and 
protein intake on blood pressure in the NU-AGE study.   
The implications of this thesis in regards to public health (question 5) are primarily 
discussed in Chapter Seven – Discussion. 
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2.0 General overview 
This chapter will begin with a review of cohort studies in nutritional epidemiology before 
going on to outline the study methods of the two cohorts (EPIC-Norfolk and NU-AGE) 
analysed in this thesis. The statistical methods employed for data analysis will also be 
detailed. 
Nutritional epidemiology aims to study and identify relationships and associations between 
dietary intakes and disease (179). A number of study designs can be employed in order to 
assess relationships between diet and disease including case-control, cohort (prospective 
and retrospective), and cross-sectional. Prospective cohort studies in nutritional 
epidemiology initially begin with the recruitment of a healthy population who are then 
followed up for a defined period of time whilst incidence of disease occurrence and dietary 
intake are recorded. In this way, by recording dietary habits and intakes before the onset 
of disease, cohort studies may be free from recall bias or changes that an individual may 
have made to their diet or lifestyle following diagnosis of disease. Repeated measures of 
dietary intakes may also be obtained throughout the study period allowing for changes in 
habits to be recorded. This is not the case for other study design methods, such as case-
control and cross sectional. Large prospective cohort studies are often limited by 
practicalities in obtaining detailed and repeated measures of dietary intake due to their 
large sample size, and long duration of follow-up which are essential in order to contain 
sufficient cases to conduct robust analyses. Financial implications can also affect 
prospective cohort studies for the same aforementioned reasons (179).   
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2.1 Study design EPIC-Norfolk 
The European Prospective Investigation of Cancer-Norfolk (EPIC-Norfolk) is part of cross 
European EPIC study spanning 10 countries (Figure 2.0) and comprising of approximately 
450,000 participants. The initial aim of EPIC, developed in 1989, was to determine potential 
associations between dietary intakes and the risk of developing cancer. Detailed 
information was collected on a number of variables including lifestyle factors, dietary 
habits, anthropometric measurements and biological samples.  
 
 
Figure 2.0 Map of participating centres of European Prospective Investigation into Cancer 
 
The EPIC-Norfolk cohort comprises over 26,000 men and women recruited between 1993 
and 1997. The EPIC-Norfolk arm of the study was co-ordinated in Cambridge. Participants 
were however, resident in the Norfolk area including the city of Norwich and surrounding 
small towns and rural areas. This area was chosen for two reasons; the first being that it is 
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primarily served by one principal hospital. The second reason was that there is little 
migration out of this geographical area which would allow more consistent follow-up of 
participants (Day et al. 1999). A total of 35 General Practices (including 121 General 
Practitioners) in the specified area agreed to be part of the study. The participants who 
were aged between 39-80 years at the start of the study were identified from the registers 
of these participating General Practices (180). Initially 77,630 individuals were invited to 
participate in the study via GP mail-out. Approximately 40%, 30,445, of those invited 
consented to be part of the study. 
Ethical approval for the EPIC-Norfolk arm of the study was obtained from Norwich Local 
Research Ethics Committee before the start of recruitment in 1993.  
Initially the sole aim of EPIC-Norfolk was to elucidate the potential associations between 
dietary habits and the risk of developing cancer. However, EPIC-Norfolk has since been 
expanded and in addition to diet-cancer associations it also investigates a number of other 
endpoints. This included coronary and cardiovascular outcomes, and collection of data on 
a number of non-dietary exposures such as blood pressure, physical activity and smoking 
status.  
The cohort characteristics were compared with the most relevant Health Survey for 
England data (181) which indicated that the cohort was representative of the general UK 
population, with the exception of smoking status. In the EPIC-Norfolk cohort there was a 
lower percentage of current smokers compared with the national average. The mean SBP 
and DBP of the EPIC-Norfolk cohort was also slightly lower than reported in the Health 
Survey for England but other anthropometric measures including height, weight and BMI 
were similar.  
The cohort analysed during the present study (n=4,920) is comprised of a random sample 
of 4,000 men and women aged 39-80 years, representative of the sample of 25,639 men 
and women with data for food diaries from EPIC-Norfolk cohort, and remaining stroke 
cases. The cohort includes 1,102 stroke cases, of which n=920 were not part of random 
sample (n=182 stroke cases were included in the random sample). After exclusion of 
participants whom reported baseline prevalent stroke, or had missing data for one or more 
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variables of interest (n=477), a sample size of 4,443 men and women remained for analysis 
and a total of 982 incident stroke cases were included.  
Anthropometric measures 
During the baseline health check, which took place either at a research clinic or 
participant’s GP surgery, a number of anthropometric measurements were taken by 
trained staff according to standardised protocols (180). This included height to the nearest 
mm, using a free-standing stadiometer. Weight measured to nearest 0.2 kg with 
participants wearing light clothing and no shoes was also recorded. From these 
measurements BMI was calculated. Waist, hip and chest measurements were also recorded 
to the nearest mm (Day et al. 1999).  
Clinical and biological measures 
In addition to the anthropometric measures a series of clinical measures and biological 
samples were also obtained from participants. This included blood pressure, which was 
taken after participants had been seated for 3 mins. Two readings were taken using 
Accutorr Sphygmomanometer (Datascope, UK) with the participants arm in the horizontal 
position in line with the mid sternum (180). A mean of these two values was calculated and 
used in analysis. At the clinic visit, non-fasting venous blood (42ml), and urine samples were 
taken. These were later analysed to determine circulating concentrations of a number of 
compounds including TC and associated fractions. Samples were stored in liquid nitrogen 
at -196 °C for later analysis including of micronutrients such as vitamin C (Day et al. 1999).  
Classification of stroke cases 
Fatal and non-fatal stroke incidence was ascertained using death certificate data and 
linkage with hospital records. Stroke was defined as ICD-9 430-448 or ICD-10 60-69. The 
current study is based on follow-up to 31st March 2008. Numbers of stroke are given in the 
tables, total person years was 42,557 years.  
Lifestyle factors 
Information was also obtained from participants in relation to a number of potential 
lifestyle risk factors via a Health and Lifestyle Questionnaire (HLQ). This included smoking 
status which was categorised as current, former, or never and physical activity which was 
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assessed with the use of a short physical activity questionnaire based on typical activity 
from the previous 12months. Physical activity status took account of work and leisure 
related activities and participants were ranked into one of four categories. These were 
‘Inactive’ representing a sedentary job and no leisure activity, ‘Moderately Inactive’ 
representing either a sedentary job and <0.5 hours of leisure activity/d or standing job but 
no leisure activity, ‘Moderately Active’ a sedentary job and 0.5-1.0 hours of leisure 
activity/d, standing job and <0.5 hours of leisure activity/d, or a physical job and no leisure 
activity, ‘Active’ sedentary job and >1.0 hours of leisure activity/d, standing job and >1.0 
hours of leisure activity/d, physical job with some leisure activity or a heavy manual job. 
Education level was determined from the HLQ and was defined as the highest qualification 
obtained at that time. Participants were ranked into one of four categories depending on 
their highest qualification: ‘degree or equivalent’, ‘A-level or equivalent’, ‘O-level or 
equivalent’, and ‘less than O-level or equivalent’.  
Previous medical history 
The presence of a number of existing underlying medical conditions was ascertained 
through HLQ. Conditions of interest included; stroke, cancer, myocardial infarction and 
diabetes amongst others at baseline. In conjunction with this, participants were requested 
to detail any medication that they were taking. Medications of particular relevance to this 
thesis include use of aspirin, antihypertensives and statins. 
Dietary assessment method 
The dietary habits of participants in the EPIC-Norfolk cohort were measured in multiple 
ways: 24hr recall, semi-quantitative food frequency questionnaire (FFQ) and 7 day diet 
diary (7DD).  
24hr recall 
All potential participants were sent a 24 hour recall to complete, to report all that had been 
consumed, food and drinks, over the previous 24h period, and example of what was 
expected was provided.  
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Semi-quantitative FFQ 
Prior to the first health check participants completed a semi-quantitative FFQ. The FFQ, 
which largely followed a standard format, was comprised of 130 food items. Some 
amendments to the FFQ were made to improve precision of information recorded, 
including measuring milk intake to the nearest ¼ pint, and questions regarding the type of 
fat used during different cooking methods. Frequency of intake was reported by ticking one 
of nine categories, this ranged from no consumption to ≥6/d. If there were ≥10 missing 
responses for food items the FFQ participants were excluded from analysis as the FFQ was 
considered incomplete. In the case of multiple choices per food item or omission of 
selection of frequency this data was also excluded from analysis (Bingham 2001). This was 
the standard method of dietary assessment across all EPIC cohorts, although the format of 
the FFQs differed between cohorts.  
7 day diet diary (7DD) 
In addition to the first 24hr recall and semi-quantitative FFQ, in EPIC-Norfolk, during the 
first health check an interviewer conducted a second 24 hour dietary recall. During this 
appointment the interviewer also explained the format of the 7DD and provided 
instructions to the participant on how to complete the remainder of the diary. The 24h 
recall, a copy of which was retained by the interviewer, then formed the first day of the 
participant’s 7DD which was the chosen method for EPIC-Norfolk. The 7DD was chosen 
after validation studies indicated the diet diaries provide a more accurate representation 
of dietary intakes, over FFQs (182-184). For example FFQs were reported to overestimate 
dietary intakes of a number of food groups including fruit and vegetables, milk and cheese. 
Whilst dietary components such as total energy and a number of micronutrients including 
potassium, carotene and vitamin C were also more accurately represented by the 7DD 
compared with either FFQ or 24h recall (180, 183, 185). In addition dietary protein intake 
recorded from 7DD was more highly correlated with 24hr urinary nitrogen than from the 
FFQ and 24hr recall. A Correlation of 0.65 between 24hr urinary nitrogen and dietary 
nitrogen intake was reported for all participants, a sample of 156 women from EPIC-
Norfolk, whereas for the FFQ and 24hr recall the correlations were 0.24 and 0.10 
respectively (183). 
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Participants were requested to record all food and drink items consumed within the 7 day 
period in a 45-page full colour food record diary. Included in each food diary were colour 
photographs of 17 foods, each with three incremental portion sizes, small, medium and 
large, an example of one set of portion size photographs is shown in Fig 2.1 on the following 
page. Participants were requested to indicate which photograph best represented their 
portion size for each of the items. In addition participants recorded the weight of food 
items or used household measures to describe the portion size. Participants were also 
requested to provide a description of the food eaten, including the preparation methods 
involved, and where appropriate the recipe for the item, type of fat used, and the brand 
names of products. This was requested for all meals, snacks and drinks consumed during 
the 7 day period, an example of a page from the EPIC-Norfolk food diary is shown in Fig 2.2 
on the following page. Instructions on how to record this information was provided in the 
front of the booklet for participants’ reference.  
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Figure 2.1 Series of colour photographs showing guide to different portion sizes of 
breakfast cereals in the EPIC-Norfolk 7DD. 
 
Figure 2.2 Example of one page from EPIC-Norfolk 7DD.  
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A specific program, DINER (Data Into Nutrients for Epidemiological Research), was 
developed for entry of dietary information from the 7DD (186). DINER allows the detailed 
information provided in the diet diaries to be translated into structured data files for 
nutritional analysis. The program is more flexible than other software available on the 
market and enables the detail of the diary, including cooking method, type of fat used and 
commercial brand names of products, to be retained (187). Due to the classification 
structure used to code food items, DINER is also able to adapt to changes in food items 
available on the consumer market (186). The input of items from the food diaries requires 
a high level of detail, this in itself greatly reduces the risk of bias between coders influencing 
the data, and analysis of consistency has echoed this (186). 
Development of protein variables 
In my thesis I aimed to determine if the source of protein, whether plant or animal based 
influenced stroke risk and risk factors. In order to investigate the relationships between 
dietary sources of protein intake and stroke risk and risk factors in the cohort additional 
information was required. This involved determining the types of protein of ~11,000 food 
items in the existing EPIC-Norfolk food database. Another PhD student and I categorised 
food items into one or more of the following four types of protein: animal-land, animal-
marine, animal-derived and plant.  
Animal-land was defined as meat and meat products from land based animals including 
beef, pork and poultry. Animal-marine was defined as protein from water dwelling animals 
including fish and seafood. The category: animal-derived, is comprised of animal products 
and includes dairy products, eggs, and animal fat used during cooking. The plant category 
is comprised of anything that is of plant origin including grains, fruit and vegetables. An 
additional category ‘unclassified’ was also created this includes items where the protein 
content was minimal and thus were deemed to not contribute highly to daily protein 
intake. Food items included in this category include those such as honey, jellies and gravies 
made up with water, artificial sweeteners and yeast. 
Food items could be assigned to more than one category, for example in the case of mixed 
dishes such as breaded fish in a white sauce. This item would be assigned to the ‘animal-
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marine’ ‘plant’ and ‘animal-derived’ categories. In the instance where description was 
lacking for example, “cod in sauce non-descript”, assumptions were made based on 
standard recipes from McCance and Widdowson  (188). In this instance it was assumed that 
for ”sauce non-descript” the base would be a white sauce made with semi-skimmed milk 
and therefore contain components that were animal derived.  
This information was then utilised by the nutritionists at EPIC-Norfolk to create a set a 
variables relating to different types of protein. A total of 21 groups were created which 
included plant, animal land, animal marine, animal derived, unclassified and a number of 
groups for individual food items or clusters of products. The groups of food items or clusters 
of products were not differentiated by the type of protein and therefore included a mixture 
of different protein sources. For example one grouping was ‘Pasta in tom sauce, rice dishes, 
fish in oil, coated fishes, sandwich filling with vegetable and fish’ which therefore includes 
a mixture of at least plant and marine protein. In order to decide which type of protein to 
assign each grouping to a series of calculations were made using standard recipes in 
McCance and Widdowson (189) to identify the component contributing most highly to 
protein intake and the group was assigned to this type of protein. For example in the 
grouping ‘Pasta in tom sauce, rice dishes, fish in oil, coated fishes, sandwich filling with 
vegetable and fish’ it was deemed that marine components would provide a higher amount 
of protein than the plant based items included in the group and thus this grouping was 
assigned to animal-marine. Variables shown later in the thesis represent protein in grams/d 
as a continuous variable.  
For statistical analysis the 21 groups were combined together to form 5 groups. The 
combined groups were as follows; plant, animal-land, animal-marine, animal-derived and 
unclassified. It should be noted that the unclassified category was not included in any 
analysis. The contents of these groups are detailed in Table 2.0. 
Protein intakes were then expressed as a percentage of total energy intake. Variables of 
protein intake as a percentage of total energy were created by multiplying the protein 
intake in g/d by 4 (the number of kcal in one gram of protein), divided by total energy intake 
and multiplying by 100: 
(protein*4/total energy)*100 
The ratio of plant:animal protein intake as a percentage of total energy was calculated by 
dividing plant protein intake as a percentage of energy by animal protein intake as a 
percentage of energy. 
Chapter Two  Subjects and Methods 
 
45 
 
Table 2.0 Contents of five protein groups. 
Protein group Content 
Plant Fruits, vegetables, grains, concentrated squashes 
Coffee beverages with soya, sweetened tea, sugared drinks, 
sweetened made up squash, beer/shandy, liqueur, gravy with veg 
juices 
 
Animal-land Beef, pork, chicken, turkey, game etc. 
Gravies with meat juices 
Gravies with meat & vegetable juices  
 egg dishes with meat/ham, meat in milk/cheese sauce, soups with 
meat and milk/cheese, sandwich fillings with meat and mayo/cheese 
Heinz sandwich filler non-specific and  sandwich filling non-specific 
Rice dishes, pasta dishes in tom sauce, veg dishes, coated chicken, 
kebab, meat/offal dishes, sandwich fillings 
Pasta dishes, savoury pies, pizzas, egg dishes, coated meat products 
and dishes with cheese/milk/cream 
Paella, rice dishes 
 
Animal-marine Fish or seafood 
Fish in milk/cheese sauce, omelette with fish, sandwich fillings with 
fish & mayo 
Pasta in tom sauce, rice dishes, fish in oil, coated fishes, sandwich 
filling with vegetable and fish 
Pasta dishes, pizzas, fish dishes 
Canapés, coated fish with ham & cheese 
 
Animal-derived Butter, lard, milk, eggs, cheese, yogurt, cream 
Pasta dishes, breads/biscuits with milk/cheese/garlic butter, porridge 
made up with milk, shortbread/homemade biscuits, cakes, savoury 
pies/quiches, sweet pastries with cream/milk, custard/milk pudding, 
pancakes, pizzas, Yorkshire pudding, milk beverages, cheesecake, 
mousse, omelettes/soufflés, vegetable/potato dishes, dairy spreads, 
(chocolate) confectionary, soups with veg and dairy, milk based 
sauces, sandwich fillings with veg and egg/cheese, meal replacement 
products 
Sweetened coffees with milk, meal replacement products 
 
Unclassified Water, water based drinks such as tea and coffee, alcoholic beverages 
(with the exception of those containing the addition of sugar, which 
would also be classified under the ‘plant’ category), water used in 
made-up products such as jellies and gravies, artificial sweeteners, 
yeast (including marmite and Bovril), honey, raising agents and stock. 
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2.2 Statistical methods 
All statistical analyses in this thesis were conducted using the statistical package Stata; 
version 11 (StataCorp. College Station Tx. 2009). Continuous variables are presented as 
mean with standard error and categorical variables are presented as number and 
percentage. A two-sided P-value of ≤0.05 was considered statistically significant. The 
independent samples t test was used to assess differences in baseline characteristics 
between men and women. 
Only participants with complete data for all the variables studied were included in each of 
the analyses. Participants with missing values for smoking status were recoded and 
classified as ‘current smoker’ (n=37). Those with missing data on the use of aspirin 
continuously for 3 months or more were recoded and categorised as ‘no’ (n=710). This was 
decided because smoking status is likely to be underreported whereas medication use is 
less likely to produce recall bias. The multivariable models used and justification of 
covariates adjusted for are detailed in section 2.2.1. 
Sex-specific analyses were conducted. This was to account for differences associated with 
a number of variables of interest including BMI, waist-hip-ratio (WHR) and energy 
consumption which may influence blood pressure, lipid profile and stroke risk. Participants 
were stratified by sex-specific quintiles of magnesium (mg/d) or protein intakes as 
percentage of energy (%en) respectively. Participants with the lowest intakes of these 
nutrients were in quintile 1 through to those with the highest dietary intakes in quintile 5. 
Quintiles were chosen as this approach enables greater analysis of observational data than 
with tertiles or quartiles, including the ability to identify U or J shaped relationships where 
present. Additionally for the association between dietary magnesium and stroke risk 
hazard ratio (HR), sex-stratified groups of data-derived categories of dietary magnesium 
intake were created. The first group contained those with the lowest 10% of dietary intakes 
and the subsequent 3 groups contained a third of the rest of the population with increasing 
magnesium intake. The lowest 10% of dietary intakes of magnesium, Group 1, was used as 
the reference category. This approach was used as it was hypothesised that those with the 
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very lowest intakes of dietary magnesium would be at the greatest risk of stroke compared 
with higher intakes. 
Multiple regression analysis with multivariable adjustment was employed to assess 
differences in SBP, DBP, and TC, LDL, HDL, and TG levels with sex specific quintiles of dietary 
intakes of magnesium and protein (including different types of protein). Analyses were 
adjusted for relevant confounding variables, which are detailed in the following section. 
Confounding variables are those factors which influence both the independent and 
dependent variables and if not accounted for may lead to bias in the relationships studied 
(dietary intakes with stroke risk and risk factors). Adjusting for these factors can reduce the 
influence of confounding and provide a more accurate representation of the actual 
relationship being studied; dietary intake with stroke risk and risk factors.  A modified 
Prentice weighted cox proportional hazards model with multivariable adjustment was used 
to estimate HR and 95% confidence intervals (CIs) for the potential associations between 
dietary magnesium and protein intakes and stroke risk in men and women separately. 
2.2.1 Justification of covariates – blood pressure analyses 
Confounding variables included in the statistical models were identified through review of 
current literature on factors shown to be associated with both the independent and 
dependent variables. 
Multivariable model 1 
In analyses of dietary magnesium and total protein intakes in relation to blood pressure 
covariates incorporated in the statistical models included in model 1 were: age, due to the 
significant increases in the incidence of hypertension with advancing age (190). Since every 
5 kg/m2 increase in BMI is associated with 5 mmHg and 4 mmHg increase in SBP and DBP 
respectively (191), BMI was included per 1 unit increment. Also included was smoking, as 
long term smoking has been linked to increased risk of developing hypertension, most 
specifically in individuals smoking ≥15 cigarettes/d (98, 99). 
Conversely being routinely physical active has been related to a decrease in BP with a 
number of studies illustrating this (192-194). Physical activity level was categorised as one 
of the following; inactive, moderately inactive, moderately active or active. A higher 
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educational attainment has been associated with more healthful dietary and lifestyle 
habits, therefore this was included in the model (195). Education level was ranked into one 
of four categories depending on their highest qualification: ‘degree or equivalent’, ‘A-level 
or equivalent’, ‘O-level or equivalent’, and ‘less than O-level or equivalent’. The use of 
antihypertensive medication was also included as a covariate, a binary variable (yes or no).  
Multivariable model 2 
In this model further adjustment was made for previous incident MI or DM at baseline, 
family history of stroke or MI. Individuals with diabetes, specifically those with type II 
diabetes, are more likely to have high blood pressure than the non-diabetic population 
(196-198). A family history of stroke or MI was also included. A family history of stroke 
specifically has been estimated to increase stroke risk by approximately 30% (199, 200). 
Dietary factors were also added, including total energy intake in order to demonstrate the 
effect of magnesium intake independent of total caloric intake as a continuous variable. It 
is important to adjust for total energy intake for a number of reasons. This includes that 
total energy intake is, often positively, associated with dietary intake of individual nutrients 
and may also be directly related to disease outcome on the causal pathway (37). 
Additionally where total energy is perhaps associated with disease but not necessarily on 
the causal pathway, not adjusting for total energy may attenuate associations between 
other nutrients and disease outcome (37). Alcohol intake, as a continuous variable, was 
adjusted for, as daily consumption above approximately 3 units is associated with increases 
in SBP and DBP. Dietary potassium intake was included due to its inverse association with 
BP in a dose dependent manner and dietary sodium is positively correlated with BP and 
prevalence of hypertension, so was also used in the model (159, 201). The use of calcium 
and magnesium supplements and the ratio of calcium to magnesium intake was included, 
these two ions antagonise each other and may also compete during intestinal absorption. 
The Ca:Mg ratio, calculated by dividing dietary calcium and magnesium intakes, may also 
influence stroke risk (154). The use of magnesium supplements was included as a covariate 
in analyses rather than combined with dietary intake as the independent variable. The 
reasons for this include differences in the formulation of magnesium supplements that 
participants may have been taking, the bioavailability of these different formulations is 
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inconsistent. In addition evidence from the NDNS (202) indicates that the inclusion of use 
of dietary supplement data does not substantially change the mean magnesium intake as 
a percentage of RNI or the percentage of people with magnesium intakes below the LRNI. 
Therefore magnesium supplement use was adjusted for in analyses. In analyses for protein 
source, the sources of protein to be analysed were incorporated in the multivariable model. 
2.2.2 Justification of covariates for lipid profile analyses 
Multivariable model 1 
Covariates incorporated in model 1 include age, as both LDL and TC increase with age (203-
206). BMI was also included in model 1 because positive associations between BMI and LDL 
and TC, and inverse associations with HDL have been reported (Schroder et al. 2003). 
Smoking status was also included in the model as LDL and TC levels tend to be higher in 
smokers than non-smokers. Whilst the opposite is true for HDL levels (207). Conversely 
physical activity may have a beneficial impact on lipid levels, with increases in HDL and 
reduced levels of LDL cholesterol reported (12, 208). Education level was included in the 
model as there is evidence to suggest that higher educational attainment is associated with 
an overall more health conscious lifestyle and dietary habits (195, 209). Baseline reported 
MI or DM, as typically type II diabetes is associated with an abnormal lipid profile (210). 
Family history of stroke or MI was also adjusted for, justification of which is as detailed 
previously. Finally the use of statin medication was included in this model.  
Multivariable model 2 
Model 2 additionally adjusted for dietary factors including total energy, alcohol intake, total 
fat intake, the ratio of dietary Ca:Mg intake and the use of calcium and magnesium 
supplements. Diets high in saturated fats negatively influence the protective effects of HDL 
cholesterol. Whilst diets lower in saturated fat and higher in MUFA and PUFA reduce LDL 
concentrations but do not affect HDL levels therefore increasing the HDL:LDL ratio (12). 
Moderate alcohol consumption, 1-2 drinks/d, positively influences HDL levels, however, 
heavy alcohol intake is associated with overall increase risk of CVD mortality (12). 
Additionally for analyses by type of protein, the sources of protein not being analysed were 
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included in the multivariable model, for example plant protein analyses were adjusted for 
animal protein intake and vice versa. 
2.2.3 Justification of covariates for stroke risk hazard ratio analyses 
Stroke risk, model 1 comprised of age, BMI, smoking, physical activity, educational 
attainment and alcohol intake. Model 2 additionally adjusted for serum total cholesterol, 
baseline reported MI or diabetes and family history of stroke or MI. Model 3 included the 
addition of SBP and DBP, use of aspirin medication >3 months, use of antihypertensive 
medication, the ratio of dietary Ca:Mg and the use of calcium and magnesium supplements. 
For protein source specific analyses, the other sources of protein were also included in the 
model as a covariate. 
Prentice weighted cox regression analysis was used to calculate hazard ratios and 95% CIs 
for the risk of incident stroke in association with dietary magnesium intake. Analyses were 
conducted by sex stratified quintiles of dietary magnesium intake with lowest intake (Q1 
<242 mg/d and <204 mg/d for men and women) as the reference category. Additionally 
due to the appearance of higher risk in the lowest intakes further analyses were conducted 
stratified by the bottom 10% of intakes (<214 mg/d and <180 mg/d for men and women) 
and subsequent 30% groups of magnesium intake. This approach was taken based on the 
hypothesis that the highest risk of incident stroke would be in those with the very lowest 
dietary magnesium intakes. In this instance the lowest intakes (<214 mg/d and <180 mg/d 
for men and women) were used as the reference categories. 
The multivariable models described in the preceding section and used in Chapter Three – 
Dietary magnesium stroke risk and risk factors and Chapter Five – Dietary protein stroke 
risk and risk factors, are summarised in the following tables (Tables 2.1, 2.2 and 2.3). 
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Table 2.1. Multivariable models magnesium or protein and blood pressure 
Model 1 age, BMI, smoking status, physical activity, education level and use of 
antihypertensive medication. 
Model 2 model 1 + baseline reported MI or DM, family history stroke or MI, 
dietary total energy, alcohol, potassium, sodium intakes, ratio of dietary 
Ca:Mg intake, calcium supplement use (including contribution from 
medication), magnesium supplement use (including contribution from 
medication) protein source* 
*in analyses of type of protein sources of protein not being analysed were included in 
multivariable model 
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Table 2.2.  Multivariable models magnesium or protein and lipid profile 
Model 1 age, BMI, smoking status, physical activity, education level, baseline 
prevalent MI or DM, family history of stroke or MI and statin 
medication used. 
Model 2 model 1 + dietary total energy, alcohol, fat, ratio of dietary Ca:Mg 
intake, calcium supplement use (including contribution from 
medication), magnesium supplement use (including contribution from 
medication) protein source* 
*in analyses of type of protein sources of protein not being analysed were included in 
multivariable model 
 
Table 2.3.  Multivariable models magnesium or protein and stroke risk 
Model 1 age, BMI, smoking status, physical activity, education level and alcohol 
intake 
Model 2 model 1 + serum cholesterol levels, baseline prevalent MI or DM. 
Family history of stroke or MI.  
Model 3 Model 2 + SBP and DBP, use of aspirin medication, use of 
antihypertensive medication, dietary total energy, ratio of dietary 
Ca:Mg intake, calcium supplement use (including contribution from 
medication), magnesium supplement use (including contribution from 
medication), protein source* 
*in analyses of type of protein sources of protein not being analysed were included in 
multivariable model  
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2.2 NU-AGE New dietary strategies for healthy ageing 
The overall aim of the NU-AGE project, a cross European collaboration, is to improve the 
quality of life and health of the ageing European population and to elucidate the role of the 
whole diet in the process of ageing (211). There are several objectives of the NU-AGE study 
including the development of a food pyramid specifically for the ageing population, aged 
65 years and older. The overall design of the NU-AGE study was as a randomised controlled 
trial to assess the influence of a whole diet intervention on healthy ageing. However, as 
this analysis is cross-sectional based on baseline data only, the methods detailed relating 
to the NU-AGE study will only be those relevant to the analysis in this thesis. More detailed 
information on the NU-AGE study can be found in the published study design (211).  
Analyses on data from the NU-AGE study aimed to compare the relationship between 
dietary intakes and biomarkers of magnesium and protein intake with blood pressure in 
older men and women. The NU-AGE study was chosen for several reasons including that 
the study participants had a smaller age range, of older participants a population where 
this relationship has previously been understudied. For urinary markers, in this instance 
urinary urea, this may have importance as renal function decreases with ageing. The NU-
AGE study enabled analysis of the associations between dietary intake and biomarkers of 
magnesium and protein in an exclusively older population, who are at greater risk of stroke 
than younger individuals. 
Ethical considerations 
NU-AGE received ethical approval from the local ethics committee, Norwich, and the 
Research and Development department of NNUH. All research was conducted in 
accordance with the Declaration of Helsinki and following Good Clinical Practice guidelines. 
The study is also registered on clinicaltrials.gov, NCT01754012. 
Participant Recruitment 
A total of 272 men and women aged between 65-79 years at baseline were recruited to the 
Norfolk arm of the study, and were randomised into either the control or intervention arm. 
Participants were resident in Norwich and the surrounding towns. Recruitment was via a 
number of methods including advertisements, flyers and posters targeted towards elderly 
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communities. Volunteer recruitment was also conducted via local GP practices utilising 
patient databases to target postal recruitment packs to relevant potential participants.  
Potential participants initially expressed interest by telephone or email and were sent an 
information sheet and response slip. In the case of recruitment via GP mail-outs 
participants’ interest in taking part in the study was ascertained by the return of a response 
slip. After this participants were invited to attend an initial meeting to further discuss the 
study and its eligibility criteria. The aim of this visit was to provide more information about 
the study in general and allow the opportunity to ask any questions.  Participants were 
given at least 48 hours to consider their involvement in the study before attending a 
screening appointment.  
Participant Screening  
At the initial screening appointment those interested, and eligible participants, gave 
informed consent and signed a medical declaration form as well as completing admission 
questionnaires, to ensure the inclusion criteria detailed below were met, completed by a 
member of the study team.  
Both men and women who were independent and free living were invited to be part of the 
study. Additionally participants must not have been suffering from chronic disease for the 
previous 2 years and they also had to be willing to comply with the requirements of the 
dietary intervention of the study.  
Potentially eligible volunteers were excluded from taking part if they were suffering from 
severe heart disease, kidney disease, respiratory insufficiency, liver cirrhosis, or Type 1 
Diabetes Mellitus. Those with significant disease (such as aggressive cancer, or dementia) 
or unstable organ failure (or organ failure necessitating a specific diet) were also excluded 
from the study. If potential participants had taken a course of antibiotics within the 
preceding 2 months or had changed their habitual medication within the past 3 months 
there were ineligible to be part of the study, additionally participants taking anti-
inflammatory medications were also excluded. Participants were not allowed to be taking 
part in a another study at the same time which involved changes to the habitual diet, or 
which required blood sampling that in combination with the current study would exceed 
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the maximum allowed volume of 500 mL within a 4 month period. Those with malnutrition, 
defined as a BMI <18.5 kg/m2 or those who reported weight loss of more than 10% of body 
weight within the past 6 months were also ineligible. If participants were diagnosed as frail 
during screening, using the criteria detailed by Fried et al (212) which takes into account 
measurements of walking speed, grip strength and physical activity levels, they were not 
eligible to take part in the trial. Those unable to provide informed consent were also 
excluded from taking part. During the screening appointment participants were requested 
to sign consent forms. The screening visit included two questionnaires which assessed both 
lifestyle habits such as alcohol intake, medication history and medical history to ensure 
eligibility for the study. Several anthropometric and physical performance measures were 
also taken including height and weight, to calculate BMI, grip strength and speed of gait.    
If participants were eligible to take part in the study, the interviewer would provide 
instructions on the completion of 7DD, 7 day activity monitor, 24h urine collection and 
faecal collection (in a sub-sample of consenting participants only). These are described in 
more detail below.  
Dietary intervention 
The overall design of the NU-AGE study was as a long term whole-diet intervention. 
However, as this thesis is related to the cross-sectional analysis of baseline data only the 
intervention will not be described in length.  Briefly the intervention was 12 months in 
length. Participants who were randomised to the control group were requested to maintain 
the normal habitual diet for the duration of the trial, they were additionally provided with 
an information leaflet about healthy eating in general from the British Dietetic Association 
(2011). Participants who were randomised to the intervention arm were requested to 
consume a diet which complied with the NU-AGE Food Based Dietary Guidelines. 
Participants received individualised dietary advice according to their 7DD in order to assist 
them in achieving the dietary goals. This support was ongoing throughout the study period. 
Participants on the intervention diet were also provided with vitamin D supplement as it 
was deemed to be extremely difficult to achieve the recommended levels through dietary 
intake alone. Participants were provided with several products to aid compliance with the 
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intervention diet, this included whole wheat pasta, olive oil, low sodium cheese and 
margarine spread. 
Dietary intake 
Dietary intake was recorded using 7 day weighed food diaries which the participant 
completed prior to first study day, and thus before randomisation to one arm of the 
intervention had taken place.  
During the screening appointment, the interviewer went through the food diary with the 
participant and provided instructions on how to complete the diary. Participants were 
requested to record all food and drink consumed over the 7 day period in the booklet 
provided. Participants were given guidance on how to report the portion size of the food 
items recorded. This was asked to be done by weighing the item in its raw or cooked form 
(and stating which). Where this was not possible they were asked to use household 
measures, such as cups, spoons and jugs or other approximates such as half a packet. 
Information on the time and location of the eating occasion were also requested. There 
was a section at the end of each day in which a participant was able to include details of 
recipes for home cooked dishes. The food diary was completed within 2 weeks of the date 
of the study day, the majority of food diaries were carried out in the week preceding the 
study day.  
After the 7DD was completed a member of the study team conducted a ‘home-visit’ to the 
participant. During the visit any queries on the food diary were made, such as omissions of 
information such as brand names of margarine/butter spreads. Measurements of the 
typical household items used to denote portion size in the food diaries were made. For 
example, measuring the amount of liquid held in mug used for hot drinks, and glasses for 
other drinks, in order to improve the accuracy of dietary coding. Participants were also 
requested to keep packaging of food items finished during the food diary period to aid with 
data entry of the diaries. Food diaries were entered in Tinuviel WISP software. 
Physical activity 
Physical activity levels for the purpose of this analysis were measured using ActiGraph 
accelerometer. The Actigraph device (Figure 2.3) was worn for 7 consecutive days (the 
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same 7 day period as the food diary was completed). Participants were instructed, by a 
member of the study team, on how to wear the ActiGraph device and provided with an 
information sheet and activity monitor log. For continuity all participants were requested 
to wear the ActiGraph on their left hip.  
Participants were informed to wear their ActiGraph device at all times except from when 
washing or swimming and overnight. Participants were requested to record these 
occasions using the provided activity monitor log, noting the time taken off and replaced 
and reason for removing e.g. Swimming, sleep. 
 
Figure 2.3 ActiGraph accelerometer device. 
Study Day 
Participants generally attended for their first study day 2 weeks after their screening 
appointment. This time frame allowed for relevant documents to be sent to the 
participants GP, and the completion of the 7DD and physical activity monitor using 
accelerometry (carried out during the same 7 day period). Participants also began their 
24hr urine collection on the proceeding day up to and including the first urine on the 
morning of their study day. On the morning of the study day participants arrived at the 
clinical trials unit having fasted for 8 hours. Participants were advised to drink plenty of 
water. The structure of the study visit is illustrated in Figure 2.4. 
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Figure 2.4 Procedures carried out on the study day  
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Anthropometric Measures 
At the start of the study day a member of the study team carried out some anthropometric 
measures. The participant’s weight was measured and along with their height, previously 
recorded at the screening visit, were used to calculate BMI. Waist and hip circumference 
were also measured following standard protocol. 
Blood pressure 
Participants attended the CRTU at the University of East Anglia for the study day. Blood 
pressure measurements were taken by a trained member of staff according to standard 
protocol with the participant rested, for 5 minutes, and seated in the upright position. The 
measurement was carried out a total of three times, with 1 minute interval between each 
reading. The mean of each of these three readings was calculated and used in analyses. 
Blood samples 
A qualified nurse, following standard procedure withdrew a total of either 100 mL or 123 
mL of whole blood (additional 23 mL taken from participants volunteered for further 
characterisation of immune function). A maximum of 33 mL of whole blood was further 
processed for serum, and plasma, samples. Samples were stored at -80 °C until baseline 
recruitment was completed. Samples were then sent to the laboratory at the NNUH for 
analysis of serum magnesium. Where there was insufficient sample to conduct analysis 
data for this variable is missing. Serum magnesium was analysed using Abbott Architect 
analysers and reagents (213). The analysis is based on magnesium acting as a cofactor in 
reaction with isocitrate dehydrogenase (Fig 2.5). Magnesium concentration is determined 
by detecting changes in absorbance at 340nm, where an increase in absorbance is as a 
result of the formation of NADPH. Magnesium concentration is directly proportional to 
NADPH (213). 
Figure 2.5 Equation of determining magnesium concentration of serum sample.  
  
Iscocitrate dehydrogenase 
D-isocitric acid + NADP  2-oxoglutarate + CO2  
Mg2+ 
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Urine 
All participants were requested to complete a 24 hour urine collection, following standard 
procedure, in the proceeding 24 hour period prior to the study day. Briefly this involved 
discarding the first urine of the ‘first’ day and collecting all subsequent urine that day and 
the first urine of the following day. Participants were given opaque containers in which to 
store the urine, these containers contained 2.7 ml of 1% concentration sodium azide as a 
preservative solution, containing 16.2 mg nitrogen. Participants were instructed to store 
the containers in a cool environment, but were not specified to refrigerate them.  
On receipt of the urine samples at the CRTU, the container was weighed. If multiple 
containers were returned the contents were combined in a bucket, reserved specifically for 
this use, to ensure urine was thoroughly mixed and the bucket was weighed. The urine was 
then aliquoted, and stored at -80 °C for future analysis. A 20 ml sample of urine was 
aliquoted and sent to the laboratory at the Norfolk and Norwich University Hospital (NNUH) 
for the analysis on the same day, including urinary urea using Abbott Architect analysers 
and reagents. The analysis is based on the hydrolysis of urea to ammonia and carbon 
dioxide by urease. Ammonia and α-ketoglutarate are then converted to glutamate and 
water, a reaction catalysed by glutamate dehydrogenase during which NADH is also 
oxidised. These are two moles of NADH per mole of urea. Urea concentration is determined 
by detecting changes in absorbance of NADH at 340nm, decrease in NADH is proportional 
to urea concentration (213). 
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To obtain values for urinary urea nitrogen and total urea nitrogen, a series of steps outlined 
below were conducted: 
1. laboratory values of total urinary urea mmol/L were converted to total urinary urea 
g/d using the formula: 
((urea mmol/L * volume of 24hr urine collection) / 1000) * 60 
2.  urinary urea nitrogen content was calculated by multiplying urinary urea g/d by 
0.46 as the molecular weight of nitrogen within urea is 28.013 comprising 46% of 
the molecular weight of urea: 
urinary urea * 0.46 
3. Total urinary nitrogen was calculated by dividing urinary urea nitrogen by 0.84 
(214): 
urinary urea nitrogen / 0.84 
4. Protein intake was estimated by multiplying total urinary nitrogen by 6.25 (215): 
total urinary nitrogen * 6.25 
Education level 
Number of years in education was used as a measure of education level, with the 
assumption that those undertaking further years in education would be obtaining higher 
qualifications. Years in education was ascertained through the question “How many years 
did you go to school for (starting from primary school)?” in the General Questionnaire 
completed at baseline. 
Smoking status 
Smoking status was manually coded into one of three categories; current smoker, former 
smoker, never smoked. Smoking status was ascertained from the following questions: 
“Have you ever smoked regularly, i.e. almost every day for at least one year?”, “If yes, for 
how many years did you smoke regularly?”, and “Do you smoke regularly, now?” in the 
General Questionnaire completed at baseline 
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Generation of dataset 
The current dataset of 272 men and women was generated by linking data from respective 
questionnaires and biological sample data files by participant ID code. The dataset was 
manually checked for discrepancies and mismatched ID codes. Some variables were 
manually created based on existing data, for example use of antihypertensive medication 
yes/no categories (1=yes, 0=no). 
Statistical methods 
All statistical analyses were conducted using the statistical package Stata; version 11 
(StataCorp. College Station Tx. 2009). Continuous variables are presented as mean with 
standard error and categorical variables are presented as number and percentage. A two-
sided P-value of ≤0.05 was considered statistically significant. The independent samples t 
test was used to assess differences in baseline characteristics between men and women. 
Pearson’s correlation was used to assess correlations between dietary intake and 
biomarker and each measurement independently with blood pressure.  
Regression, with adjustment for confounding variables, detailed below, was used to assess 
the relationship between dietary intake and biomarkers of magnesium and protein intake 
and blood pressure.  
Model 1 included age, BMI, smoking status, moderate physical activity, school years, use 
of antihypertensive medication, total energy intake and dietary sodium intake. Model 2 
(magnesium analysis only) additionally adjusted for dietary potassium intake and calcium 
supplement use.  
In addition sensitivity analysis was conducted excluding those taking antihypertensive 
medication and adjusting for confounding factors (model 1 for protein and model 2 for 
magnesium intake and biomarkers respectively). 
Contribution to the study 
I undertook several roles including in early stages of participants expression of interest and 
screening for the study. This included tasks such as contacting participants whom had 
returned a response slip of expression of interest in the study to invite them to an initial 
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meeting to learn more about the study and to arrange a screening appointment. I was also 
involved in undertaking screenings of some participants. In addition I had some experience 
of sample preparation on study days, preparing biological samples for storage. Contacting 
participants in the control arm of the intervention at 4 and 8 month intervals of the study 
to complete a telephone based follow-up questionnaire. I also had a role in data entry. 
Entering study data, including questionnaires, anthropometric and biological measures into 
the central NU-AGE database following standardised study-wide protocol. Finally I 
generated the dataset used in the analyses presented in Chapter Six – Associations 
between dietary intakes and biomarkers of magnesium and protein intake in the NU-AGE 
study as described in the section above.
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3.0 Introduction 
Magnesium is one of the most abundant cations in the human body. Magnesium has a 
number of important roles, including development and maintenance of skeletal bone, 
regulation of glucose homeostasis, and metabolism of calcium. It is also involved during the 
synthesis of adenosine triphosphate (ATP), and acts as a co-factor for over 300 enzymes 
(216-219). The majority of magnesium is stored in bone and skeletal muscle with serum 
concentrations accounting for <1% of total body magnesium (218). Intestinal absorption of 
dietary magnesium is dependent on the magnesium status of the body rather than the 
amount consumed. Therefore, in individuals with depleted magnesium status intestinal 
absorption is likely to be greater than individuals with saturated magnesium levels (156). 
Extracellular magnesium concentrations are tightly regulated, primarily by the kidneys, 
with intestine and bones also having a role. It is estimated that approximately 25-75% of 
dietary magnesium is absorbed daily, with the remainder excreted in urine and faeces 
(156). 
One of the highest sources of magnesium is nuts, other good sources include seeds, 
unprocessed grains, tofu, pulses and leafy green vegetables due to magnesium being a 
central part of chlorophyll (156, 188, 219) (Table 3.0). It is also believed that approximately 
10% of daily magnesium intake is from drinking water. However, this varies geographically, 
depending on the hardness of water, as magnesium is more abundant in hard water (156, 
220). The dietary magnesium intake in the EPIC-Norfolk cohort does not take account of 
water hardness due to the variability of mineral composition of local water. This may mean 
that the dietary magnesium intakes of this cohort are higher than those reported. 
Magnesium is present in lower levels in meat, dairy products, white flour and rice (219). In 
the UK however, cereals and cereal products are the main contributing sources of dietary 
magnesium in the adult diet. These products account for approximately 27% of dietary 
intakes, 13% of this is from bread alone. Additionally beverages contributed highly to 
magnesium intake in men, approximately 20% (women ~10%). With half of this amount 
coming from beer and lager in men, and a further 4% from coffee, the contribution of 
coffee was the same for men and women (221).    
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Table 3.0.The magnesium content of commonly consumed foods 
Food item Magnesium content 
 (mg/100g) 
Fruit and vegetables  
New potatoes (boiled) 12 
Chickpeas (dried, boiled) 37 
Swiss chard (boiled) 86 
Spinach (raw) 54 
Banana 34 
Dried mixed fruit 29 
Meat and fish and animal products  
Beef mince (extra lean, stewed) 18 
Chicken (roasted, light meat) 26 
Cod (baked or poached) 26 
Salmon (grilled) 25 
Milk (semi-skimmed) 11 
Egg (boiled) 12 
Cereal and cereal products  
Brown rice (cooked) 43 
White easy cook rice (cooked) 11 
All bran cereal 240 
Nuts and seeds  
Almond 270 
Brazil nut 410 
Sesame seeds 370 
Sunflower seeds 390 
Beverages  
Coffee (infusion, average) 8 
Drinking chocolate powder (made up with 
milk) 
21 
Orange juice (unsweetened) 8 
Tea (black, infusion, average) 2 
Alcohol  
Beer (bitter, average) 7 
Cider (dry) 3 
Red wine  11 
White wine (medium) 8 
Adapted from McCance and Widdowson (189) 
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Table 3.0a. Dietary sources of magnesium in UK for men and women combined, ordered 
by percentage contribution to mean intake.  
Food item Percentage contribution  
Cereal and cereal products 27 
 White bread 6 
 Wholemeal bread 4 
 Breakfast cereals 7 
Drinks 17 
 Beer and lager 7 
 Coffee 4 
 Tea 2 
Meat and meat products 12 
Milk and milk products 11 
Potatoes and savoury snacks 10 
Vegetables (excluding potatoes) 8 
Fruit and nuts 7 
Fish and fish dishes 3 
Eggs and egg dishes 1 
Adapted from NDNS (202). 
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The literature review of previous research in this chapter which follows the section on 
mechanisms of action will firstly start with evidence from animal studies, followed by 
epidemiological studies and then research from clinical trials. Each section (animal studies, 
epidemiology and clinical trials) will be divided to first cover the risk factors blood pressure 
and lipid profile and will subsequently review the literature surrounding stroke risk.  
3.0.1 Mechanisms 
Experimental studies suggest that magnesium has a role in the regulation of a number of 
aspects of the vascular system including; endothelial function, vascular inflammation and 
smooth muscle tone (167, 222) which may influence stroke risk via effects on risk factors 
blood pressure and serum lipid levels.  
The primary mechanism of action in the reduction of BP is thought to be due to magnesium 
acting as a natural calcium channel blocker (159) this leads to a  decrease in the intracellular 
calcium concentration which may be linked to the reported decrease in SBP and DBP (223). 
Magnesium deficiency has been associated with a number of adverse vascular properties 
including inflammation, endothelial dysfunction, and poor regulation of calcium. This can 
lead to an influx of calcium ions into vascular smooth muscle cells resulting in vasospasm 
and subsequent constriction (223). Magnesium however, blocks calcium channels by 
competitive inhibition preventing an influx of calcium ions (223). In addition to this it has 
been proposed that vasodilatation is partly mediated by magnesium and magnesium may 
also reduce oxidative stress and decrease platelet coagulation. Increased magnesium 
intakes have also been inversely associated with C-reactive protein concentrations, an 
indicator of inflammation (223, 224).  
The mechanism by which increased magnesium intake improves endothelial function is 
potentially linked to the intracellular increase in ATP, as magnesium is a cofactor for ATP, 
and this in turn enhances glucose metabolism (225). Additionally low dietary magnesium 
intake may encourage Inflammation (226). Inflammation can also lead to changes in lipid 
profile, characterised by increased serum triglyceride and very low density lipoprotein 
(VLDL) and an enhanced susceptibility to oxidation (227). 
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Magnesium’s association with serum lipid levels may be in relation to its role during the 
rate limiting step of cholesterol biosynthesis where HMG-CoA is converted to mevalonate 
by the enzyme HMG-CoA Reductase. Two processes which can deactivate HMG-CoA are 
dependent on magnesium and ATP (228). Magnesium may also have a role in the activity 
of Lecithin—cholesterol acyltransferase, which acts to lower LDL and triglyceride levels, 
whilst increasing HDL concentration (228, 229).   
Magnesium’s role in cardiovascular risk reduction is also thought to be potentially related 
to the development of diabetes. Intracellular abnormalities in magnesium levels can 
increase insulin resistance leading to an increased risk of developing type II diabetes (168). 
It should be noted that it has been previously reported that there is only a weak association 
between dietary and serum magnesium and so the ways in which low magnesium levels 
may increase stroke risk are likely to be different for serum magnesium and dietary 
magnesium (167). 
These mechanisms are summarised in Figure 3.0 and will be further discussed where 
appropriate in individual sections of the following literature review. The evidence 
presented in this narrative literature review was obtained through searches of MEDLINE 
(Ovid) and PubMed. The terms “dietary magnesium” or “magnesium” were combined with 
relevant key words such as “blood pressure”, “systolic blood pressure”, “diastolic blood 
pressure”, “cholesterol”, “LDL”, “HDL”, and “stroke risk”. Titles and abstracts of returned 
search items were reviewed and the full text of relevant articles was obtained. The 
reference lists of full text articles were also reviewed to identify additional relevant 
publications.  
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Figure 3.0 Summary of mechanisms of action of dietary magnesium on stroke risk via 
effects on risk factors blood pressure and lipid levels.  
 
Chapter Three                                                     Dietary magnesium stroke risk and risk factors 
 
71 
 
 
3.0.2 Animal models 
Blood pressure  
In rat models, supplementation with magnesium not only reduced  blood pressure, but also 
exhibited beneficial effects on plasma glucose levels and circulating HDL, LDL and VLDL 
levels (Table 3.1) (230-232). However, earlier work conducted by Overlack et al (232) 
reported that blood pressure was not influenced by magnesium intake following 12 or 20 
weeks of supplementation in normotensive or spontaneously hypertensive rats 
respectively. Despite this, there was a significant increase in plasma and non-significant 
increase in intracellular concentrations of magnesium in rats fed a higher magnesium diet 
(1%) compared with normal diet (0.1%). A low magnesium diet (0.01%) was associated with 
significantly lower plasma and intracellular magnesium compared with normal magnesium 
diet (0.1%) (232). The conflicting results may be attributable to differences in study 
methodology, for example duration, ranging from 6 to 20 weeks, the composition of 
experimental diet, the magnesium status of rats at the onset of the study, and presence of 
other disease states which affect blood pressure including diabetes (230). In this instance 
the studies by Mervaala (231) and Soltani (230) were conducted in rat populations at risk 
of low magnesium levels. The first of these was in rats treated with cyclosporin A, an 
immunosuppressant that is commonly associated with loss of magnesium (231). The study 
by Soltani et al (230) was conducted in diabetic rats, and this population have been 
indicated to be prone to magnesium deficiency (230, 233). Both of these studies reported 
beneficial effects of magnesium on blood pressure, and this effect may have resulted from 
these populations’ increased sensitivity to magnesium that occurs when magnesium status 
is low.
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Table 3.1. Overview of Magnesium and Blood Pressure Studies - Animal Models 
Author Model Treatment and duration Measurements Results 
Soltani 
2007 
(230) 
M Wistar 
Rats 
(induced 
diabetes) 
1. Non diabetic control no treatment, 2. Acute 
diabetic (10 days), 3. Chronic diabetic (8 
weeks), 4. Chronic diabetic  treated with 0.46 
g/24h MgSo4 8 weeks 
 
BP, blood samples: glucose, TG, 
TC, HDL, LDL, VLDL and Mg,  
 
 
Significant lower SBP (P<0.05) and DBP 
(P<0.05) of Mg treated chronic diabetic 
compared with non-diabetic control and 
chronic diabetic model.  
 
Mervaala 
1997 
(231) 
 
Male 
SHRs 
 
 
Low Na, high Na, CsA & low Na, CsA & high Na, 
CsA & low Na & Mg supp, CsA & high Na & Mg 
supp. 
6 weeks 
SBP, CsA conc (whole-blood, 
renal, myocardial, hepatic, 
striated muscle) 
 
CsA & high Na and Mg sup decreased SBP 
by ~20 mmHg vs. CsA & high Na 
 
Overlack  
1987 
(232) 
 
 
 
Male 
wistar 
rats and 
SHRs 
 
 
 
 
Control, low Mg - NC, High Mg - NC, 1% TC, 2% 
TC, low Mg & 1% TC, low Mg % 2% TC, high Mg 
& 1% TC or high Mg & 2% TC. 
High Mg water contained 17.8g Mg Ap-Hcl/litre 
All others distilled water 
4 and 8 weeks 
TC, TG, total protein, albumin, 
serum Mg, aorta samples-itimal 
and media thickness 
 
 
 
 
No significant association in 
normotensive or hypertensive rats 
 
Abbreviations 
BP, blood pressure; CsA, cyclosporin A; DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; Mg, magnesium; Mg Ap-
HCl, magnesium-aspartate HCl; Na, sodium; SBP, systolic blood pressure; TG, triglycerides; SHRs, spontaneously hypertensive rat species; supp, supplement; 
VLDL, very low density lipoprotein. 
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Lipid Profile 
In some animal models, rats and rabbits, a magnesium deficiency has been associated with 
increased peroxidation of lipoproteins. This can subsequently lead to acceleration of 
atherosclerotic plaque formation, a risk factor for stroke incidence, as well as increased 
blood pressure (Table 3.2) (234, 235).  
Two separate studies (233, 236), have investigated the effects of magnesium 
supplementation in diabetic rats. Soltani et al (233) reported that induction of diabetes led 
to an increase in total cholesterol, LDL, VLDL, HDL and triglyceride concentrations. A 
decrease in plasma magnesium was also reported. They found that supplementation with 
10 g/L magnesium sulphate for 8 weeks resulted in normalisation of levels of total 
cholesterol, LDL, VLDL and triglycerides. Plasma HDL concentrations were significantly 
higher in the magnesium supplementation group compared with the non-diabetic control 
and chronic diabetic control.  
Dou et al (237) fed rats a diet high in fat and glucose (100g lard/kg of diet and 200g 
glucose/kg of diet respectively) which also included 25g cholesterol/kg diet. In addition two 
groups were fed diets with additional magnesium; medium-magnesium diet (0.6 g/kg 
magnesium) and high-magnesium dose (1.2 g/kg magnesium). Compared with the control 
group rats in the medium-magnesium diet had significantly lower total cholesterol levels 
after 5 weeks of diet, but not the high-magnesium diet. HDL levels were significantly higher 
in the high-magnesium diet compared with the control group. There were small non-
significant increases in the triglyceride and LDL levels of rats in both the medium and high-
magnesium diets compared with the control group. These increases were greater in the 
high-magnesium diet. This study also investigated the effects of vitamin E 
supplementation, and when either the medium or high-magnesium diet were combined 
with vitamin E supplementation the triglyceride and LDL levels were higher than vitamin E 
alone (237) thus suggesting that perhaps the magnesium content of the diet was a 
contributing factor in the increases in LDL and triglyceride levels.  
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Two other studies looking at the effects of deficient or low magnesium diets in rats and 
rabbits respectively (234, 238), noted that there were significant increases in total 
cholesterol and triglyceride levels in rats consuming a diet deficient in magnesium (80 
mg/kg) compared with the control diet (960 mg/kg) (238) and rabbits consuming low 
magnesium (35% of normal diet) compared with a normal magnesium diet (0.23% of diet) 
(234). In rabbits that were additionally fed diets with added cholesterol (either 1% or 2%) 
the low magnesium diet was associated with greatly increased presence of atherosclerotic 
lesions and intima thickening, whereas the high magnesium diet appeared to reduce the 
likelihood and extent of occurrence (234). The formation of atherosclerotic plaques and 
associated thickening of the intimal surface are associated with increased risk of stroke. 
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Table 3.2. Overview of Magnesium and Lipid Profile - Animal Models 
Author Model Treatment and duration Measurements Results 
Dou 
2009 
(237) 
 
M/F Wistar 
Rats 
(diabetic) 
 
 
1 week run in, randomised to 1. Control, 2. Vit E (0.5 
g/kg), 3. Middle-dose Mg (0.6 g/kg), 4. High dose M 
(1.2 g/kg), 5. Vit E & middle-dose Mg, 6. Vit E & high 
dose Mg and high fat high glucose diet. 4 weeks 
 
Fasting blood glucose, 
weight, MDA, serum lipid 
levels. 
 
 
NS difference in MDA on Mg alone diets. 
TC sig different in mid dose Mg but other lipid 
levels NS. 
HDL sig in high dose Mg but other lipid levels 
NS. 
Mid and high dose Mg sig reduced blood 
viscosity. 
Soltani 
2007 
(230) 
 
 
M Wistar 
Rats 
(induced 
diabetes) 
 
 
1. Non diabetic control no treatment, 2. Acute 
diabetic 
(10 days), 3. Chronic diabetic (8 weeks), 4. Chronic 
diabetic  treated with 0.46 g/24h MgSo4 
8 weeks 
 
BP, blood samples: glucose, 
TG, TC, HDL, LDL, VLDL and 
Mg,  
 
 
Induced diabetes lead to increased plasma 
glucose, TG, TC, HDL, LDL, and VLDL. 
Mg supp returned TC, TG, LDL and VDL levels 
to baseline 
 
Laurant 
1999 
(238) 
M Wistar 
Rats 
 
Mg deficient 80 mg/kg. Control 960 mg/kg. 
19 weeks 
SBP, blood samples: Ca, Mg, 
TG TC. Diameter carotid 
artery. 
 
Sig increase in TC and TG after 19 wks P<0.005.  
 
Altura 
1990 
(234) 
Male, New 
Zealand 
rabbits 
 
Control, low Mg - NC, High Mg - NC, 1% TC, 2% TC, low 
Mg & 1% TC, low Mg % 2% TC, high Mg & 1% TC or high 
Mg & 2% TC. 
High Mg water contained 17.8g Mg Ap-Hcl/litre 
All others distilled water 
4 and 8 weeks 
TC, TG, total protein, 
albumin, serum Mg, aorta 
samples-itimal and media 
thickness 
 
Low Mg – NC; 35% increase serum TC, 20% 
increase TG (4 weeks) vs control. 
High Mg – NC; 24% decrease serum TC, 33% 
decrease TG 
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Abbreviations 
BP, blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; MDA, malondialdehyde; Mg, magnesium; Mg Ap-Hcl, magnesium-aspartate 
HCl; Na, sodium; NC, normal chow; SBP, systolic blood pressure; TG, triglycerides; SHRs, spontaneously hypertensive rat species; supp, supplement; Vit E, 
vitamin E; VLDL, very low density lipoprotein. 
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Stroke Risk 
Few studies have been conducted looking specifically at magnesium intake and stroke risk 
in animal models. However, one study investigated the effects of magnesium on the infarct 
size of stroke (239). They identified that in magnesium deficient rats, fed a diet with 0.015% 
magnesium for 5-6 weeks, the infarct size was up to 45% larger at 24 hours compared with 
the normal (0.08%) and high (0.32%) magnesium diets.  Other studies which have 
investigated the effects of extracellular magnesium availability indicated that acute or long-
term deficiency may lead to greater endothelial damage and thus an increased 
susceptibility to stroke (Table 3.3). Touyz et al (240) investigated the effects of low 
magnesium on hypertension in stroke prone spontaneously hypertensive rat species 
(SPSHRs). They identified that although initially a low magnesium diet, <0.1% magnesium, 
led to a decrease in SBP, after 5 weeks of the diet SBP rose significantly. Circulating 
magnesium levels are tightly controlled, and this may suggest that short term diets low or 
deficient in magnesium may be compensated by internal regulation, but this cannot be 
maintained and thus at this point there is a sharp rise in SBP. The authors also noted signs 
of endothelial dysfunction with increased media thickness and ratio of media:lumen in the 
rats fed a low magnesium diet. Additionally an increased susceptibility to oxidative stress 
was also identified in the rats after consuming a low magnesium diet. This can lead to the 
initiation of inflammatory response. The inflammatory response is characterised by 
increased synthesis of vascular cell adhesion molecule, enhanced susceptibility to oxidative 
stress and subsequent changes to vascular structure including an increase in media:lumen 
ratio (240, 241). Magnesium deficiency was also shown to impair acetylcholine mediated 
vasodilation and increase intracellular calcium concentration resulting in vasoconstriction. 
Many of these factors have been associated with increased risk of stroke, and their 
combined effects may be associated with increased risk of stroke incidence (240, 241). 
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Table 3.3.Overview of magnesium, stroke risk and risk factors in animal models 
Author Model Treatment and duration Measurements Results 
Demougeot  
2004 
(239) 
 
Male Wistar 
Rats 
 
 
Low (0.015%) normal (0.08%) or high (0.32%) 
magnesium diet 
5-6 weeks 
Induced infarction using; photothrombosis 
 
SBP, Infarct volume, plasma total Mg, 
Ca and K, plasma antioxidant activity at 
4hr and 24hr post photothrombosis 
Mg deficient rats 45% higher infarct 
volume at 24hr 
 
Touyz  
2002 
(240) 
 
Male 
SPSHRs 
 
Low (<0.1% Mg2+) control (0.21% Mg2+)  or 
high (0.75% Mg2+) MO diet 
16 weeks 
Serum Mg2+ TBARS, small artery 
samples, SBP 
 
 
Low Mg diet: decrease plasma Mg and 
rapid increased SBP after 6 weeks 
diet. 
High Mg diet; Decreased SBP, 
oxidative stress and improved vascular 
structure 
 
Malpuech-
Brugere 
2000 
(242) 
Male wistar 
rats 
 
 
 
Mg deficient or control diet 32 or 950 g/kg 
MO respectively (4 or 8 days) 
 
 
WBC, Plasma Mg and Zn, TNFα, IL-6, 
 
 
  
Decrease in plasma Mg 0.14±0.02 vs 
0.81±0.01 (p <0.01) 
Increase circulating leukocytes; 
primarily neutrophils,  IL-6, and 
plasma fibrinogen  
 
Mervaala 
1997 
(231) 
 
 
Male SHRs 
 
 
 
Low Na, high Na, CsA & low Na, CsA & high 
Na, CsA & low Na & Mg supp, CsA & high Na 
& Mg supp. 
6 weeks 
 
SBP, CsA conc (whole-blood, renal, 
myocardial, hepatic, striated muscle) 
 
 
CsA & high Na and Mg sup decreased 
SBP by ~20 mmHg vs. CsA & high Na 
 
 
Chapter Three                                                                                                                 Dietary magnesium stroke risk and risk factors 
 
79 
 
 
 
Altura 
1990 
(234) 
 
 
Male, New 
Zealand 
rabbits 
Control, low Mg - NC, High Mg - NC, 1% TC, 
2% TC, low Mg & 1% TC, low Mg % 2% TC, 
high Mg & 1% TC or high Mg & 2% TC. 
 
High Mg water contained 17.8g Mg Ap-
Hcl/litre 
All others distilled water 
4 and 8 weeks 
 
TC, TG, total protein, albumin, serum 
Mg, aorta samples-itimal and media 
thickness 
Low Mg – NC; 35% increase serum TC, 
20% increase TG (4 weeks) vs control. 
High Mg – NC; 24% decrease serum 
TC, 33% decrease TG 
Overlack 
1987 
(232) 
 
Male wistar 
rats and 
SHRs 
 
 
Low 0.01%, normal 0.1% or high 1% Mg diet 
(Mg Asp-Hcl) 20 wks (SHRs) or 12 wks (wistar) 
Nifedipine 300-1000 ppm added wks 9-12 (2 
wks each dose) 
 
SBP (weekly), plasma and intracellular; 
Na, K, Mg, (wks 8 and 12) 
 
 
Wistar; ns diff in SBP w/ low or high 
Mg intake 
SHRs; ns diff in SBP w/ low or high Mg 
intake 
 
Abbreviations 
Ca, calcium; K, potassium; Mg, magnesium; Mg Ap-Hcl, magnesium-aspartate HCl; Na, sodium; NC, normal chow; SBP, systolic blood pressure; TBARS, 
thiobarbituric acid reactive substances; TG, triglycerides; SHRs, spontaneously hypertensive rat species; supp, supplement; Vit E, vitamin E; VLDL, very low 
density lipoprotein; WBC, white blood cell; Zn, zinc. 
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3.0.3 Epidemiological studies 
Blood pressure 
A number of prospective studies and several cross-sectional studies have aimed to 
investigate the associations between dietary magnesium and blood pressure or 
hypertension (Table 3.4) with varying findings. A number of different population groups 
have been studied including American and Asian, but little has been conducted in European 
or English populations.  
One of the earliest studies by Joffres et al (165) which investigated the associations 
between total magnesium intake and blood pressure in 615 Japanese men living in Hawaii 
identified a significant inverse association between SBP and DBP and magnesium intake (P 
0.01 and 0.01 respectively). They also reported significant differences in the blood pressure 
of those in the extreme quartiles of total magnesium intake. A difference of -6.4 mmHg 
and -3.1 mmHg for SBP and DBP respectively was seen between those with the highest and 
lowest intakes. Dietary intake was assessed using 24hr recall and adjustment was made for 
age and BMI. In a study of 58,218 women, in the Nurse’s Health Study, aged 34-59 years, a 
potential benefit from increased consumption of magnesium was also reported. Using 
dietary data collected from an FFQ, Witteman et al (166) showed a reduction in relative 
risk (RR 0.77 95%CI: 0.67-0.88) for developing hypertension in women with magnesium 
intakes greater than 300 mg/d compared with intakes less than 200 mg/d, after adjustment 
for age, Quetlet’s score and alcohol intake.  
Two prospective studies by Peacock et al (164) in men and women, and Ascherio et al (22) 
in women only, reported no significant associations between dietary magnesium intake 
and incidence of hypertension. It was however, noted that women who developed 
hypertension over the course of the study had lower serum magnesium levels at baseline 
(164). Both studies utilized FFQ to determine dietary intakes. In a separate study of 30,681 
men aged 40-75 years, Ascherio et al (243) reported a significant increase in risk of 
developing hypertension in men consuming <250 mg/d magnesium compared to those 
consuming >400 mg/d (RR 1.49 95% CI 1.15-1.92) (P trend 0.003). However, after 
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additionally adjusting for potassium and fibre intakes the trend was attenuated and was 
non-significant (P trend 0.66). 
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Table 3.4. Overview of dietary magnesium and cross sectional and prospective epidemiological blood pressure studies 
Author Study Popn- 
Sex, 
Age (y) 
Dietary 
Method 
Endpoints Adjustments Size of Effect 
Song 
2006 
(244) 
 
 
 
Women’s Health 
Study 
(n=28,349) 
 
W, ≥45 
 
 
 
FFQ 
 
 
 
Incident 
hypertension 
 
 
Age, randomized treatment (Vit E and 
aspirin), family history MI<60, physical 
activity, alcohol intake, HRT, 
multivitamin, smoking, total energy 
intake, BMI, DM, high cholesterol, Q5: 
SFA, cholesterol, GL, and Na 
 
RR 0.93 (95% CI0.86-1.02) for 
developing hypertension P trend 0.03 
 
 
Zhao 
2004 
(245) 
 
Northern & Southern 
Chinese INTERMAP 
(n=561/278) 
 
M & W, 
40-59 
 
 
24h 
recall 
 
 
 
N/A 
 
 
 
Age, sex, sample, CVD disease, DM, 
special diet, heavy physical activity, 
nutrient groups: Na & K, electrolytes & 
Mg, electrolytes & phosphorus 
 
Addition of Mg to model reduced 
differences in North/South  SBP 
coefficient by -11.7% and  -28.4% for 
DBP 
 
 
Stamler 
2003 
(246) 
 
US INTERMAP 
(n=2195) 
 
M & W, 
40-59 
 
24h 
recall 
 
 
N/A 
 
 
Ethnicity, history; high BP, heart disease, 
MI, stroke or DM. special diet, age, 
sample, sex, BMI, dietary variables singly 
including: Mg 
Adjusting for BMI and Mg intake 
reduced association between education 
and BP by -12.4% and -11.6% for SBP 
and DBP respectively 
 
Peacock 
1999 
(164) 
 
ARIC Study (n=7731 
(3541/4190))  
 
 
M & W, 
45-64 
 
 
FFQ 
 
 
 
Incident 
hypertension 
 
 
Age, sex, race, ARIC centre, BMI, WHR, 
DM, education, family history 
hypertension, leisure activity, HRT, 
Mean dietary Mg lower in with 
hypertension vs without (239±3.1 mg/d 
vs 246±1.5 mg/d P=0.006). NS in M. 
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     baseline SBP, total energy, K, Ca, fibre, 
protein, ratio PUFA:SFA/protein/caffeine. 
 
 
NS association between dietary Mg and 
incident hypertension in M/W 
 
Ascherio 
1996 
(22) 
 
 
 
Nurses’ Health Study 
(n=41,541) 
 
 
 
 
W, 38-
63 
 
 
 
 
 
FFQ 
 
 
 
 
 
Incident 
hypertension 
 
 
 
 
Age, BMI, alcohol, WHR, physical activity, 
caffeine intake, menopausal status, HRT 
use, dietary intakes 
 
 
 
 
No significant association between Mg 
intake and incidence of hypertension. 
In normotensive inverse association 
between Mg and BP; w/ average BP 
1.1/1.3 mmHg lower in women w/ 
intakes ≥0.35 g/d compared w/ intake 
≤0.2 g/d. 
 
Ascherio  
1992 
(243) 
Health Professionals 
Follow-Up 
(n=30,681) 
 
M,40-
75 
 
 
 
FFQ 
 
 
 
Incident 
hypertension 
 
 
Energy adjusted, age, weight, alcohol, 
and additional fibre and K 
 
 
RR 1.49 for intakes <0.250 g/d 
compared with intakes ≥0.400 g/d (P 
trend 0.003) after adjustment for fibre 
and K became non-significant. 
 
Witteman  
1989 
(166) 
Nurses’ Health Study 
(n=58,218) 
 
 
W, 34-
59 
 
 
 
FFQ 
 
 
 
Incident sr 
hypertension 
 
 
Energy adjusted, age,  
 
 
 
RR 0.77 (95% CI, 0.67-0.88) for intakes 
about 300 mg/d compared with intakes 
<200 mg/d 
 
 
Joffres 
1987 
(165) 
Honolulu Heart Study 
(n=615) Japanese 
popn- 
M, 63-
82 
 
 
24h 
recall 
 
 
N/A 
 
 
Age and BMI 
 
 
Total Mg strong inverse associated with 
SBP and DBP (P-value 0.006 and 0.008 
respectively).  
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Abbreviations 
BMI, body mass index; Ca, calcium; DBP, diastolic blood pressure; DM, diabetes; GL; glycaemic load HRT, hormone replacement therapy; K, potassium; Mg, 
magnesium; MI, myocardial infarction; Na, sodium; NS: non-significant; PUFA, polyunsaturated fatty acids; Q5, quintile 5; SBP, systolic blood pressure; SFA, 
saturated fat; sr, self-reported; supp, supplement; Vit E, vitamin E; WHR, waist-to-hip ratio. 
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Lipid Profile 
Total serum cholesterol has been implicated as a major modifiable risk factor for stroke 
(74, 77, 79, 247). Over the years substantial research has been conducted investigating the 
influence of diet on total serum cholesterol level, and more recently on specific lipoproteins 
namely HDL and LDL (Table 3.5) (31, 32, 248-250). However, research has predominately 
focused on the effects of macronutrients with most emphasis on dietary fat intake (25, 138, 
248, 249, 251). Other dietary constituents including those of plant origin have, to date, 
been less thoroughly studied (13, 252, 253).   
A cross-sectional study by Huang et al (254) in 210 Taiwanese elderly patients, aged over 
65 years, with type II diabetes reported that magnesium intake was positively correlated 
with HDL levels (p<0.006). Triglyceride levels were not significantly associated with 
magnesium intake after adjustment for a number of confounding factors including age, sex, 
physical activity, total energy intake and smoking. Despite this there was a non-significant 
inverse trend with increasing magnesium intakes for triglyceride levels. The majority of this 
population (88.6%) had magnesium intakes which were below the reference nutrient 
intake (RNI) which in Taiwan is 360 mg/d for men and 315 mg/d for women (UK RNI values 
are 300 mg/d for men and 270 mg/d for women). They also reported a further 37.1% of the 
population with deficient circulating magnesium levels (<0.75 mmol/L). In the UK the 
normal range for magnesium is 0.7-1.0 mmol/L, mild hypomagnesaemia is between 0.7-0.5 
mmol/L and moderate to severe hypomagnesaemia is <0.5 mmol/L. Therefore the effects 
seen in this population may differ from those of a healthy population free from type II 
diabetes and frequently associated co-morbidities. In a prospective study, of 14,221 men 
and women aged 45-64 years, investigating the associations between dietary and serum 
magnesium and stroke risk Ohira et al (167)  reported a significant inverse association 
between dietary magnesium intake and LDL cholesterol (P<0.001) adjusting for age, sex 
and race. A significant positive association was also shown with HDL and dietary 
magnesium intake (P<0.001) after adjustment for age, sex and race. However, no other 
adjustments were made and other factors such as BMI, smoking status, physical activity 
levels and dietary factors including total energy and total fat intakes amongst others may 
also affect and potentially attenuate the relationship.  
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Table 3.5. Overview of magnesium intake and lipid profile in cross sectional and prospective epidemiological studies 
Author Study Popn- 
Sex, Age 
(y) 
Dietary 
Method 
Adjustments Size of Effect 
Huang 
2012 
(254) 
 
Type II diabetics 
Taiwan 
 
M/W 
 >65 
 
 
 
24h recall 
 
 
Sex, Age, PA, total energy, CHO (% 
energy), protein (% energy), total fat 
(% energy), smoking and alcohol 
intake 
 
Sig increase in HDL across quartile 5.3 mg/dL (P 
trend 0.006) 
NS change in TG levels. 
NS OR low HDL or high TG, but lower OR with 
increasing quartile. 
Larsson 
2008 
(169) 
ATBC 
Finland 
(n=26,556) 
M  
50-69 
 
 
FFQ 
 
 
Energy adjusted Mg, K, Ca, Na 
 
 
NS difference in TC across quintile Mg at 
baseline 
Sig diff in HDL (P<0.01) across quintile Mg at 
baseline 
Ohira  
2009 
(167) 
ARIC 
(n=13,560) 
 
M/W, 
 45-64 
 
FFQ 
 
Age, Sex, Race 
 
Sig difference in LDL (P trend 0.01) and HDL (P 
trend 0.001) across quartile dietary Mg intake.  
Song  
2005 
(168) 
 
Women’s Health 
Study (n=35,601) 
US popn- 
W,  
39-89 
 
 
FFQ 
 
 
Nutrients energy adjusted 
 
 
NS difference in percentage with 
hypercholesterolemia at baseline across quintile 
dietary Mg intake. 
 
Abbreviations 
Ca, calcium; CHO, carbohydrate; K, potassium; HDL, high density lipoprotein; LDL, low density lipoprotein; Mg, magnesium; MI, myocardial infarction; Na, 
sodium; NS: non-significant; PA, physical activity; PUFA, polyunsaturated fatty acids; SBP, systolic blood pressure; SFA, saturated fat; sr, self-reported; supp, 
supplement; TC, total cholesterol; TG, triglyceride. 
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Stroke Risk 
Iso et al (255) and Song et al (168) independently reported no significant association 
between magnesium intake (dietary and/or supplements) and stroke risk after adjustment 
for cardiovascular risk factors including BMI, smoking status and hypertension (Table 3.6). 
These two studies were exclusively comprised of American female health professionals. 
These participants were part of the Nurses’ Health Study and Women’s Health Study 
respectively and therefore were not population-based. They were also relatively healthy, 
reflected by their magnesium intakes. There was a relatively narrow range of magnesium 
intakes between the lowest and highest quintile; median of 211-318 mg magnesium and 
255-433 mg respectively (168, 255). Despite these null findings in association with stroke 
risk, dietary magnesium intake may be linked to a reduced risk of developing hypertension 
and beneficial influences on lipid profile which are significant risk factors for stroke (255).  
A systematic review and meta-analysis conducted by Larsson et al (161) evaluated the data 
from prospective studies, published between  January 1997 and September 2011, on 
dietary magnesium intake and stroke risk. They identified seven prospective studies which 
met their search criteria amounting to 241,378 participants and 6,477 stroke cases in total. 
In summary the findings indicated that a 100 mg increase of magnesium intake per day, the 
equivalent to approximately 40 g serving of all bran breakfast cereal with 125 ml semi 
skimmed milk or 8 Brazil nuts, could lead to a decrease in total stroke risk by 8% and 
ischaemic stroke risk by 9%.  No association was shown between magnesium intake and 
haemorrhagic stroke, although this may be due to relatively small sample size (n=1,015) for 
haemorrhagic stroke (161). It should be noted that only two out of the seven studies were 
conducted on specific European populations.  One study was conducted in a Finnish 
population, which comprised of males who smoked ≥5 cigarettes/d (169). The other study 
conducted in Sweden was comprised exclusively of females, and only presented significant 
associations in those reporting a history of hypertension (256).  
A more recent meta-analysis by Nie et al (163) which also included earlier literature than 
that conducted by Larsson et al (161), examined the period between 1966 and 2011, 
reported similar findings. They identified eight prospective studies, a total of 304,551 
participants, this included one study, by Zhang et al (257) that was not present in the 
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previously mentioned meta-analysis. Zhang et al (2012) also reported a significant 
association between dietary magnesium and cardiovascular mortality in 58,615 Japanese 
men and women 40-79 years. They concluded that higher magnesium intakes (compared 
with lowest intakes) were associated with a reduction in risk of haemorrhagic stroke in 
males, HR 0.59 (0.35-0.99, P trend 0.03) after adjusting for cardiovascular risk factors 
including age, BMI, alcohol intake, educational attainment and menopausal status and use 
of HRT in women among other factors. However, this association was attenuated when 
additionally adjusted for sodium, calcium and potassium intakes. In women, total stroke 
was significantly inversely associated with magnesium intake after additional adjustment 
for dietary sodium HR 0.68 (HR 0.48-0.96, P=0.009). However, with the addition of calcium 
to the model this association was attenuated (P=0.952). Additional adjustment for 
potassium intake, further influenced the association, a significant positive trend was 
reported (P=0.015). Ischaemic stroke was significantly associated with magnesium intakes 
after adjustment for dietary sodium intake only (P<0.001) and was attenuated with the 
addition of dietary calcium and potassium intakes.  
A small meta-analysis, of six prospective studies including 210,776 men and women, by Xu 
et al (258) on the association between dietary magnesium intake and CVD disease 
mortality, also included subgroup analysis on stroke risk. However, the subgroup analysis 
only included 1 study, Leurs et al (259), which was separated into men and women to create 
two studies and therefore the results which suggest no significant association, relative risk 
(RR) 0.85 (95% CI 0.70-1.04), between dietary magnesium intake and stroke risk could not 
be described as conclusive. There was also no significant association reported in association 
with overall CVD mortality across ten study groups. The study included in the stroke risk 
analysis was investigating the associations between water hardness in relation to 
magnesium levels and ischaemic heart disease (IHD) and stroke in a Dutch population of 
4,114 men and women aged 55-69 years (259). For analyses of water hardness, soft water 
(≤1.50 mmol/L calcium carbonate) was used as reference category and compared with two 
other categories of water hardness, medium (1.60-2.00 mmol/L calcium carbonate) and 
hard (>2.00 mmol/L calcium carbonate). They did not report any significant association 
between water hardness and stroke risk in men or women. For men HR 0.90 (95% CI 66-
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1.21) P trend 0.46 and for women HR 0.86 (95% CI 0.61-1.30) P trend 0.37 was reported. 
They also analysed associations between quintiles of magnesium concentration in water 
and stroke risk in men and women, with a range of 1.7-26.2 mg/L. No significant 
associations were reported between the concentration of magnesium in water and stroke 
risk in men or women HR 0.69 (95% CI 0.37-1.31) P trend 0.44 men and HR 0.77 (95% CI 
0.38-1.57) P trend 0.97 women (259).  
Another more recent systematic review and meta-analysis, investigating the associations 
between dietary and circulating magnesium on CVD risk reported no significant association 
between dietary magnesium intake and CVD endpoints. However, a significant inverse 
association was shown between circulating magnesium and CVD risk (162). Their literature 
range was limited to articles in submission up to May 2012. The primary aim was to 
establish if there was an association between dietary or circulating magnesium and CVD, 
IHD and mortality from IHD, rather than stroke specifically. A total of 16 studies met the 
inclusion criteria, 313,041 individuals, and the authors concluded that there was no 
significant association between dietary magnesium intake, measured in 200 g increments, 
and CVD (RR 0.89 95%CI 0.75-1.05) based on 11,995 CVD incidents. In additional analyses 
using generalised least squares with fixed effects model a RR of 0.87 (95% CI 0.80-0.95) was 
reported. However, this fixed-effects method is based on the premise that the effect size 
is constant across the studies included in the analysis. In contrast, the random effects 
model, which illustrated no significant trend, assumes that there are differences between 
the effect sizes of the different studies. Therefore the more cautious findings of the random 
effects model are often more appropriate. 
Most recently Adebamowo et al (171) investigated the associations of intakes of 
magnesium, potassium and calcium on stroke risk in two Nurses’ Health Study cohorts. 
They sought to investigate the relationship of these nutrients individually and as a 
combined score with stroke risk. The women in cohort I were aged 30-55 years and in 
cohort II 25-42 years at baseline. Follow-up was 30 years and 22 years for cohorts I and II 
respectively, with a total of 3,780 incident stroke cases reported.  The two cohorts were 
pooled for analyses. After adjusting for a number of relevant confounding factors which 
included, age, calendar year, total energy intake, BMI, parental history of heart disease ≤60 
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years, alcohol intake, physical activity, smoking, HRT use, oral contraceptive, menopausal 
status, aspirin use, multivitamin, hypertension, hypercholesterolemia, DM baseline, and 
thiazide use the RR for total stroke between extreme quintiles of total magnesium was 0.87 
(95% CI 0.78-0.97) P trend = 0.007. However, this was attenuated with the addition of 
potassium and calcium intakes to the model; RR 0.93 (95% CI 0.79-1.08) P trend = 0.69 for 
total stroke and total magnesium intake. A stronger association was seen between dietary 
magnesium and total stroke, RR 0.81 (95% CI 0.73-0.90) P trend = 0.001 before adjustment 
for potassium and calcium. After additional adjustment for calcium and potassium the RR 
of extreme quintiles of dietary magnesium intake and total stroke was 0.82 (95% CI 0.69-
0.97) P trend = 0.08. They also investigated the relationship of a mineral score combining 
mineral intakes of magnesium, potassium and calcium. This was achieved by assigning each 
quintile of each mineral a point, 1 for the lowest quintile through to 5 for the highest 
quintile, and summing the total score. The score ranged between 3 and 15 points. Pooled 
analysis of the two cohorts indicated a significant trend toward lower stroke risk with 
higher intakes of these three minerals P trend = 0.003 across quintiles of the score. A RR of 
0.81 (95% CI 0.72-0.91) was reported between the extreme quintiles after adjustment for 
the confounding variables previously mentioned.
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Table 3.6. Overview of Magnesium and Stroke Risk Studies in prospective and cross-sectional cohort studies 
Author Study Popn- Sex,  
Age (y) 
Dietary 
Method 
Endpoints Adjustments Size of Effect 
Adebamowo 
2015 
(171) 
Nurse’s Health 
Study I & II 
(n=86,149 & 
94,715) 
W, 
60-85 & 
47-64 
FFQ stroke Age, calendar year, energy, BMI, parental 
history heart disease ≤60 years, alcohol, 
PA, smoking, HRT, oral contraceptive, 
menopausal status, aspirin use, 
multivitamin, hypertension, 
hypercholesterolemia, DM baseline, 
thiazide use, (model 2; dietary potassium 
and calcium) 
 
Attenuated with addition of K and 
Ca to model 
Total stroke dietary magnesium 
Q5 vs. Q1: RR 0.82 (95% CI 0.69-
0.97) P trend = 0.08 
Ischemic stroke: RR 0.91 (95% CI 
0.71-1.15) P trend = 0.71 
Heamorrhagic stroke: RR 0.87 
(95% CI 0.59-1.29) P trend = 0.69 
 
Guasch-Ferré 
2014 
(260) 
 
 
PREDIMED 
(n=7216) 
 
 
 
 
M/W, 55-
80/60-80  
 
 
 
 
FFQ 
 
 
 
 
 
CVD events 
CVD, 
cancer & 
all-cause 
mortality 
 
Stratified by recruitment centre. 
Sex, age, intervention group, BMI, 
smoking status, leisure time PA, 
education, hypertension, DM, 
hypercholesterolemia, family history CHD, 
aspirin use, oral diabetic medication, 
antihypertensive, hypocholesterolemia 
medication, alcohol, (dietary fibre, Ca – 
not included in stroke risk model). 
 
Stroke: RR 1.10 (95% CI 0.70-1.74) 
P trend = 0.64 
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Del Gobbo 
2013 
(162) 
Meta-analysis 
16 prospective 
studies  
(n=313,041) 
 
M/W - CVD - Dietary Mg 200 mg increment not 
associated with CVD risk (RR 0.89 
95% CI 0.75-1.05) 
Circulating Mg 0.2 mmol/L 
increment decrease CVD risk (RR 
0.70 95% CI 0.56-0.88) 
Zhang 2012 
(257) 
 
 
 
 
The Japan 
Collaborative 
Cohort Study 
(n=58,615) 
 
 
 
 
M/W, 40-
79 
 
 
 
 
 
 
FFQ 
 
 
 
 
 
 
Death from 
CVD incl 
stroke, (IS 
and HS), 
CHD and 
heart 
failure 
 
 
Age-adjusted.  
Covariates; BMI, smoking, alcohol, history; 
hypertension, diabetes. Physical activity, 
walking time, education, perceived mental 
stress, menopausal status, HRT. 
Dietary intake; sodium, calcium, 
potassium.  
 
 
Men; HR (lowest vs highest mg 
quintile) 0.49 (0.26-0.95), P trend 
0.074 for HS for sodium (inverse 
non-sig when potassium and 
calcium included) 
Women; HR 0.68 (0.48-0.96) P 
trend 0.010 and 0.47 (0.29-0.77) P 
trend <0.001 for total stroke and 
IS respectively, with sodium 
(weakened when potassium and 
calcium included)   
 
Larsson 
2012 
(161) 
Meta-analysis 
7 prospective 
studies 
(n= 241,378) 
M/W,  
 
- stroke - 100 mg/d Mg associated 8% 
decrease total stroke risk (RR 0.92 
95% CI 0.88-0.97) 
Mg intake inversely associated 
with IS risk (RR 0.91 95% CI 0.87-
0.96) 
 
Larsson 2011 
(256) 
Swedish 
Mammography 
W, 49-83 
 
FFQ 
 
stroke  
 
Age, energy, smoking (incl pack years) 
education, BMI, self-reported 
Mg intake was strongly positively 
correlated with potassium 
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Cohort 
(n=34,670) 
   hypertension, aspirin, familial MI history, 
alcohol, protein, cholesterol, fibre and 
folate.                                                                                              
(r=0.81) No association with 
stroke risk reduction and Mg 
 
Leurs 
2010 
(259) 
 
 
 
Netherlands 
Cohort Study 
(n=4,114) 
 
 
 
 
M/W, 55-
69 
 
 
 
 
 
FFQ 
 
 
 
 
 
stroke, IHD 
 
 
 
 
 
Sex stratified. 
Age, smoking, hypertension, BMI, leisure 
time PA, education, total energy, alcohol, 
energy adjusted SFA/MUFA/PUFA, fruit & 
vegetable (g/d), use of diuretics, 
multivitamin use, Ca supplementation, 
energy adjusted dietary Ca/Mg, volume 
tap water (for Mg analysis tap water Ca 
concentration) 
No significant association water 
hardness and stroke risk HR 0.90 
(95% CI 66-1.21) P trend 0.46 men 
and HR 0.86 (95% CI 0.61-1.30) P 
trend 0.37 women 
No significant association 
concentration of Mg in water and 
stroke risk HR 0.69 (95% CI 0.37-
1.31) P trend 0.44 men and HR 
0.77 (95% CI 0.38-1.57) P trend 
0.97 women. 
 
Larsson 2008 
(169) 
 
ATBC trial Finnish 
Cohort 
(n=26,556) 
 
 
M, 50-69 
 
 
 
FFQ 
 
 
 
First stroke 
 
 
 
Age, energy, supplement group, alcohol, 
smoking, BMI, S/DBP, serum  and HDL 
levels, history diabetes or CHD, PA, folate, 
vitamin C,E, fat, CHO, protein and fibre 
 
RR 0.85 (95% CI 0.76-0.97) P trend 
0.004 increasing Mg 
RR 0.76 (95%CI, 0.64-0.89) for 
men <60 and 1.02 (95% CI 0.84-
1.23) for men ≥60  highest vs 
lowest Mg quintile for cerebral 
infarction 
 
Ohira 2009 
(167) 
 
ARIC 
(n=13,560) 
 
M/W, 45-
64 
 
FFQ 
 
 
stroke 
events  
 
age, sex, race, smoking, BMI, LDL, HDL, 
cholesterol, fibrinogen, von Willebran 
factor, educational, energy, SBP, 
after adjustment rate ratios of 
ischaemic stroke incidence were 
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  antihypertensive medication , diabetes 
status. 
 
non-significantly associated with 
dietary Mg 
 
 
Weng 2008 
(261) 
 
 
CardioVascular 
Disease risk 
FACtor Two-
township Study - 
Taiwan (n=1772) 
 
 
M/W, >40 
 
 
 
 
FFQ 
 
 
 
 
Ischaemic 
stroke 
 
 
 
 
Age, energy, sex, age-sex interaction, 
urea?, alcohol, smoking, sex-smoking 
habit, hypertension, diabetes, 
hypertensive medication, BMI, sr CHD, 
central obesity, PA, hypertriglyceridemia, 
hypercholesterolemia, plasminogen, 
apolipoprotein B and fibrinogen 
Mg was weakly inversely 
associated with risk of IS with a 
borderline significant P-value 
0.059 
 
 
 
Song 2005 
(168) 
 
Women’s Health 
Study (n=35,601) 
US popn- 
 
W, 39-89 
 
 
 
FFQ 
 
 
 
CVD incl 
stroke, 
non-fatal 
MI, fatal 
CVD. 
 
Age, energy, randomised assignments 
(aspirin and vitamin E), smoking, exercise, 
alcohol, HRT, BMI, multivitamin, 
hypertension, high cholesterol, diabetes 
and parental MI <60. 
 
No significant trend between mg 
and total stroke. 
RR Q1-Q5 0.80 for total stroke, 
0.84 for IS and 0.87 for HS. 
 
 
Ascherio 
1998 
(262) 
 
The Health 
Professionals 
Follow-Up Study 
(n=43,738) 
 
M, 40-75 
 
 
 
FFQ  
 
 
 
fatal or 
nonfatal 
stroke 
 
 
Time (2 year intervals), energy, smoking, 
alcohol, history hypertension, 
hypercholesterolemia, parental history MI 
<65, profession, quintiles BMI and PA. 
 
Multivariable + K and fibre RR 
0.92 (95% CI, 0.58-1.46) 
 
 
 
Iso  
1999 
(255) 
 
 
Nurse's Health 
Study (n=85,764) 
 
 
 
W, 34-59 
 
 
 
 
FFQ 
 
 
 
 
fatal or 
nonfatal 
stroke 
 
 
Age, energy, smoking, time interval, 
hypertension, BMI, alcohol, menopausal 
status, HRT, vigorous exercise, aspirin use, 
multivitamin use, vit E, w=3 fatty acid, 
diabetes, high cholesterol. 
Mg strongly positively correlated 
with potassium (r=0.83)      all 
stroke RR 0.80 (95% Ci, 0.63-1.01) 
age and smoking adjusted.      
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Ischaemic stroke 0.84 (95% CI 
0.60-1.19) after adjustment, 1.04 
(95% CI 0.71-1.52) when calcium 
added 
Mg not correlated with 
subarachnoid or intraparenchymal 
haemorrhage after adjustment, 
Abbreviations 
Ca, calcium; CHO, carbohydrate; CHD, coronary heart disease; CVD, cardiovascular; K, potassium; HDL, high density lipoprotein; HRT, hormone replacement 
therapy; HS, haemorrhagic stroke; IHD, ischaemic heart disease; IS, ischaemic stroke; LDL, low density lipoprotein; Mg, magnesium; MI, myocardial infarction; 
MUFA, monounsaturated fatty acids; Na, sodium; NS: non-significant; PA, physical activity; PUFA, polyunsaturated fatty acids; SBP, systolic blood pressure; 
SFA, saturated fat; sr, self-reported; TC, total cholesterol; TG, triglyceride. 
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3.0.4 Supplementation trials  
Blood pressure 
Clinical studies investigating the effect of oral magnesium supplementation indicate a 
potential benefit on BP (Table 3.7). To date the majority of these trials have investigated 
the effects of supplementation rather than increased dietary intakes (263-265). Direct 
comparisons between the studies are difficult due to differences in the source of 
magnesium supplemented and in addition to this the varying concentrations and durations 
of supplementation. This may partially explain the variation in reported findings as Walker 
et al (266) illustrated significant differences in the bioavailability of different magnesium 
supplements. Bioavailability of magnesium is largely dependent on physiological 
requirements and absorption from the gastrointestinal tract, with the primary site of 
absorption being the ileum. Approximately 30-40% of magnesium consumed will be 
absorbed, however this can range from 20-80% in saturated and deficient individuals 
respectively (267-269). The bioavailability of oral supplements has not been extensively 
researched. However, evidence indicates that organic magnesium supplements, including, 
magnesium citrate have a higher bioavailability than inorganic formulations such as 
magnesium oxide whereby bioavailability may be as little as 4% (266, 268). Therefore, 
increased dietary magnesium intakes may produce differing results to those exhibited with 
oral supplementation. RCTs investigating the effects of dietary magnesium intake 
compared with oral supplements and their effect on blood pressure may help to elucidate 
these potential differences.   
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Table 3.7. Overview of human studies investigating the effects of magnesium supplementation on blood pressure 
Author Study Popn- Sex, 
Age (y) 
Design Intervention Blinding Duration Results 
Lee 
2009 
(264) 
Overweight 
Korean (n=141) 
M/W, 
30-60 
 
RCT 
 
300 mg Mg/d (Mg oxide) or placebo 
 
DB 
 
12 weeks 
 
Sig change in SBP from baseline 
to 12 weeks for Mg and placebo 
(P<0.001) and DBP for Mg 
(P=0.006) 
Walker 
2002 
(263) 
Mild 
hypertensives 
(n=36) 
M/W, 
middle 
aged 
Randomis
ed 
Parallel 
 
1. Placebo – cellulose, 2. 600 mg Mg/d 
(Mg aa chelate), 3. 500 mg/d dried 
extract hawthorn leaves and berries, 4. 
Combination of 2&3 
 
DB 
 
 
10 weeks 
 
 
NS difference in SBP or DBP with 
Mg, hawthorn or combination 
supplement. 
Sacks  
1998 
(265) 
 
 
 
 
 
Nurses’ Health 
Study II 
(n=290) 
 
 
 
 
 
 
W, 
mean 
39 
 
 
 
 
 
 
Randomis
ed 
Parallel 
 
 
 
 
 
4 wks placebo, then; 4 mmol/d 
potassium chloride, 1200 mg/d 
calcium carbonate, 336 mg/d Mg 
lactate, combination of these or 
placebo-matching calcium carbonate 
 
 
 
 
DB 
 
 
 
 
 
 
16 weeks 
 
 
 
 
 
 
Average change vs placebo 
Mg  
SBP -0.9 (P=0.29) 
DBP -0.7 (P0.32) 
Combined  
SBP -1.3 (P=0.13) 
DBP-0.9 (P-0.17) 
 
Kawano  
1998 
(270) 
 
Japanese mild-
mod 
hypertensives  
(n=60) 
M/W 
(34/26), 
35-74 
 
Randomis
ed 
crossover 
 
20 mmol/d Mg oxide control period no 
placebo given 
 
 
No 
 
 
 
8 weeks 
 
 
 
Office: 144.9 ±1.7/88.3 ±0.9 
(P0.01/0.05) 
Home: 134.4 ±1.4/85.4 ±0.8 
(P=0.01) 
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ABPM day: 135.2 ±1.3/79.6 ±0.8 
(P=0.01) 
ABPM night: 123.4 ±1.5/73.6 
±0.9 (NS) 
Borrello 
1996 
(271) 
 
 
 
Italian, 
untreated mild 
hypertensives 
(n=83) 
 
 
M/W  
Mg 
group 
51 ±7  
placebo 
49 ±5   
Parallel 
 
 
 
 
 
4 wk placebo, then either placebo 
(n=41) or 200 Mg oxide (n=42) 
 
 
 
 
DB 
 
 
 
 
 
12 weeks 
 
 
 
 
 
 
Supine: 148.5 ±7.1/87.5 6.3 
(P0.01/NS) 
ABPM NS 
 
Sacks  
1995 
(272) 
 
American, 
Untreated 
mild-mod 
hypertensives  
(n=125) 
M/W  
21-70 
 
 
Randomis
ed parallel 
 
 
 
4-6 wk placebo, then; Ca (25 mmol/d) 
and Mg (15 mmol Mg diglycine 
chelate), Ca and K(60 mmol), K and Mg 
or placebo 
 
 
 
DB 
 
 
 
 
6 months 
 
 
 
 
Difference: 
Ca & Mg: -0.6 ±1.9/-0.4 ±2.0 
(NS) 
K & Mg: -3.9 ±1.2/-2.7 
±1.2(P<0.05) 
NS from placebo 
 
Witteman  
1994 
(273) 
Dutch, mild-
mod untreated 
hypertensives  
(n=91) 
 
W, 35-
77 
RCT 2 wk placebo, then either 20 mmol 
Mg/d (magnesium aspartate HCl) or 
placebo 
DB 6 months 143.8 ±14/86.1 ±7.0 
(P=0.18/0.003) 
Cappuccio  
1985 
(274) 
Mild-mod 
untreated 
hypertensives 
(n=17) 
M/W, 
33-66 
 
Randomis
ed 
crossover 
 
15 mmol/d Mg aspartate HCl and then 
placebo 
 
 
DB 
 
 
1 month 
 
 
Supine: 154 ±3.4/98 ±2.2 (NS) 
Standing: 157 ±4.3 105 ±1.9 (NS) 
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Dyckner  
1983 
(275) 
 
 
 
 
Patients on 
long term 
diuretics for 
hypertension 
or congestive 
heart failure 
(n=39) 
M/W  
62.2 
±4.2 SD 
 
 
 
Randomis
ed 
 
 
 
 
 
Continued diuretic treatment and 
potassium supplementation. 
Additionally supplemented 15 mmol/d 
Mg aspartate HCl (n=20) (as 365 mg 
magnesium or 3689 mg Mg aspartate 
HCl/d) or control (n=19) 
 
 
DB 
 
 
 
 
 
6 months 
 
 
 
 
 
Supine: 140 ±15/85 ±7 (P=0.001) 
Standing: 139 ±18/87 ±10 
(P=0.05) 
 
 
 
 
Abbreviations 
ABPM, ambulatory blood pressure monitor; Ca, calcium; DBP, diastolic blood pressure; K, potassium; Mg, magnesium; NS, non-significant; PA, physical 
activity; PUFA, polyunsaturated fatty acids; RCT, randomised control trial; SBP, systolic blood pressure; SFA, saturated fat; sr, self-reported; TC, total 
cholesterol; TG, triglyceride. 
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Lipid Profile 
A number of studies have investigated the effects of oral magnesium supplementation on 
the symptoms of the metabolic syndrome, which includes dyslipidaemia and hypertension, 
in diabetic patients (Table 3.8). The findings have been equivocal with several studies 
reporting no effect of magnesium on serum lipid levels (276, 277). However, others 
illustrated positive associations between magnesium and HDL, LDL, TC and TG levels (233, 
254, 278). This may in part be explained by the variation in oral magnesium supplement 
and also duration of the study with interventions ranging in length from 1 meal to 24 weeks, 
with many of the shorter studies (3 months duration) reporting no significant differences 
in serum lipid levels with magnesium supplementation (229, 276-278). However, even in 
the study by Djurhuss et al (233) where 10 patients with type I diabetes, and 5 controls, 
were given 1000 mg/d magnesium oxide there were differences in the effects on serum 
lipids. A significant decrease in total cholesterol and LDL (P<0.02 and P<0.05 respectively) 
were reported but no significant effect was shown on triglyceride, HDL or ratio of LDL:HDL 
levels (233).   
Fewer studies have involved healthy participants, but in one study where healthy 
participants received high doses of oral magnesium supplements, 411-585 mg/d, an 
increase in circulating HDL was reported. An improvement in TC:HDL was also noted (229). 
Thus indicating that the effects of magnesium supplementation may also be relevant to 
more general populations. Kishimoto et al (279) investigated the effects of magnesium 
supplementation on postprandial lipid profile. Sixteen healthy men, with a mean age of 
41.7 (±2.6) took part in the randomised crossover study. Their findings suggest that 
supplementation with the equivalent of 500 mg magnesium in the form of MgCl2 may lead 
to improvement in postprandial lipid profile compared with a meal without 
supplementation.  
Itoh et al. (1997) conducted a trial in 33 healthy subjects and illustrated a benefit of 
supplementation with high doses of oral magnesium, 411 mg/d for women and 584 mg/d 
for men. The effect was reported for both LDL and HDL levels. Although, this benefit was 
not reported in relation to TC or triglyceride levels. A second small study on 16 healthy 
middle aged men by Kishimoto et al (279) indicated a potential improvement in 
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postprandial lipid levels with magnesium supplementation. Before the start of the study 
the participants underwent a 12 hour fast, after which a venous blood sample was taken. 
Participants were then given a standardised meal of a bread roll and 30 g butter. The 
intervention meal also included 5 ml bittern, which contained 500 mg magnesium in the 
form of MgCl2. Venous blood samples were taken postprandially at 2, 3, 4 and 6 hours. 
Samples were analysed for serum TG, chylomicron TG, non-esterified fatty acids (NEFA), 
remnant-like particle cholesterol and apo-B48. After a one week washout period the 
participants were given the other meal combination. Serum TG was significantly reduced 
compared with the fat only meal at 2 and 3 hours, whilst chylomicron TG was additionally 
significantly reduced at 4 hours. However, at 6 hours, postprandial levels of both serum TG 
and chylomicron TG were non-significantly higher than the fat only meal. Although levels 
did not spike in the same way as was seen with the fat only meal. The authors hypothesised 
that magnesium supplementation, which significantly increased serum magnesium levels 
but not calcium, reduced absorption of fat by binding with fatty acids to form insoluble 
structures (279). Evidence suggests that postprandial elevated lipid levels may have 
atherogenic effects, particularly the presence of TG-remnants, which in high levels may 
decrease HDL concentrations whilst also increasing LDL concentration (279). 
These findings, although inconclusive, suggest this is a relationship which requires further 
investigation to elucidate potential associations. The identification of dietary factors that 
may have favourable associations with lipid profile is of importance because even relatively 
small differences in lipid levels can substantially reduce stroke risk. For example a 1.0 
mmol/l reduction in LDL may reduce stroke risk by approximately 10% in the general 
population (280). 
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Table 3.8. Overview of human intervention studies investigating the effects of magnesium supplementation on lipid profile 
Author 
Study 
Popn- 
Sex, Age 
y 
Design Intervention Blinding Duration Measurements Results 
Kishimoto 
2010 
(279) 
 
Healthy 
n=16 
 
 
M,  
41.7 
(mean) 
 
 
Randomised 
crossover 
 
 
Bread roll and 30 g 
butter, with 5 ml 
bittern (500 mg 
Mg) during 
intervention 
 
- 
 
 
 
1 meal 
 
 
 
 
Fasting blood sample. 
Postprandial blood 
samples 2, 3, 4 & 6h 
after meal. 
Serum TG, NEFA, 
lipoproteins, apoB48,  
serum Mg & Ca 
 
Mg supplementation 
may delay postprandial 
serum and chylomicron 
TG, up to 4h. And RLP-
cholesterol and NEFA at 
2h post meal. 
Farvid 
2004 
(278) 
 
Type II 
diabetic 
n=69 
 
 
M/W 
 30-69 
 
 
 
RCT 
 
 
 
 
1. 200 mg Mg 
oxide & 30 mg Zn 
sulfate, 2. 200 mg 
vit C & 150 mg Vit 
E, 3. Mg, Zn, Vit C 
& Vit E, 4. placebo 
DB 
 
 
 
3 months 
 
 
 
 
Fasted blood for: 
ascorbic acid serum α-
tocopherol, Zn, Mg, TC, 
TG, HDL, LDL, apo AI & 
B. 
spot urine: Mg, Zn, 
creatinine 
24h recall, 
 
NS difference in serum 
lipid levels with Mg and 
Zn supp. 
Ns difference in serum or 
urine Mg with supp. 
 
Djurhuus 
2001 
(233) 
 
Type I 
diabetic 
n=14 
 
 
M/W  
25-53 
 
 
 
Case control 
 
 
 
IV 30 mmol MgSO4 
in 500 ml 0.9% 
NaCl over 12h 
No 
 
 
 
24 weeks 
 
 
 
 
blood sample for: 
serum insulin, free 
insulin, HbA1c 
 
IV MgSO4 sig decreased 
TC (P <0.001) and TG 
(P<0.005) 
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Then type I 
patients: 1000 
mg/d MgO 
fructosamine, lipid, Mg. 
24h urine for: Mg, K. 
muscle biopsy muscle 
Mg, dietary intake (7d) 
24 wks supp sig 
decreased TC P<0.02), 
LDL (P<0.05) NS TG, HDL, 
LDL/HDL ratio. 
De Valk  
1998 
(277) 
Type II 
diabetic 
n=50 
 
 
M/W  
mean 
age intv 
63 
 
 
Placebo 
controlled 
 
 
15 mmol/d Mg 
aspartate HCl or 
placebo 
 
 
DB 
 
 
 
3 months 
 
 
 
 
Fasted blood sample 
before and after supp; 
plasma Mg(+ 
erythrocyte), Ca, 
glucose, TC, HDL, TG, 
creatinine, HbA1c. 24h  
urine for: Mg, Ca, 
creatinine.  
NS difference in TC, HDL 
or TG levels between 
supp and control 
 
 
Itoh 
1997 
(229) 
 
 
 
 
Healthy 
Japanese 
n=33 
 
 
 
 
 
M/W 
mean 
age intv 
64  
 
 
 
 
 
 
Placebo 
controlled 
 
 
 
 
 
 
548 mg/d Mg(OH)2 
M, or 411 mg 
Mg/d W 
 
 
 
 
 
 
DB 
 
 
 
 
 
 
 
1 wk run 
in 
4 weeks 
 
 
 
 
 
 
 
Dietary intake (food 
samples), BP, heart 
rate, weight, fasted 
blood samples: serum 
TC, HDL, TG, apo – AI, 
AII, B, CII, CIII, and E 
lecithin-cholesterol 
acyltransferase, total 
protein, glucose and 
insulin. Plasma renin 
activity. 24h urine: Na, 
K, Ca, Mg, creatinine, 
aldosterone, 
NS change in TC, HDL, 
LDL or TG with Mg sup in 
M or W. 
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noradrenaline, and 
adrenaline. 
Eibl 
1995 
(276) 
 
 
 
Diabetic 
with hypo-
magnesem
ia 
n=68 
 
 
M/W 
mean 
age intv 
63 
 
 
 
 
RCT 
 
 
 
 
 
30 mmol/d Mg 
citrate or placebo 
 
 
 
 
DB 
 
 
 
 
 
4 wks run 
in 
3 months 
 
 
 
Baseline and end: oral 
glucose tolerance, 
dietary questionnaire. 
Monthly: fasting blood 
for; plasma Mg, blood 
glucose, lipids, HbA1c. 
24h Urine for Mg, 
plasma insulin,  
 
NS change in lipid profile 
with Mg. 
Plasma Mg lower in 
diabetic patients than 
controls at baseline. No 
change at 2 mo. Increase 
at 3 mo. Return to 
baseline 6mo after study  
Abbreviations 
ABPM, ambulatory blood pressure monitor; Ca, calcium; DBP, diastolic blood pressure; HDL, high density lipoprotein; IV, intravenous; K, potassium; LDL, low 
density lipoprotein; Mg, magnesium; NEFA, non-esterified fatty acid; NS, non-significant; PA, physical activity; PUFA, polyunsaturated fatty acids; RCT, 
randomised control trial; RLP-cholesterol, remnant like particle cholesterol; SBP, systolic blood pressure; SFA, saturated fat; sr, self-reported; TC, total 
cholesterol; TG, triglyceride; Vit C, vitamin C; Vit E, vitamin E; Zn, zinc. 
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In summary many of the previously undertaken studies have been conducted in single sex 
populations. Therefore direct sex comparisons within the same population group are 
limited. Many studies were also recruited solely from specific populations with certain 
synonymous characteristics such as occupation, or social class, as opposed to the general 
population. For associations with serum lipid levels, previous studies have often comprised 
of a particular at risk group such as diabetics and therefore are not necessarily 
representative of the effects in the general healthy population. In addition only a handful 
of studies have been conducted on European populations to date (169, 256) and, to the 
best of my knowledge no other study has simultaneously investigated the associations of 
dietary magnesium intake blood pressure, serum lipid levels and stroke risk in one single 
population of men and women. EPIC-Norfolk is a mixed sex cohort that is representative of 
the general UK population. It also utilises data from 7DDs which may provide a more 
accurate representation of dietary intake compared with other commonly used dietary 
assessment methods (167-169, 255, 256, 261, 262). 
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3.1 Aims and hypotheses 
This chapter aims to address research question 1, outlined in the introductory Chapter, 
Chapter One. 
 
“What is the relationship between dietary magnesium intake and stroke risk factors, blood 
pressure and serum lipid levels and the risk of stroke in middle and older aged men and 
women?” 
 
They hypothesis was that higher intakes of dietary magnesium intake would be associated 
with lower blood pressure, more favourable lipid profile and overall lower risk of stroke. 
The relationship between dietary magnesium intakes with blood pressure, lipid profile and 
stroke risk are understudied, particular with reference to the UK general population. In 
addition the proposed study allows for the concurrent analysis of associations between 
dietary magnesium intake with stroke risk factors and risk of stroke in one population of 
men and women. The findings of the present study may be relevant for the development 
of future interventions which where appropriate may inform public health policies aiming 
to reduce the risk of stroke in the UK population. 
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3.2 Methods 
Four thousand four hundred and forty three participants were included in the main 
analyses for blood pressure and stroke risk. Participants were excluded from analyses if 
they reported stroke at baseline or had missing data for any of the variables included in the 
multivariable models (n=477). Additional sub-group analyses were conducted on 4,268 
men and women to assess associations between dietary magnesium intake and serum 
cholesterol. In these analyses participants were excluded if they had missing data for serum 
total cholesterol, triglyceride, HDL or LDL levels (n=175). This sub-group analysis differs 
from that presented in the paper ‘The relationship between dietary magnesium intake, 
stroke and its major risk factors, blood pressure and cholesterol in the EPIC-Norfolk cohort’ 
whereby only associations between dietary magnesium intake and total cholesterol were 
investigated in 4,443 participants (281) . 
Missing data were recoded to the ‘no’ category where there was no response for use of 
aspirin (n=813) and dietary supplements (n=2). However, with regard to smoking status, to 
reduce the risk of bias from under reporting individuals with missing data for cigarette 
smoking were coded as current smokers (n=37).  
Dietary mis-reporting 
Dietary mis-reporting was evaluated by calculating the ratio of reported energy intake, 
determined from 7 day food diary, with expected energy requirement (EER). EER was 
estimated using the equation and physical activity coefficients supplied by Otten et al (282).  
Physical activity coefficients used were 1.00 (both men and women) ‘sedentary’ 
representing typical daily living activities e.g. household chores; 1.11 and 1.12 (men and 
women respectively) ‘low active’ representing typical daily living activities and 30-60 mins 
of daily moderate activity; and 1.25 and 1.27 (men and women respectively) ‘active’ 
representing typical daily living activities and at least 60 mins of moderate activity. The 
coefficient for ‘very active’ representing typical daily living activities, at least 60mins of 
moderate activity and 60 mins of vigorous activity or 120 mins of moderate activity, was 
not used as the majority of the general population do not meet the physical activity 
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requirements of this level. The physical activity categories determined from the HLQ for 
EPIC-Norfolk participants included four classifications. These classifications were given the 
following physical activity coefficients: ‘inactive’ 1.00 (men and women); ‘moderately 
inactive’ and ‘moderately active’ 1.11 and 1.12 (for men and women respectively); ‘active’ 
1.25 and 1.27 (for men and women respectively). 
The following formulae were used to calculate the EER of men and women: 
Men 
EER = 662 - (9.53 * age[y]) + physical activity x ((15.91*weight [kg]) = (539.6 * height [m])) 
Women 
EER = 354 - (6.91 * age [y]) + physical activity x ((9.36*weight [kg]) = (726 * height [m])) 
Analysis 
The main risk factors analysed were blood pressure and serum lipid levels. Hypertension 
(blood pressure of >140/90 mmHg) is the most modifiable risk factor for stroke and is 
reported to have a contributory role in up to 70% of all strokes (41, 283). Abnormal lipid 
levels can negatively affect stroke risk. For example a 0.55 mmol/l increase in serum LDL 
increases stroke risk by ~11% (284). A similar increase in triglyceride levels, 0.55 mmol/l 
may increase stroke risk by 5.5% although it is not clear if accumulative increases in both 
LDL and triglycerides would lead to a further increase in stroke risk (77).  
Multiple regression analysis with multivariable adjustment, for relevant confounding 
variables, was used to identify potential associations between quintiles of dietary 
magnesium intake in relation to blood pressure (SBP and DBP) and lipid profile (TC, LDL, 
HDL and TG). A modified Prentice weighted cox regression analysis was used to determine 
risk of stroke across quintiles of dietary magnesium intake and data-derived groups of 
intake. Quintile 1, lowest dietary intakes, was used as the reference category. For data 
derived categories of intake the Group 1, containing those with the lowest 10% of dietary 
magnesium intakes, was used as the reference category. The three subsequent groups each 
contained a third of the remaining dietary magnesium intakes. All analyses were sex 
stratified.  
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Full study methods and further detail of the covariates included in each model, including 
justification, can be found in Chapter Two – Subjects and methods.  Additionally the 
statistical models used are stated below each table of results.  
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3.3 Results EPIC 
Baseline characteristics 
In the 4,443 participants included in the main analyses 45.0% were male. The mean age 
was 61 and 60 years for men and women respectively (Table 3.9). Mean BP was 140/85 
and 136/82 mmHg for men and women respectively which was significantly different 
(P<0.001 for both SBP and DBP). TC was 6.07 (±1.10) and 6.36 (±1.22) in men and women 
respectively. A significantly higher percentage of men reported taking aspirin continuously 
for 3 months or more 13.6% compared with 8.1% of women (P<0.001), but there was no 
significant difference in the use of antihypertensive medication. There was also no 
significant difference in the percentage of men and women reporting a family history of 
stroke, MI or diabetes. Women were however, more likely than men to have never smoked, 
but also had a slightly higher percentage of current smokers 12.9% than men 11.7%. 
Physical activity levels between men and women were significantly different (P<0.001). 
Similar percentages of men and women reported being inactive 32.2% and 32.8% 
respectively. However, more women than men reported being moderately inactive 32.3% 
compared with 23.8% of men, whilst men were more likely to be active (the highest of four 
categories) 22.0% compared with 13.9% of women. Men were most likely to be educated 
to A-Level or equivalent 44.4% (women 33.7%) whilst women were most likely to have no 
qualifications 44.5% (men (33.4%). 
Dietary intakes were significantly different (P<0.001) between men and women for total 
energy and a number of macronutrients including magnesium, sodium and potassium. 
However, there was no significant difference in the dietary ratio of calcium to magnesium 
intakes of men and women. Alcohol intakes were significantly higher in men than women 
(P<0.001). Women were significantly more likely to take calcium or magnesium 
supplements than men (P<0.001 and P<0.01 respectively). 
Dietary mis-reporting 
Dietary mis-reporting was evaluated by calculating the ratio of reported energy intake, 
determined from 7 day food diary, with EER and assessed across quintiles of dietary 
magnesium intake (data not shown). The mean ratios of energy intake to EER across 
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quintiles of dietary magnesium intake indicated that the majority of men and women 
under-reported dietary intakes as illustrated by ratio less than 1.00. The highest level of 
under-reporting was in quintile 1 for both men and women. The mean ratios of energy 
intake to EER were 0.72 for men and 0.73 for women in quintile 1 of dietary magnesium 
intake. Whereas in quintile 5 (the highest dietary magnesium intake) there were mean 
ratios of 1.02 for both men and women indicating a potential small amount of over-
reporting. The level of mis-reporting was similar between men and women across quintiles 
of magnesium intake. 
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Table 3.9 Baseline characteristics by sex in 4443 men and women, aged 39-80 years in EPIC-
Norfolk cohort (1993-1997) 
 
 
Men 
n=2000 
Women 
n=2443 
P-value1 
Age (years) 61.1 (±9.53) 60.4 (±9.71) 0.02 
BMI (kg/m2) 26.5 (±3.18) 26.2 (±4.24) <0.01 
Family History Stroke (%) 465 (23.3%) 601 (24.6%) 0.29 
Family History MI (%) 720 (36.0%) 934 (38.2%) 0.13 
Family History DM (%) 222 (11.1%) 305 (12.5%) 0.16 
Blood pressure mmHg    
SBP 140 (±18.5) 136 (±19.5) <0.001 
DBP 85.3 (±11.5) 81.8 (±11.4) <0.001 
Pulse pressure 54.2 (±11.2) 54.0 (±11.4) 0.66 
Antihypertensive Use (%) 417 (20.9%) 516 (21.1%) 0.83 
Blood lipids mmol/l    
Total Cholesterol 6.07 (±1.10) 6.36 (±1.22) <0.001 
Aspirin Use (%) 271 (13.6%) 197 (8.06%) <0.001 
Smoking (%)    
Current  234 (11.7%) 314 (12.9%) <0.001 
Former 1114 (55.7%) 774 (31.7%)  
Never 652 (32.6%) 1355 (55.5%)  
Physical activity (%)    
Inactive 644 (32.2%) 800 (32.8%) <0.001 
Moderately Inactive 476 (23.8%) 790 (32.3%)  
Moderately Active 440 (22.0%) 514 (21.0%)  
Active 440 (22.0%) 339 (13.9%)   
Education level (%)    
0 – No Qualifications 667 (33.4%) 1086 (44.5%) <0.001 
1 – O-Level or Equivalent 165 (8.3%) 249 (10.2%)  
2 – A-Level or Equivalent 887 (44.4%) 822 (33.7%)  
3 – Degree or Equivalent 281 (14.1%) 286 (11.7%)  
Dietary factors    
Total Energy (kcal/d) 2218 (±505) 1685 (±384) <0.001 
Magnesium (mg/d) 318 (±92.0)  265 (±73.2) <0.001 
Ca:Mg Ratio 2.93 2.93 0.96 
Potassium (mg/d) 3423 (±819)  2962 (±683) <0.001 
Alcohol (g/d) 15.9 (±20.8) 7.70 (±11.7) <0.001 
Sodium (mg/d) 3150 (±864) 2405 (±660) <0.001 
Calcium Supplement Use (%) 34 (1.70%) 160 (6.55%) <0.001 
Magnesium supplement use (%) 22 (1.10%) 53 (2.17%) <0.01 
1P-value difference between males and females. 
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Values are mean and standard deviations where continuous and number and percentage 
where categorical. 
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Table 3.10 Characteristics of 2000 men aged 39-80 years stratified by quintiles of magnesium intake. Values expressed as mean and standard deviation or 
frequency and percentage 
 Q1 Q2 Q3 Q4 Q5  
 85-242 mg 
206 mg 
n=400 
243-284 mg 
266 mg 
n=400 
285-328 mg 
307 mg 
n=400 
329-385 mg 
355 mg 
n=400 
386-829 
456 mg 
n=400 
P trend 
Age (years) 64.2 (±8.94) 62.3 (±9.17) 61.1 (±9.43) 59.6 (±9.47) 58.1 (±9.46) <0.001 
BMI (kg/m2) 26.8 (±3.34) 26.9 (±3.27) 26.5 (±3.16) 26.3 (±3.08) 26.0 (±2.97 <0.001 
Waist/Hip ratio (cm) 0.95 (±0.06) 0.94 (±0.06) 0.93 (±0.06) 0.92 (±0.06) 0.93 (±0.06) <0.001 
Current smoker (%) 68 (17.0%) 63 (15.6%) 40 (10.0%) 33 (8.25%) 30 (7.50%) <0.001 
Inactive (%) 152 (38.0%) 161 (40.3%) 125 (31.3%) 116 (29.0%) 90 (22.5%) 0.02 
Educated to degree or equivalent (%) 38 (9.50%) 36 (9.00%) 50 (12.5%) 74 (18.5%) 83 (20.8%) 0.01 
Aspirin use >3months (%) 57 (14.3%) 58 (14.5%) 54 (13.5%) 53 (13.3%) 49 (12.3%) 0.33 
Antihypertensive medication use (%) 104 (26.0%) 99 (24.8%) 78 (19.5%) 80 (20.0%) 56 (14.0%) <0.001 
Family history of stroke (%) 97 (24.3%) 90 (22.5%) 90 (22.5%) 101 (25.3%) 87 (21.8%) 0.74 
Dietary intake       
Total energy (kcal/d) 1727 (±376) 2082 (±374) 2269 (±382) 2392 (±392) 2618 (±496) <0.001 
Fruit (g/d) 91.2 (±95.2) 112 (±96.0) 140 (±118) 158 (±119) 213 (±173) <0.001 
Vegetables (g/d) 72.9 (±59.5) 81.3 (±63.2) 89.4 (±62.9) 97.9 (±70.8) 109 (±81.8) <0.001 
Nuts and seeds (g/d) 0.82 (±2.92) 1.70 (±7.35) 2.16 (±5.97) 3.18 (±7.25) 5.28 (±13.10) <0.001 
Legumes (g/d) 26.0 (±26.2) 28.8 (±29.0) 33.0 (±30.1) 34.3 (±32.1) 38.4 (±37.9) <0.001 
Bread and cereals (g/d) 205 (±90.0) 248 (±94.9) 277 (±109) 307 (±108) 350 (±137) <0.001 
Dairy (g/d) 193 (±124) 250 (±139) 297 (±158) 311 (±169) 378 (±198) <0.001 
Meat (g/d) 82.8 (±73.0) 80.9 (±54.3) 97.1 (±69.3) 98.7 (±72.9) 95.3 (±74.7) <0.001 
Alcohol (g/d) 10.6 (±17.1) 13.5 (±19.2) 15.7 (±17.7) 17.9 (±20.7) 21.7 (±26.1) <0.001 
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Potassium (mg) 2496 (±465) 3058 (±361) 3422 (±424) 3731 (±440) 4404 (±766) <0.001 
Ca:Mg ratio 3.23 (±0.94) 3.10 (±0.80) 3.03 (±0.80) 2.78 (±0.69) 2.52 (±0.70) <0.001 
Vitamin C (mg) 57.9 (±32.5) 74.5 (±41.9) 85.8 (±45.3) 91.8 (±44.4) 111.5 (±61.7) <0.001 
Sodium (mg) 2510 (±678) 3000 (±710) 3208 (±778) 3403 (±757) 3631 (±930) <0.001 
Magnesium supplement use (%) 1 (0.25%) 2 (0.50%) 3 (0.75%) 8 (2.00%) 8 (2.00%) <0.01 
Calcium supplement use (%) 5 (1.25%) 4 (1.00%) 5 (1.25%) 12 (3.00%) 8 (2.00%) 0.09 
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Table 3.11 Characteristics of 2443 women aged 39-80 years stratified by quintiles of dietary magnesium intake. Values expressed as mean and standard 
deviation or frequency and percentage 
 Q1 Q2 Q3 Q4 Q5  
 48-204 mg 
176 mg 
n=489 
205-240 mg 
223 mg 
n=489 
241-274 mg 
258 mg 
n=489 
275-319 mg 
295 mg 
n=489 
320-692 mg 
374 mg 
n=488 
P trend 
Age (years) 63.3 (±9.62) 60.7 (±9.59) 59.8 (±9.76) 59.6 (±9.48) 58.6 (±9.49) <0.001 
BMI (kg/m2) 27.0 (±4.59) 26.3 (±4.36) 26.1 (±4.14) 25.9 (±3.91) 25.5 (±4.05) <0.001 
Waist/Hip ratio (cm) 0.81 (±0.07) 0.79 (±0.06) 0.80 (±0.07) 0.79 (±0.06) 0.78 (±0.06) <0.001 
Current smoker (%) 85 (17.4%) 73 (14.9%) 56 (11.5%) 48 (9.82%) 52 (10.7%) 0.001 
Inactive (%) 223 (45.6%) 176 (36.0%) 147 (30.1%) 135 (27.6%) 119 (24.4%) <0.001 
Educated to degree or equivalent (%) 25 (5.11%) 39 (7.98%) 65 (13.3%) 67 (13.7%) 90 (18.4) <0.001 
Aspirin use >3months (%) 48 (9.82%) 33 (6.75%) 43 (8.81%) 37 (7.57%) 36 (7.38%) 0.30 
Antihypertensive medication use (%) 141 (28.8%) 98 (20.0%) 100 (20.5%) 87 (17.8) 90 (18.4%) <0.001 
Family history of stroke (%) 125 (25.6%) 114 (23.3%) 119 (24.4%) 124 (25.4%) 119 (24.4%) 0.96 
Dietary intakes       
Total energy (kcal/d) 1340 (±284) 1571 (±301) 1706 (±305) 1812 (±308) 1999 (±365) <0.001 
Fruit (g/d) 109 (±97.3) 138 (±101) 172 (±118) 194 (±121) 253 (±157) <0.001 
Vegetables (g/d) 69.2 (±51.3) 91.4 (±58.9) 95.0 (±66.5) 107 (±67.9) 117 (±73.2) <0.001 
Nuts and seeds (g/d) 0.52 (±2.43) 1.07 (±3.01) 1.50 (±4.15) 2.73 (±6.15) 4.44 (±9.46) <0.001 
Legumes (g/d) 19.2 (±23.3) 21.2 (±21.0) 23.0 (±23.1) 24.2 (±24.0) 26.6 (±27.5) <0.001 
Bread and cereals (g/d) 154 (±69.8) 188 (±69.5) 213 (±85.3) 226 (±86.9) 264 (±105) <0.001 
Dairy (g/d) 176 (±107) 233 (±130) 263 (±140) 298 (±149) 359 (±191) <0.001 
Meat (g/d) 64.7 (±54.0) 72.2 (±53.9) 76.2 (±59.0) 75.9 (±58.7) 82.8 (±70.0) <0.001 
Alcohol (g/d) 5.09 (±9.70) 6.76 (±10.56) 7.98 (±11.9) 9.14 (±12.7) 9.54 (±12.9) <0.001 
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Potassium (mg) 2171 (±367) 2648 (±310) 2949 (±353) 3254 (±366) 3788 (±591) <0.001 
Ca:Mg ratio (mg) 3.16 (±0.89) 3.08 (±0.80) 2.97 (±0.81) 2.84 (±0.71) 2.60 (±0.72) <0.001 
Vitamin C (mg) 63.2 (±37.0) 78.2 (±40.8) 88.6 (±50.8) 97.7 (±46.2) 118 (±58.9) <0.001 
Vitamin K (mg) 64.9 (±40.5) 80.9 (±50.8) 87.3 (±45.1) 95.4 (±52.5) 107 (±56.8) <0.001 
Sodium (mg) 1932 (±525) 2236 (±506) 2463 (±578) 2552 (±580) 2843 (±714) <0.001 
Magnesium supplement use (%) 1 (0.20%) 10 (2.04%) 14 (2.87%) 11 (2.25%) 17 (3.48%) 0.001 
Calcium supplement use (%) 14 (2.86%) 31 (6.34%) 30 (6.15%) 37 (7.57%) 48 (9.84%) <0.001 
Chapter Three                                                                                                                 Dietary magnesium stroke risk and risk factors 
 
118 
 
Table 3.12 Association of quintiles of dietary magnesium intake (range and mean quintile intake) and blood pressure (means and SE) in 2000 men, aged 40-
75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary Magnesium Intake  
  Q1 Q2 Q3 Q4 Q5  
  85-242 mg 
206 mg 
n=400 
243-284 mg 
266 mg 
n=400 
285-328 mg 
307 mg 
n=400 
329-385 mg 
355 mg 
n=400 
386-829 
456 mg 
n=400 
P trend 
SBP Unadjusted 143 (±0.98) 140 (±0.97) 140 (±0.88) 139 (±0.90) 136 (±0.87) <0.001 
 Model 11 140 (±0.87) 139 (±0.86) 140 (±0.86) 140 (±0.86) 139 (±0.87) 0.64 
 Model 22 143 (±1.16) 140 (±0.90)*3 140 (±0.85)* 138 (±0.89)** 136 (±1.18)*** 0.002 
DBP Unadjusted 86.1 (±0.58) 85.9 (±0.60) 85.4 (±0.57) 85.2 (±0.56) 84.1 (±0.56) 0.008 
 Model 11 85.4 (±0.57) 85.4 (±0.56) 85.3 (±0.56) 85.5 (±0.56) 85.0 (±0.57) 0.68 
 Model 22 87.2 (±0.76) 86.1 (±0.59) 85.1 (±0.55)* 84.9 (±0.58)* 83.4 (±0.77)** 0.01 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, potassium, ratio Ca:Mg, total energy 
and calcium supplement use (including contribution from medication) 
3P value for significance compared with Q1: *= P value ≤0.05, ** = P value ≤0.01, *** = P value ≤0.001 
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Table 3.13 Association of quintiles of dietary magnesium intake (range and mean quintile intake) and blood pressure (means and SE) in 2443 women, aged 
40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary Magnesium Intake 
  Q1 Q2 Q3 Q4 Q5  
  48-204 mg 
176 mg 
n=489 
205-240 mg 
223 mg 
n=489 
241-274 mg 
258 mg 
n=489 
275-319 mg 
295 mg 
n=489 
320-692 mg 
374 mg 
n=488 
P trend 
SBP Unadjusted 140 (±0.90) 135 (±0.85) 137 (±0.93) 135 (±0.89) 133 (±0.81) <0.001 
 Model 11 136 (±0.79) 135 (±0.77) 137 (±0.77) 136 (±0.77) 135 (±0.78) 0.85 
 Model 22 137 (±1.07) 135 (±0.82) 137 (±0.77) 135 (±0.81) 135 (±1.09) 0.45 
DBP Unadjusted 83.5 (±0.51) 81.5 (±0.50) 82.4 (±0.55) 80.9 (±0.53) 80.7 (±0.48) <0.001 
 Model 1 82.0 (±0.49) 81.3 (±0.48) 82.6 (±0.48) 81.4 (±0.48) 81.7 (±0.49) 0.71 
 Model 2 82.5 (±0.67) 81.6 (±0.51) 82.5 (±0.48) 81.1 (±0.51) 81.2 (±0.68) 0.26 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, potassium, ratio Ca:Mg, total energy 
and calcium supplement use (including contribution from medication) 
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Blood Pressure 
In men a significant inverse association was identified between dietary magnesium intake 
and SBP and DBP (P<0.01 and P=0.01 respectively) after full adjustment for confounding 
variables (Table 3.12). A significant difference in extreme quintiles was also seen. This 
difference was 7 mmHg for SBP (P≤0.001) and 3.8 mmHg for DBP (P=0.01). In women no 
significant association was seen with either SBP or DBP after adjustment for relevant 
confounding variables including age, smoking status, physical activity and dietary factors 
such as total energy, sodium, potassium and the ratio of dietary Ca:Mg intakes (Table 3.13). 
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Table 3.14 Association of quintiles of dietary magnesium intake (range and mean quintile intake) and blood lipids (means and SE) in 1888 men, aged 40-75 
years in EPIC-Norfolk cohort (1993-1997). 
  Dietary magnesium intake  
  Q1 Q2 Q3 Q4 Q5  
  85.1-243 mg 
207 mg 
n=378 
244-286 mg 
266 mg 
n=378 
287-329 mg 
308 mg 
n=377 
330-386 mg 
357 mg 
n=378 
387-829 mg 
458 mg 
n=377 
P trend 
Total Cholesterol Unadjusted 6.17 (±0.06) 6.07 (±0.06) 5.96 (±0.06) 6.02 (±0.06) 5.86 (±0.05) <0.001 
 Model 11 6.14 (±0.06) 6.06 (±0.06) 5.97 (±0.06)* 3 6.03 (±0.06) 5.88 (±0.06)** 0.003 
 Model 22 6.14 (±0.07) 6.06 (±0.06) 5.97 (±0.05)* 6.02 (±0.06) 5.89 (±0.07)* 0.04 
Triglycerides Unadjusted 1.89 (±0.05) 2.02 (±0.05) 1.86 (±0.05) 1.85 (±0.04) 1.83 (±0.05) 0.06 
 Model 1 1.85 (±0.05) 1.98 (±0.05)* 1.87 (±0.05) 1.87 (±0.05) 1.88 (±0.05) 0.77 
 Model 2 1.92 (±0.06) 2.00 (±0.05) 1.86 (±0.05) 1.85 (±0.05) 1.82 (±0.06) 0.06 
HDL Unadjusted 1.21 (±0.02) 1.19 (±0.02) 1.21 (±0.02) 1.27 (±0.02) 1.26 (±0.02) <0.001 
 Model 1 1.21 (±0.02) 1.20 (±0.02) 1.21 (±0.02) 1.26 (±0.02)* 1.25 (±0.02) 0.02 
 Model 2 1.23 (±0.02) 1.21 (±0.02) 1.21 (±0.02) 1.26 (±0.02) 1.24 (±0.02) 0.23 
LDL Unadjusted 4.11 (±0.05) 3.97 (±0.05) 3.91 (±0.05) 3.91 (±0.05) 3.77 (±0.05) <0.001 
 Model 1 4.09 (±0.05) 3.97 (±0.05) 3.92 (±0.05)* 3.92 (±0.05)* 3.77 (±0.05)*** <0.001 
 Model 2 4.04 (±0.06) 3.95 (±0.05) 3.92 (±0.05) 3.93 (±0.05) 3.83 (±0.06)* 0.06 
HDL:LDL Unadjusted 0.31 (±0.01) 0.32 (±0.01) 0.33 (±0.01) 0.35 (±0.01) 0.36 (±0.01) <0.001 
 Model 1 0.32 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.34 (±0.01)** 0.36 (±0.01)*** <0.001 
 Model 2 0.32 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.34 (±0.01) 0.35 (±0.01)* 0.02 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI or diabetes, family history stroke, family history MI, statin medication use 
2Model 2: model 1 + alcohol, dietary total fat intake, ratio Ca:Mg, total energy and calcium supplement use (including contribution from medication). 
3P value for significance compared with Q1: *= P value ≤0.05, **= P value ≤0.01, *** = P value ≤0.001 
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Table 3.15 Association of quintiles of dietary magnesium intake (range and mean quintile intake) and blood lipids (means and SE) in 2380 women, aged 40-
75 years in EPIC-Norfolk cohort (1993-1997).  
  Dietary magnesium intake  
  Q1 Q2 Q3 Q4 Q5  
  48.3-204 mg 
176 mg 
n=476 
205-240 mg 
223 mg 
n=476 
241-274 mg 
258 mg 
n=476 
275-318 mg 
295 mg 
n=476 
319-692 mg 
375 mg 
n=476 
P trend 
Total Cholesterol Unadjusted 6.60 (±0.06) 6.33 (±0.06) 6.21 (±0.05) 6.29 (±0.05) 6.13 (±0.05) <0.001 
 Model 11 6.45 (±0.05) 6.32 (±0.05)* 3 6.24 (±0.05)** 6.33 (±0.05) 6.22 (±0.05)** 0.01 
 Model 22 6.45 (±0.06) 6.32 (±0.05) 6.24 (±0.05)** 6.34 (±0.05) 6.22 (±0.06)* 0.09 
Triglycerides Unadjusted 1.76 (±0.04) 1.56 (±0.03) 1.56 (±0.03) 1.57 (±0.04) 1.46 (±0.03) <0.001 
 Model 11 1.64 (±0.03) 1.54 (±0.03)* 1.58 (±0.03) 1.60 (±0.03) 1.53 (±0.03)* 0.14 
 Model 22 1.73 (±0.04) 1.57 (±0.03)*** 1.58 (±0.03)** 1.57 (±0.03)** 1.45 (±0.04)*** <0.001 
HDL Unadjusted 1.49 (±0.02) 1.57 (±0.02) 1.57 (±0.02) 1.60 (±0.02) 1.59 (±0.02) <0.001 
 Model 11 1.51 (±0.02) 1.58 (±0.02)** 1.56 (±0.02) 1.59 (±0.02)** 1.57 (±0.02)* 0.03 
 Model 22 1.49 (±0.02) 1.57 (±0.02)** 1.56 (±0.02)** 1.60 (±0.02)*** 1.60 (±0.02)** 0.01 
LDL Unadjusted 4.32 (±0.05) 4.06 (±0.05) 3.93 (±0.05) 3.99 (±0.05) 3.88 (±0.05) <0.001 
 Model 11 4.20 (±0.05) 4.04 (±0.05)* 3.96 (±0.05)*** 4.02 (±0.05)** 3.96 (±0.05)*** <0.01 
 Model 22 4.18 (±0.06) 4.04 (±0.05)* 3.97 (±0.05)** 4.03 (±0.05) 3.97 (±0.06)* 0.08 
HDL:LDL Unadjusted 0.37 (±0.01) 0.43 (±0.01) 0.44 (±0.01) 0.45 (±0.02) 0.45 (±0.01) <0.001 
 Model 11 0.39 (±0.01) 0.44 (±0.01)** 0.43 (±0.01)* 0.45 (±0.01)*** 0.43 (±0.01)* 0.01 
 Model 22 0.39 (±0.01) 0.44 (±0.01)** 0.43 (±0.01)* 0.45 (±0.01)** 0.44 (±0.01)* 0.05 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI or diabetes, family history stroke, family history MI, statin medication use 
2Model 2: model 1 + alcohol, dietary total fat intake, ratio Ca:Mg, total energy and calcium supplement use (including contribution from medication). 
3P value for significance compared with Q1: *= P value ≤0.05, ** = P value ≤0.01, *** = P value ≤0.001
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Lipid Profile 
Analyses of associations of dietary magnesium intake and serum lipid levels were 
conducted on a sub-group of the cohort, additionally excluding participants with missing 
data for serum lipid levels (n=175). This approach differs to that presented in our paper 
‘The relationship between dietary magnesium intake, stroke and its major risk factors, 
blood pressure and cholesterol in the EPIC-Norfolk cohort’ (281) where only associations 
between dietary magnesium intake and total cholesterol were assessed and thus those 
with missing data for LDL, HDL, and triglycerides (n=175) were not excluded as they have 
been in these sub-group analyses. As such there are slight differences in the presented 
results, most notably in the significance of the association between dietary magnesium 
intake and total cholesterol levels in women. In the article, we report a significant inverse 
association between dietary magnesium intake and total cholesterol in women. However, 
after exclusion of those with missing data for other lipid fractions the association is 
attenuated and becomes non-significant in the sub-group analyses presented in this 
chapter.  
In the 1888 men, a significant inverse association was identified in relation to dietary 
magnesium intake and total cholesterol (P=0.04) after full adjustment for confounding 
variables including age, use of statin medication, and dietary intakes of alcohol, fat and 
total energy amongst other factors (Table 3.14). No significant association was identified 
in relation to triglyceride or LDL levels; however, there was a non-significant inverse trend 
in both triglyceride and LDL levels and additionally a non-significant difference of 0.10 
mmol/L between the extreme quintiles in the fully adjusted model for triglycerides. The 
difference in LDL levels of the extreme quintiles reached significance (P≤0.05) the 
difference was 0.21 mmol/L. There was no significant association between dietary 
magnesium intake and HDL levels in men, however, a significant positive association was 
identified in relation to the ratio of HDL:LDL (P=0.02). Additionally a significant difference 
of 0.03 mmol/L was seen between the extreme quintiles of the fully adjusted model. There 
were some contrasting results in associations of dietary magnesium intake and serum lipid 
levels in women (Table 3.15).  A significant inverse association was identified for total 
cholesterol (P=0.01) in the first model of adjustment for factors including age, smoking 
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status, and use of statin medication. However, in the fully adjusted model, with the 
addition of dietary factors such as total energy, total fat and alcohol intakes, the association 
was attenuated (P=0.09). There was still a significant difference of 0.05 mmol/L between 
the serum cholesterol levels of the extreme quintiles in the fully adjusted model (P≤0.05). 
There was a strongly significant inverse association between magnesium intakes and 
triglyceride levels (P<0.001), in the fully adjusted model, and a significant difference of 0.28 
mmol/L was also identified (P≤0.001). A significant positive association was identified in 
relation to HDL levels and dietary magnesium intake after adjustment for model 1 (P0.03). 
This association was strengthened with the addition of dietary factors such as total energy, 
ratio of dietary Ca:Mg intake, total fat and alcohol intakes to the model (P=0.01). There was 
also a significant difference of 0.11 mmol/L between the extreme quintiles in the fully 
adjusted model (P≤0.01). For LDL cholesterol a significant inverse association was seen 
after adjustment for model 1 which included age, BMI, use of statin medication and 
smoking status amongst other factors (P<0.01), however, this association was attenuated 
with the addition of dietary factors in model 2 (P=0.08). There was however, still a 
significant difference of 0.21 mmol/L between the mean LDL levels of the extreme quintiles 
(P≤0.05). Finally a significant positive association was identified between the ratio of 
HDL:LDL and dietary magnesium intake. After adjustment for factors such as age and use 
of statin medication in model 1 the significance was P=0.01, this association was attenuated 
but remained significant with the addition of dietary factors in model 2 (P=0.05). 
Additionally there was a significant difference of 0.05 mmol/L between the extreme 
quintiles in the fully adjusted model (P≤0.05).  
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Table 3.16 Quintiles of dietary magnesium intake (range and mean quintile intake) at baseline (1993-1997) and stroke risk (HR and 95%CI), follow-up March 
2008, in 2000 men, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary magnesium intake  
 Q1 Q2 Q3 Q4 Q5  
 85-242 mg 
206 mg 
n=400 
243-284 mg 
266 mg 
n=400 
285-328 mg 
307 mg 
n=400 
329-385 mg 
355 mg 
n=400 
386-829 
456 mg 
n=400 
P trend 
Stroke Events 126 (30.6%) 111 (26.9%) 93 (22.6%) 85 (20.6%) 75 (18.3%)  
Model 11 1.0 (reference) 0.85 (0.60-1.20) 0.70 (0.49-1.00) 0.86 (0.60-1.24) 0.80 (0.55-1.16) 0.22 
Model 22 1.0 (reference) 0.86 (0.60-1.20) 0.68 (0.47-0.99) 0.81 (0.56-1.17) 0.74 (0.50-1.09) 0.11 
Model 33 1.0 (reference) 0.87 (0.61-1.25) 0.73 (0.50-1.06) 0.80 (0.55-1.17) 0.81 (0.53-1.22) 0.21 
 
1Model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2Model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI  
3Model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, ratio Ca:Mg and magnesium and calcium supplement use (including 
contribution from medication) 
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Table 3.17 Quintiles of dietary magnesium intake (range and mean quintile intake) at baseline (1993-1997) and stroke risk (HR and 95%CI), follow-up March 
2008, in 2443 women, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary magnesium intake  
 Q1 Q2 Q3 Q4 Q5  
 48-204 mg 
176 mg 
n=489 
205-240 mg 
223 mg 
n=489 
241-274 mg 
258 mg 
n=489 
275-319 mg 
295 mg 
n=489 
320-692 mg 
374 mg 
n=488 
P trend 
Stroke Events 152 (30.5%) 102 (20.5%) 87 (17.5%) 82 (16.5%) 88 (17.7%)  
Model 11 1.0 (reference) 0.74 (0.53-1.05) 0.74 (0.51-1.06) 0.84 (0.59-1.20) 0.83 (0.57-1.20) 0.39 
Model 22 1.0 (reference) 0.71 (0.50-1.01) 0.71 (0.49-1.03) 0.82 (0.57-1.17) 0.76 (0.52-1.11) 0.23 
Model 33 1.0 (reference) 0.72 (0.50-1.04) 0.73 (0.50-1.08) 0.86 (0.59-1.26) 0.82 (0.54-1.24) 0.45 
1Model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2Model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI  
3Model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, ratio Ca:Mg and magnesium and calcium supplement use (including 
contribution from medication) 
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Table 3.18 Stroke risk (HR 95% CI) by magnesium groups (range and mean intake), bottom 10% (Group 1 reference category) and 3 groups of 30% intakes 
each, in 2000 men, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary magnesium intake  
 Group 1 Group 2 Group 3 Group 4  
 85-214 mg 
181 mg 
n=199 
215-285 mg 
254 mg 
n=605 
286-353 mg 
318 mg 
n=591 
354-828mg 
427 mg 
n=605 
P trend 
Stroke Events 65 (32.7%) 157 (26.0%) 123 (20.8%) 104 (17.2%)  
Model 11 1.00 0.73 (0.50-1.07) 0.63 (0.43-0.94)*4 0.67 (0.44-1.01) * 0.07 
Model 22 1.00 0.72 (0.48-1.07) 0.61 (0.41-0.92) * 0.61 (0.40-0.94) * 0.03 
Model 33 1.00 0.67 (0.45-1.01)* 0.60 (0.40-0.90) * 0.59 (0.38-0.93) * 0.04 
1Model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2Model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI 
3Model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, ratio Ca:Mg and magnesium and calcium supplement use (including 
contribution from medication)  
4P value for significance compared with reference (Group 1): *= P value ≤0.05 
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Table 3.19 Stroke risk (HR 95% CI) by magnesium groups (range and mean intake), bottom 10% (Group 1 reference category) and 3 groups of 30% intakes 
each, in 2443 women, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary magnesium intake  
 Group 1 Group 2 Group 3 Group 4  
 48-180 mg 
156 mg 
n=232 
181-240 mg 
213 mg 
n=745 
241-294 mg 
267 mg 
n=740 
295-691 mg 
352 mg 
n=726 
P trend 
Stroke Events 73 (31.5%) 165 (22.2%) 126 (17.0%) 115 (15.8%)  
Model 11 1.00 0.73 (0.49-1.08) 0.70 (0.46-1.06) 0.74 (0.48-1.12) 0.27 
Model 22 1.00 0.67 (0.45-1.00) *4 0.65 (0.43-0.98) * 0.66 (0.43-1.02) 0.14 
Model 33 1.00 0.65 (0.43-0.99) * 0.65 (0.42-1.01) 0.69 (0.44-1.09) 0.27 
1Model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2Model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI 
3Model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, ratio Ca:Mg and magnesium and calcium supplement use (including 
contribution from medication) 
4P value for significance compared with reference (Group 1): *= P value ≤0.05 
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Stroke risk 
A modified Prentice weighted cox proportional hazards regression was used to determine 
hazard ratios of risk of stroke in association with quintiles and groups of dietary magnesium 
intake. There was no significant association between dietary magnesium intake, by 
quintiles of intake, and stroke risk in men (Table 3.16). There was however, a non-
significant trend towards lower risk with increasing intakes of dietary magnesium. To assess 
whether those with the very lowest magnesium intakes (lowest 10% of magnesium intakes) 
had the greatest risk of stroke we also stratified analyses by data-derived groups of 
magnesium intake. These groups were the lowest 10% of magnesium intake and 3 further 
groups (the lowest intake was used as the reference category). A significant association of 
reduction in risk with increasing magnesium intakes was identified in men after full 
adjustment for factors including age, BMI, smoking status, serum total cholesterol levels, 
family history of stroke, use of aspirin or antihypertensive medication and dietary factors 
including alcohol intake the ratio of Ca:Mg intake amongst other factors (P=0.04) (Table 
3.18). There was also a significant difference in the HR between those in the lowest 10% of 
dietary magnesium intakes and those in in the category with the highest intakes. HR for 
men consuming the highest magnesium intakes was 0.59 (95% CI 0.38-0.93). In women 
there was no significant association between dietary magnesium intake by quintiles and 
stroke risk (Table 3.17). Although non-significant the HR in Q5 indicated a potential lower 
risk of stroke with increasing magnesium intakes. For analyses by groups of magnesium 
intake, group 1 comprising of lowest 10% of dietary magnesium intakes was the reference 
category, there was a no significant association across the groups of magnesium intake 
(Table 3.19). However, there was a significant difference in the HR of those in group 2, 
magnesium intakes 181-240 mg/d, compared with the lowest 10% of intakes, 48-180 mg/d 
(P≤0.05) HR 0.65 (95% CI 0.43-0.99). A decreased risk was also seen in those with the 
highest magnesium intakes, 295-691 mg/d, however this was non-significant, HR 0.69 (95% 
CI 0.44-1.09). 
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3.4 Discussion 
The main findings from this chapter, summarised in Table 3.0, suggest that after 
adjustment for several important confounding factors including age, smoking status, 
history of MI or DM, medication use and total energy intake and other dietary variables 
there was a significant association between dietary magnesium intake and SBP and DBP in 
males.  However, in females there was no significant association between dietary 
magnesium intake and blood pressure after adjustment for confounding variables. Total 
cholesterol was inversely associated with magnesium intake in men and positively 
associated with ratio of HDL:LDL in the fully adjusted model. For women a significant 
inverse association was identified in relation to triglyceride levels, whilst a significant 
positive association was shown in relation to HDL and the ratio of HDL:LDL after full 
adjustment. Dietary magnesium intake, stratified by quintiles, was not significantly 
associated with stroke risk in either sex. However, when investigating the effects of very 
low intakes (lowest 10% of dietary magnesium intakes) compared to higher intakes a 
significant inverse association was identified for men only. 
Table 3.20 Summary of results investigating the relationship between dietary magnesium 
intake and blood pressure, serum lipid levels and stroke risk in men and women aged 39-
80 years. 
 Men Women 
Blood Pressure   
SBP ↓ ↔ 
DBP ↓ ↔ 
Cholesterol   
Total Cholesterol ↓ ↔ 
Triglycerides  ↔ ↓ 
HDL ↔ ↑ 
LDL ↔ ↔ 
HDL:LDL ↑ ↑ 
Stroke Risk   
Quintiles of magnesium intake ↔ ↔ 
Groups magnesium intake ↓ ↔ 
↔ - no significant association 
↓ - significant inverse association 
↑ - significant positive association 
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The strongest associations with blood pressure were found in males after adjusting for total 
energy, age, BMI, smoking status, physical activity, education level, baseline reported 
stroke, MI or DM, family history of stroke or MI, use of antihypertensive or aspirin 
medication, dietary intakes of sodium, potassium, total fat and alcohol, for SBP and DBP (P 
trend <0.001 and P=0.01 respectively) (Table 3.12). This difference in effect of dietary 
intakes on men and women may be due to in their consumption of other nutrients such as 
sodium and potassium which have been identified to have an influence on blood pressure. 
For example men had significantly higher sodium intakes compared with women (P<0.001) 
(Table 3.9). 
Increased dietary magnesium intake was inversely associated with LDL and positively 
associated with HDL levels in men after adjustment for multivariable model 1. However, 
these associations were attenuated when adjusting for dietary covariates; total fat and 
alcohol intakes, total energy, ratio of dietary Ca:Mg intake and use of calcium supplements 
(Table 3.14). For total cholesterol and the ratio of HDL:LDL cholesterol the association 
remained significant (P trend = 0.04 and 0.02 respectively) after full adjustment. Significant 
differences were also identified between the extreme quintiles of dietary magnesium 
intake for serum total cholesterol, LDL and ratio of HDL:LDL cholesterol levels, small 
differences of 0.25 mmol/L, 0.21 mmol/L and 0.03 mmol/L for TC, LDL and ratio HDL:LDL 
respectively was also observed in men.  
In women a significant inverse trend was identified between dietary magnesium intake and 
total cholesterol and LDL levels after adjustment for model 1 including age, BMI, smoking 
status, use of aspirin medication and educational status amongst other factors, but was 
attenuated with the addition of dietary variables (P trend 0.09 and P trend 0.08 for total 
cholesterol and LDL respectively in the fully adjusted model) (Table 3.15). However, 
significant differences of the TC and LDL levels of the extreme quintiles were also observed 
as was seen in men. The difference was 0.23 mmol/L for TC and 0.21 mmol/L for LDL 
between those with the highest and lowest dietary magnesium intakes. Despite being 
relatively small reductions, these differences may still be relevant for reducing stroke risk. 
Previously a decrease of 1 mmol/l in serum LDL concentration has been associated to 
decrease RR of total stroke by approximately 10% (280). A significant positive association 
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was found for HDL cholesterol level and dietary magnesium after adjustment in women, 
with a difference of 0.11 mmol/L between those with the highest and lowest dietary 
magnesium intakes. In men a significant positive trend was seen after adjustment for model 
1 but was attenuated and became non-significant with the addition of dietary factors in 
model 2. This would suggest that for men dietary factors such as alcohol intake, total 
energy and total fat intakes have a greater influence on HDL levels than dietary magnesium 
intakes. Additionally a significant positive association was identified between dietary 
magnesium intake and the ratio of HDL:LDL cholesterol in women, which was maintained 
with full adjustment (P trend = 0.05). No significant association was observed between 
serum triglyceride levels and dietary magnesium intake for men. However, in women a 
strongly significant inverse association was identified after full adjustment for confounding 
factors (P trend <0.001).  
The participants mean dietary intakes (Table 3.09) were mainly in line with the dietary 
reference value (DRV) set out for adult men and women in UK (216). Percentage energy 
intake from carbohydrates, total and saturated fat was slightly greater than the 
recommendations for both men and women. For both sexes percentage energy from MUFA 
and PUFA were in accordance with recommendations and despite protein intake being 
greater than the DRV, participant’s intakes were in line with the average consumption of 
the general population (285) and percentage energy from protein was also similar to that 
of the general population. 
Blood pressure and dietary magnesium Intake 
The present findings agree with those of Joffres et al (165) who found a significant inverse 
association between dietary magnesium intake and SBP and DBP. Their cohort was 
relatively small (n=615) and exclusively comprised of elderly males, aged between 63-82 
years, and conducted on a Japanese population and is therefore not necessarily directly 
comparable to this cohort. In addition they used a 24hr recall to assess dietary intakes 
which have previously been indicated to provide different intakes of a number of nutrients, 
particularly micronutrients when compared with 7DD (286). To my knowledge, to date, 
there has not been a directly comparable study conducted on a UK population. Joffres et al 
(165) reported the greatest reduction in blood pressure between the first and second 
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quartile, with a decrease of 4.6 mmHg and 2.8 mmHg for SBP and DBP. In the current 
analyses a more substantial difference in blood pressure was observed between those 
consuming lowest and highest dietary magnesium intakes with a difference of 7 mmHg 
(P<0.001) and 3.8 mmHg (P<0.01) for SBP and DBP respectively in males in the fully 
adjusted model. There were also, linear decreases in SBP, DBP across the quintiles in males 
(P trend 0.001 for SBP and 0.01 for DBP) (Table 3.12).   
Witteman et al (166) also showed a potential benefit from increased consumption of 
magnesium, in women only. They reported almost a quarter of reduction in relative risk 
(RR 0.77 (95%CI: 12%-33%)) for developing hypertension, with magnesium intakes greater 
than 300 mg/d compared with intakes less than 200 mg/d. More recently, Song et al (244) 
indicated a potential inverse association between dietary magnesium intake and the 
development of hypertension. They reported a RR 0.91 (95% CI 0.83-0.99) for women in 
the highest quintile, with median dietary magnesium intakes of 400 mg/d, compared to 
those in the lowest quintile, with median intakes of 253 mg/d. The cohort was however, 
exclusively female. In the present analyses no significant association was identified 
between dietary magnesium intake in women (Table 3.13). These contrasting findings may 
in part be due to differences in the confounding variables included during adjustment. For 
example Witteman et al (166) did not adjust for several factors, such as smoking status and 
physical activity levels, which have been shown to influence blood pressure.  
The majority of intervention trials investigating the effects of magnesium on blood pressure 
have used oral magnesium supplements. Many studies have reported significant 
reductions in blood pressure ranging from 2.0 – 12.0 and 2.7 – 8.0 mmHg for SBP and DBP 
respectively (270-273, 275). This range in effect size is likely due to variations in study 
methodology implemented, including the dose and type of magnesium supplementation 
used. The largest effects for both SBP and DBP were seen in the study by Dyckner and 
Wester (275) which involved hypertensive participants who were being treated with long 
term diuretics. Therefore it cannot be ruled out that the participants medication use may 
have influenced those findings, as the same dose of magnesium supplementation was used 
by Cappuccio et al (274) which showed no effect. Diuretics may have a negative effect on 
magnesium status. Therefore it is possible that participants in Dyckner and Wester’s (275) 
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study were depleted in magnesium. It has been reported that depletion can lead to an 
increase in the bioavailability of dietary magnesium consumed. Another possibility may be 
in part attributable to differences in the length of supplementation. In Dyckner and 
Wester’s (275) trial, supplementation was for 6 months compared to only 1 month in the 
study by Cappuccio et al (274). Therefore it may be that in order to obtain a beneficial effect 
from magnesium supplementation it may need to be taken on a more long-term basis. 
Future clinical trials and dietary intervention studies could aim to address this, in order to 
establish the long-term effects of increased magnesium intake.  
A limited number of studies to date have assessed and investigated the effects of increasing 
dietary magnesium intakes on blood pressure in relation to stroke risk in UK general 
population. The present study is one of the few to have involved participants of both sexes, 
allowing for direct comparison of effects of sex on a given population.  
Lipid profile and dietary magnesium intake 
An abnormal lipid profile is an established risk factor for stroke, and the influence of certain 
aspects of the diet, specifically fat intakes, has been extensively studied. However, less 
research has, to date, investigated the effect of other dietary components including those 
of plant origins on the lipid profile. 
A number of studies have investigated the effects of nut consumption on serum lipid levels, 
as nuts contain a number of potentially beneficial macro and micronutrients including 
unsaturated fats. They are also a good source of magnesium and the benefit associated 
with nut consumption may not solely be due to their unsaturated fat content (287, 288). 
Therefore it is possible that positive effects on lipid profile may at least in part be due to 
the magnesium content of nuts (Table 3.0). Although nut consumption was relatively low 
in this cohort there was a significant positive trend for higher nut and seed consumption 
with increasing dietary magnesium intakes (Tables 3.10 and 3.11). In addition to this, one 
of the primary contributing food groups to magnesium intake in the average UK diet (8), 
cereal and cereal products, also significantly increased across quintiles of magnesium 
intake in both men and women (P<0.001) (Table 3.10 and 3.11). 
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Several studies have investigated the effects of oral magnesium supplementation on serum 
lipid levels in diabetic patients with varied findings. Djurhuus et al (233) reported similar 
decreases in LDL levels after the supplementation period, of 24 weeks, (0.29 mmol/l) as 
were reported between the quintiles of dietary magnesium in the current analyses (0.21 
and 0.21 mmol/l for men and women respectively). However, Eibl (276) did not report any 
significant effects on TC, HDL, LDL or triglyceride levels after 3 months supplementation 
with 30 mmol/l magnesium citrate (equivalent to 365 mg magnesium). Although these 
studies are not directly applicable to the general population or dietary magnesium, due to 
the potential differences in absorption and bioavailability of dietary and supplemental 
magnesium, they suggest magnesium could have a positive influence on serum lipid 
profiles.  
Itoh et al (229) conducted a trial in healthy subjects and illustrated a benefit of 
supplementation with high doses of oral magnesium, 411 mg/d for women and 584 mg/d 
for men. The effect was reported for both LDL and HDL levels. Although, this benefit was 
not reported in relation to TC or triglyceride levels. A second small study on 16 healthy 
middle aged men by Kishimoto et al (279) indicated a potential improvement in 
postprandial lipid levels with magnesium supplementation. The authors hypothesised that 
magnesium supplementation, which significantly increased serum magnesium levels but 
not calcium, reduced absorption of fat by binding with fatty acids to form insoluble 
structures (279).  Evidence suggests that postprandial elevated lipid levels may have 
atherogenic effects, particularly the presence of TG-remnants, which in high levels may 
decrease HDL concentrations whilst also increasing LDL concentration (279).  
However, these supplementation trials are not necessarily comparable with observational 
studies of the general population, as the lowest supplementation doses were high ranging 
from 400-580 mg/d. The RNI is 300 mg/d and 270 mg/d men and women respectively. In 
addition to this currently, the average magnesium intake of the UK general population is 
below the RNI (285). There is also evidence to indicate that magnesium intakes, particular 
from supplements, of this level may result in adverse side effects including diarrhoea and 
nausea. Although these were not reported in participants during the course of either of 
these studies (229, 279). 
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Several studies have previously investigated stroke risk and dietary magnesium intakes, 
however, to our knowledge none have included general populations of both men and 
women simultaneously or concurrently analysed major risk factors as well as stroke risk 
(167-169, 171, 255-257, 261, 262, 289, 290). A number of these studies in large populations 
of American, Taiwanese and Northern European cohorts have reported no association 
between dietary magnesium intake and stroke risk (167, 168, 255, 256, 289, 290). However, 
several studies have reported significant associations in men (169), women (171), and men 
and women (261). Additionally, a large meta-analysis by Larsson et al (161), in 241,378 
people, reported an inverse association between dietary magnesium intake, recorded by 
FFQ, and risk of stroke. The findings of this thesis indicated a non-significant trend across 
quintiles of dietary magnesium intake and stroke risk in men and women. However, a 
significant inverse trend (P=0.04) was identified when we compared men with the lowest 
10% of magnesium intake with the remainder of the cohort. This finding would suggest that 
it is the very lowest magnesium intakes that may infer the greatest risk of stroke incidence 
in men. 
3.4.1 Strengths and Limitations 
The strengths of the present analyses include; the size of the cohort and prospective design, 
which reduces the susceptibility of the study to selection bias. Additionally adjustment for 
a number of potential confounding factors allows for the identification of dietary 
associations independent of known risk factors. 
As with all epidemiological studies involving self-reported dietary intakes, there is the 
potential for response bias. However, in comparison with the government guidelines and 
the average intakes of the UK population this EPIC-Norfolk sub-cohort was representative 
of the general population. A number of participants had one or more missing values for 
variables of interest and were excluded from analyses. In the case of smoking status and 
the use of aspirin medication the observations with missing values were recoded and 
categorised into the current smoker and no category for aspirin medication use 
respectively. In this way it may be possible that individual observations have been 
misclassified. In addition to this, by excluding those participants with missing values for 
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some variables including; history at baseline of stroke or MI, BP measurements or lipid 
profile variables bias may have been introduced. Selection bias is also possible although 
the whole EPIC-Norfolk cohort was representative of the UK population. Additionally, 
truncation of the sample distribution would likely only attenuate the observed associations 
and therefore associations may actually be stronger than are presented. 
The possibility of mis-reporting of dietary intakes also needs to be considered. When 
comparing the reported energy intake with EER there was evidence of under-reporting for 
the majority of the population across quintiles of dietary magnesium intake. With the 
exception of highest magnesium intakes, quintile 5, where the mean ratio of energy intake 
to EER suggested slight over-reporting by participants. However, analyses assessing the 
associations between dietary magnesium intake and risk factors for stroke, blood pressure 
and lipid levels, were adjusted for total energy intake and BMI and therefore I do not 
believe that the mis-reporting identified would have a substantial influence on the findings 
of theses analyses.   
Despite adjusting for a number of relevant covariates it is still possible for residual 
confounding to occur, although the likelihood is reduced due to previous validation of 
dietary methods and results of EPIC-Norfolk cohort. 
Finally due to the nature of this investigation analyses are restricted to one time point 
(baseline), and therefore do not take into account changes in dietary habits or lifestyle 
variables over the course of the follow-up. 
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3.5 Summary 
In summary, from the review of the literature it was identified that the current research in 
relation to dietary magnesium intake and stroke risk, and risk factors; blood pressure and 
lipid profile, indicated a potential benefit of increased consumption of dietary magnesium.  
Gaps in the literature, of areas which to date have been understudied were also 
highlighted. This includes the requirement for observational studies involving both sexes 
to allow direct comparisons of differences in risk and risk factors in the sexes. Additionally 
there are limited studies to date involving cohorts that are representative of the general 
population, particularly within European countries and more specifically to the best of my 
knowledge no other study has been conducted in the UK.  
Therefore further research was required to identify if dietary magnesium intake beneficially 
influences BP and lipid profile in this specific population independent of a number of 
confounding factors and therefore potentially also contribute to a reduction in overall 
stroke risk.  
The results of the current analyses indicate the potential of increased dietary magnesium 
intakes to impact positively on blood pressure and lipid profile in men and women. It has 
been reported that a reduction of SBP and DBP by 1-3 mmHg and 4 mmHg respectively may 
reduce stroke risk by up to 30% and 23% for SBP and DBP respectively.  In this cohort the 
effects on BP were stronger in males than females with differences in males of -7 mmHg 
and -4.3 mmHg, for SBP and DBP, between those with the highest and lowest dietary 
magnesium intakes. In females a difference of -1.4 mmHg was reported in relation to DBP 
only prior to adjustment for specific dietary confounders. Additionally in males a linear 
trend across the quintiles was also identified with all blood pressure variables which 
indicates that modest increases dietary magnesium intakes may be of benefit to the male 
population. 
Significant inverse associations with TC in men and triglyceride levels in women were seen 
in relation to dietary magnesium intakes. Significant positive associations were seen in 
relation to HDL levels in women only and between the ratio of HDL:LDL in both men and 
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women and dietary magnesium intake. Despite differences in LDL levels between highest 
and lowest magnesium intakes being relatively small (0.21 mmol/L and 0.21 mmol/L for 
men and women respectively) they are still relevant in terms of reduction of stroke risk, as 
a 1 mmol/L decrease in LDL is associated with a 10% reduction in total stroke risk (280). 
This would indicate a potential benefit to the UK general public of increased dietary 
magnesium intake on lipid levels in relation to a reduction in stroke risk. Therefore dietary 
magnesium intakes may be important in reducing stroke risk in terms of beneficial effects 
on risk factors including blood pressure and lipid levels. 
A significant decrease in stroke risk was identified in men for higher magnesium intakes 
compared with the lowest 10% of dietary magnesium intake (HR 0.59 (95% CI 0.38-0.93) P 
trend = 0.04). There was no significant association in women, and also no significant 
association in either sex when analysed by quintiles of dietary magnesium intake. Despite 
this, non-significant trends towards a lower risk of stroke were shown in both sexes across 
the quintiles and also in the data derived categorised analysis for women. In this instance 
the HR was 0.69 (95% CI 0.44-1.09) P trend = 0.27. These findings may suggest that it may 
be those with the very lowest dietary magnesium intakes that are most at risk and as a 
higher dietary magnesium intake may also influence stroke risk factors beneficially it may 
be an important addition to the diet to reduce the overall risk of stroke. 
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4.0 Introduction 
In the early nineteenth century animal studies showed that diets free from nitrogen (thus 
containing no protein) lead to muscle and tissue wasting and subsequently premature 
death (291, 292) thereby illustrating that protein is an integral part of human requirements 
and dietary needs. Protein is a key nutrient for growth and development in early life and 
ongoing repair throughout the life-cycle. Protein has a number of roles in sustaining good 
physical health, including maintaining muscle condition and the prevention of sarcopenia 
(293, 294) and CHD (295). Although total protein is important, the subtypes of protein 
(animal and vegetable) may also be important for health. There is also evidence that total 
protein and intake of foods higher in protein such as soy (296), processed meats (175) and 
fish (297) may influence stroke risk and risk factors including blood pressure and lipid levels 
(140, 174, 175). There is also emerging evidence of potential effects of overall plant or 
animal intakes, although this is an understudied area (124, 174).  
It is likely that dietary sources of protein differ between countries, within 10 European 
countries there was substantial variation in the reported meat intakes alone (298). In 
addition dietary patterns and nutrient intakes have also been shown to differ between 
European countries and therefore it is likely differences would also exist with other 
populations across the world (299, 300). To date there is limited data investigating the main 
contributing sources to total protein and subtypes in the UK diet. As illustrated above the 
composition of food sources contributing to total protein and subtypes likely differs 
between countries, this chapter therefore aims to address this gap in knowledge of the UK 
diet. 
Proteins are synthesised from combinations of 20 individual amino acids and protein is the 
greatest source of nitrogen both in the human body and the diet (219, 292). All proteins, 
with the exception of proline, are comprised of the same basic structure, shown in Figure 
4.0, of an amine (-NH3+) and carboxylic acid (-COOH) group, whilst the additional R group 
allows for specificity of function (219, 292). 
Chapter Four  Contribution to dietary protein intake  
 
144 
 
 
Figure 4.0 Basic Amino Acid Structure adapted from (301). 
Amino acids are sub classified into one of three groups; essential, non-essential and 
conditionally essential. Essential amino acids are those that, under normal conditions, 
cannot be produced within the body at a rate required for normal growth and 
development. Therefore they must be obtained from dietary sources such as meat, eggs 
and dairy. Essential amino acids include leucine, methionine and phenylalanine amongst 
others (219). Non-essential amino acids are those which can be synthesised within the body 
such as alanine and aspartate and are present in higher quantities in plant foods (219). 
Conditionally essential amino acids are those which may in limited quantities be 
synthesised in the body, often only in specific tissues, and not necessarily at a rate 
applicable to growth or function. Conditionally essential amino acids also generally rely on 
the presence of another amino acid to act as the donor of a carbon or accessory group. This 
includes arginine, glycine and proline (302). Sources of protein (animal and plant) are 
composed of differing amino acids. Animal protein, such as meat and eggs, contain all the 
essential amino acids. Plant-based protein foods, such as whole grains, legumes, fruit and 
vegetables, contain lower levels of some amino acids such as lysine, threonine and 
tryptophan which may be present in rate limiting levels if not consumed with other sources 
as their synthesis can require additional amino acids, for example, citrulline for arginine 
synthesis (219).  
The protein content of plant and animal foods differs substantially as is illustrated in Table 
4.0. From this table it is evident that animal sources have higher protein content per serving 
than plant based sources. Therefore in order for plant sources to contribute highly to daily 
protein intake, they are required to be consumed more frequently or in higher quantities.  
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Table 4.0 The protein content in an average portion of a selection of animal and plant 
foods. 
Food Item Protein content per 
average portion (g) 
Animal based foods  
Minced beef 34.6 
Roast chicken 27.3 
Semi-skimmed milk (glass) 7.00 
Cheddar cheese 10.2 
Plain whole milk yogurt 7.13 
Boiled egg 6.25 
Cod 25.7 
Plant based foods 
Easy cook white basmati rice 4.68 
White spaghetti 7.92 
Brown bread (1 slice) 2.84 
Weetabix (2 biscuits) 4.48 
New potatoes  2.45 
Baked beans 7.02 
Red lentils (1 tbsp) 3.04 
Peas  4.20 
Carrots  0.36 
Apple  0.44 
Peach (canned in juice) 1.08 
Based on calculations from McCance and Widdowson’s 6th edition (189, 303).   
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This chapter will give an overview of the current knowledge of the contributing sources to 
dietary total protein and types of protein (plant or animal) intakes in adult populations.  
The subsequent chapter ‘Chapter Five – Dietary protein intake and stroke risk factors and 
risk of stroke’ is concerned with the influence of dietary total protein and types of protein 
on stroke risk factors, blood pressure and serum lipids, and risk of stroke in the EPIC-Norfolk 
sub-cohort. The evidence presented in this narrative literature review was obtained 
through searches of MEDLINE (Ovid) and PubMed and published reports from relevant 
organisations including Department of Health and the European Food Safety Authority. The 
search term dietary was combined with; protein, total protein, plant protein, animal 
protein and relevant key words such as intake* or source*. Titles and abstracts of returned 
search items were reviewed and the full text of relevant articles was obtained. The 
reference lists of full text articles were subsequently reviewed to identify additional 
relevant publications.     
Dietary recommendations for protein intake 
The European Food Safety Authority indicates a European Population Reference Intake of 
0.83 g/kg of body weight (304), this value was deemed applicable to both high quality 
protein intakes and protein from mixed diets. The average requirements of European 
population were estimated to be 0.66 g/kg body weight (304). More specifically for the UK 
population the RNI for protein is 55.5 g/d for men aged 19-50 years and 53.3 g/d for men 
over 50. The RNI for women in the UK is 45.0 g/d and 46.5 g/d for ages 19-50 and over 50 
years respectively (216). Although it is worth noting that these reference intakes for the UK 
population were last updated in 1991. In addition it is recommended that protein 
contributes to approximately 15% of total energy intake (305). In the UK National Diet and 
Nutrition Survey (NDNS) 2008-09 rolling programme, the current average percentage of 
energy from protein is 16.8% and 17.1% for adults aged 19-64 years in men and women 
respectively (306). There are currently no recommendations on the type of protein to 
consume. However, in older populations for healthier ageing intakes of 0.75 g/kg per day 
have been suggested (294). Additionally in relation to the development of sarcopenia 
specifically, age-related muscle loss, or in those with established sarcopenia, dietary 
Chapter Four  Contribution to dietary protein intake  
 
147 
 
protein intake is suggested to be 1.0-1.2 g/kg per day (293) but the exact recommendation 
remains to be determined.   
Difficulties in comparing discreet studies often arise due to differences in the classification 
and aggregation/disaggregation of food items. For example in the subsequent paragraphs 
some studies such as NDNS (221) and MONICA project (307) used aggregated meat and 
meat products as a variable whereas others such as Cade and Margetts (178) and NHANES 
(145) used disaggregated variables. Composite food items such as meat pie can either 
remain as aggregated foods and are categorised based on their predominant component, 
often meat, whereas disaggregated foods take account of each individual component of 
the food item. For example a meat pie could be crudely broken down into meat, sauce, 
vegetables and pastry respectively. This can lead to differences in the overall estimation of 
nutrient intakes, the rank order of contributing foods to protein intake, and also presents 
difficulties in making direct comparisons between studies. Some studies have also 
investigated protein intake and sources of protein for the whole population, whilst others 
have conducted sex-stratified analyses.   
4.0.1 Sources of protein in the UK diet 
The quality of protein may be dependent on the amino acid content of the food items but 
is also related to the bioavailability of amino acids. In developed countries the primary 
source of protein is meat and meat products, whilst in the developing world the major 
source is from cereals (308). In the NDNS (221) the mean daily protein intake for men and 
women was 88.2 g and 63.7 g respectively and the main sources of protein were meat and 
meat products (36% of intake), cereal and cereal products (23% of  intake) and milk and 
milk products (16% of intake) (221).  When comparing the meat consumption of European 
countries as part of the EPIC study, the adjusted mean total meat intake of the UK general 
population (72.3 g/d ±3.3) (EPIC-Norfolk cohort) was lower than the majority of other 26 
EPIC centres, with the exception of Greece, Granada (Spain), Naples (Italy) and Oxford (UK) 
(298). However, it should be noted that the EPIC-Oxford cohort was comprised of health 
conscious individuals, and a large proportion were vegetarian, and was thus not 
representative of the general population (298). 
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Cade and Margetts (178) studied the dietary protein intakes of participants in three English 
towns, Ipswich, Stoke and Wakefield. Dietary intakes in the study were based on a 1-day 
record using household measures, where this was not completed a 24h recall was taken; 
~20% of participants had recalls. The authors reported that the nutrient intakes of those 
providing a recall tended to be lower than those completing the 1-day record. Their study 
highlighted the primary contributing source to protein intake was white bread and flour 
(10.5% of total intake) in a cohort of 2,402 middle aged men and women aged 35-54 years. 
However, the primary food source of protein would have been different if a combined total 
meat intake was used, as was the approach in NDNS (178). Whole milk was the second 
highest contributing food to protein intake, accounting for 9.8% of protein intake. A total 
of 30 different food items contributed to 90% of protein intake in this population, 
illustrating that protein is obtained from a variety of sources. The majority of these (18 out 
of 30) were animal food items (including meat, fish and animal products). In terms of 
vegetable sources potatoes contributed 4.3% (7th highest item) and peas 1.0% of total 
protein intake (26th item). No fruit featured in the list. Cereal based products including 
wholemeal bread, cakes, puddings and biscuits contributed 2.3%, 1.9%, 1.9% and 1.3% of 
protein intake respectively.  
A study on the food sources of protein intake in European countries included small sub-
samples of the EPIC-Norfolk (general population), n=972, and EPIC-Oxford (health 
conscious), n=311, cohorts (309). Dietary intakes were recorded using 24h recall. Analyses 
were sex stratified and adjusted for age and weighted for day of recall and seasonality. The 
mean intakes of total protein were 91.2 (±1.9) and 70.8 (±1.1) for men and women in EPIC-
Norfolk and 72.1 (±3.5) and 59.8 (±1.9) in EPIC-Oxford respectively. They also investigated 
the percentage contribution of subtypes of protein intake (animal, plant and unknown) to 
total protein intake. In men and women from the general population animal protein intake 
contributed similarly to total protein intake 58% and 57% respectively. However, in the 
health conscious EPIC-Oxford group the percentage intake of animal protein was higher in 
women 29% compared with 23% in men, in addition the percentage from unclassified 
protein sources was the same for both men and women. In the EPIC-Norfolk general 
population the percentage intake from plant protein was the same for men and women 
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34% of total protein intake (309). Halkjær et al (309) additionally ascertained the 
percentage contribution of food sources to animal and plant protein intake. Analyses were 
also sex stratified, age adjusted and weighted for seasonality and day of recall. They 
reported that for both men and women in the EPIC-Norfolk general population cohort the 
total meat intake contributed most highly to animal protein intake (55.3% and 50.4% for 
men and women respectively). Subgroup analysis of meat sources indicated that men had 
higher intakes of red meat (22.1% vs. 18.8%) and processed meat (15.1% and 8.3%) than 
women. Whereas women had higher intakes of poultry (19.2% vs. 17.3%), fish (12.6% vs. 
10.3%), and eggs (4.3% vs. 3.0). In the EPIC-Oxford cohort, including a large number of 
lacto-ovo vegetarians and vegans, considerably lower mean intakes of meat, but higher 
intakes of dairy and eggs than the general population were reported (309). 
4.0.2 Sources of protein in the European diet  
Belgium 
A Belgian study aimed to determine the association of plant and animal protein with 
overweight and obesity in 3,083 men and women aged 15 years and older (310). Dietary 
intake was ascertained using two non-consecutive 24hr recalls. The recalls were completed 
2-8 weeks apart (with the median time being 3 weeks). In addition the dietary recall period 
of the whole study was spread throughout the year to account for variation in season across 
the population (310).  
Lin et al (310) reported a mean animal protein intake of 47 g/d compared with plant protein 
which contributed 25 g/d to the total protein intake of 72 g/d. Total protein intake 
accounted for 15.4% of energy intake, whilst animal protein intake contributed to 64% of 
total protein intake. Men had significantly higher intakes of total, animal and plant protein 
than women (P<0.001 for all). Meat and meat products were the primary sources 
contributing 53% of animal protein, and cereal and cereal products contributed most highly 
to plant protein 54% (310).  
They also noted that total protein intake in g/d tended to decrease with increasing age. 
However, as a percentage of energy contribution in adult life (19 years and older) there 
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was no significant difference between the age groups (19-59, 60-74 and 75 years and 
older). This was the same for men and women (310). 
In terms of specific food contributions, dairy products contributed similarly to animal 
protein intake in men and women. However, in the age groups 60-74 and 75 years and 
older the percentage contribution to animal protein intake was significantly lower than for 
younger age groups (16-18 and 19-59 years). Men had significantly higher intakes of meat 
and meat products (g/d) than women for all age groups (P<0.001) and also for fresh meat, 
which included red meat and pork, P<0.001 for 15-18, 19-59, and 60-74, and P=0.029 for 
age group 75 years and older. There was no significant difference in intake of poultry 
between men and women at any age group. Women had significantly lower intakes of 
processed meat compared with men at all ages (P<0.001 for all). Fish and shellfish intake 
was only significantly different between men and women aged 60-74 years, at other ages 
women tended to have slightly lower intakes than men (but not significantly). A similar 
pattern was seen with egg consumption whereby there was no significant difference 
between intake of younger men and women, but in those aged 75 and older, men 
consumed significantly more animal protein from eggs than women (P=0.009) 1.4 g/d for 
men vs 0.75 g/d for women, although in real terms this intake is likely to be negligible. The 
percentage contributions to total energy intake across the sexes were relatively similar 
(310).  
The majority of plant protein was derived from cereal and cereal products for both men 
and women, in all age groups.  Cereal and cereal products accounted for 18-20% (13-18 
g/d) of plant protein intake in adult men and 16-20% (9-12.5 g/d) of plant protein intake in 
adult women. This was followed by potatoes and other tubers contributing 3.4-4.8% (2.8-
3.5 g/d) in adult men and 2.8-4.4% (1.7-2.5 g/d) in adult women and vegetables 
contributing 2.5-2.9 % (2.1-2.4 g/d) in adult men and 3.2-3.7% (1.9-2.3 g/d) in adult women. 
The difference in intake of cereal and cereal products and potatoes and tubers was 
significant between men and women (P<0.001 for all ages). There was no significant 
difference in the vegetable intake of men and women at any age (310). Women did 
however, tend to have a higher contribution to plant protein from combined fruit and 
vegetables than men.  Legumes, soya products, and disaggregated fresh fruit and nuts and 
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seeds categories contributed only minimally to plant protein intake in this cohort of Belgian 
men and women (310). 
France 
In 1,912 French adults, dietary intake was assessed using a 7-day open ended food record 
and the nutritional adequacy of the diet was determined using PANDiet (311). PANDiet 
assessed the probability of nutritional adequacy of the diet on a scale, with a range of 0-
100. A score of 100 indicates the highest nutritional adequacy and 0 indicates lowest 
nutritional adequacy. The study aimed to determine associations between the adequacy of 
nutrient intakes and protein intake from plant and animal sources (311).  
In this cohort men had an energy adjusted mean total protein intake of 87.7 g/d (17.1% of 
energy) and women had an energy adjusted mean intake of 84.4 g/d (16.5% of total energy) 
(P<0.0001 for both g/d and %en). The difference in intake in both g/d and as a percentage 
of total energy was statistically significant between men and women. Men also had 
significantly higher intakes of animal protein in g/d than women, 62.1 g/d compared with 
59.0 g/d (P<0.0001). However, there was no significant difference between animal protein 
intake as a percentage of total energy 12.0% for men and 11.7% for women or as a 
percentage of total protein intake 69.8% for men and 69.3% for women. Mean plant 
protein intake was 25.7 g/d for men and 25.4 g/d for women, which was not significantly 
different. However, men had a significantly higher percentage of energy from plant protein 
5.1% than women 4.8% (P<0.0001). There was no significant difference in plant protein 
intake as a percentage of total protein 30.2% for men and 30.7% for women.  
In terms of intake of specific animal protein foods in g/d, men had significantly higher 
intakes of red meat (P<0.0001), poultry (P<0.05) and processed meat (P<0.01) than women. 
Whereas women had significantly higher intakes of fish (P<0.05), and dairy products 
(P<0.05) including disaggregated milk (P<0.05), yogurt (P<0.0001) and other dairy products 
(P<0.001) but not cheese. There was no significant difference in egg intake. For intake of 
plant foods in g/d men had significantly higher cereals intake (P<0.01) and women had 
significantly higher intakes of nuts and seeds (P<0.05), and fruit (P<0.001) but there was no 
significant difference in intake of potatoes, vegetables or legumes.  
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There were also some reported changes in consumption pattern with age. For example in 
men in older age groups lower amounts of red meat were consumed, but higher amounts 
of offal and fish were eaten, perhaps due to offal being a more common constituent of the 
older generation’s diets than the younger population. In women there was an overall 
increase in animal protein intake with age, with individual increases in offal, fish and yogurt 
consumption. In both sexes milk intake was lower in older individuals (aged 55-79) 
compared with younger age groups (18-34 years). There was higher fruit and vegetable 
intake in older age groups of both men and women, and potato intake in women only 
compared with younger age group. In women nuts and seeds intake was lowest in the 
oldest group (55-79 years). There was no significant change in poultry or processed meat, 
although intakes tended to be lower in older age groups. Egg and cereals intake was largely 
similar across the age groups for both men and women.  
Total protein intake in this cohort was largely driven by animal protein intake for both men 
and women. Analysis of protein intakes from specific foods across quartiles of protein 
intake showed significant increases in a number of animal protein foods including muscle 
red meat, poultry and fish (P<0.0001 for all) and dairy proteins (P<0.0001) for both men 
and women. Fruit intake in men decreased significantly (P<0.001) across quartiles and 
vegetable intake in both men and women showed a significant positive trend with 
increasing total protein intake (P<0.01 for men and P<0.0001 for women). Whereas there 
was little change in intake of other plant protein food sources across quartiles of total 
protein intake for men and women.  
Germany 
In a German population of men and women aged 45-64, two 7-day weighed records 
completed as part of the MONICA Project were used to assess trends in sources of dietary 
nutrients (307). Survey two was carried out in 1994/95 close to the time the EPIC-Norfolk 
food diaries were completed. Meat and meat products were the highest source of protein 
and accounted for 44.0% of protein intake. In an earlier survey, completed in 1984-85, the 
contribution of meat was higher and accounted for 47.5% of protein intake (307). Milk 
products, including cheese, and bread and cereal products also contributed highly to 
protein intake 13.3% and ~20% respectively. Vegetables contributed more highly, 8.0%, 
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than fruit, 1.4%. Fish and eggs were also relatively small contributors to protein intake 4.4% 
and 5.1% respectively in this German cohort.  
Spain 
A population study of 4,701 Spanish men and women aged 10-75 years assessed dietary 
intake using two repeated 24hr recalls between 1992 and 93 (312). This study assessed 
protein intake for the whole population and also across a range of age groups. For the 
purpose of this thesis only age groups which correspond with the age range of the EPIC-
Norfolk cohort (39-80 years) will be included. In addition the protein requirements of 
children and adolescents differs from that of the adult population due to increased demand 
to support growth and development. The total protein intake of adults in the Spanish 
cohort was 110.5, 96.4 and 90.2 g/d for men aged 25-44, 45-64 and 65-75 years respectively 
(312). Total protein intake was lower in women 85.8, 84.7 and 79.4 g/d for women aged 
25-44, 45-64 and 65-75 years respectively. In both men and women animal protein intake 
contributed most highly to total protein intake in all age groups, 82.2, 70.9 and 64.8 g/d for 
men aged 25-44, 45-64 and 65-75 years respectively and 64.0, 65.3 and 56.7 g/d for 
women. Vegetable protein intake was higher in men 27.8, 24.5 and 24.2 g/d for men and 
aged 25-44, 45-64 and 65-75 years respectively than women 19.3, 19.0 and 18.6 g/d for 
women aged 25-44, 45-64 and 65-75 respectively (312).  
The three main contributing sources to total protein intake as a percentage energy for the 
whole cohort (ages 10-75 years) were meats, accounting for 18% of intake, fish contributing 
to 14.7% of intake and poultry contributing 14.0% to total protein (312). These also formed 
the three highest contributing sources to animal protein intake. There was also a relatively 
high contribution from dairy products, 16.7%, and sausages, 9.9%. The majority of plant 
protein was from cereals, 51.4%, and this contributed 13% to total protein intake. 
Vegetables, pulses and fruits also contributed highly to plant protein intake 9.2%, 8.3% and 
7.8% respectively but a lesser extent to total protein intake 2.3%, 2.1% and 2.0% for 
vegetables, pulses and fruits respectively (312).   
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Comparisons across European populations 
In the previously mentioned study by Halkjær et al (309), there is further evidence of 
differences to protein intake and the contributing food sources across countries (309). In 
their study, which included 27 cohorts across 10 European countries, the highest total 
protein intakes were seen in Spanish populations. The San Sebastian cohort had the highest 
total protein intakes for both men and women, 144.0 and 102.2 g/d respectively. This was 
also reflected in the animal protein consumption where the San Sebastian cohort also had 
the highest intake. Animal protein contributed to 73% and 71% of total protein intake of 
men and women in the Spanish cohort. The lowest protein intakes, other than the health 
conscious group in the UK were from the Greek cohort with mean intakes of 88.5 and 62.2 
g/d for men and women. Men and women in the Potsdam, Germany, cohort also had 
relatively low protein intakes, compared with other cohorts, 89.7 and 62.7 g/d for men and 
women (309). There was also wide variation in the mean intakes of animal and plant 
protein between the different cohorts. Animal protein intakes ranged from 105.2 g/d in the 
San Sebastian cohort to 16.5 g/d in the UK health conscious cohort in men and 66.8 g/d 
and 17.1 g/d for women in the same cohorts. There was also variation in the percentage 
contribution to total protein intake, 73% in Asturias, Spain, and 23 % in the health conscious 
UK group for men. In women the highest contribution to total protein was 71% in the San 
Sebastian cohort, Spain, and lowest was 29% in the health conscious UK cohort.  
The contributing food sources to protein subtypes also tended to differ between countries. 
For example in the San Sebastian cohort where total protein and animal protein intakes 
were highest, red meat contributed 30.2% and 22.2% of intake for men and women. 
Whereas in Umeå, Sweden, it was only 21.9% and 18.7% respectively (note intakes were 
lower in health conscious UK cohort). There was also wide variation in the consumption of 
processed meat, the lowest contributions were seen in the Greek cohort where processed 
meat contributed 3.5% and 3.3% of animal protein intake for men and women respectively. 
This was actually lower than the health conscious UK cohort. The highest percentage 
contribution from processed meat was 29.7% and 20.9% for men and women in the 
Potsdam, Germany, cohort (309).  
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There was also a difference in the percentage contribution of food sources to plant protein 
intake. Cereals were the highest contributing source to plant protein intake in all cohorts. 
In men the highest contribution of 69.1 % in the Ragusa, Italy, cohort and in women it was 
60.7% in the female only Naples, Italy, cohort. Vegetable intake tended to be the second 
highest source of plant protein for both men and women, followed by fruit. There was more 
variation in the intake of legumes, with higher intake tending to be in the more southern 
European countries for example 15.6% in Asturias, Spain and 0.1% in Aarhus, Denmark for 
men. The contribution of cakes to plant protein intake ranged from 1.4% in Ragusa, Italy, 
to 6.3% in Umeå, Sweden, in men. In women the range was 3.1% in Florence, Italy and 
Copenhagen, Denmark, to 8.1% in Umeå, Sweden. In some countries, Germany and 
Denmark, there was also relatively high percentage contribution of non-alcoholic drinks to 
plant protein intake. The highest was 13.1% and 11.0% for men and women respectively in 
Heidelberg, Germany, compared with lowest of 0.7% in men in San Sebastian and 1.4% for 
women in Murcia, both Spain (309). 
Halkjaer et al (309) also highlighted the difference in protein intakes of men and women, 
and contribution of animal and plant protein to total protein intake. In addition there is 
evidence to suggest that the contributing sources to animal and plant protein intake also 
differ between sexes and it is therefore important to conduct sex-stratified analyses.  
These differences in the overall intake of protein and also variation in the contributing 
sources to protein intakes illustrate the requirement to investigate the effects of dietary 
protein intakes and health outcomes in individual countries.  
4.0.3 Sources of protein in the American Diet 
In the US as part of the National Health and Nutrition Examination Survey (NHANES) the 
dietary sources of a number of nutrients, including protein, were determined. Data from 
24h recalls completed between 1989-1991 highlighted the main contributing source to 
protein intake in American adults was beef (313) which contributed to 17.7% of energy 
from protein for adults. Poultry accounted for a further 13.7%. In an update of the NHANES 
study 2003-2006 the two highest contributing sources of protein in adults diets remained 
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beef and poultry, however poultry contributed slightly more to total protein intake than 
beef.  
Using dietary data from NHANES 1988-1991 Smit et al (145) sought to establish intakes of 
animal and plant protein in US population. They reported a mean intake of 97 (±1.5) g/d 
total protein for men and 65 (±0.7) g/d for women. This was equivalent to 15% of energy 
intake for both men and women. Total animal protein intakes were 67.5 (±0.4) g/d and 66.1 
(±0.4) g/d for men and women. This difference was statistically significant (P≤0.01). The 
highest individual source was beef 18.4% protein for men and 13.6% for women (P≤0.01). 
Total plant protein intakes were significantly higher in women, 33.9% of protein compared 
with men 32.5% (P≤0.01). Plant protein intake was largely made up of grain consumption 
accounting for 18.0% and 18.1% of protein intake for men and women respectively. 
Women had significantly higher fruit and vegetable intake than men 10.5% compared with 
9.1% (P≤0.01). There was no significant difference in percentage contribution of legumes 
or nuts and seeds. In addition Smit et al (145) investigated at the ratio of animal:plant 
protein intake, and noted that men had a significantly higher ratio of animal:plant protein 
intake than women, 2.9 compared with 2.7 (P≤0.05). 
4.0.4 Sources of protein in other countries 
Japan 
In a small study of 59 men and 60 women conducted in a rural Japanese population, the 
main contributing source of protein intake was found to be rice, accounting for 13.0% of 
protein intake (314). Intakes were recorded using four 3 day food diaries repeated over the 
period of a year to account for potential effects of different seasons on dietary intakes 
(314). Miso soup was the second highest contributing source to protein intake (8.7%) and 
intakes of fish also contributed highly (7.5 and 6.2% for roast and raw fish respectively). 
Two of these foods, Miso soup and roast fish, were the two primary sources of sodium in 
the diet accounting for a cumulative total of 24.5% of total sodium intake. In terms of stroke 
risk this is significant, as high salt intakes are a risk factor for stroke directly and also for 
blood pressure, which is a contributing factor to stroke risk. 
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Iran 
In a cohort of 2,537 Iranian men and women aged 19-70 years, part of the Tehran Lipid and 
Glucose Study, total protein intake was significantly associated with higher animal protein 
intake (P<0.05) but not plant protein intake in men and women (173). There was also a 
significant trend towards a higher ratio of animal:plant protein intake with increase total 
protein intake in both men and women (P<0.05). Several differences in the association of 
total protein intake and ratio of animal:plant protein intake were noted between men and 
women. For example a higher total protein and ratio of animal:plant protein intake was 
associated with significantly lower waist circumference in women but not men. And a 
higher ratio of animal:plant protein intake was associated with significant lower fasting 
serum glucose in women, however a higher total protein intake appeared to have the 
converse affect (173). This suggests that it is perhaps the ratio of consumption of animal 
and plant protein that is of importance to reduce fasting glucose, and potentially other risk 
factors, rather than overall protein intake.  
In summary this evidence demonstrates differences in the contributing sources to protein 
intake in different countries. In the UK Cade and Margetts (178) reported white bread and 
flour as the primary source of dietary protein. However, this was largely due to the 
methodology employed to disaggregate food items in this study, for example choosing to 
look at individual meat components e.g. beef as opposed to total meat intake which is more 
commonly used approach in other studies. More recently, the NDNS identified meat and 
meat products as the highest contributors to total and animal protein intake (221). This is 
similar to a study reporting on dietary intakes of a German population in 1994/95 where 
meat and meat products contributed to 44% of protein intake and in the US NHANES study 
beef was identified as the highest single contributing source to protein in %en accounting 
for 17.7 %en. In contrast to Western populations in a rural Japanese population rice was 
the primary source of protein, although fish was the second highest source of protein (314).  
The majority of previous research has been focussed on total dietary protein intake and 
consumption of specific high protein foods such as red meat and fish. There has, to date, 
been less emphasis on the origin of protein being plant or animal based and how 
contributing sources differ across a range of intakes of animal and plant-based protein %en 
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and ratio of plant:animal protein (178, 307, 309-315). However, it is clear that the 
contributing sources to protein intake differ between the UK and other countries, and there 
has been limited research on the contributing sources to protein intake in the UK diet. The 
quality of dietary protein intake is an emerging field in terms of health outcomes, therefore 
it is important to establish the pattern of protein consumption in the UK diet so that the 
findings, where appropriate, may inform future dietary interventions and public health 
policy. To the best of my knowledge no other study has investigated how contributions of 
foods differ depending on the type of protein (animal, plant and ratio plant:animal). It is 
important to understand the contributions to protein intake and how they differ between 
subtypes of protein and sex. This knowledge may help to elucidate mechanisms of action 
of potential associations between dietary protein intake (including subtypes of protein) and 
stroke risk and risk factors.  
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4.1 Aims and hypotheses 
This chapter aims to address research question 2, outlined in the introductory chapter, 
Chapter One. 
2. “What are the main contributing sources of dietary protein intake, and how do the 
subtypes of protein (animal, plant and ratio of plant:animal) and food group sources of 
protein differ between men and women?” 
 
2a. How do different groups of animal and plant-based protein intakes (animal-land, -
marine, -derived and plant protein) contribute to intakes of total protein, total animal, total 
plant protein and the ratio of plant:animal protein. The hypothesis was that higher total 
protein intake would be associated with higher intakes of animal protein and lower intakes 
of plant-based protein.   
2b. To investigate if there was a difference in the main contributing sources of protein for 
men and women. The hypothesis was that protein intake would come from different 
sources for men and women. 
2c. To investigate whether there were differences in the main contributions for the 
different sources of protein (animal, plant and ratio of plant:animal). The hypothesis was 
that the contribution of protein (animal-land, -marine, -derived and plant protein) would 
differ across quintiles of subtypes of protein (animal protein, plant protein and ratio of 
plant:animal protein). This also included investigating how the contribution of individual 
food items of plant and animal origin, such as red meat, eggs, milk, bread, cereals and fruit 
and vegetables, contribute to the ratio of plant:animal protein intake specifically, as it was 
hypothesised this approach would be less prone to potential bias associated with total 
energy intake. The hypothesis was that the consumption of plant-based foods such as 
bread, cereal, fruits and vegetables would contribute more highly to protein intake with an 
increasing ratio of plant:animal protein intake and that consumption of animal-based foods 
would decrease. 
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4.2 Methods 
This chapter is based on the dietary intakes of 4,443 men and women aged 39-80 years. 
These participants are a representative sub-sample of the larger (n>25,000) EPIC-Norfolk 
cohort. Full study methods including further detail on the study population are presented 
in Chapter Two – Subjects and Methods. 
Dietary protein intake was measured using 7DD. Myself and another PhD candidate in 
nutritional epidemiology independently classified the protein composition of 
approximately 11,000 food items from the previously entered EPIC-Norfolk food diary 
database. Food items were classified to contain one or more of the following types of 
protein; animal-land, animal-marine, animal-derived and plant protein, more detail on the 
criteria for inclusion into each category is detailed in the subsequent paragraph. After 
independently classifying food items, we compared results and discussed discrepancies. 
For food items where we were unsure of their classification we further discussed 
classification with collaborators at EPIC-Norfolk. In some instances foods were not able to 
be classified according to source of protein and these were incorporated into an 
unclassified group. 
The types of food and food items included in each of these categories were as follows; 
animal-land encompassed items which included meat from land based animals (such as 
beef, poultry, and pork). Animal-marine was comprised of items containing fish or seafood. 
Animal-derived included items where animal products, such as milk, eggs and lard formed 
part or all-of the items. Plant-protein was food items from any plant based source including 
grains, pulses, fruits and vegetables. In addition there was a small ‘unclassified’ category 
which included products such as honey. These products were deemed to not substantially 
influence overall protein intake and therefore their exclusion from other groups is unlikely 
to influence findings and conclusions. It was possible that items could contain more than 
one source of protein. For example ‘fish in white sauce’ would be categorised to include 
animal-marine, animal-derived and plant-protein for the fish, milk and plain flour 
components respectively. Collaborators at EPIC-Norfolk then assigned the amount of 
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protein from each subtype (animal-land, -marine, -derived, plant protein) during the 
creation of new variables. 
Statistical analysis 
Sex stratified analyses were conducted due to the differences in dietary requirements of 
men and women and to reflect the stratification by sex throughout the thesis. Dietary 
intakes were stratified by quintiles of type of protein and included quintiles of protein as 
%en, animal protein %en intake, plant protein %en intake and the ratio of plant to animal 
protein intake. These categories were chosen to identify if there were differences in 
patterns of intake in those with higher and lower intakes of plant and animal based protein 
intakes. Additionally quintiles of ratio of plant:animal protein intake were used to 
determine if there were differences in the main contributing food items and the intake of 
nutrients and foods with established associations with stroke risk in those with a higher 
ratio of plant:animal protein (i.e. high plant-protein intake) than those with lower ratio (i.e. 
higher animal-protein intake). The mean and SD of each type of protein (animal-land, 
animal-marine, animal-derived and plant protein) were calculated for each quintile and 
expressed as g/d. 
Variables of protein intake as a percentage of total energy were created by multiplying the 
protein intake in g/d by 4 (the number of kcal in one gram of protein), divided by total 
energy intake and multiplying by 100: 
(protein*4/total energy)*100 
The ratio of plant:animal protein intake was calculated by dividing plant protein intake by 
animal protein intake. 
Regression analysis was used to determine trends across quintiles of protein intake 
(including subtypes) as %en and significant differences in intakes compared with the lowest 
quintile. A P value was considered significant if ≤0.05. 
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4.3 Results 
Baseline characteristics are as described in full in the previous chapter, Chapter Three – 
Influence of dietary magnesium intake on stroke risk and risk factors, Table 3.9. Briefly the 
cohort was comprised of 4,443 men and women, with a mean age of 61 and 60 years 
respectively. Forty five percent of the cohort were male. Mean BP was 140/85 and 136/82 
mmHg for men and women respectively which was significantly different (P<0.001 for both 
SBP and DBP). TC was 6.07 (±1.10) and 6.36 (±1.22) in men and women respectively. 
Significantly more men than women reported taking aspirin, 13.6% compared with 8.1% 
(P<0.001), there was no significant difference in the use of antihypertensive medication. 
There was also no significant difference in the percentage of men and women reporting a 
family history of stroke, MI or diabetes. Women were more likely to have never smoked, 
but be less physically active than men. Men were most likely to be educated to A-Level or 
equivalent 44.4% (women 33.7%) whilst women were most likely to have no qualifications 
44.5% (men (33.4%).  
Dietary protein intakes were mostly significantly different between men and women (Table 
4.0) with the exception of animal-land %en (P=0.11) and the ratio of plant:animal protein 
intake (P=0.82). Women had a slightly higher percentage of energy from total protein, 
15.8% vs 15.0% (P<0.001), total animal protein, 67.8% vs 67.2% (P<0.001), animal-marine 
1.54% vs 1.36% (P<0.001), animal-derived, 4.29% vs 3.69% (P<0.001) and plant protein 
4.73% vs 4.64 (P=0.01). 
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Table 4.0 Mean intakes of dietary total protein and types of protein in grams/d, as a 
percentage of energy intake and as a percentage of protein intake for men and women 
(mean and standard deviation). 
 Men 
n=2000 
Women 
n=2443 
P value 
Total Energy kcal/d 2218 (±505) 1685 (±384) <0.001 
Total protein    
Total protein g/d 81.5 (±17.8) 65.1 (±14.1) <0.001 
Total protein %en 15.0 (±2.58) 15.8 (±2.87) <0.001 
Animal protein    
Animal protein g/d 55.0 (±14.8) 44.5 (±12.4) <0.001 
Animal protein % en 10.1 (±2.49) 10.8 (±2.81) <0.001 
Animal protein %protein 67.2 (±8.33) 67.8 (±8.77) 0.01 
Animal-land g/d 27.4 (±12.7) 20.3 (±10.3) <0.001 
Animal-land %en 5.08 (±2.37) 4.96 (±2.60) 0.11 
Animal-land %protein 33.3 (±12.6) 30.6 (±13.2) <0.001 
Animal-marine g/d 7.16 (±6.56) 6.23 (±5.24) <0.001 
Animal-marine %en 1.36 (±1.33) 1.54 (±1.38) <0.001 
Animal-marine %protein 8.79 (±7.88) 9.56 (±8.04) 0.001 
Animal-derived g/d 20.4 (±8.93) 18.0 (±7.85) <0.001 
Animal-derived %en 3.69 (±1.40) 4.29 (±1.65) <0.001 
Animal-derived %protein 25.1 (±9.45) 27.6 (±10.1) <0.001 
Plant protein    
Plant protein g/d 25.5 (±7.94) 19.6 (±5.87) <0.001 
Plant protein %en 4.64 (±1.17) 4.73 (±1.21) 0.01 
Plant protein %protein 31.5 (±8.20) 30.7 (±8.65) 0.001 
Ratio plant:animal protein    
Ratio plant:animal protein g/d 0.50 (±0.23) 0.49 (±0.54) 0.82 
Ratio plant:animal protein  0.50 (±0.23) 0.49 (±0.54) 0.82 
Ratio plant:animal protein %protein 0.50 (0.23) 0.49 (±0.43) 0.82 
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Table 4.1. The contribution of four sources of protein (g/d), animal land, animal marine, animal derived and plant protein, stratified by quintiles of total 
protein intake as a percentage of total energy intake in 4443 men and women aged 39-80 years 
 Total protein %en  
Men Q1 Q2 Q3 Q4 Q5  
 7.18-12.9% 
n=400 
13.0-14.1% 
n=400 
14.2-15.2% 
n=400 
15.3-16.9% 
n=400 
17.0-32.2% 
n=400 
P trend 
Animal land (g/d) 20.9 (±10.5) 25.5 (±10.5) 27.6 (±11.1) 29.5 (±11.5) 33.5 (±15.8) <0.001 
Animal marine (g/d) 4.92 (±5.05) 6.33 (±5.67) 6.68 (±5.57) 8.05 (±6.29) 9.80 (±8.59) <0.001 
Animal derived (g/d) 20.6 (±9.35) 21.0 (±8.00) 20.9 (±8.51) 20.7 (±9.34) 19.0 (±9.25) 0.01 
Plant (g/d) 26.3 (±8.30) 26.0 (±7.58) 25.5 (±7.12) 25.6 (±8.71) 24.0 (±7.74) <0.001 
Women 8.13-13.2% 
n=489 
13.3-14.7% 
n=489 
14.8-16.1% 
n=488 
16.2-17.8% 
n=489 
17.9-30.8% 
n=488 
 
Animal land (g/d) 13.9 (±8.34) 18.7 (±8.36) 20.1 (±8.85) 22.6 (±9.63) 26.0 (±11.9) <0.001 
Animal marine (g/d) 4.48 (±4.73) 5.83 (±4.73) 6.48 (±4.93) 6.78 (±4.95) 7.56 (±6.19) <0.001 
Animal derived (g/d) 17.4 (±7.12) 19.1 (±7.43) 18.3 (±7.97) 17.8 (±7.12) 18.0 (±7.85) 0.40 
Plant (g/d) 20.4 (±6.33) 20.4 (±6.04) 20.1 (±5.87) 19.2 (±5.22) 18.1 (±5.51) <0.001 
Animal-land includes all land-based meat and meat products such as beef, pork, sausages; animal-marine includes all fish and seafood; animal-derived 
includes all animal products such as milk, eggs and lard; plant is from any plant source including grains, fruit, vegetables nuts and legumes. 
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Total protein as percentage of total energy 
Table 4.1 shows the contributions of different sources of protein across quintiles of total 
protein intake, expressed as a percentage of energy intake. As total protein intake increases 
there is a marked and significant increase in protein intakes from animal-land and animal-
marine based protein sources (P trend <0.001 for animal-land and animal-marine for both 
men and women). These categories include items such as meat and meat products, fish 
and seafood, and also mixed food dishes, where the main contributing source to protein 
intake was deemed to be through the animal-land or animal-marine source. For example a 
fish or meat in a dairy based sauce that could not be disaggregated at this time into 
individual components. In this instance the main protein source was deemed to be from 
the meat or fish. In men there was a small but significant decrease in protein from animal-
derived sources such as milk, eggs and cheese as total protein intakes increased (P trend 
0.01). For both men and women there was a modest but significant decrease, of 
approximately 2 g/d, in protein from plant sources between extreme quintiles of total 
protein intake (P trend <0.001 for men and women respectively).  
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Figure 4.1. The percentage contribution of different types of protein intake (animal-land, -
marine, –derived, and plant) to total protein intake %en in 2,000 men aged 39-80 years.  
Figure 4.2. The percentage contribution of different types of protein intake (animal-land, -
marine, -derived, and plant protein) to total protein %en in 2,443 women aged 39-80 years.  
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Figures 4.1 and 4.2 illustrate the percentage contribution of different types of protein 
(animal-land, -marine, -derived, and plant protein) across quintiles of total protein as %en 
intake for men and women respectively. In both men and women, the percentage 
contribution of animal-land increased sequentially with each quintile. In addition there was 
a steady decrease in the percentage contribution of plant protein intake with increasing 
total protein as %en intake. In men (figure 4.1) there was a greater increase in contribution 
of animal-marine across the quintiles than for women which was coupled by a slightly larger 
decrease in the proportion of consumption of animal-derived sources.   
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Table 4.2 The contribution of four sources of protein (g/d), animal land, animal marine, animal derived and plant protein, stratified by quintiles of total 
animal protein intake as a percentage of total energy intake in 4443 men and women aged 39-80 years 
 Animal protein %en  
Men Q1 Q2 Q3 Q4 Q5  
 2.71-8.23% 
n=400 
8.24-9.41% 
n=400 
9.42-10.4% 
n=400 
10.5-11.8% 
n=400 
11.9-27.4% 
n=400 
P trend 
Animal land (g/d) 18.5 (±9.50) 24.4 (±9.55) 28.1 (±10.6) 30.2 (±10.9) 35.8 (±15.2) <0.001 
Animal marine (g/d) 4.83 (±5.15) 6.02 (±5.02) 7.46 (±6.19) 7.73 (±6.34) 9.75 (±8.47) <0.001 
Animal derived (g/d) 18.9 (±8.72) 21.1 (±8.17) 21.1 (±8.46) 21.3 (±9.53) 19.8 (±9.51) 0.17 
Plant (g/d) 30.5 (±9.23) 26.4 (±6.76) 25.7 (±7.12) 23.4 (±6.46) 21.4 (±6.77) <0.001 
Women 0.43-8.58% 
n=489 
8.59-9.99% 
n=489 
10.0-11.2% 
n=488 
11.3-12.8% 
n=489 
12.9-26.0% 
n=488 
 
Animal land (g/d) 11.9 (±7.74) 18.4 (±7.48) 20.3 (±8.06) 23.5 (±9.11) 27.3 (±11.6) <0.001 
Animal marine (g/d) 4.27 (±4.25) 5.92 (±4.93) 6.40 (±4.73) 6.75 (±5.21) 7.79 (±6.22) <0.001 
Animal derived (g/d) 16.4 (±7.10) 17.9 (±6.84) 18.8 (±7.31) 18.5 (±8.01) 18.4 (±9.51) <0.001 
Plant (g/d) 23.5 (±7.11) 20.4 (±5.17) 19.5 (±4.79) 18.4 (±4.84) 16.5 (±4.63) <0.001 
Animal-land includes all land-based meat and meat products such as beef, pork, sausages; animal-marine includes all fish and seafood; animal-derived 
includes all animal products such as milk, eggs and lard; plant is from any plant source including grains, fruit, vegetables nuts and legumes. 
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Animal protein as percentage of total energy 
As expected higher animal protein intakes were associated with increasing intakes of 
protein from animal-land and animal-marine sources (Table 4.2). For men there was a 
difference of ~17 g/d and women ~15 g/d between the extreme quintiles of protein from 
animal-land sources (P trend <0.001). In men protein from animal-marine sources 
approximately doubled from the lowest to the highest quintile of animal protein (4.83 g/d 
to 9.75 g/d) (P trend <0.001). There was also a difference of protein from animal-marine 
sources in women of approximately 3 g/d between the extreme quintiles (P trend <0.001). 
The mean intakes of protein from animal-derived sources remained fairly consistent across 
the quintiles with small variation of 1-2 g/d for both men and women. There was no 
significant association between protein from animal-derived sources and intakes of animal 
protein in men (P trend 0.17). However in women there was a trend towards an increase 
in protein from animal-derived sources across the quintiles (P trend <0.001). 
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Table 4.3 The contribution of four sources of protein (g/d), animal land, animal marine, animal derived and plant protein, stratified by quintiles of plant 
protein intake as a percentage of total energy intake in 4443 men and women aged 39-80 years 
 Plant protein %en  
Men Q1 Q2 Q3 Q4 Q5  
 1.44-3.67% 
n=400 
3.68-4.23% 
n=400 
4.24-4.75% 
n=400 
4.76-5.51% 
n=400 
5.52-11.0% 
n=400 
P trend 
Animal land (g/d) 30.2 (±13.2) 29.8 (±11.9) 27.9 (±11.6) 26.4 (±13.2) 22.7 (±12.3) <0.01 
Animal marine (g/d) 7.24 (±7.24) 7.00 (±5.95) 6.94 (±6.17) 7.47 (±6.45) 7.14 (±6.94) 0.79 
Animal derived (g/d) 22.4 (±9.98) 21.4 (±9.14) 21.1 (±8.59) 19.1 (±8.11) 18.3 (±8.08) <0.001 
Plant (g/d) 18.5 (±5.03) 22.8 (±4.88) 25.2 (±5.48) 27.5 (±6.20) 33.4 (±8.70) <0.001 
Women 0.00-3.75% 
n=489 
3.76-4.34% 
n=489 
4.35-4.91% 
n=488 
4.92-5.58% 
n=489 
5.59-13.2% 
n=488 
 
Animal land (g/d) 23.0 (±11.4) 21.3 (±9.72) 21.1 (±9.21) 19.8 (±9.70) 16.1 (±10.1) <0.001 
Animal marine (g/d) 6.44 (±5.76) 6.42 (±5.07) 5.95 (±4.74) 6.30 (±5.43) 6.03 (±5.12) 0.21 
Animal derived (g/d) 20.8 (±9.26) 18.7 (±8.05) 18.3 (±7.33) 16.9 (±6.38) 15.4 (±6.85) <0.001 
Plant (g/d) 14.6 (±3.91) 17.7 (±3.95) 19.8 (±3.98) 21.5 (±4.51) 24.7 (±6.90) <0.001 
Animal-land includes all land-based meat and meat products such as beef, pork, sausages; animal-marine includes all fish and seafood; animal-derived 
includes all animal products such as milk, eggs and lard; plant is from any plant source including grains, fruit, vegetables nuts and legumes. 
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Plant protein as a percentage of total energy 
There were marked decreases in the intake of protein from animal-land sources across 
quintiles of plant protein in both men and women (P trend <0.001 for men and women) 
(Table 4.3). However, protein from animal-marine sources remained relatively constant 
and was reflected in no significant trend (P trend = 0.79 and 0.21 for men and women 
respectively). There was a small, but significant, trend of lower intakes of protein from 
animal-derived sources with increasing plant protein %en in both men and women (P trend 
<0.001 for both). A difference of approximately 4 g/d and 5 g/d was identified for men and 
women respectively between the extreme quintiles. Protein from plant sources 
significantly increased, as expected, across the quintiles for both men and women (P trend 
<0.001 for both).  
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Table 4.4 The contribution of four sources of protein (g/d), animal land, animal marine, animal derived and plant protein, stratified by quintiles of the ratio 
of plant:animal protein intake in 4443 men and women aged 39-80 years 
 Ratio plant:animal protein   
Men Q1 Q2 Q3 Q4 Q5  
 0.07-0.33% 
n=400 
0.34-0.40% 
n=400 
0.41-0.48% 
n=400 
0.49-0.59% 
n=400 
0.60-2.71% 
n=400 
P trend 
Animal land (g/d) 34.4 (±14.2) 30.8 (±12.5) 27.9 (±10.6) 25.8 (±9.13) 18.1 (±10.4) <0.001 
Animal marine (g/d) 8.77 (±7.96) 7.49 (±6.48) 7.22 (±6.29) 6.36 (±5.24) 5.94 (±6.21) <0.001 
Animal derived (g/d) 22.0 (±10.2) 21.1 (±8.73) 20.8 (±8.68) 19.7 (±7.86) 18.7 (±8.75) <0.001 
Plant (g/d) 18.0 (±4.69) 22.5 (±4.74) 25.2 (±5.40) 28.0 (±5.62) 33.7 (±8.53) <0.001 
Women 0.00-0.32% 
n=489 
0.33-0.38% 
n=489 
0.39-0.46% 
n=488 
0.47-0.57% 
n=489 
0.58-22.4% 
n=488 
 
Animal land (g/d) 26.3 (±11.7) 22.7 (±9.06) 21.4 (±8.33) 18.8 (±8.22) 12.1 (±7.94) <0.001 
Animal marine (g/d) 7.43 (±6.20) 6.94 (±5.35) 5.92 (±4.82) 614 (±4.81) 4.70 (±4.40) <0.001 
Animal derived (g/d) 20.8 (±9.65) 18.5 (±7.97) 18.2 (±7.15) 16.6 (±6.40) 15.9 (±6.76) <0.001 
Plant (g/d) 14.3 (±3.82) 17.4 (±3.54) 19.6 (±3.74) 21.5 (±4.43) 25.4 (±6.40) <0.001 
Animal-land includes all land-based meat and meat products such as beef, pork, sausages; animal-marine includes all fish and seafood; animal-derived 
includes all animal products such as milk, eggs and lard; plant is from any plant source including grains, fruit, vegetables nuts and legumes. 
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Ratio of plant:animal protein 
As the ratio of protein from plant to animal sources increased there was a significant trend 
towards lower intakes of protein from animal-land, animal-marine and animal-derived 
sources in both men and women (P trend <0.001 for all) (Table 4.4). In addition there was 
significant trend towards higher intakes of protein from plant sources across quintiles (P 
trend <0.001 for men and women). In men the protein from animal-land sources of the 
highest quintile of ratio plant:animal protein was approximately half that of the lowest 
quintile. There were also differences of approximately 3 and 4 g/d for protein from animal-
marine and animal-derived sources between the extreme quintiles for men. Similarly in 
women the intake of protein from animal-land sources in the lowest quintile of ratio 
plant:animal was more than double that of the highest quintile and there were differences 
of 3 and 5 g/d for protein from animal-marine and animal-derived sources respectively.  
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Figure 4.3 The percentage contribution of different types of protein intake (animal-land, -
marine, -derived, and plant protein) across quintiles of ratio plant:animal protein in 2,000 
men aged 39-80 years. 
Figure 4.4 The percentage contribution of different types of protein intake (animal-land, -
marine, -derived, and plant protein) across quintiles of ratio plant:animal protein in 2,443 
women aged 39-80 years. 
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Figures 4.3 and 4.4 illustrate the differences in contributing sources of protein across 
quintiles of the ratio of plant:animal protein for men and women respectively representing 
data shown in Table 4.3. There was a similar percentage contribution of plant protein to 
total intakes for men and women. Differences in percentage contributing sources were 
mainly in relation to the proportion of animal-land and animal-derived consumption. In 
men animal-land contributed more highly to total intake than in women, whereas women 
had a higher percentage contribution from animal-derived sources. The percentage 
contribution of animal-marine was relatively similar for both men and women across 
quintiles of ratio plant:animal protein. 
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Table 4.5 The contribution of food items (g/d) stratified by ratio of plant:animal protein intake in 4,443 men and women age 39-80 years 
 Ratio plant:animal protein  
Men Q1 Q2 Q3 Q4 Q5  
 0.07-0.33 
n=400 
0.34-0.40 
n=400 
0.41-0.48 
n=400 
0.49-0.59 
n=400 
0.60-2.71 
n=400 
P trend 
Red meat (g/d) 25.7 (±33.7) 23.3 (±24.4) 21.0 (±25.4) 17.9 (±20.6) 11.0 (±17.9) <0.001 
Poultry (g/d) 18.5 (±24.0) 19.1 (±26.3) 17.1 (±20.6) 16.2 (±21.4) 11.8 (±19.7) <0.001 
Meat other (g/d) 122 (±96.1) 98.7 (±67.3) 93.4 (±66.7) 86.8 (±56.7) 64.3 (±59.4) <0.001 
Fish (g/d) 50.6 (±48.3) 42.5 (±38.8) 41.2 (±37.3) 36.6 (±30.7) 34.4 (±36.9) <0.001 
Eggs (g/d) 18.5 (±22.2) 17.2 (±19.3) 15.1 (±15.5) 15.2 (±19.9) 13.8 (±18.7) <0.001 
Milk (g/d) 234 (±186) 224 (±147) 218 (±148) 200 (±139) 196 (±137) <0.001 
Dairy other (g/d) 74.5 (±72.8) 73.2 (±66.9) 69.1 (±64.0) 72.5 (±60.0) 66.6 (±66.2) 0.12 
Bread (g/d) 75.8 (±37.1) 101 (±45.8) 113 (±47.4) 125 (±51.9) 146 (±68.8) <0.001 
Cereal (g/d) 157 (±119) 161 (±107) 166 (±97.5) 162 (±91.1) 180 (±117) 0.01 
Fruit and vegetables (g/d) 219 (±137) 237 (±137) 240 (±1430 262 (±143) 318 (±233) <0.001 
Nuts, seeds and legumes (g/d) 26.5 (±28.2) 30.5 (±26.3) 35.4 (±29.9) 38.2 (±33.1) 43.1 (±40.1) <0.001 
Women 0.00-0.32 
n=489 
0.33-0.38 
n=489 
0.39-0.46 
n=488 
0.47-0.57 
n=489 
0.58-22.4 
n=488 
 
Red meat (g/d) 17.6 (±23.2) 16.2 (±18.2) 13.4 (±15.5) 13.0 (±17.3) 8.29 (±12.0) <0.001 
Poultry (g/d) 19.3 (±26.4) 16.9 (±21.0) 16.5 (±21.5) 14.5 (±17.6) 9.51 (±16.3) <0.001 
Meat other (g/d) 97.3 (±26.4) 75.0 (±51.8) 76.1 (±53.0) 63.9 (±48.6) 39.1 (±40.8) <0.001 
Fish (g/d) 41.8 (±38.4) 40.0 (±32.9) 32.8 (±27.3) 34.8 (±29.0) 27.4 (±28.7) <0.001 
Eggs (g/d) 12.9 (±14.8) 12.9 (±12.6) 12.3 (±13.6) 11.0 (±12.7) 10.8 (±16.4) <0.01 
Milk (g/d) 219 (±175) 195 (±147) 190 (±144) 171 (±117) 151 (±109) <0.001 
Dairy other (g/d) 92.3 (±95.2) 80.5 (±67.6) 77.1 (±62.2) 76.0 (±66.7) 75.3 (±67.7) <0.001 
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Bread (g/d) 57.5 (±29.2) 69.1 (±28.9) 81.3 (±30.4) 86.7 (±36.0) 95.1 (±43.5) <0.001 
Cereal (g/d) 134 (±95.6) 128 (±81.5) 125 (±85.2) 128 (±78.4) 140 (±93.0) 0.35 
Fruit and vegetables (g/d) 243 (±151) 276 (±144) 286 (±160) 312 (±167) 345 (±196) <0.001 
Nuts, seeds and legumes (g/d) 18.4 (±20.9) 22.5 (±20.3) 24.5 (±22.3) 25.7 (±22.8) 33.5 (±32.7) <0.001 
Meat other includes meat incorporated in dishes (poultry, red meat, offal and game) offal, game and meat products; dairy other includes all dairy except 
milk (e.g. cheese, yogurt, butter, cream); cereal includes breakfast cereals and other cereal and grains (e.g. rice, crispbreads); nuts, seeds and legumes 
includes all nuts, seeds and legumes (e.g. beans, lentils, peas). 
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In both men and women there was a significant trend towards lower intakes of red meat, 
poultry, other meat, fish, eggs and milk across quintiles of ratio of plant:animal protein 
intake (Table 4.5). Indicating that as the proportion of plant protein in the diet increased 
there was a trend towards lower intakes of these food items (P trend <0.001 for all for men 
and women except eggs in women P trend 0.01). In men there was no significant trend with 
consumption of other dairy products (excluding milk) (P trend 0.12). However, in women 
there was a significant trend towards lower intakes of dairy with higher ratio of 
plant:animal protein intake (P trend <0.001). In both men and women there was a 
significant trend towards higher intakes of fruit and vegetables, and nuts, seeds and 
legumes across quintiles of ratio plant:animal protein intake (P trend <0.001 for both for 
men and women). 
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Table 4.6 Dietary intakes of selected nutrients and foods (g/d unless otherwise specified) associated with stroke risk and risk factors stratified by quintiles of 
ratio of plant:animal protein intake in 4,443 men and women aged 39-80 years.  
 Ratio plant:animal protein  
Men Q1 Q2 Q3 Q4 Q5  
 1.44-3.67 
n=400 
3.68-4.23 
n=400 
4.24-4.75 
n=400 
4.76-5.51 
n=400 
5.52-11.0 
n=400 
P trend 
Total fat 85.5 (±26.6) 86.0 (±24.2) 86.3 (±28.1) 85.7 (±24.8) 81.8 (±25.4 ) 0.06 
MUFA 29.9 (±9.17) 30.0 (±8.67) 30.0 (±9.71) 29.9 (±8.92) 28.7 (±9.37) 0.09 
PUFA 14.8 (±5.68) 15.6 (±5.32) 16.3 (±6.57) 16.4 (±6.01) 17.2 (±6.46) <0.001 
Saturated fat 33.5 (±12.4) 33.2 (±10.9) 32.7 (±12.1) 32.3 (±11.0) 29.2 (±10.9) <0.001 
Sodium (mg) 2986 (±903) 3149 (±853) 3178 (±840) 3205 (±794) 3234 (±907) <0.001 
Fruit and vegetable 219 (±137) 237 (±137) 240 (±143) 262 (±156) 318 (±233) <0.001 
Nut, seeds and legumes 26.5 (±28.2) 30.5 (±26.3) 35.4 (±29.9) 38.2 (±33.1) 43.1 (±40.1) <0.001 
Alcohol 16.2 (±19.1) 16.4 (±20.7) 16.1 (±22.6) 15.9 (±19.9) 14.9 (±21.4) 0.38 
Women 0.00-3.75 
n=489 
3.76-4.34 
n=489 
4.35-4.91 
n=488 
4.92-5.58 
n=489 
5.59-13.2 
n=488 
 
Total fat 66.4 (±22.3) 64.5 (±21.2) 65.6 (±19.4) 63.4 (±19.2) 62.9 (±20.5) 0.01 
MUFA 22.9 (±7.85) 22.3 (±7.38) 22.6 (±6.81) 22.0 (±6.80) 21.7 (±7.55) 0.01 
PUFA 11.6 (±4.87) 11.8 (±4.29) 12.1 (±4.15) 12.5 (±4.30) 13.2 (±5.09) <0.001 
Saturated fat 26.3 (±10.2) 25.0 (±9.68) 25.4 (±8.81) 23.6 (±8.80) 22.8 (±8.80) <0.001 
Sodium (mg) 2387 (±741) 2339 (±621) 2436 (±656) 2446 (±613) 2416 (±658) 0.08 
Fruit and vegetable 243 (±151) 276 (±144) 286 (±160) 312 (±167) 345 (±196) <0.001 
Nut, seeds and legumes 18.4 (±20.9) 22.5 (±20.3) 24.5 (±22.3) 25.7 (±22.8) 33.5 (±32.7) <0.001 
Alcohol 8.13 (±12.7) 8.09 (±12.0) 7.99 (±11.4) 6.99 (±10.6) 7.30 (±11.7) 0.10 
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The difference in intakes of selected nutrients which can influence cardiovascular risk by 
quintiles of ratio plant:animal protein intake is shown in Table 4.5. In men there was no 
significant trend between intakes of total fat and MUFA (P trend 0.06 and 0.09 
respectively). However, in women there was a small, but significant trend towards lower 
intakes of these nutrients with increasing ratio of plant:animal protein intake (P trend 0.01 
for both). There were also contrasting associations between sexes for sodium intakes, in 
men there was a trend towards higher sodium intakes (P trend <0.001) whereas there was 
no significant trend in women (P trend 0.08). There was no significant association between 
alcohol intakes and the ratio of plant:animal protein intake in either men or women (P 
trend 0.38 and 0.10 for men and women respectively).   
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By distributing intakes of animal and plant protein as %en intake in sex-stratified tertiles it 
was possible to assess the relationship between the two types of protein.  It tended to be 
that men in the lowest tertile of plant protein intake as percentage of energy were in the 
highest tertile of animal protein intake as %en (37.7% of population) (Fig 4.5). And vice 
versa for the highest tertile of plant %en and lowest tertile of animal protein as %en (43.0% 
of population). This is also illustrated in relation to total protein intake as %en and animal 
protein % en (Fig 4.6) and plant protein as %en (Fig 4.7) in men. For animal protein (Fig 4.6) 
the majority of the population are in either the lowest tertiles of both total protein and 
animal protein as %en or the highest tertiles. There was a less stark contrast for plant 
protein as %en (Fig 4.7). The same was also true for women (Fig 4.8, 4.9 and 4.10). 
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 Men 
 
Figure 4.5 Percentage of the population in each of the tertiles of plant and animal protein 
as a percentage of total energy intake for 2,000 men. 
 
Figure 4.6 Percentage of population in each of the tertiles of total protein and animal 
protein as a percentage of total energy intake for 2,000 men. 
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Figure 4.7 Percentage of the population in each of the tertiles of total protein and plant 
protein as a percentage of energy for 2,000 men. 
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 Women 
 
Figure 4.8 Percentage of the population in each of the tertiles of animal and plant protein 
as %en for 2,443 women. 
 
Figure 4.9 Percentage of the population in each of the tertiles of total and animal protein 
as a percentage of energy intake in 2,443 women. 
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Figure 4.10 Percentage of the population in each of the tertiles of total and plant protein 
as a percentage of energy intake in 2,443 women. 
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4.4 Discussion 
The findings of the present study indicate that as total protein intake increased there was 
a significant increase in protein intakes from animal-land and animal-marine based sources 
(P trend <0.001 for animal-land and animal-marine for both men and women) (Table 4.1). 
In men there was a small but significant decrease in protein from animal-derived sources 
(P trend 0.01) and protein from plant sources in both men and women (P trend <0.001 for 
men and women respectively) with increasing total protein intake (Table 4.1).  
Women tended to have higher intakes of total protein %en, total animal protein %en, 
protein from animal-marine %en and animal-derived %en sources than men (P<0.001 for 
each respectively) and plant protein %en (P=0.01) (Table 4.0). There was no significant 
difference between protein from animal-land sources (P=0.11) or the ratio of plant:animal 
protein (P=0.82) in this cohort. 
Previously studies in the UK and other Western and Asian countries have aimed to highlight 
the main sources of protein in the respective diets of these populations. Globally there are 
differences in the main contributing sources to protein intake, in more developed countries 
the primary sources of protein tend to be from meat and meat products. Whereas lower 
economically developed countries rely more heavily on plant protein to meet their needs.  
To the best of my knowledge this thesis work describes the contributions to protein intake 
for the first time in the literature by investigating the differences in consumption across 
quintiles of different subtypes of protein intake (total, -animal, -plant and ratio 
plant:animal protein) as a percentage of total energy. The aim of this novel approach was 
to identify how different groups of protein contribute to intakes of total protein and protein 
subtypes. An additional aim was to determine if there is a difference in the contributing 
sources between men and women. Finally to establish if contributing sources differed with 
higher or lower intakes of protein (assessed across quintiles) and whether intakes of 
specific foods and nutrients also differed across quintiles of ratio of plant:animal protein, 
and whether these findings may partially explain potential differences in associations with 
stroke risk and risk factors between men and women.  
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Contribution of types of protein to protein intakes 
The first hypothesis was that the amount of protein from different sources would differ 
across quintiles of intakes of total protein and subtypes and that a higher total protein 
intake would be associated with higher intakes of animal protein and concurrently lower 
intakes of plant protein. 
As was hypothesised there were considerable differences in the sources of protein 
consumed across quintiles of different subtypes of protein. For example men in the lowest 
quintile of animal protein %en intake had a mean protein intake from animal-land sources 
of 18.5 g/d (Table 4.2) whereas those with the lowest %en from plant protein had 30.2 g/d 
from animal-land sources (Table 4.3). There were similar differences for women of 11.9 g/d 
animal-land compared with 23.0 g/d animal-land for the lowest quintiles of animal and 
plant protein as %en intake respectively (Tables 4.2 and 4.3 respectively). There was less 
difference in the amount of animal-marine and animal-derived protein sources between 
the quintiles of sub-types of protein. This was the case for both men and women therefore 
suggesting that the main contributors to the respective protein sources are animal-land 
and plant protein.  
 As would be expected across quintiles of animal protein as %en intake (Table 4.2) there 
was a significant trend towards higher intakes of animal-land, and animal-marine for both 
men and women (P<0.001 for all) and animal-derived for women only (P<0.001). In 
conjunction there was a significant inverse trend between animal protein as %en intake 
and protein from plant sources for both men and women (P<0.001 for both) (Table 4.2). 
Plant protein as %en intake was inversely associated with animal-land (P<0.01 and <0.001 
for men and women respectively) and animal-derived intakes for both men and women 
(P<0.001 for both) (Table 4.3). Animal-marine intake was not significantly associated with 
plant protein as %en intake in men or women (P=0.79 and 0.21 respectively) (Table 4.3). 
Plant protein intake significantly increased across quintiles of plant protein as %en intake 
in both sexes (P<0.001 for both) (Table 4.3).  
These findings may have significance in terms of stroke risk, as higher meat intake, 
particularly red and processed meat consumption, which was greater with higher 
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consumption of animal protein and specifically protein from animal-land sources, has been 
associated with increased risk of stroke (316, 317). Whereas there may be a beneficial 
effect of increased consumption of fish (318) and plant protein sources such as nuts (175) 
which tended to be lower in those with higher total animal protein intakes. 
Differences between men and women 
There were some small differences between the intakes of other foods and nutrients for 
men and women, which may have implications for stroke risk and risk factors (Table 4.5). 
In a study of French men and women, there was also a statistically significant difference 
between the total protein intakes of men and women in g/d and as a percentage of energy 
intake (P<0.0001 for both) (311). Similarly men in Belgium and Spain had higher protein 
intakes than women (310). In Belgium this included total protein, animal protein and plant 
protein g/d (P<0.001 for all). For specific food sources, red meat tended to contribute more 
highly to protein intake of men than women, this was also reported to be the case in other 
European countries (309-312) and the US (145). Whereas, fish and dairy consumption 
tended to be higher in women (145, 309). Although previous studies found the patterns of 
consumption for men and women may be similar between countries, there was wide 
variation in the percentage contribution that food sources made to total protein intake 
(145, 309) therefore it is important to understand the sources contributing to protein 
intake the in the UK diet as these may influence stroke risk and risk factors. 
The higher intake of red meat reported in men, may also be reflected in the analysis which 
investigated the differences in proportion of nutrients and other foods related to stroke 
risk and risk factors such as dietary fat and sodium which also tended to be higher in men 
(Table 4.6). Across the quintiles of the ratio plant:animal protein intake men tended to have 
total fat intakes that were approximately 20 g/d higher than women (Table 4.6). They also 
had substantially higher sodium intakes which actually tended to increase with a higher 
ratio of plant:animal protein intake in men whereas for women sodium intake remained 
relatively stable across quintiles (Table 4.6). 
Across quintiles of ratio of plant:animal protein in each of the quintiles men had slightly 
higher intakes of red meat and processed meat than women (Table 4.5). Although the 
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significance between sexes was not tested. For red meat the largest difference between 
men and women was in those with the lowest ratio of plant:animal (Table 4.5) (higher 
animal protein intakes). Men in quintile 1 consumed a mean of 25.7 g/d red meat compared 
with 17.6 g/d for women. However, in quintile 5, where there is a higher ratio of 
plant:animal protein, men were consuming on average 11.0 g/d and women 8.29 g/d (Table 
4.5). As previously indicated, high consumption of red meat has been associated with 
increased risk of stroke in men and women (316, 317).  
Contribution of food sources to protein intakes (including differences between men and 
women) 
The final hypothesis was that foods contributing to protein intake would differ between 
quintiles of different types of protein (total, -animal, -plant, ratio plant:animal protein). 
However, I found this was not necessarily the case as the results of this chapter illustrate 
that the foods contributing to protein intake do not appear to differ substantially.  
The differences in the consumption of specific food items across quintiles of the ratio of 
plant:animal protein were also investigated (Table 4.4). Men tended to have higher intakes 
of other ‘Meat other’. This category includes all processed meat and meat products as well 
as meat dishes and offal. This would therefore indicate that men tend to have a higher 
consumption of processed meat, meat dishes and offal compared with women, which is 
not necessarily led by their consumption of plant based protein sources. The poultry 
intakes of men and women were relatively similar. Poultry intakes of men ranged from 
11.8-18.5 g/d in the lowest to highest ratio plant:animal protein (Table 4.5). For women the 
range was 9.51-19.3 g/d. Women with lower ratios of plant:animal protein were consuming 
more poultry, a lean protein source, as opposed to red meat consumed by men (Table 4.5). 
In a study by Bernstein et al (175) it was reported that not only were higher intakes of red 
meat associated with increased risk of stroke, but also that higher poultry intakes, 1 
serving/d compared with red meat, were associated with 27% decrease in stroke risk (175). 
Therefore the pattern of protein consumption of women in this, EPIC-Norfolk cohort, may 
be such that it is protective against stroke compared with men’s pattern of consumption. 
It is important to note that these differences in types of foods consumed by men and 
women may influence the effects of protein intake on stroke risk factors and stroke risk. 
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For example, red meat and processed meat tends to be high in saturated fat. In addition 
processed meat products also often have a high salt content. These factors are known to 
influence blood pressure, lipid levels and stroke risk (319), therefore higher intakes of these 
products by men may influence the effects of protein on stroke risk. 
In women there was little fluctuation in the consumption of eggs across the quintiles of 
ratio of plant:animal protein intake (Table 4.5). Although a significant trend towards lower 
intake was indicated across the quintiles (P trend <0.001), the actual difference was 
approximately 2 g/d for women (a medium egg weighs approximately 53g). In a meta-
analysis Rong et al (320) concluded that there was no significant association between egg 
consumption and total stroke (P=0.27), and the RR associated with higher consumption of 
1 egg per day was 0.91 (95% CI 0.81-1.02 P trend=0.10) but may be associated with reduced 
risk of haemorrhagic stroke in diabetic population specifically (320). 
Men tended to have lower intakes of ‘Dairy other’ than women (Table 4.5). This group 
includes all dairy products except milk such as cheese, yogurt and cream. In men there was 
no significant trend between intakes of ‘Dairy other’ and quintiles of ratio of plant:animal 
protein in men (P trend 0.12) although there was a tendency towards lower intakes with 
higher ratio of plant:animal protein. However, in women there was a significant trend (P 
trend <0.001) with decreasing intakes of ‘Dairy other’ with an increasing ratio of 
plant:animal protein intake. The fat content of dairy products consumed may have an 
influencing factor on the effect of this group of food on stroke risk and risk factors. Previous 
research in a Swedish population indicated that the consumption of low fat dairy products 
was inversely associated with total stroke and ischaemic stroke (321). When comparing 
lowest intake (median 0 servings/d) with highest intakes (median 4 servings/d) of low-fat 
dairy products, after adjustment for confounding factors including age, sex, smoking, BMI, 
total energy, alcohol, fruit, vegetable and meat intakes, low fat dairy and high fat dairy 
intake, a RR 0.88 (95% CI 0.80-0.97 P trend=0.03) was reported for total stroke and RR 0.87 
(95% CI 0.78-0.98 P trend=0.03) for ischaemic stroke (321). There was no differentiation 
between consumption of low and full-fat dairy products in the current analysis, however, 
due to the ‘Dairy other’ group containing cheese and cream it is likely these would be linked 
with high fat intake, but low-fat yogurt may have been consumed and contributed to this 
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category. Intakes of milk, which were also not differentiated on fat content in the present 
study, were relatively high for both men and women and a significant inverse trend was 
seen in both sexes (P<0.001 for men and women) (Table 4.5). There was a slightly wider 
range of milk consumption in women with a difference of 68 g/d in women compared with 
38 g/d in men between the extreme quintiles.  
Fruit and vegetable intakes were consistently higher in women compared with men (Table 
4.5). However, in both sexes there was a difference of approximately 100 g/d between the 
extreme quintiles of fruit and vegetables. This is slightly more than one extra portion of 
fruit and vegetables per day (one portion being approximately 80g). In the US NHANES 
study combined fruit and vegetable intake was the second highest contributing source to 
plant protein intake after grains (145) and are therefore an important source of plant-based 
protein in the diet. It must be acknowledged that high consumption of fruit and vegetables 
will also incorporate a number of other health benefits, such as high fibre and 
micronutrient content, which may have a greater effect than the protein content of these 
foods. However, as little is known about the effect of protein quality on health outcomes, 
it may still be of importance to increase plant protein intake at the expense of less healthful 
protein sources such as processed meat. 
4.4.1 Strengths and limitations 
Strengths of the analysis include the use of 7DD to record food intake, in addition the 
detailed way in which food diaries were coded meant that there were a large number 
(~11,000) of food items and a high level of detail for classification of protein content. This 
sub-cohort is representative of the EPIC-Norfolk cohort which itself is representative of the 
overall UK population. Therefore the findings of this chapter may be applicable to the wider 
general population.  
Differences in the classification of food items, can make direct comparisons between 
studies difficult. For example some studies including the NDNS report on aggregated meat 
and meat products whereas other studies use varying degrees of disaggregated food 
groups/items. Due to the groupings of some mixed food items (those which contained 
protein from more than one source e.g. animal-marine, animal-derived and plant protein) 
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it was not always possible to assign food items to one group only. Where this was the case, 
a decision was made based on the source of the protein that was likely to be contributing 
most highly to total protein intake. For example in a mixed dish such as a pastry pie, it was 
deemed that the meat content of the pie would contribute more highly to the total protein 
content of the item than the aggregated plant based products that may be included (such 
as vegetables and flour). Despite these limitations these findings are still of interest due to 
the novel approach used in assessing the contributing sources to different types of protein 
intake. The results of this chapter may have implications for the findings presented in the 
subsequent chapter ‘Chapter five - Dietary protein intake and stroke risk factors and risk of 
stroke’. They may help to clarify potential differences in associations between protein 
intake and stroke risk and risk factors in men and women. 
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4.5 Summary 
In this cohort, protein intake was above the recommended daily intakes of 55.5 and 55.3 
g/d for men and women respectively. Total protein intake contributed 15.0% and 15.8% of 
energy for men and women respectively which compares well with other countries. The 
majority of total protein intake was derived from meat and meat based derivatives. 
However, in those with a higher ratio of plant:animal protein intake significantly less meat 
and meat products were consumed by both men and women. In addition higher amounts 
of fruit and vegetables, nuts, seeds and legumes were consumed. Women tended to have 
higher overall intakes of fruit and vegetables than men across all quintiles of ratio 
plant:animal protein intake. However, this was not the case for nuts, seeds and legumes. 
These differences in the contributing sources of foods to protein intake may influence 
disease risk between men and women.
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Chapter Five - THE INFLUENCE OF DIETARY PROTEIN INTAKE ON STROKE RISK 
AND RISK FACTORS  
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5.0 Introduction 
Total dietary protein intake has been indicated to beneficially influence blood pressure, a 
significant risk factor for stroke (140). Serum lipid levels may also be influenced by dietary 
protein intake (251). However, little is known about whether the type of protein (animal or 
plant based) affects these stroke risk factors or influences the risk of stroke. Previously 
reported associations between total dietary protein intake and the risk of coronary heart 
disease have been inconsistent (122, 322, 323). These inconsistent findings could be 
attributed to the consumption of different sources of protein, absolute amount of protein 
eaten and the foods contributing most highly to protein intake (177, 322-324). More 
recently work has been conducted investigating the influence of protein on stroke risk 
directly and whether the source of protein has an influence on stroke risk (175, 177). To 
the best of my knowledge no previous study has investigated the potential associations of 
total protein intake and effects of different sources of dietary protein %en, either plant or 
animal, with risk factors for stroke and stroke risk simultaneously. Previously studies have 
investigated the influences individually on risk factors and stroke risk (123, 124, 174, 176). 
Additionally few studies have investigated whether differences in the ratio of plant:animal 
protein in the diet has an effect on stroke risk factors and stroke risk. 
Role of protein in human body 
Proteins have a number of significant roles in the body, these vary depending on their 
structure. For example fibrous proteins with many cross-links often have structural 
functions such as collagen. Whereas globular proteins which have a more complex tertiary 
and occasionally quaternary structure include enzymes and haemoglobin (292). Protein is 
an essential component of cell membranes maintaining structure and regulating transport 
of ions, and is the primary component of all types of muscle. On a daily basis protein 
turnover is equivalent to approximately 300g, whilst the typical Western diet provides 
approximately 100g of amino acids in the form of dietary protein per day (302).  Dietary 
protein intake may influence stroke risk factors and stroke risk via a number of 
mechanisms. This includes beneficial influences of increased dietary protein intakes on 
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insulin sensitivity, vascular function, renal function, improvements in lipid levels and blood 
pressure.  
Stroke risk factors and stroke risk 
The literature review of previous research in this chapter which follows the section on 
mechanisms of action will firstly start with evidence from animal studies, followed by 
epidemiological studies and then research from clinical trials subdivided into evidence 
related to total protein intakes followed by animal and plant protein intakes. Each section 
(animal studies, epidemiology and clinical trials) will be divided to first cover the risk factors 
blood pressure and lipid profile and will subsequently review the literature surrounding 
stroke risk.  
Previous research on dietary protein intake in relation to CHD and CVD risk in general 
indicates that both the source and the amount consumed may have an effect on blood 
pressure, lipid profile and body composition among other stroke risk factors (175, 176, 
251).  
It is possible that the different types of protein may have different effects on risk factors 
and hence overall stroke risk (175, 176). The consumption of animal products, particularly 
red meat, has in most cases been associated with increased risk of stroke (316). However, 
in some instances an inverse association was identified (325). However, these studies were 
often conducted in Asian populations whose sources of animal protein are primarily fish, 
which are not only lower in saturated fats but have also been linked to reduction in risk of 
stroke due to the presence of n-3 PUFA (324-327). 
5.0.1 Mechanisms 
Reduction in stroke risk may be through in-direct effects on risk factors such as vascular 
health, circulating insulin and serum lipid levels (328). 
Vascular health 
Dietary protein intakes may influence vascular health including blood pressure and 
endothelial function specifically. 
Chapter Five   Dietary protein stroke risk and risk factors 
 
197 
 
 
Several specific amino acids may have a role in influencing blood pressure. For example 
tyrosine, a non-essential amino acid, is required for the synthesis of catecholamines in the 
central nervous system. Circulating concentrations of tyrosine have been shown to be 
influenced by protein intake, on both an acute (single meal) and more long term (weeks) 
basis (329). Catecholamines have been implicated in raising blood pressure. However, their 
circulating presence also stimulates the synthesis and release of renalase which degrades 
catecholamines and therefore catecholamines may in fact have a net effect in reducing 
blood pressure (330). In animal studies the injection of tryptophan and tyrosine resulted in 
a decrease in blood pressure (331, 332). This is believed to be as a result of increased 
uptake in the brain leading to increased release of serotonin. However, the uptake of both 
of these amino acids can be influenced by the presence of other amino acids such as valine 
(331, 332) and thus this mechanism may or may not remain applicable for dietary intakes 
where the amino acids are not consumed in isolation. 
Soy protein, specifically, has been associated with beneficial effects on vascular function 
and blood pressure which may be attributable to the higher levels of arginine that are found 
in such products. Soy protein is also noted for containing estrogenic isoflavones and 
angiotensin-converting-enzyme inhibitory peptides which can lead to a reduction in blood 
pressure (296, 333). Isoflavones may improve endothelial function by increasing eNOS 
expression thus increasing levels of NO, and leading to vasodilation as well as supressing 
production of endothelin-1 (296). As well as the potential beneficial effect of isoflavones 
from soy protein the higher content of arginine in soy protein has also been indicated to 
enhance NO production. Arginine is a conditionally essential amino acid present in high 
amounts in turkey breast and pumpkin seeds (per household measure) (334), it is a 
precursor in the synthesis of NO, a potent vasodilator. NO has an important role in the 
maintenance of vascular tone and arterial pressure and may therefore be involved in 
reducing blood pressure and therefore stroke risk by its role in maintenance of endothelial 
function (328, 335, 336). Endothelial dysfunction, results due to disruption of the balance 
between vasoconstrictors and vasodilators which can be due to a reduction in the 
bioavailability or production of NO and other vasodilators, and an increase in endothelium-
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derived vasoconstrictors (337, 338). The result of this may be vasoconstriction, activation 
of platelets and increased coagulation, and increased inflammation which can all 
contribute to the development of atherosclerosis which has been implicated in the risk of 
stroke (337-339). The progression of atherosclerosis can increase stroke risk either through 
continued narrowing of the artery, which can eventually lead to complete blockage. 
However, the more common way that atherosclerosis can be involved in the onset of stroke 
is if an atherosclerotic plaque ruptures, this fragment may then travel through the blood 
stream and cause a blockage in a narrower vessel (54).  
Insulin levels 
Higher dietary intakes of non-essential amino acids have been beneficially associated with 
improvements in circulating insulin levels, through upregulation of gluconeogenesis. This 
leads to a reduction in circulating insulin levels, a risk factor for stroke (177). In addition 
lower intakes of essential amino acids, which would be common with vegetable protein 
intake is considerably higher in non-essential amino acids such as arginine, glycine, alanine 
and serine compared with animal protein. It also contains lower quantities of essential 
amino acids such as lysine, methionine and tryptophan, which may be associated with 
increased insulin levels (177, 340). Table 5.0 details the differences in levels of selected 
amino acids of several plant and animal foods.
Chapter Five      Dietary protein stroke risk and risk factors 
 
199 
 
Table 5.0 Levels of selected essential and non-essential amino acids in a sample of animal and plant foods.  
 Essential amino acid Non-essential amino acid 
 Lysine Methionine Tryptophan Arginine Glycine 
Animal foods      
 Beef (mince, 7% fat, cooked) 2.39 0.74 0.15 1.88 1.96 
 Chicken (roast, light meat only) 2.30 0.75 0.32 1.64 1.33 
 Milk 0.28 0.09 0.05 0.09 0.06 
Plant foods      
 Potatoes (boiled) 0.11 0.03 0.03 0.09 0.06 
 Carrots (boiled) 0.08 0.02 0.01 0.08 0.04 
 Bread (whole-wheat) 0.24 0.14 0.12 0.38 0.33 
 Soya milk 0.13 0.03 0.04 0.19 0.10 
Based on USDA National Nutrient Database for Standard Reference, Release 28 (341).
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Serum lipids 
Higher protein intakes have also been reported to reduce circulating cholesterol levels 
(342) and it has been suggested that protein from plant sources may exert more beneficial 
effects than protein from animal sources (343). This may be due to a decrease in the 
formation of micelles which leads to a reduction in the absorption of cholesterol in the 
intestine, which is then excreted in faeces (344). Dietary proteins and their peptides may 
also reduce cholesterol synthesis by acting as an inhibitor to HMG-CoA reductase which is 
required during the synthesis of cholesterol (344).   
Although not a mechanism it is also possible that protein intake has indirect effects through 
modulation of the whole diet. For example a higher dietary protein intake may replace or 
reduce the intake of carbohydrate or fat content of the habitual diet and may therefore 
help with weight management, a contributing factor to raised BP and poor serum lipid 
profile (147). 
Mechanisms of action of dietary magnesium on stroke risk via effect on risk factors blood 
pressure and lipid levels are summarised in Figure 5.0. The following narrative literature 
review was obtained through searches of MEDLINE (Ovid) and PubMed. The search term 
dietary was combined with; protein, total protein, plant protein, animal protein and 
relevant key words such as blood pressure, systolic blood pressure, diastolic blood 
pressure, cholesterol, LDL, HDL, and stroke risk. Titles and abstracts of returned search 
items were reviewed and the full text of relevant articles was obtained. The reference lists 
of full text articles were subsequently reviewed to identify additional relevant publications. 
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Figure 5.0. Summary of mechanisms of action of dietary protein intake on stroke risk via 
effects on risk factors blood pressure and lipid levels. 
5.0.2 Animal models 
Blood pressure 
Total protein 
Few studies in animal models have investigated the overall impact of total protein on blood 
pressure (Table 5.1). Studies largely use either a specific protein source in varying 
concentrations (333, 345) or compare different sources of protein (346-348).  
Studies on adult rats frequently investigate protein intake and blood pressure in models 
with renal dysfunction. Differences in blood pressure were reported in Dahl salt-sensitive 
rats fed a low (6% of energy), normal (18% of energy) or high casein protein diet (30% of 
energy) (345). The high protein diet was associated with a significant increase in blood 
pressure compared to rats on the low and normal protein diet. However, there was no 
significant difference in the blood pressure of rats on the low and normal diets. The 
mechanisms of action remain unclear but may be related to renal damage (345). 
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Plant and animal protein 
The type of protein, whether animal or plant based, may influence risk factors for stroke 
via effects on endothelial function.  
Magne et al (339) studied rats, fed a high saturated fat diet, with either milk protein (MP), 
rapeseed  protein isolate (RP) or milk protein with the addition of L-cycsteine and L-arginine 
(MP+AA) in concentrations similar to that present in rapeseed protein isolate. Diet 
composition was 60% fat, 20% carbohydrate and 20% protein. Postprandial plasma amino 
acid levels were measured. During the RP and MP+AA diets compared with the MP diet, 
there were increases in the concentration of many amino acids at 4, 6 and 8h after the meal 
including arginine, aspartate, glutamate and methionine. However, there was no significant 
difference in plasma total cysteine across the diets. This could indicate that these amino 
acids have a higher bioavailability from the RP and MP+AA diets than the MP diet. There 
was a decrease in vascular reactivity, indicated by increase in blood pressure, after 
consumption of MP meal and this decrease in vascular reactivity was less pronounced after 
MP+AA and inhibited with consumption of RP.  This may be attributable to the presence of 
L-arginine. Previous research that has also focussed on L-arginine supplementation has 
shown a reduction in endothelial dysfunction in human participants (349, 350). L-arginine 
is a precursor to NO which is a potent vasodilator. Therefore it is likely that the beneficial 
influences on vascular function that are indicated with supplementation with this amino 
acid stem from this effect. In the study by Magne et al (339) plasma triglyceride levels 
increased after consumption of the high fat meal but were not influenced by the 
composition of the protein component of the diet. However, the effects may not be the 
same for a different meal composition for example higher in carbohydrate. Although, it 
could be hypothesised that any potential effect on plasma triglyceride levels would be 
more pronounced after the consumption of high fat meal. 
In a study on soyabean protein hydrolysate (SPH) Yang et al (333) reported significantly 
lower blood pressure in rats fed SPH compared with those without. Twenty four 
spontaneously hypertensive rats were fed a high sodium diet containing 0% SPH, 0.5% SPH 
or 1% SPH. A control group of 8 Wistar-Kyoto rats were also included in the study. Every 4 
weeks (for 12 weeks total), fasting blood samples were taken and plasma total cholesterol, 
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triglyceride, sodium, potassium and chlorine levels were determined. Blood pressure was 
also measured at 4 weekly intervals. At 4 and 8 weeks of the diet, rats fed either 0.5% SPH 
or 1% SPH had significantly lower SBP than the spontaneously hypertensive rats fed 0% 
SPH. The SBP of these two groups (0.5% and 15% SPH diets) was significantly higher than 
the control group of Wistar-Kyoto rats. At 12 weeks SBP and mean BP of rats on the 0.5% 
SPH and 1% SPH diets were similar to that of the control group and significantly lower than 
the spontaneously hypertensive rats fed 0% SPH diet. Thus indicating that the addition of 
SPH in the diet may delay the onset of hypertension.  
Consumption of a fish protein diet in spontaneously hypertensive rat species has been 
shown to lead to a reduction in blood pressure compared with rats consuming a casein diet 
(351). The fish protein diet was also related to a decrease in plasma total cholesterol as 
well as liver triacylglycerol and total cholesterol. These findings have relevance in terms of 
total animal protein intake, as they may explain potential discrepancies between findings 
reported in studies investigating Western populations and Asian populations. Whereby, in 
Western populations, high animal protein intake is often negatively associated with health 
status including blood pressure, lipid profile and CVD risk. However, this is not always the 
case in Asian populations where their animal protein may be from fish and lean meats such 
as poultry rather than red meat, more typically consumed in Western diets.   
Lipid profile 
Dietary protein intakes may also influence circulating lipid levels, a risk factor for stroke. 
There is conflicting evidence as to whether the effects are attributable to animal or plant-
based protein sources or overall protein intake. 
Plant and animal protein 
Two studies by Tomotake et al (346, 347) investigated the effects of different protein 
sources on the lipid profile in a number of animal models; hamsters, rats and mice (Table 
5.2). They indicated that the plant-based sources, buckwheat protein (BWP) or soy protein 
isolate (SPI), significantly improved lipid profile in the rat and hamster studies compared 
with the animal protein diet (casein), with the exception of TC:HDL in hamsters. In hamsters 
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fed a diet with 5 g/kg cholesterol and 200 g/kg of casein, SPI or BWP, both SPI and BWP 
reduced cholesterol levels in gallbladder bile.  
Aziz et al (348) however, reported contradictory results regarding protein source and lipid 
profile in hamsters. Both wheat gluten and casein diets significantly lowered HDL levels 
when compared with beef protein or soya protein diets. These findings may indicate that 
it is potentially the specific amino acid content of diets that influences stroke risk factors. 
However, to date there has been limited research in this area. 
In the study previously described by Yang et al (333) in relation to soy protein intake and 
blood pressure, the authors reported measures of total cholesterol and triglyceride levels. 
There was no significant difference in levels of total cholesterol or triglycerides between 
the different levels of soyabean protein hydrolysate supplementation (0%, 0.5% and 1% 
diets) in the stroke prone spontaneously hypertensive rat species. However, total 
cholesterol and triglyceride levels were significantly lower (P<0.05) in each of the SPH 
supplementation groups than those of the control group of Wistar Kyoto rats. Despite no 
significant difference being reported between the SPH supplementation groups, there was 
a non-significant difference of 0.20 mmol/L in total cholesterol between the lowest SPH 
supplementation group (0%) and highest supplementation group (1% SPH). It should be 
noted that rats on 0.5% and 1.0% SPH diets had significantly higher weight gain across the 
course of the study compared with both the 0% SPH diet group and that total cholesterol 
levels were still lower despite this.  
Stroke risk 
Several animal studies have indicated a potential association between dietary protein 
intake and onset of stroke, in stroke prone spontaneously hypertensive rat species 
(SPSHRs) (Table 5.3) (296, 352). Chiba et al (2009) reported a significant delay in the onset 
of stroke in rats fed an experimental diet, high in protein, compared with placebo diet. They 
aimed to determine the macronutrient influencing stroke onset by changing the ratios of 
two macronutrients whilst keeping the third constant. In high protein (45% and 55% of total 
energy) low carbohydrate (45% and 35% respectively) diets, where fat content remained 
constant at 10% there was a significant delay in onset of stroke compared with the placebo 
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diet (20% protein, 70% CHO, 10% fat) (P=0.009 for 45% protein diet and P<0.001 for  55% 
protein diet). 
In addition, when rats were fed a low protein diet (5% protein, 85% CHO 10% fat) onset of 
stroke occurred more rapidly, 16 days compared with 55 days for the rats fed a diet 55% 
protein. In the diet with protein intakes closest to those recommended in humans (10% of 
energy from protein) the number of days to onset of stroke was 22, which was the same 
mean time to stroke onset as the control group (352).  A higher protein diet (60%) with only 
30% of energy from carbohydrates was associated with a delay in stroke onset. Additionally 
a low protein diet (7.5%) and high carbohydrate (85%) led to earlier onset of stroke (23 
days compared with 29 days) when compared with a diet comprised of 15% protein. These 
findings further indicate that the effect was specifically in relation to the protein 
composition of the diet.  
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Table 5.1. Overview of animal studies investigating the effects of protein on blood pressure in rat models. 
Author 
Model 
Treatment and duration Results 
Yang 
(2004) 
(333) 
M SHR or Wistar-Kyoto 
rats 
 
Control wistar rats 0% soyabean protein hydrolysate (SPH). 
All other SHR rats 1. 0% SPH, 200 g/kg casein 2. 0.5% SPH, 3. 1% SPH 
All fed a high Na diet 
 
 
SBP significantly lower in diets higher in SPH 
compared with control 
 
 
Ait-Yahia 
(2003) 
(353) 
M SHR 
200 g/kg casein or fish protein 
2 months 
Fish protein significantly lowered SBP compared 
with casein diet.  
-14% (P<0.05) 
 
Endoh 
(2001) 
(354) 
M  Sprague-Dawley 
rats 
 
1. 23% casein, 28% sucrose, 8% α-corn starch, 24% β-corn starch, 7% corn oil, 
2. 6% casein, 35% sucrose,10% α-corn starch, 31% β-corn starch, 7% corn oil, 
3. 6% casein, 28% sucrose, 10% α-corn starch, 38% β-corn starch, 7% corn oil 
4. 3 & 1 mg/kg prazocin hydrochide, 5. 3 & reduced NaCl, 6. 3 & 2% L-arginine 
8 weeks 
 
 
Diets 2, 5 & 6 significantly increased SBP 
compared with 1, 3 & 4 (P<0.05) by 10-15 mmHg. 
High sucrose low protein significantly increases 
SBP over low sucrose low protein (P<0.01). 
 
Martin 
(2001) 
(355) 
F SHR or Wistar-Kyoto 
rats 
Control: casein protein or 19% soy protein diet 
Minimum 8 weeks 
NS change in mean arterial pressure in sham 
wistar-Kyoto or SHR, and ovariectomized wistar 
rats between casein and soy diets. 
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Significant decrease in mean arterial pressure 
~14 mmHg, in SHR ovariectomized rats with soy 
diet (p<0.05). 
Abbreviations 
NS, non-significant; SBP, systolic blood pressure; SPH, soy protein hydrolysate; SHRs, spontaneously hypertensive rat species;  
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Table 5.2. Overview of animal studies investigating the effect of protein on lipid profile in hamster and rat models.  
Author 
Model 
Treatment and duration Results 
Aziz 
(2008)  
(348) 
M Golden Syrian 
hamsters 
 
20% diet: casein, beef protein, wheat gluten, or soya protein. 
15.5% diet fat 
8 weeks. 
Casein, wheat gluten and soya protein were sig different to 
beef protein for TC and LDL and Casein and wheat gluten for 
HDL (P<0.05). 
 
Tomotake 
(2007)  
(347) 
M  Sprague-Dawley 
rats 
M ddY mice 
 
20% of protein from: casein, tartary buckwheat or buckwheat 
protein 
With increasing conc of cholesterol to induce 
hypercholesterolemia in rats and gallstones in mice 
27 days. 
Rats: serum TC sig lower (P≤.05) w/ buckwheat or tartery 
buckwheat vs casein 
Mice: NS diff in TC 
Tomotake 
(2000)  
(346) 
M Golden Syrian 
hamsters 
1. 230 g/kg casein, 2. 238 g/kg SPI, 3. 381 g/kg buckwheat 
2 weeks. 
Sig lower plasma TC & HDL (P≤0.05) w/BWP vs SPI and casein. 
Sig lower TC:HDL (P≤0.05) w/ casein vs SPI and BWP. 
Sig lower TG (P≤0.05) w/ SPI or BWP vs casein. 
 
Abbreviations 
HDL, high density lipoprotein; LDL, low density lipoprotein; NS, non-significant; TC, total cholesterol; TG, triglyceride; 
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Table 5.3. Overview of animal studies investigating the effects of protein on stroke risk in stroke prone spontaneously hypertensive rat models 
Author 
Model 
Treatment and duration Results 
Chiba 
(2012)  
(356) 
Male SPSHRs 
Control: 20% protein, 10% fat, 70% CHO 
Four experiments: (all diets 10% fat) 
1. 5%, 20% or 55% total energy from casein (20% control) or 
soybean 
2. 55% total energy from casein (control), whey, soybean or egg 
white 
3. 20% casein (control) 55% casein or 55% amino acid (casein 
composition) 
4. 10% butter & 20% casein (control), 50% butter, 50% beef tallow, 
50% cocoa butter 
Duration - not specified 
 
1. Delayed onset stroke with 20% and 55% casein vs 5% (P=0.016 
and P<0.001), similar for 55% soybean (P=0.018). 55% Casein 
delayed onset more than soybean (P=0.019). 
NS diff in BP between 20 and 55% casein diets at 1 or 2 wks. 
2. Delayed onset order (least effect first): soybean, egg white, 
casein, whey. 
3. delayed onset in rats fed 55% casein but not 55% aa vs 20% casein 
(P=0.002 and P=0.069) 
4. NS diff in onset of stroke with 50% butter, beef tallow, or cocoa 
butter. 
 
Chiba 
2009 
(352) 
Male SPSHRs 
Percentage energy from diet. All diets 10% fat 
5% protein, 85% CHO. 2. 10% protein, 80% CHO. 3. Placebo 20% 
protein, 70% CHO. 4. 45% protein, 45%CHO. 5. 55% protein, 
35%CHO 
 
Rats fed high protein low CHO diet (45% and 55% protein) had 
delayed onset of stroke P=0.009 and P<0.001 respectively. 
Low protein high CHO (5% protein). 
 
Gilani 
(2009) 
(296) 
Male SPSHRs1 
1. Casein, 2. casein + isoflavones 500 mg/kg, 3. casein + 
anthocyanins 500 mg/kg,      4. Soy protein isolate (SPI), 5. SPI + 
isoflavones 500 mg/kg, 6. SPI + anthocyanins 500 mg/kg  
(31 days) 
 
NS difference in mean survival time between casein and SPI diets.  
Addition of anthocyanins and isoflavones was associated with 
significantly shorter time to death (P<0.05) 
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Gilani 
2006 
(357) 
Male SPSHRs 
Casein (222 g/kg) & cysteine (232 mg/MJ) , casein & methionine 
(550 mg/MJ), SPI (222 g/kg) & cysteine (340 mg/MJ), SPI & 
methionine (340 mg/MJ) 
 
Type of protein casein vs SPI had no effect on survival time. 
Methionine supplemented group had sig longer mean survival time 
over cysteine group (P<0.05) 
 
Abbreviations 
CHO, carbohydrate; SPI, soy protein isolate; SPSHRs, stroke prone spontaneously hypertensive rat species
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5.0.3 Epidemiological studies 
Blood pressure 
Total protein 
A number of studies have prospectively investigated associations between dietary total 
protein intake and blood pressure and hypertension (Table 5.4) (123, 124, 149, 358-361). 
However, only a small number of studies were conducted in European populations. In 
addition the majority of studies use either 24hr recall or FFQs to determine dietary intakes. 
Studies validating methods of recording dietary intake have indicated that dietary protein 
intake is more accurately determined using weighed or estimated food records than FFQs 
or 24hr recall which tend to overestimate protein intakes (183, 362, 363). Two systematic 
reviews have also been conducted, including most of these studies, aiming to determine 
the relationship between dietary protein intake and blood pressure. The first of these by 
Altorf-van der Kuil et al (140) which included 12 observational studies concluded that total 
protein intake tended to be weakly inversely associated with blood pressure and that there 
was no clear association between total protein intake and development of hypertension in 
two separate studies (364, 365). A more recent meta-analysis by Tielemans et al (174) on 
observational studies and RCTs aimed to determine relationships between dietary protein 
intake and blood pressure and development of hypertension. They included 6 cross-
sectional studies (n=48,985 participants) in their analyses of total protein and blood 
pressure which included cohorts from China, Japan, USA, Italy and The Netherlands. There 
was a small, but significant, inverse association between dietary total protein intake, per 
~25g increments, and SBP with an effect size of -0.20 mmHg SBP (95% CI -0.39—0.01) with 
non-significant variability using random effects model. There was no significant association 
between increasing total protein intake (~25 g increments) and development of 
hypertension across three prospective studies (n=11,761 participants) RR 0.99 (95% CI 
0.96-1.02) (366).  
Plant and animal protein 
The previously mentioned systematic reviews (140) and meta-analyses (174) also sought 
to determine the independent effects of plant and animal protein intake on blood pressure 
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(Table 5.4). Altorf-van der Kuil (140) identified a total of 10 cross-sectional and prospective 
studies between 1987 and 2008 which recorded information on plant and animal protein 
intake. Only one of these studies (INTERMAP) included a UK cohort (141). The INTERMAP 
study included a sample of n=501 UK participants who were middle aged 40-59 years with 
a mean blood pressure of 120.4/77.3 mmHg. Mean protein intakes were 15.8% (±3.1) of 
total energy intake and plant and animal protein accounted for 6.1% (±1.4) and 9.8% (±3.3) 
respectively. Dietary protein intake was estimated using four repeated 24hr dietary recalls. 
The fully adjusted multivariable model included; sample, age, sex, special diet, history CVD 
or DM, family history of hypertension, physical activity, dietary supplement use, 24hr 
urinary sodium and potassium, alcohol intake, calcium, SFA, PUFA, dietary cholesterol, 
magnesium, and fibre intakes. Prior to adjusting for height and weight there was a 
significant difference in estimated blood pressure per two standard deviations of plant 
protein intake (-1.29 mmHg P<0.05 for SBP and -1.12 mmHg P<0.01). However, after 
adjusting for height and weight the values for SBP were -1.01 and non-significant. Despite 
the estimated decrease being less, DBP remained significant with an estimated difference 
of -0.95 (P<0.05) per two standard deviations of plant protein intake. Animal protein was 
not significantly associated with blood pressure in the fully adjusted model, with the 
exception of DBP prior to adjustment for height and weight, where an estimated difference 
of 0.70 (P<0.05) was reported. However, there did appear to be a trend towards an 
estimated increase in blood pressure in many earlier models, but no estimated differences 
were significant after adjustment for height and weight (141). 
In a population of 20,820 Dutch adults after adjustment for a number of relevant 
confounding factors including; age, sex, BMI, total energy, magnesium and other protein 
sources amongst others there was no significant association between animal protein 
intakes and SBP or DBP (P trend =0.39 and 0.71 respectively) (124). However, a significant 
inverse association was seen in relation to plant protein intake and SBP and DBP (P<0.001 
for both). In addition the authors aimed to identify if modelled substitution of 3% of energy 
from protein intake for 3% energy from another macronutrient (carbohydrate or MUFA 
source) was associated with blood pressure. There was no reported benefit of substituting 
animal protein for 3% of energy intake from either carbohydrate or MUFA sources. There 
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is no justification for the choice of MUFA as the ‘fat’ source to replace, and there may 
therefore be different results for substituting protein for other fat sources such as 
saturated fat intake. However, when substituting 3% of total energy from either 
carbohydrate, or MUFA sources with plant protein sources a decrease in SBP and DBP was 
reported. Analyses substituting plant protein for carbohydrate estimated a decrease in BP 
of -2.1/-1.0 mmHg (P trend<0.01). An estimated decrease in BP of -1.3/-1.2 mmHg was 
reported when plant protein was substituted for MUFA (P trend<0.05). These findings 
suggest that the effect on blood pressure reduction by increased protein intake may be 
exclusively from plant protein (124). However, the study utilised FFQs to determine dietary 
intakes, and whilst total protein intake was validated by 24h dietary recalls and urinary 
nitrogen, there was no validation for individual protein sources.  
In the INTERMAP study cohort, an inverse association between vegetable protein intake 
and blood pressure was identified (141). It should also be noted that this study reported 
no significant association between animal protein or total protein intakes and blood 
pressure. Thus suggesting that it may be the non-animal (vegetable/plant) component of 
the diet that may have a benefit on blood pressure. It was also reported that that 
individuals consuming higher intakes of vegetable protein as opposed to animal sources 
had increased circulating concentrations of a number of amino acids. This included; 
glutamic acid, cystine, proline, and serine, which are all non-essential amino acids, these 
reportedly do not elevate insulin levels, as opposed to essential amino acids, which are 
abundantly present in animal foods, which have been associated with increasing insulin 
levels (141, 177). Conversely Altorf-van der Kuil et al (123) reported no significant trend 
between plant protein and hypertension (SBP ≥140 mmHg and/or DBP ≥90 mmHg), but 
higher intakes (≥18 g/d) vs lower intakes (≤17 g) of protein from grains was associated with 
a significant decrease in risk of hypertension in point estimate, albeit with only a marginal 
significance, HR 0.85 (95% CI 0.73-1.00 P trend=0.04). However, the FFQ used in this study 
was not validated for the specific types of protein intake including grains (123). Participants 
in the cohort were also relatively healthy with a mean blood pressure of 118/76 mmHg. It 
is likely that the effects of protein source on blood pressure may be more pronounced in 
pre-hypertensive (SBP 120-139 mmHg and DBP 80-89 mmHg) or hypertensive (SBP >140 
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and DBP >60 mmHg) participants, therefore, it is possible that the magnitude of difference 
in blood pressure inferred by plant-based protein was not obvious within this study 
population (149).  
The previously mentioned systematic review and meta-analyses by Tielemans et al (174) 
also aimed to determine if dietary intakes of plant or animal protein were associated with 
blood pressure.  From 7 cross-sectional studies, including 42,938 participants, a non-
significant inverse association with plant protein intake, per ~11 g increments, was 
identified (-0.52 mmHg SBP 95% CI -1.10-0.05). There was significant heterogeneity 
reported (I2=75%, P=0.01) which was deemed to be attributable to one study by Umesawa 
et al (361). After removing this study the findings in association with plant protein were 
strengthened -0.73 mmHg SBP (95% CI -1.08- -0.38) and animal protein intake was 
associated with an estimated increase in +0.24 mmHg SBP (95% CI -0.09-0.57).  
This difference in findings in a Japanese population may be due to the different contributing 
food sources to plant and animal protein intakes. For example Japanese populations 
consume more fish than Western populations. In this instance it may be that animal protein 
intake is a surrogate of other nutrient intakes which can also affect blood pressure, 
saturated fat which is found in higher levels in red meat which is consumed in higher 
quantities in Western countries. Additionally, traditional Japanese cuisine can be very high 
in salt, and this includes vegetables which are often pickled or eaten with high salt 
seasonings (361, 367). Therefore if this were the case in this Japanese population it may be 
that the relatively high salt intakes that accompanied vegetable intake had a greater 
influence on blood pressure than protein component.  
Lipid profile 
The majority of studies investigating the effect of dietary protein intake on lipid levels have 
focused specifically on the effect of soy protein intake. Findings generally indicate an 
inverse relationship between increased intakes of soy protein and TC and LDL levels. More 
inconsistent findings are reported on the potential effects on HDL and TG levels (Table 5.5) 
(27-29, 368).  
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Total protein 
Recently Mirmiran et al (173) evaluated the effects of different protein sources on lipid 
profile, specifically HDL.  This cohort consisted of 2,537 men and women, part of the Tehran 
Lipid and Glucose Study, who were aged 19-70 years. Dietary protein intake was estimated 
using a validated semi-quantitative FFQ. The mean protein %en was 13.7% for men and 
13.6% for women. 
They reported a significant positive association with total protein intake and HDL levels in 
both men and women (P<0.05 for both) after adjustment for a number of covariates 
including; age, physical activity, BMI, smoking, SBP, DBP and dietary factors such as total 
energy (despite nutrients already being energy adjusted per 4186.8 KJ), dietary fat and 
carbohydrate intakes as percentage of energy, saturated fat, MUFA, PUFA, cholesterol, 
fibre and sodium (adjusted grams per 4168.8 KJ). However, no significant association 
between total protein and triglyceride levels was reported (173). These findings are in 
contrast to previous work by Smit et al (369) which indicated no significant association. In 
the study by Smit et al (369) lower serum TC was associated with higher percentage energy 
from protein. 
These inconsistent results may be attributable to differences in the characteristics of study 
populations, one an Iranian population, the second US, study methodologies, Mirmiran et 
al (173) estimated intakes from FFQ whilst Smit et al (369) used 24hr dietary recall, or the 
confounding variables included in adjusted models.  
Plant and animal protein 
In the previously mentioned study by Mirmiran et al (173) (total protein and lipids section) 
they also investigated the effects of the ratio of animal:plant protein intake with lipid levels. 
The mean ratio of animal:plant protein intake was 1.4 (±0.9) for men and 1.8 (±1.4) for 
women, which was significantly higher in women than men. They reported no significant 
difference in the sources of protein consumed by men and women, with the highest 
contributing sources to protein intake being grains which accounted for approximately 
29.7% of protein intake. Meat intakes were segregated into specific types for example red 
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meat and poultry, and therefore their individual contributions were lower. However, if total 
meat intake was a combined variable this would have been the highest source of protein.  
There was no significant association with increasing ratio of animal:plant protein intake and 
increasing HDL or triglyceride levels after adjustment for a number of covariates, previously 
mentioned. This finding is in accordance with the study by Smit et al (369) which also 
reported no significant association between the ratio of animal:plant protein intake and 
HDL after adjustment for saturated fat intake. Total animal protein intake was significantly 
different in the highest quartile of serum total cholesterol (≥5.68 mmol/L) compared with 
the lowest quartile (≤4.29 mmol/L). Age, sex and race adjusted mean intakes of animal 
protein were 65.3% and 67.7% for the lowest and highest quartiles of serum cholesterol 
levels (P<0.01). In contrast plant protein intake was significantly lower in those in the 
highest quartile of serum total cholesterol compared with the lowest quartile. Age, sex and 
race adjusted mean plant protein intakes were 34.7% and 32.3% for the lowest and highest 
quartiles of serum total cholesterol respectively (P<0.01). Smit et al (369) also failed to 
identify an association between source of protein intake and LDL levels.  
Stroke risk 
Fung et al (370) compared the risk associated with consumption of a prudent pattern – 
characterised by higher intakes of fruit, vegetables, fish and whole grains vs a Western 
pattern – higher in red and processed meats, processed grains and full-fat dairy products. 
They identified in women that a typical Western dietary pattern is associated with an 
increased risk of total and ischaemic stroke RR of 1.58 and 1.56 respectively. A prudent 
dietary pattern on the other hand may infer a protective effect RR 0.78 for total stroke 
(370). There may be a benefit from swapping one protein source for another, Bernstein et 
al (175) identified that substituting one serving/d of red meat for poultry, nuts or fish 
equated to a 27% (95% CI, 12-39%), 17% (95% CI, 4%-27%) and 17% (95% CI 5-17%) 
reduction in stroke risk respectively. 
Total protein 
In a biomarker calibrated study of n=80,370 postmenopausal women, part of the Women’s 
Health Initiative Dietary Modification Trial between 2004 and 2005 and Women’s Health 
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Initiative Observational Study, an inverse association was reported between protein intake 
and ischaemic stroke (Table 5.6) (371). There was no association with non-calibrated 
protein intakes, however, the authors reported that the dietary FFQ tended to 
overestimate protein intake in grams per day and to underestimate protein as a percentage 
of energy intake (protein %en). Therefore the calibrated protein intake may more 
accurately predict associations between dietary protein intake and stroke risk. There was 
a total of 1224 stroke cases reported (714 ischaemic stroke and 217 haemorrhagic stroke). 
Calibrated protein intakes were 78.1 g/d (95% CI 58.5-104.4) for the Dietary Modification 
Trial Comparison Group and 74.3 g/d (95% CI 55.0-100.5) and Observational Study. The 
calibrated protein %en was 14.4 (95% CI 12.0-17.3) and 14.4 (9%% CI 11.9-17.6) for the two 
study groups respectively. The HR for each 20% increment increase in calibrated protein 
intake and total stroke was 0.87 (95% CI 0.78-0.98) and similar significant HR was reported 
for ischaemic stroke 0.87 (95% CI0.75-1.00) after adjusting for ethnicity, education, history 
of CVD, family history premature CVD, smoking, hypertension, diabetes, statin use, aspirin 
use, previous hormone use, leisure-time physical activity and BMI. They did not however, 
adjust for some key risk factors for stroke; blood pressure and serum lipid levels or any 
other dietary factors which may also influence stroke risk such as sodium, alcohol and 
dietary fat intakes. In addition haemorrhagic stroke risk was not significantly associated 
with increasing calibrated protein intake (in 20% increments) after adjusting for 
confounding variables. This may in part have been due to the smaller number of incident 
cases of haemorrhagic stroke, thus making it difficult to establish associations.  
A study of 34,670 Swedish women, part of the Swedish Mammography Study, sought to 
establish potential associations between dietary protein intake and stroke risk (176). 
Women were free from cancer and CVD at the start of the study (in 1997).  Dietary protein 
intake was estimated using FFQ, and all nutrients were residually energy adjusted. During 
a mean follow up of 10.4 years there were 1,680 incident stroke cases, of which 1,310 were 
ischaemic in origin and 216 haemorrhagic strokes, a further 137 cases were unclassified. 
There was a higher reported history of hypertension with higher intakes of total protein in 
g/d. Higher total protein intakes were associated with a  significant trend towards lower 
risk of total stroke and ischaemic stroke after adjustment for relevant confounding 
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variables including; age, smoking (and number of years smoking), education, BMI, physical 
activity, history hypertension, history diabetes, aspirin use, family history MI, dietary total 
energy, calcium, cholesterol, total fat, fruit, and vegetables intakes. The RR for total stroke 
risk in those with highest total protein intakes (≥78.7 g/d) was 0.74 (95% CI 0.61-0.91) 
compared with lowest total protein intakes (<61.8 g/d) which was the reference category. 
P trend across quintiles of total protein intake was 0.006. For ischaemic stroke specifically 
the P trend was 0.008 and the RR for the highest total protein intakes was 0.72 (95% CI 
0.58-0.90) compared with the lowest total protein intakes.  
Plant and animal protein 
In the previously mentioned study on Swedish women (176) analyses were also conducted 
for plant and animal protein and risk of stroke (Table 5.6). There was a significant trend 
towards lower risk of stroke across increasing quintiles of animal protein for total stroke 
and ischaemic stroke (P trend 0.01 and 0.004 respectively). A RR for total stroke of 0.71 
(95% CI 0.57-0.88) was reported for those with the highest intakes of animal protein (≥58.0 
g/d) compared with the lowest animal protein intakes (<38.3 g/d). Ischaemic stroke was 
associated with a RR of 0.65 (95% CI 0.51-0.84) in the highest quintile of animal protein 
compared with the lowest quintile. Plant protein intake was not significantly associated 
with total stroke or ischaemic stroke (P trend 0.22 and 0.07 respectively). However, in sub 
analysis of those without a history of hypertension neither animal protein nor plant protein 
intakes were significantly associated with total stroke risk (P trend 0.23 and 0.60 
respectively) or ischaemic stroke risk (P trend 0.11 and 0.14 for animal and plant protein 
respectively). Thus suggesting that history of hypertension, which is likely to be associated 
with elevated blood pressure – a significant risk factor for stroke, has a greater influence 
on stroke risk than dietary intakes of animal and plant protein.    
  
Chapter Five   Dietary protein stroke risk and risk factors 
 
219 
 
Specific foods and stroke risk 
This section aims to provide a brief overview of studies that have investigated intakes of 
specific high protein food items and stroke risk.  
Eggs 
A number of studies have investigated the specific effects of egg consumption on stroke 
risk (324, 372-375). A recent meta-analysis by Rong et al (320) concluded that higher egg 
consumption, increase consumption of one egg/d, was not associated with increased 
stroke risk. However, in sub-group analyses of a diabetic population a higher consumption 
of eggs, compared with lowest intakes, was associated with a reduced risk of haemorrhagic 
stroke (0.75 95% CI 0.57-0.99). These findings are however, based on very small numbers 
of cases, n=8 and n=3 respectively for total stroke and diabetic sub-group analysis and may 
not be able to be extrapolated to the wider diabetic or healthy population.  
The potential mechanism by which higher intakes of eggs may increase stroke risk is likely 
linked to the cholesterol content of eggs, however, it has been reported that dietary 
cholesterol intake only has a small impact on circulating levels (376). Egg consumption may 
actually reduce the development of atherosclerotic plaques as evidence suggests egg 
consumption leads to the formation of larger HDL and LDL particles which may infer a 
protective effect (377, 378). Higher egg consumption may also be of benefit by acting as a 
substitute for other dietary constituents such as carbohydrates and fat. Protein is also 
satiating and therefore may lead to overall reduced calorie intake which may initiate the 
benefit. The satiating effect may be mediated via slight increases in thermogenesis of 
protein compared with carbohydrates. The benefits or negative effects of egg consumption 
on health may also be dependent on the cooking method used and this was not stated. For 
example fried or scrambled eggs would usually incorporate additional ingredients such as 
fat or dairy products which may affect the relationship between the food and health.  
The effect of higher egg consumption on haemorrhagic stroke in diabetics may be due to 
the reduced insulin sensitivity of this population group. This leads to decrease in the 
sequestration of circulating cholesterol which in the case of HS may actually be beneficial 
(with lower TC levels related to increase risk of haemorrhagic stroke). Therefore, this 
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finding may only be applicable to this particular population group and the findings not 
directly extractable to the wider population. Another potential mechanism of action, may 
be related to the vitamin D content of eggs. Eggs are one of only few dietary sources of 
vitamin D and higher vitamin D intakes may reduce visceral adipose tissue and other CVD 
risk factors (379, 380). 
Meat 
Western diets, characterised by higher intakes of meat have been associated with 
increased risk of stroke (381). The risk of stroke can differ between sources of meat and 
meat products. For example processed meats infer an increase in stroke risk, whilst poultry 
and fish have been associated with decrease in stroke risk (175). This may be due to 
differences in nutritional composition of meat and meat products. For example processed 
meat, is typically more calorie dense and has a higher sodium content than red meat or 
poultry. Processed meats also tend to be lower in both protein and iron compared with red 
and white meats such as poultry (381). The overall increase in risk seen in higher meat 
eaters, such as seen in the Western dietary pattern may be in part attributable to the iron 
content. Haem iron, the form present, in meat has been associated with an increased risk 
of CVD mortality (175). Whereas foods that are rich in non-haem iron, such as fruit and 
vegetables, cereals and wine, may reduce risk. However, this may be associated with other 
beneficial properties of these food items, such as phytochemicals, antioxidants, fibre and 
other vitamins and minerals. 
Where comparisons are made between dietary protein sources the difference in stroke risk 
inferred by each product may result from differences in nutritional composition including 
saturated fat and haem iron content as well as traditionally different cooking methods 
(175). 
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Table 5.4. Overview of epidemiological studies investigating the associations between dietary protein intake and blood pressure.  
Author 
Study Popn- 
Sex, 
Age (y) 
Dietary 
Method 
Type of 
Protein 
Adjustments Size of Effect 
Altorf-van der 
Kuil 
(2012) 
(123) 
Doetinchem 
cohort (n=3,588) 
Netherlands 
M/W,  
26-65, 
FFQ and 
24h recall 
Total 
Animal 
Plant 
Dairy 
Meat 
and grain 
Total energy (residual method), age, sex, 
BMI, education, smoking, alcohol, SBP, 
energy, SFA, PUFA, CHO, fibre, Ca, Mg, and 
K, and protein from other sources.  
Total, plant and animal protein was not significantly associated 
with incident hypertension. 
Grain protein 15% reduction in hypertension HR 0.85 (95% CI 
0.73-1.00 P trend=0.04) highest vs. lowest tertile. 
Other sources of plant protein were not associated with 
hypertension risk 
 
Altorf-van der 
Kuil 
(2012) 
(124) 
MORGEN 
(n=20,820) 
Netherlands 
 
M/W,  
20-65, 
FFQ 
Total 
Animal 
Plant 
Dairy 
Meat 
and grain 
 
Protein adjusted for total energy (residual 
method), age, sex, BMI, education, 
smoking, alcohol, total energy, SFA, CHO, 
fibre, Ca, Mg, K, and protein from other 
sources. 
No significant association between total and animal protein and 
blood pressure. 
Plant protein -1.8 mmHg lower SBP and -1.0 mmHg lower DBP 
highest vs lowest quintile (P trend<0.01). 
 
Umesawa  
2009 
(361)  
CIRCS (n=7,585) 
Japan 
M/W, 
40-69, 
24h recall 
Total 
Animal 
Plant 
 
Age, sex, community, BMI, 
antihypertensive medication, alcohol, 
smoking Na, K, Ca. 
NS association in M or W for SBP/DBP after dietary Na, K, and Ca 
added to model. 
P trend M: 0.466/0.268 and W:0.305/0.128. 
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Elliot  
(141) 
(2006)  
INTERMAP 
(n=4,680) 
Japan, China, UK, 
USA 
M/W,  
40-59, 
24h recalls 
Total  
Animal 
Veg 
 
Height, weight, sample, age, sex, special 
diet, history CVD/DM, family history 
hypertension, moderate/heavy PA, 
supplement, 24h urinary Na & K, alcohol,  
PUFA, dietary cholesterol, Ca, SFA, Mg, 
fibre. 
 
Age and sex interaction terms 
Inverse association between vegetable protein and BP but not 
total or animal protein.  
Stamler  
(364) 
(2002) 
 Chicago Western 
Electric Study 
(n=1,714) 
M,  
40-55, 
Interview 
& FFQ 
Total 
Animal 
Veg 
 
Time, age, height, education, smoking, 
alcohol, and variables to average BP. 
Positive association between total and animal protein with 
change in SBP, and inverse association for vegetable protein. 
Inverse association between vegetable protein and change in 
DBP 
No associations with change in DBP and total or animal protein. 
Abbreviations: BMI, body mass index; Ca, calcium; CHO, carbohydrate; CVD, cardiovascular disease; D, dairy protein; DBP, diastolic blood pressure; DM, 
diabetes; FFQ, food frequency questionnaire; k, potassium; Mg, magnesium; Na, sodium; PA, physical activity; PUFA, polyunsaturated fat; SBP, systolic blood 
pressure; SFA, saturated fat. 
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Table 5.5. Overview epidemiological studies investigating the associations between dietary protein intakes and circulating lipid levels. 
Author 
Study 
Population 
Sex, 
Age (y) 
Dietary Method 
Adjustments Size of Effect 
Mirmiran  
(173) 
(2012)  
Tehran Lipid and 
Glucose Study 
(n=2537) 
 
M/W,  
19-70, 
FFQ 
Energy adjusted nutrients, age, PA, smoking, 
BMI, total energy, dietary fat, CHO, SFA, 
MUFA, PUFA, cholesterol, fibre, Na 
Higher total protein (but not animal:plant) intake positively associated 
with HDL in M&W (P trend <0.05). 
NS association with TG in M/W for total or animal:plant protein 
 
Zhang  
(27) 
(2008)  
Chinese  
(n=406) 
 
M/W,  
40-65, 
FFQ 
Age, BMI, waist circumference, smoking, 
total energy, SFA, dietary fibre, 
Sig inverse association between soy intake and TC (P trend 0.003 & 
0.016) and LDL (P trend 0.002 & 0.028) in men and women. HDL and 
TG NS in both sexes. 
 
Rosell 
(28)  
(2004) 
EPIC-Oxford 
(n=1033) 
W,  
≥20, 
FFQ 
Age, menopausal status, smoking, alcohol, 
HRT use, BMI, total energy, % energy SFA, % 
energy PUFA, dietary cholesterol, fibre, diet 
group (non-vegetarian, vegetarian,  vegan). 
Sig inverse association between soy intake and TC (P=0.048 &0.002) 
and LDL (0.029 & <0.001) in pre and postmenopausal women  
Sig inverse association Total:HDL in postmenopausal women (P=0.006) 
NS association with HDL 
 
Ho  
2000 
(29) 
M/W,  
24-74, 
Questionnaire  
Age, education, dietary cholesterol, dietary 
fats, SFA. 
Sig inverse association TC and LDL in males and women <50. Women 
≥ not adjusted. 
NS association with HDL (data not presented) 
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Chinese 
(n=1010) 
& FFQ 
 
Smit  
1999 
(369) 
NHANES III  
(n=6228) 
M/W,  
≥20, 
24h recall 
Age, sex, race, recall day, BMI, smoking, 
income, dietary variables incl SFA,  
 Higher % energy from plant protein in lower quartiles serum 
cholesterol. 
Animal:plant NS after adjustment for SFA 
NS association with LDL or HDL 
 
Nagata  
(368) 
(1998)  
Takayama Study 
(n=4837) 
M/W,  
≥35, 
FFQ 
Total energy, age, BMI, coffee consumption, 
vitamin C, smoking (W only), alcohol, green 
tea, PA, dietary variables associated with 
serum cholesterol or soy intake 
Sig inverse association with TC and soy intake in M&W (P trend 0.0001 
both sexes) 
Abbreviations: 
BMI, body mass index; Ca, calcium; CHO, carbohydrate; FFQ, food frequency questionnaire; HDL, high density lipoprotein; HRT, hormone replacement 
therapy; k, potassium; LDL, low density lipoprotein; Mg, magnesium; MUFA, monounsaturated fat; Na, sodium; NS, non-significant; PA, physical activity; 
PUFA, polyunsaturated fat; SBP, systolic blood pressure; SFA, saturated fat; TC, total cholesterol. 
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Table 5.6. Overview of epidemiological studies investigating associations between dietary protein intake and risk of stroke.  
Author 
Study Popn- 
Sex, 
Age (y) 
Dietary 
Method 
Type of 
Protein 
Adjustments Size of Effect 
Larsson 
(176)  
(2012) 
Swedish 
Mammography Cohort 
(n=34,670) 
W 
49-83 
FFQ 
Total Age, smoking, eduction, BMI, PA, 
hypertension, DM, aspirin, family history MI, 
dietary: total energy, Ca, cholesterol, total 
fat, fruits and vegetables, animal protein, 
plant protein. 
Analyses n=1680 
Total stroke 0.74 (95% CI 0.61-0.91) 
P trend=0.006 
Park  
(382) 
(2010) 
Stroke cases (n=69) vs 
Control (n=69) Korean 
M/W 
Mean age 
57.7 
24h recall 
Total 
Plant 
Animal 
 
Age, sex, BMI, family history stroke, total 
energy 
Non-significant association for  
Total (P=0.087), 
Plant (P=0.801), 
Animal (P=0.338) 
 
Preis 
(177) 
(2010) 
Health Professionals 
Follow-Up (n=43,960) 
M, 
40-75, 
FFQ 
Total 
Animal 
Veg 
 
Quintiles of % energy from protein, SFA, 
MUFA, PUFA and trans fat, total energy, BMI, 
smoking, parental MI <65, alcohol, 
multivitamin use, quintiles; PA, GI, folate, B6, 
B12, vitamin C, K, Mg, and total omega-3 
FAs. 
In addition baseline hypertension, diabetes 
and hypercholesterolemia status) 
 
Extreme quintiles  
Total Protein;TS 1.14 (95% CI 0.90-1.43 P trend=0.43)  
Animal Protein; TS 1.11 (95% CI 0.87-1.41 P trend= 0.52)  
Vegetable Protein: TS 0.82 (95% CI 0.60-1.12 P trend= 
0.17) 
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Iso  
(383) 
(2003) 
Japanese (n=4,775) 
M/W, 
40-69 
24hr 
recall 
Total Age, sex, quartiles of total energy and BMI, 
hypertension category, DM, cholesterol 
categories, smoking status, alcohol intake 
and menopausal status (in women) 
 
N.B analyses n=68 
Comparison extreme quintiles fully adjusted RR for 
intraparenchymal haemorrhage 
RR 0.58 (0.26-1.28) P trend=0.14 
Sauvaget  
(324) 
(2003)  
The Life Span Study 
(n=37,130) 
M/W,  
34-103, 
FFQ 
Animal Age, stratified by sex and birth cohort. 
adjustment; smoking, alcohol, BMI (sr), 
education, DM, hypertension, radiation 
dose, city 
12% reduction in stroke mortality. 
After adjustment for fruit and veg intake, HR 0.96 (95% CI 
0.84, 1.09) for stroke mortality 
Abbreviations: BMI, body mass index; Ca, calcium; CHO, carbohydrate; DM, diabetes; FFQ, food frequency questionnaire; GI, glycaemic index; K, potassium; 
MI, myocardial infarction; Mg, magnesium; MUFA, monounsaturated fat; Na, sodium; PA, physical activity; PUFA, polyunsaturated fat; SFA, saturated fat; sr, 
self-reported;.
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Table 5.7. Overview of epidemiological studies investigating the associations between dietary patters and risk of stroke.  
Author 
Study Popn- 
Sex, 
Age (y) 
Dietary 
Method 
Dietary Pattern Adjustments Size of Effect 
Fung  
(384) 
(2009) 
Nurse’s Health 
Study 
(n=74,886) 
 
F 
38-63, 
FFQ 
Mediterranean  Age, smoking, BMI, menopausal status (incl HRT use), 
aspirin use, energy intake, alcohol,  hours of PA, 
multivitamin use, family history 
 
Extreme quintiles 
RR 0.87 (95% CI 0.73- 1.02 P trend = 0.03) 
total stroke 
Fung 
(385) 
(2008) 
Nurse’s Health 
Study 
(n=88,517) 
 
F 
38-63, 
FFQ 
DASH  Age, smoking, BMI, menopausal status (incl HRT use), 
aspirin use, energy intake, alcohol,  hours of PA, 
multivitamin use, family history 
 
Extreme quintiles 
RR 0.83 (95% CI 0.71- 0.96 P trend = 0.007) 
total stroke 
Fung  
(370) 
(2004)  
Nurse’s Health 
Study 
(n=71,768) 
F,  
30-55, 
FFQ 
Prudent vs. 
Western  
Age, smoking, BMI, menopausal status (incl HRT use), 
aspirin use, energy intake, alcohol,  hours of PA 
 
Extreme quintiles 
Prudent 
RR 0.78 (95% CI 0.61-1.01 P trend= 0.13) 
total stroke 
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Western 
RR 1.58 (95% CI, 1.15-2.15 P trend=0.0002) 
total stroke 
 
Key  
(386) 
(1999) 
Multiple*1 
(n=76,172) 
M/w,  
16-89, 
FFQ 
Vegetarian vs 
non-vegetarian 
Age (per 5yr), sex, smoking.  
N.B some data was missing for different cohorts e.g. BMI, 
alcohol, education, PA 
NS difference in stroke mortality. 
 
Abbreviations: BMI, body mass index; FFQ, food frequency questionnaire; HRT, hormone replacement therapy; NS, non-significant; PA, physical activity. 
1 The Adventist Mortality Study, Health Food Shoppers Study, The Adventist Health Study, The Heidleberg Study, The Oxford Vegetarian Study
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5.0.4 Randomised controlled trials 
Blood pressure 
A number of clinical trials have been conducted investigating the effect of supplementation 
with protein on blood pressure and lipid profile. However, the majority of these have 
involved specific populations comprised of participants with existing risk factors including; 
prehypertension, stage one hypertension, hyperlipidaemia or obesity. They have also 
primarily assessed the effects of soy protein supplementation (127, 128, 387-390).  
A number of studies have identified a significant association with diets higher in protein 
and also specifically soy protein (388-390) (Table 5.8). The difference between sources of 
protein, animal/dairy compared with soy may also result from different amino acid 
composition of the diets, or from other compositional changes to the diet associated with 
changes in protein content e.g. carbohydrate and fat content, although there is a lack of 
conclusive evidence in this area.  
Plant and animal protein 
Recently Teunissen-Beekman et al (391) investigated the effect of consumption of either a 
mixed protein drink, comprised of 20% each of soy and pea, and 30% each of egg and milk 
protein-isolate, or maltodextrin drink 20g 3 times/d on blood pressure in overweight Dutch 
men and women with prehypertension or stage I hypertension. This ratio of plant to animal 
protein (40:60) was said to reflect the pattern of protein consumption in the Dutch 
population. Their main findings indicate that additional mixed protein supplementation 
(pea, soy, egg, and milk-protein isolate) can significantly reduce in-office and daytime 
ambulatory BP. An average change after four weeks intervention of -4.9±1.7 mmHg (95% 
CI 1.65-8.2, P=0.005) and -4.6±1.7 mmHg (95% CI 1.3-7.9, P=0.006) for SBP for in-office and 
daytime ambulatory respectively. A change of-2.7±1.3 mmHg (95% CI0.1-5.4, P=0.05) was 
reported for in office DBP. There was no significant change in daytime ambulatory DBP. 
Previously reductions of 1-3 mmHg and 4mmHg in SBP and DBP have been associated with 
20-30% and 23% reductions in overall stroke risk (16, 70, 71). However, the protein 
supplementation appeared to cause greater daily fluctuations in BP, up to 4 mmHg from 
one day to the next, compared with supplementation with maltodextrin. Whether these 
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fluctuations would settle with prolonged intake of these diets is unclear. There is evidence 
to suggest that long-term intra-individual variation in BP is an independent predictor of 
stroke risk (392, 393) and therefore may indicate that supplementation of this nature 
actually increases stroke risk. 
In addition a recent systematic review and meta-analysis on RCTs investigating dietary 
protein intake and blood pressure identified 40 relevant trials, published between1980 and 
2011, to include in their analysis (366). The majority of the RCTs compared protein intake 
versus carbohydrate intake (32 studies). Twelve of the RCTs also specifically investigated 
differences between animal and plant protein. Only two of the identified studies were 
conducted in UK populations (Scotland) (394, 395), the majority were from the United 
States (11 studies) and Australia (13 studies). Both of the Scottish studies used 
supplementation to achieve differences in protein intakes of the control and intervention 
groups and in addition only investigated vegetable protein intake compared with 
carbohydrate intake. Only the study by Sagara et al (395) which supplemented 20 g 
protein/d for 5 weeks showed a significant decrease in blood pressure of -7.2 mmHg and -
3.4 mmHg for SBP and DBP. In the study by Harrison et al (394) where 25 g/d of vegetable 
protein supplement was consumed for 5 weeks there was a slight net increase in SBP of 
0.95 mmHg and a small reduction in DBP of -1.0 mmHg. Participants in both studies had an 
average blood pressure in the pre-hypertensive range. 
The authors concluded that the pooled results of all 40 RCTs suggested that an increase in 
total protein led to an estimated decrease of -1.76 mmHg (-2.33 to -1.20) for SBP and -1.15 
(-1.59 to -0.71) for DBP. There was no statistically significant difference in blood pressure 
in studies assessing the effect of animal compared with plant protein. 
Lipid profile 
Plant protein 
Clinical trials have predominately focused on investigating the effects of differing amounts 
of soy or dairy protein on changes in lipid profile. Most indicate no significant association 
between soy protein intake and HDL levels, but a significant inverse association with TC, 
LDL, TC:HDL and LDL:HDL (Table 5.9) (127, 128, 387, 396). Although, findings in relation to 
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other lipid profile variables are more inconsistent. Appel et al (251) looking at the impact 
of a mixed protein diet (including some soy) compared with a high CHO diet on lipid profile 
reported a negative effect. A small (0.03 mmol) but significant decrease in HDL (P=0.02) 
was reported in those on the protein diet.  
Jenkins et al (396) investigated the effect of replacing 93% of animal protein with plant 
protein (including some soy). They reported significant differences in TC, LDL, TC:HDL and 
LDL:HDL ratios. This indicates that diets higher in plant protein as opposed to animal 
protein may exert beneficial effects on lipid profile. However, it cannot be ruled out that 
other factors associated with this diet including a high fibre content and increase in 
micronutrients were contributing to the differences exhibited.  
One important factor that should be noted is that these studies were conducted in specific 
populations with many of the participants having existing dyslipidaemia or high blood 
pressure. Therefore the findings may not be directly comparable to the effects that would 
be seen in the general population.  
 
Chapter Five          Dietary protein stroke risk and risk factors 
 
232 
 
Table 5.8. Overview of intervention studies investigating the effect of protein supplementation on blood pressure.  
   Change in BP (mmHg) 
Author Sex,  
Age (y) 
 
Intervention (Design, blinding, duration, protocol) SBP DBP 
Teunissen-Beekman 
(391)  
(2012)  
Prehypertensives or stage 1 
hypertension PROPRES 
(n=94) 
Dutch 
 
M/W,  
20-70, 
 
Randomised parallel 
Double blind 
2 wks run in 4 wks 
Base diet 15% energy protein, 30% fat, 55% CHO.  
20 g malodextrin (control) or 20 g mixed protein in 200 ml 
water at each meal.  
Protein vs malodextrin 
Office: -4.9±1.7 mmHg (95% 
CI 1.65-8.2) 
P=0.005 
Daytime -4.6±1.7 mmHg 
(95% CI 1.3-7.9) 
P=0.006 
 
Office: -2.7±1.3 mmHg 
(95% CI0.1-5.4) 
P=0.05 
Daytime: NS 
Azadbakhtn 
(389) 
(2011) 
Overweight + Obese (n=23) 
 
W,  
18-30 
 
Crossover  
No blinding 
6 wks (3 wks washout) 
Soy drink replacement (one glass replacement of  cow’s 
milk) control; only cow’s milk 
 
% change 
Soy -4.0±0.9 
Cow’s -1.7±0.5 
P trend 0.4 
% change 
Soy -0.4±0.1 
Cow’s 0.4±0.1 
P trend 0.4 
He  
(390) 
(2011) 
Prehypertensives or stage 1 
hypertension (n=352) 
 
M/W, 
≥22, 
 
Crossover 
Double blind 
8 wks (3 wks washout) 
40 g/d soy protein, milk protein or CHO supplementation 
(control) 
Soy protein  -2.0 
Milk protein -2.3 
NS 
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USA 
Appel  
(251) 
(2005)  
Omni-Heart (n=164) 
US 
M/W, 
≥30, 
 
Randomised Crossover 
Single blind 
6 days run in 6 wks each 
CHO rich (58%), protein (mixed) rich (25%), unsaturated 
fat rich (mainly MUFA)  
Mean change w/ protein 
diet 
All: -9.5 (95% CI -10.9 to -
8.2) 
Stage 1 hypertensive: -16.1 
(95% CI -19.7 to-12.5) 
Prehypertensive: -8.0 (95% 
CI -9.3 to -6.6) 
 
Mean change w/ protein 
diet 
All: -5.1 (95% CI -6.1 to   -
4.4) 
Stage 1 hypertensive: -8.6 
(95% CI -10.9 to -6.4) 
Prehypertensive:  -4.4 
(95% CI -5.3 to -3.6) 
 
Jenkins 
(388) 
(2002)  
Hyperlipidemic M and 
postmenopausal W (n=41 
(23/18)) 
M/W 
mean 
age 62, 
 
Randomised Crossover 
Single blind 
1 mo each (2 wk washout between) 
High isoflavone 50 g/d soy & 73 mg/d isoflavones, low 
isoflavone 52 g/d soy & 10 mg/d isoflavones) control low 
fat dairy food. 
NS difference in SBP or DBP in combined M&W analyses. 
M only isoflavone diets lower blood pressure than 
control P=0.065 and 0.007 for low and high respectively. 
Abbreviations: CHO, carbohydrate; DBP; diastolic blood pressure; MUFA, monounsaturated fat; NS, non-significant; SBP, systolic blood pressure 
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Table 5.9. Overview of intervention studies investigating the effect of protein supplementation on circulating lipid levels. 
Author 
Study Popn- 
Sex, 
Age 
(y) 
 
Intervention (duration, protocol) Design and 
Blinding 
Results 
Thorp 
(127) 
(2008)  
Raised TC (n=91 
(33/58)) 
M/W,  
18-80 
6 wks each (3 wk washout) 
1. 24 g/d soy protein, 2. 12 g/d dairy % 12 
g/d soy, 3. Control: 24 g/d dairy. 
Randomised 
Crossover 
Double Blind 
Sig diff w/ soy diet for TC (P=0.014) soy & 
dairy diet for TG  
NS effect on LDL or HDL (P<0.001). 
 
Gardner 
(128) 
(2007)  
Hyperlipidemic (n=28) 
 
M/W,  
30-65 
4 wks each (4 wk washout) 
25 g/d from 1. Whole soy bean milk, 2. SPI 
milk, 3. Low-fat dairy milk 
Randomised 
Crossover 
Single Blind 
Sig decrease in LDL with whole soy bean 
and SPI compared with dairy milk (P=0.02). 
NS TG and HDL 
Appel 
(251) 
(2005)  
Omni-Heart (n=164) 
US 
 
M/W  
≥30 
6 days run in 6 wks each 
CHO rich (58%), protein rich (25%), 
unsaturated fat rich (mainly MUFA)  
Randomised 
Crossover 
Single Blind 
Protein sig decrease TG by 0.18 mmol 
(P<0.001) LDL by 0.09 (P=0.01), and HDL by 
0.03 (P=0.02) compared to CHO diet. 
Wang 
(387) 
(2004)  
M/W  
>50 
6 wks each 
1. SPI (25 g/1000 kcal) minus isoflavones, 2. 
Isoflavone (49 mg/1000 kcal) enriched SPI, 
Randomised 
Crossover 
Single Blind 
Sig decrease with soy protein vs animal 
protein TC (P<0.001), TG (P<0.001), LDL 
(P<0.003), TC:HDL (P=0.037) and LDL:HDL 
(P=0.018). But not HDL or VLDL. 
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Hyperlipidemic(n=20 
(6/14)) 
US 
3. Animal protein (25 g/1000 kcal), 4. Animal 
protein with isoflavones (49 mg/1000 kcal). 
NS effect of isoflavone enriched diet, 
except TC (P=0.009). 
 
 
 
 
 
 
 
Jenkins 
(388) 
(2002)  
Hyperlipidemic M and 
postmenopausal W 
(n=41 (23/18)) 
M/W 
mean  
62 
1 mo each (2 wk washout) 
High isoflavone 50 g/d soy & 73 mg/d 
isoflavones, low isoflavone 52 g/d soy & 
10m g/d isoflavones) control low fat diary 
food. 
Randomised 
Crossover 
Single Blind 
NS difference between high and low 
isoflavone diets and lipid levels. 
Sig difference between control and 
isoflavone diets (low high respectively) 
TC P=0.016 & 0.045 
Total:HDL P=0.001 & 0.018 
LDL:HDL P=0.001 & 0.004 
 
Jenkins 
(396) 
(1999)  
Hyperlipidemic M and 
postmenopausal W 
(n=31 (19/12)) 
M/W,  
31-70 
1 mo each (2 wk washout) 
Test diet: 93% animal protein replaced with 
vegetable-soy, other legumes, and cereals, 
high soluble fibre content. 
Control: lacto-ovo vegetarian incl low fat 
dairy. 
Cholesterol content same in both diets 
Randomised 
Crossover 
No Blinding 
Sig difference in TC, LDL, TC:HDL, and 
LDL:HDL P=<0.001, <0.001, 0.002 and 0.004 
respectively. 
NS difference HDL or TG with treatment. 
Abbreviations: CHO, carbohydrate; HDL, high density lipoprotein; LDL, low density lipoprotein; MUFA, monounsaturated fat; NS, non-significant; SPI, soy 
protein isolate; TC, total cholesterol; TG, triglyceride; VLDL, very low density lipoprotein. 
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To summarise the findings of the literature review indicated that there were inconsistent 
reports of the influence of protein on stroke risk and risk factors. In addition there has been 
limited research conducted in UK populations, although a UK cohort was included in the 
INTERMAP study investigating the effects of dietary protein on blood pressure. Previous 
research suggests that there may be a benefit of increased consumption of dietary protein 
on stroke risk factors blood pressure and lipid profile and also directly on stroke risk. Some 
reports have provided conflicting findings, often potentially due to differences in the source 
of protein investigated which warranted further investigation.  
With this in mind, it is important to elucidate the potential associations between dietary 
protein intake, including the effects of different sources, on blood pressure, lipid levels 
and stroke risk in a UK population. To date to my knowledge, no other study has 
simultaneously investigated the associations between dietary protein intake and stroke 
risk and risk factors in a UK population of men and women. This may elucidate if the 
beneficial effects previously reported are due to protein content (composition) or other 
factors associated with the intake of the dietary pattern or specific protein source.  
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5.1 Aims and hypotheses 
This chapter aims to address research question 3, outlined in the Introductory Chapter, 
Chapter One. 
 
3. What are the relationships between dietary protein intake, including that from 
different types (animal and plant) and stroke risk factors, blood pressure and serum 
lipid levels and the risk of stroke in middle and older aged men and women? 
 
The hypothesis was that overall higher total protein intake would be inversely associated 
with blood pressure, a more favourable lipid profile and lower risk of stroke. 
For subtypes of protein intake it was hypothesised that higher animal protein intake would 
be associated with higher blood pressure, less favourable lipid profile and overall increase 
in stroke risk. Whereas for plant protein, the hypothesis was that higher plant protein 
intakes would be inversely associated with blood pressure and a more favourable lipid 
profile and lower stroke risk. 
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5.2 Methods 
Methods are provided in full in Chapter Two – Subjects and methods. 
Briefly 4,361 participants were included in these analyses after subjects with missing data 
for one or more of the following variables were excluded; BMI, WHR, SBP, DBP, LDL, HDL, 
or TG levels, education status, baseline prevalent stroke, MI, DM, family history of stroke 
or MI (n=559). Individuals with missing data for cigarette smoking were coded as current 
smoker (n=37) and no response to the question ‘Have you taken aspirin continuously for 3 
months or more’ where recoded into the ‘no’ category (n=710). 
Protein categorisation 
Protein was classified into total protein, animal protein, plant protein and unclassified. 
Total protein was all protein intake. Animal protein was a combination of three protein 
groups, animal-land, animal-marine and animal-derived. In addition a number of mixed 
foods where the main bulk of protein was derived from animal sources were also added to 
this group, such as food in milk or cheese based sauces. Plant protein contains anything of 
plant origin including fruit, vegetables and grains. An ‘unclassified’ category was created 
for items which did not fit into either the plant or animal group. This included items such 
as water, artificial sweeteners, spirits, yeast and honey, as these do not contribute highly 
to protein intake, they are therefore unlikely to influence the findings. Further details of 
the categorisation of protein is included in the previous chapter; Chapter Four – 
Contribution to dietary protein intake. 
Protein intakes were expressed as a percentage of total energy intake. This unit was chosen 
to account, to some extent, for total energy intake as protein intake is strongly correlated 
with total energy. Expressing intakes as a percentage of energy also allows comparison 
between sexes and populations. Variables of protein intake as a percentage of total energy 
were created by multiplying the protein intake in g/d by 4 (the number of kcal in one gram 
of protein), divided by total energy intake and multiplying by 100: 
(protein*4/total energy)*100 
The ratio of plant:animal protein intake was calculated by dividing plant protein by animal. 
Chapter Five   Dietary protein stroke risk and risk factors 
 
239 
 
Statistical analyses 
The risk factors analysed for associations with percentage energy from protein were blood 
pressure and blood lipids. These risk factors were chosen as raised blood pressure and 
abnormal lipid profile are significant independent risk factors for stroke.  
Analyses were conducted by sex-specific quintiles of percentage energy from protein 
intake. Percentage of energy from protein was used as this provides a better 
representation of protein intake independent of total energy intake.  Multiple regression 
analysis with multivariable adjustment was used to identify potential associations between 
percentage energy from protein intake in relation to blood pressure (SBP and DBP) and lipid 
profile (TC, LDL, HDL and TG) in men and women aged 40-75 years.  
  
Chapter Five   Dietary protein stroke risk and risk factors 
 
240 
 
5.3 Results EPIC 
Table 5.10 Baseline characteristics of men and women aged 39-80 years in the EPIC-Norfolk 
sub-cohort. 
 Men 
n=2000 
Women 
n=2443 
P-value1 
Age (years) 61.1 (±9.53) 60.4 (±9.7) 0.02 
BMI (kg/m2) 26.5 (±3.18) 26.2 (±4.24) 0.01 
Stroke Cases (%) 449 (22.5%) 479 (19.6%) 0.02 
Family History Stroke (%) 465 (23.3%) 601 (24.6%) 0.29 
Family History MI (%) 720 (36.0%) 934 (38.2%) 0.13 
Family History DM (%) 222 (11.1%) 305 (12.5%) 0.16 
Blood Pressure mmHg    
SBP 140 (±18.5) 136 (±19.5) <0.001 
DBP 85.3 (±11.5) 81.8 (±11.4) <0.001 
Antihypertensive Use (%) 417 (20.9%) 516 (21.1%) 0.83 
Aspirin Use (%) 271 (13.6%) 197 (8.06%) <0.001 
Blood Lipids mmol/l    
Total Cholesterol 6.07 (±1.10) 6.36 (±1.22) <0.001 
Statin use (%) 27 (1.35%) 43 (1.76%) 0.28 
Smoking (%)   <0.001 
Current  234 (11.7%) 314 (12.9%)  
Former 1,114 (55.7%) 774 (31.7%)  
Never 652 (32.6%) 1,355 (55.5%)  
Physical Activity (%)   <0.001 
Inactive 644 (32.2%) 800 (32.8%)  
Moderately Inactive 476 (23.8%) 790 (32.3%)  
Moderately Active 440 (22.0%) 514 (21.0%)  
Active 440 (22.0%) 339 (13.9%)  
Education Level (%)   <0.001 
0 – No Qualifications 667 (33.4%) 1,086 (44.5%)  
1 – O-Level or Equivalent 165 (8.25%) 249 (10.2%)  
2 – A-Level or Equivalent 887 (44.4%) 822 (33.7%)  
3 – Degree or Equivalent 281 (14.1%) 286 (11.7%)  
Dietary Factors    
Total Energy (kcal/d) 2218 (±505) 1685 (±384) <0.001 
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Protein percentage energy 
(%) 
15.0 (±2.58) 15.8 (±2.87) <0.001 
Plant protein (g/d) 25.5 (±7.94) 19.6 (±5.87) <0.001 
Animal protein (g/d) 55.0 (±14.8) 44.5 (±12.4) <0.001 
Ratio plant:animal (g/d) 0.50 (±0.23) 0.49 (±0.54) 0.82 
Unclassified protein (g/d) 1.03 (±0.65) 0.94 (±0.59) <0.001 
Alcohol (g/d) 15.9 (±20.8) 7.70 (±11.7) <0.001 
Total fat (g/d) 85.1 (±25.9) 64.6 (±20.6) <0.001 
Sodium (mg/d) 3150 (±864) 2405 (±660) <0.001 
 
  
Chapter Five          Dietary protein stroke risk and risk factors 
 
242 
 
Table 5.11 Association of quintiles of percentage energy from protein (range and mean quintile intake) and blood pressure (mean and SE) in 2,000 men, 
aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Total protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  7.18-12.93% 
11.8% 
n=400 
12.94-14.16% 
13.7% 
n=400 
14.17-15.26% 
14.7% 
n=400 
15.27-16.95% 
16.0% 
n=400 
16.96-32.16% 
18.8% 
n=400 
P trend 
SBP Unadjusted 139 (±0.86) 138 (±0.87) 140 (±0.95) 140 (±0.94) 141 (±1.00) 0.03 
 Model 11 140 (±0.86) 139 (±0.86) 140 (±0.86) 140 (±0.86) 139 (±0.86) 0.35 
 Model 22 140 (±0.91) 139 (±0.86) 140 (±0.85) 140 (±0.86) 139 (±0.92) 0.95 
DBP Unadjusted 85.6 (±0.56) 84.2 (±0.53) 85.8 (±0.60) 85.6 (±0.59) 85.5 (±0.59) 0.54 
 Model 11 86.3 (±0.56) 84.9 (±0.56) 85.7 (±0.56) 85.4 (±0.56) 84.4 (±0.56)*3 0.07 
 Model 22 85.8 (±0.59) 84.8 (±0.56) 85.8 (±0.55) 85.4 (±0.56) 84.9 (±0.60) 0.60 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy 
3P value ≤0.05 compared with Q1 
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Table 5.12 Association of quintiles of percentage energy from protein (range and mean quintile intake) and blood pressure (mean and SE) in 2,443 women, 
aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Total protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  8.13-13.33% 
12.1% 
n=489 
13.34-14.82% 
14.2% 
n=489 
14.83-16.16% 
15.5% 
n=488 
16.17-17.91% 
16.9% 
n=489 
17.92-30.79% 
20.0% 
n=488 
P trend 
SBP Unadjusted 135 (±0.92) 135 (±0.89) 136 (±0.85) 137 (±0.90) 136 (±0.86) 0.07 
 Model 11 137 (±0.77) 136 (±0.77) 136 (±0.77) 136 (±0.77) 134 (±0.78)**3 0.01 
 Model 22 137 (±0.82) 136 (±0.78) 136 (±0.77) 136 (±0.77) 134 (±0.83)** 0.02 
DBP Unadjusted 81.4 (±0.53) 81.5 (±0.49) 82.0 (±0.54) 82.8 (±0.53) 81.2 (±0.49) 0.59 
 Model 11 82.7 (±0.48) 81.9 (±0.48) 82.1 (±0.48) 82.3 (±0.48) 79.9 (±0.48)*** 0.001 
 Model 22 82.7 (±0.51) 82.0 (±0.49) 82.0 (±0.48) 82.3 (±0.48) 79.9 (±0.52)*** 0.01 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy 
3P value ≤0.05, ** P value ≤0.01 ***≤0.001 compared with Q1 
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Total protein %en 
There was no significant association between the percentage of energy from protein and 
blood pressure in 2,000 men (Table 5.11) after adjusting for relevant confounding variables 
including age, BMI, use of antihypertensive medication and dietary factors; total energy 
and sodium intake. There was however, a significant difference in DBP between extreme 
quintiles of -1.9 mmHg (P≤0.05) which was identified after adjustment for factors including 
age and physical activity levels. This significance was attenuated to -0.9 mmHg, with the 
addition of family history of stroke or MI, prevalent MI or DM and dietary factors; alcohol 
intake, total energy intake and sodium intake. In women (Table 5.12) a significant inverse 
trend was seen across quintiles of protein %en for both SBP and DBP after full adjustment 
for confounding variables (P trend =0.02 and 0.01 respectively). Significant differences of -
3 mmHg (P≤0.01) and -2.8 mmHg (P≤0.001) in mean SBP and DBP were identified between 
the extreme quintiles. 
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Table 5.13 Association of quintiles of dietary plant protein intakes (range and mean quintile intake) and blood pressure (mean and SE) in 2,000 men, aged 
40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary plant protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  1.44-3.67% 
3.20% 
n=400 
3.68-4.23% 
3.98% 
n=400 
4.24-4.75% 
4.49% 
n=400 
4.76-5.51% 
5.11% 
n=400 
5.52-11.0% 
6.43% 
n=400 
P trend 
SBP Unadjusted 142 (±0.91) 140 (±0.96) 139 (±0.91) 139 (±0.93) 138 (±0.92) <0.01 
 Model 11 141 (±0.86) 140 (±0.85) 139 (±0.85) 138 (±0.85)*3 139 (±0.85)* 0.01 
 Model 22 141 (±0.88) 140 (±0.85) 139 (±0.85) 139 (±0.85) 139 (±0.89) 0.06 
DBP Unadjusted 86.3 (±0.56) 86.0 (±0.60) 85.0 (±0.55) 84.5 (±0.59) 84.8 (±0.57) 0.01 
 Model 11 86.6 (±0.56) 85.9 (±0.56) 85.1 (±0.56)* 84.2 (±0.56)** 84.9 (±0.56)* <0.01 
 Model 22 86.4 (±0.58) 85.7 (±0.56) 85.1 (±0.55) 84.4 (±0.57)* 84.9 (±0.58) 0.03 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy, animal protein 
3P value ≤0.05 **≤0.01 compared with Q1 
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Table 5.14 Association of quintiles of plant protein intake (range and mean quintile intake) and blood pressure (mean and SE) in 2,443 women, aged 40-75 
years in EPIC-Norfolk cohort (1993-1997). 
  Dietary plant protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  0.00-3.75% 
3.22% 
n=489 
3.76-4.34% 
4.07% 
n=489 
4.35-4.91% 
4.63% 
n=488 
4.92-5.58% 
5.23% 
n=489 
5.59-13.2% 
6.51% 
n=488 
P trend 
SBP Unadjusted 136 (±0.88) 137 (±0.92) 136 (±0.89) 136 (±0.85) 134 (±0.89) 0.10 
 Model 11 136 (±0.77) 137 (±0.77) 136 (±0.77) 136 (±0.77) 135 (±0.77) 0.23 
 Model 22 136 (±0.80) 137 (±0.77) 136 (±0.77) 136 (±0.77) 134 (±0.81) 0.09 
DBP Unadjusted 81.8 (±0.50) 82.5 (±0.54) 81.7 (±0.49) 82.1 (±0.52) 80.8 (±0.52) 0.13 
 Model 11 81.7 (±0.48) 82.6 (±0.48) 81.8 (±0.48) 81.9 (±0.48) 80.8 (±0.48) 0.10 
 Model 22 81.9 (±0.50) 82.7 (±0.48) 81.8 (±0.48) 81.9 (±0.48) 80.6 (±0.51) 0.05 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy, animal protein.
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Plant protein %en 
In men no significant association was identified between quintiles of dietary plant protein 
%en and SBP after full adjustment (P trend =0.06) (Table 5.13). Prior to adjusting for 
medical history and dietary variables there was a significant inverse trend (P trend =0.01) 
between plant protein intake and SBP with a significant difference of -2 mmHg between 
extreme quintiles (P≤0.05). A non-significant difference of -1.5 mmHg was present between 
extreme quintiles for DBP after full adjustment including age, BMI, and dietary factors; total 
energy and intake of animal protein and there was a significant trend towards lower DBP 
with increasing intakes of plant protein %en (P trend =0.03). For women, there was no 
significant association between SBP and plant protein %en (P trend =0.09) (Table 5.14), 
there was however, a non-significant difference of -2.0 mmHg between the extreme 
quintiles in the fully adjusted model, which also adjusted for animal protein intakes in 
addition to other dietary factors, medical history and lifestyle factors.  There was a weakly 
significant (P trend =0.05) trend towards lower DBP with increasing plant protein %en in 
the fully adjusted model.  
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Table 5.15 Association of quintiles of animal protein intake (range and mean quintile intake) and blood pressure (mean and SE) in 2,000 men, aged 40-75 
years in EPIC-Norfolk cohort (1993-1997). 
  Dietary animal protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  2.71-8.23% 
6.96% 
n=400 
8.24-9.41% 
8.87% 
n=400 
9.42-10.4% 
9.94% 
n=400 
10.5-11.8% 
9.94% 
n=400 
11.9-27.4% 
13.7% 
n=400 
P trend 
SBP Unadjusted 138 (±0.90) 139 (±0.88) 138 (±0.90) 142 (±0.95) 140 (±0.99) 0.02 
 Model 11 140 (±0.86) 140 (±0.86) 138 (±0.85) 141 (±0.85) 138 (±0.86) 0.43 
 Model 22 140 (±0.91) 140 (±0.85) 138 (±0.85) 141 (±0.85) 139 (±0.90) 0.64 
DBP Unadjusted 84.7 (±0.58) 85.3 (±0.56) 85.1 (±0.56) 86.2 (±0.58) 85.3 (±0.60) 0.24 
 Model 11 85.5 (±0.56) 85.8 (±0.56) 85.0 (±0.56) 86.1 (±0.56) 84.3 (±0.56) 0.26 
 Model 22 85.3 (±0.59) 85.6 (±0.56) 85.1 (±0.55) 86.1 (±0.56) 84.5 (±0.59) 0.61 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy, plant protein 
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Table 5.16 Association of quintiles of animal protein intake (range and mean quintile intake) and blood pressure (mean and SE) in 2,443 women, aged 40-75 
years in EPIC-Norfolk cohort (1993-1997). 
  Dietary animal protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  0.43-8.58% 
7.14% 
n=489 
8.56-9.99% 
9.37% 
n=489 
10.0-11.2% 
10.6% 
n=488 
11.3-12.8% 
12.0% 
n=489 
12.9-26.0% 
14.9% 
n=488 
P trend 
SBP Unadjusted 134 (±0.90) 136 (±0.91) 136 (±0.83) 137 (±0.90) 137 (±0.87) 0.01 
 Model 11 137 (±0.77) 136 (±0.77) 136 (±0.77) 135 (±0.77) 135 (±0.77) 0.04 
 Model 22 137 (±0.82) 136 (±0.78) 136 (±0.77) 135 (±0.77) 135 (±0.82) 0.04 
DBP Unadjusted 81.1 (±0.52) 81.7 (±0.52) 82.0 (±0.50) 82.4 (±0.53) 81.8 (±0.50) 0.19 
 Model 11 82.4 (±0.48) 82.0 (±0.48) 82.2 (±0.48) 81.6 (±0.48) 80.6 (±0.49)**3 0.01 
 Model 22 82.6 (±0.51) 82.0 (±0.48) 82.1 (±0.48) 81.6 (±0.48) 80.6 (±0.51)** 0.01 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy, plant protein 
3P value ≤0.05 **≤0.01 compared with Q1 
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Animal Protein %en 
No significant associations were identified between animal protein %en and blood pressure 
in men (Table 5.15). However, for women (Table 5.16) there was a significant inverse 
association between dietary animal protein %en and SBP and DBP (P trend = 0.04 and 0.01 
respectively). There was a significant difference of -2 mmHg between extreme quintiles of 
the fully adjusted model for DBP (P≤0.01). In addition there was a difference of -2 mmHg 
between extreme quintiles for SBP, however, this did not reach significance.  
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Table 5.17 Association of quintiles of ratio plant:animal protein intake (range and mean quintile intake) and blood pressure (mean and SE) in 2,000 men, 
aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary plant:animal protein Intake  
  Q1 Q2 Q3 Q4 Q5  
  0.07-0.33 
0.28 
n=400 
0.34-0.40 
0.38 
n=400 
0.41-0.48 
0.45 
n=400 
0.49-0.59 
0.54 
n=400 
0.60-2.71 
0.83 
n=400 
P trend 
SBP Unadjusted 142 (±0.96) 140 (±1.00) 140 (±0.86) 139 (±0.89) 137 (±0.90) <0.001 
 Model 11 141 (±0.86) 139 (±0.86) 140 (±0.85) 139 (±0.86) 139 (±0.86) 0.13 
 Model 22 141 (±0.85) 139 (±0.85) 140 (±0.85) 139 (±0.85) 139 (±0.85) 0.17 
DBP Unadjusted 86.3 (±0.56) 85.6 (±0.66) 85.3 (±0.52) 85.1 (±0.56) 84.4 (±0.57) 0.02 
 Model 11 85.9 (±0.56) 85.4 (±0.56) 85.2 (±0.56) 84.3 (±0.56) 84.9 (±0.56) 0.21 
 Model 22 85.9 (±0.56) 85.3 (±0.55) 85.2 (±0.55) 85.3 (±0.55) 84.9 (±0.56) 0.23 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy
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Table 5.18 Association of quintiles of ratio plant:animal protein intake (range and mean quintile intake) and blood pressure (mean and SE) in 2,443 women, 
aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary plant:animal protein intake  
  Q1 Q2 Q3 Q4 Q5  
  0.00-0.32 
0.27 
n=489 
0.33-0.38 
0.36 
n=489 
0.39-0.46 
0.43 
n=488 
0.47-0.57 
0.52 
n=489 
0.58-22.4 
0.90 
n=488 
P trend 
SBP Unadjusted 137 (±0.89) 136 (±0.85) 138 (±0.91) 136 (±0.88) 133 (±0.87) 0.01 
 Model 11 135 (±0.77) 135 (±0.77) 137 (±0.77) 137 (±0.77) 136 (±0.77) 0.44 
 Model 22 135 (±0.77) 135 (±0.77) 137 (±0.77) 136 (±0.77) 135 (±0.77) 0.54 
DBP Unadjusted 82.1 (±0.52) 81.6 (±0.49) 82.6 (±0.52) 82.1 (±0.55) 80.5 (±0.49) 0.09 
 Model 11 81.4 (±0.48) 81.2 (±0.48) 82.3 (±0.48) 82.6 (±0.48) 81.5 (±0.48) 0.33 
 Model 22 81.4 (±0.48) 81.2 (±0.48) 82.3 (±0.48) 81.6 (±0.48) 81.5 (±0.48) 0.33 
1Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive medication use 
2Model 2: model 1 + baseline MI or diabetes, family history stroke, family history MI, alcohol intake, dietary sodium, total energy
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Ratio of plant:animal protein 
The ratio of plant:animal protein intake was not significantly associated with blood 
pressure in men (Table 5.17) or women (Table 5.18) after adjustment for confounding 
variables including age, BMI, smoking status physical activity, education level, use of 
antihypertensive medication, MI or diabetes at baseline, family history of stroke or MI, 
alcohol intake, and dietary sodium and total energy intakes. 
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Table 5.19 Association of quintiles of percentage energy from protein (range and mean quintile intake) and cholesterol and sub fractions (means and SE) in 
1,888 men, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary total protein as %en  
  Q1 Q2 Q3 Q4 Q5  
  7.18-12.93% 
11.7% 
n=373 
12.94-14.16% 
13.6% 
n=383 
14.17-15.26% 
14.7% 
n=375 
15.27-16.95% 
16.0% 
n=379 
16.96-32.16% 
18.7% 
n=378 
P trend 
Total Cholesterol Unadjusted 5.98 (±0.06) 6.03 (±0.05) 6.00 (±0.06) 6.06 (±0.05) 6.02 (±0.05) 0.52 
 Model 11 5.97 (±0.06) 6.04 (±0.06) 6.00 (±0.06) 6.06 (±0.06) 6.01 (±0.06) 0.64 
 Model 22 5.94 (±0.06) 6.04 (±0.06) 6.02 (±0.05) 6.06 (±0.05) 6.03 (±0.06) 0.32 
Triglycerides Unadjusted 1.89 (±0.05) 1.87 (±0.05) 1.86 (±0.04) 1.92 (±0.05) 1.91 (±0.05) 0.55 
 Model 11 1.91 (±0.05) 1.94 (±0.05) 1.85 (±0.05) 1.91 (±0.05) 1.84 (±0.05) 0.25 
 Model 22 1.91 (±0.05) 1.93 (±0.05) 1.85 (±0.05) 1.92 (±0.05) 1.84 (±0.05) 0.36 
HDL Unadjusted 1.25 (±0.02) 1.25 (±0.02) 1.21 (±0.02) 1.24 (±0.02) 1.18 (±0.02) <0.01 
 Model 11 1.25 (±0.02) 1.24 (±0.02) 1.22 (±0.02) 1.24 (±0.02) 1.20 (±0.02)* 3 0.09 
 Model 22 1.20 (±0.02) 1.22 (±0.02) 1.23 0.02) 1.25 (±0.02)* 1.24 (±0.02) 0.03 
LDL Unadjusted 3.87 (±0.05) 3.93 (±0.05) 3.95 (±0.05) 3.96 (±0.05) 3.97 (±0.05) 0.14 
 Model 11 3.86 (±0.05) 3.93 (±0.05) 3.95 (±0.05) 3.95 (±0.05) 3.98 (±0.05) 0.12 
 Model 22 3.88 (±0.05) 3.94 (±0.05) 3.96 (±0.05) 3.94 (±0.05) 3.95 (±0.05) 0.45 
HDL:LDL Unadjusted 0.36 (±0.01) 0.34 (±0.01) 0.32 (±0.01) 0.33 (±0.01) 0.32 (±0.01) 0.001 
 Model 11 0.36 (±0.01) 0.33 (±0.01) 0.33 (±0.01)** 0.33 (±0.01) 0.32 (±0.01)** 0.01 
 Model 22 0.34 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.34 (±0.01) 0.34 (±0.01) 0.51 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy 
3P value *≤0.05, **≤0.01 compared with Q1 
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Table 5.20 Association of quintiles of protein as percentage of energy intake (range and mean quintile intake) and cholesterol and sub fractions (means and 
SE) in 2,380 women, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary total protein as %en  
  Q1 Q2 Q3 Q4 Q5  
  8.13-13.34% 
12.1% 
n=484 
13.35-14.82% 
14.2% 
n=478 
14.83-16.16% 
15.5% 
n=475 
16.17-17.91% 
16.9% 
n=474 
17.92-30.79% 
20.0% 
n=469 
P trend 
Total Cholesterol Unadjusted 6.32 (±0.06) 6.26 (±0.05) 6.35 (±0.05) 6.24 (±0.05) 6.40 (±0.05) 0.45 
 Model 11 6.41 (±0.05) 6.28 (±0.05) 6.35 (±0.05) 6.20 (±0.05)** 3 6.32 (±0.05) 0.09 
 Model 22 6.42 (±0.05) 6.29 (±0.05) 6.35 (±0.05) 6.20 (±0.05)** 6.31 (±0.05) 0.07 
Triglycerides Unadjusted 1.56 (±0.04) 1.53 (±0.04) 1.59 (±0.03) 1.58 (±0.04) 1.64 (±0.04) 0.08 
 Model 11 1.65 (±0.03) 1.56 (±0.03) 1.60 (±0.03) 1.54 (±0.03)* 1.54 (±0.03)* 0.02 
 Model 22 1.67 (±0.03) 1.56 (±0.03)* 1.60 (±0.03) 1.53 (±0.03)** 1.54 (±0.04)* 0.02 
HDL Unadjusted 1.60 (±0.02) 1.54 (±0.02) 1.61 (±0.02) 1.54 (±0.02) 1.53 (±0.02) 0.03 
 Model 11 1.57 (±0.02) 1.53 (±0.02) 1.60 (±0.02) 1.55 (±0.02) 1.56 (±0.02) 0.89 
 Model 22 1.53 (±0.02) 1.52 (±0.02) 1.60 (±0.02)** 1.57 (±0.02) 1.60 (±0.02)* 0.01 
LDL Unadjusted 4.02 (±0.05) 4.03 (±0.05) 4.03 (±0.05 3.98 (±0.05) 4.12 (±0.05) 0.31 
 Model 11 4.10 (±0.05) 4.05 (±0.05) 4.03 (±0.05) 3.95 (±0.05)* 4.06 (±0.05) 0.27 
 Model 22 4.14 (±0.05) 4.07 (±0.05) 4.02 (±0.05) 3.94 (±0.05)** 4.02 (±0.05) 0.03 
HDL:LDL Unadjusted 0.44 (±0.01) 0.42 (±0.01) 0.44 (±0.01) 0.42 (±0.01) 0.42 (±0.02) 0.18 
 Model 11 0.43 (±0.01) 0.42 (±0.01) 0.44 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.39 
 Model 22 0.41 (±0.01) 0.41 (±0.01) 0.44 (±0.01)* 0.44 (±0.01) 0.45 (±0.01)** <0.01 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy 
3P value *≤0.05, **≤0.01 compared with Q1 
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Lipid Levels 
Analyses for associations between dietary protein intake and serum lipid levels were 
conducted on a sub-sample of the cohort, additionally excluding individuals with missing 
data for serum lipid levels. A total of 4,268 participants were included, 1,888 men and 2,380 
women. 
Total protein %en 
Table 5.19 illustrates the findings of analyses assessing associations between quintiles of 
percentage of energy from protein in men. No significant associations were identified 
between total cholesterol, triglyceride, LDL levels or ratio of HDL:LDL levels. Although for 
triglycerides there was a non-significant trend (P trend=0.36) towards lower levels across 
quintiles and a non-significant difference of -0.05 mmol/L between extreme quintiles of the 
fully adjusted model. There was a significant positive trend identified between percentage 
energy from protein and HDL levels (P=0.03) and non-significant difference of +0.04 
mmol/L between extreme quintiles in the fully adjusted model which included covariates 
such as age, BMI, use of statin medication, and dietary factors such as alcohol intake, total 
fat and energy intake. A significant inverse trend was identified for the ratio of HDL:LDL 
cholesterol and percentage of energy from protein in model 1 adjusting for anthropometric 
and lifestyle factors such as BMI, and smoking status. However, this was attenuated with 
the addition of dietary variables to the model. In women (Table 5.20) no significant 
association was reported for total cholesterol, but a significant difference of -0.22 mmol/L 
(P≤0.01) was seen between quintile 1 and 4. A non-significant difference of -0.09 mmol/L 
was present between extreme quintiles. Significant inverse associations were identified 
with increasing percentage of energy from dietary protein and triglyceride and LDL levels 
(P trend = 0.02 and 0.03 respectively). A significant difference between the extreme 
quintiles of 0.13 mmol/L was also identified in the fully adjusted model (P≤0.05). In addition 
significant positive associations were present between HDL and the ratio of HDL:LDL and 
quintiles of percentage energy from protein (P=0.01 and <0.01 respectively) after full 
adjustment for confounding variables. Significant differences of +0.07 mmol/L and +0.04 
mmol/L were also identified between extreme quintiles for HDL and ratio HDL:LDL 
respectively (P≤0.05 for HDL and P≤0.01 for HDL:LDL). 
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Table 5.21 Association of quintiles of dietary plant protein intake (range and mean quintile intake) and cholesterol and sub fractions (means and SE) in 1,888 
men, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary plant protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  1.44-3.67% 
3.21% 
n=377 
3.68-4.23% 
3.98% 
n=372 
4.24-4.75% 
4.49% 
n=378 
4.76-5.51% 
5.11% 
n=379 
5.52-11.0% 
6.42% 
n=382 
P trend 
Total Cholesterol Unadjusted 6.20 (±0.06) 6.07 (±0.05) 6.05 (±0.05) 5.90 (±0.06) 5.87 (±0.05) <0.001 
 Model 11 6.19 (±0.06) 6.06 (±0.06) 6.05 (±0.05) 5.91 (±0.05)***3 5.87 (±0.05)*** <0.001 
 Model 22 6.13 (±0.06) 6.04 (±0.06) 6.05 (±0.05) 5.93 (±0.06)* 5.92 (±0.06)* 0.01 
Triglycerides Unadjusted 1.91 (±0.05) 1.83 (±0.04) 1.94 (±0.05) 1.90 (±0.05) 1.87 (±0.05) 0.98 
 Model 11 1.96 (±0.05) 1.82 (±0.05)* 1.93 (±0.05) 1.87 (±0.05) 1.88 (±0.05) 0.61 
 Model 22 1.97 (±0.05) 1.82 (±0.05)* 1.93 (±0.05) 1.87 (±0.05) 1.86 (±0.05) 0.34 
HDL Unadjusted 1.30 (±0.02) 1.24 (±0.02) 1.20 (±0.02) 1.19 (±0.02) 1.21 (±0.02) <0.001 
 Model 11 1.29 (±0.02) 1.25 (±0.02) 1.21 (±0.02)*** 1.19 (±0.02)*** 1.21 (±0.02)*** <0.001 
 Model 22 1.23 (±0.02) 1.22 (±0.02) 1.21 (±0.02) 1.22 (±0.02) 1.26 (±0.02) 0.37 
LDL Unadjusted 4.04 (±0.05) 4.00 (±0.05) 3.96 (±0.05) 3.86 (±0.05) 3.81 (±0.04) <0.001 
 Model 11 4.03 (±0.06) 4.00 (±0.05) 3.97 (±0.05) 3.88 (±0.05)* 3.82 (±0.05)** 0.001 
 Model 22 4.02 (±0.05) 4.00 (±0.05) 3.97 (±0.05) 3.87 (±0.05)* 3.82 (±0.05)* 0.01 
HDL:LDL Unadjusted 0.35 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.34 (±0.01) 0.43 
 Model 11 0.35 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.34 (±0.01) 0.41 
 Model 22 0.33 (±0.01) 0.32 (±0.01) 0.33 (±0.01) 0.34 (±0.01) 0.36 (±0.01)* 0.02 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy, animal protein 
3P value *≤0.05, **≤0.01, ***≤0.001 compared with Q1 
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Table 5.22 Association of quintiles of dietary plant protein intake (range and mean quintile intake) and cholesterol and sub fractions (means and SE) in 2,380 
women, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary plant protein as %en  
  Q1 Q2 Q3 Q4 Q5  
  0.00-3.76% 
3.22% 
n=478 
3.77-4.34% 
4.07% 
n=473 
4.35-4.91% 
4.63% 
n=478 
4.92-5.58% 
5.23% 
n=474 
5.59-13.2% 
6.51% 
n=477 
P trend 
Total Cholesterol Unadjusted 6.49 (±0.06) 6.33 (±0.05) 6.26 (±0.05) 6.31 (±0.05) 6.18 (±0.05) <0.001 
 Model 11 6.44 (±0.05) 6.32 (±0.05) 6.27 (±0.05)*3 6.30 (±0.05)* 6.23 (±0.05)** 0.01 
 Model 22 6.45 (±0.06) 6.32 (±0.05) 6.28 (±0.05)* 6.39 (±0.05) 6.21 (±0.06)** 0.01 
Triglycerides Unadjusted 1.57 (±0.03) 1.58 (±0.04) 1.60 (±0.04) 1.56 (±0.03) 1.59 (±0.04) 0.81 
 Model 11 1.55 (±0.03) 1.59 (±0.03) 1.61 (±0.03) 1.54 (±0.03) 1.60 (±0.03)* 0.60 
 Model 22 1.58 (±0.04) 1.60 (±0.03) 1.61 (±0.03) 1.53 (±0.03) 1.57 (±0.04) 0.45 
HDL Unadjusted 1.60 (±0.02) 1.59 (±0.02) 1.56 (±0.02) 1.56 (±0.02) 1.51 (±0.02) <0.001 
 Model 11 1.59 (±0.02) 1.59 (±0.02) 1.56 (±0.02) 1.57 (±0.02) 1.52 (±0.02)** 0.01 
 Model 22 1.54 (±0.02) 1.56 (±0.02) 1.56 (±0.02) 1.59 (±0.02) 1.58 (±0.02) 0.14 
LDL Unadjusted 4.18 (±0.05) 4.02 (±0.05) 3.98 (±0.05) 4.05 (±0.05) 3.95 (±0.05) 0.01 
 Model 11 4.15 (±0.05) 4.02 (±0.05)* 3.99 (±0.05)* 4.04 (±0.05) 3.98 (±0.05)* 0.04 
 Model 22 4.20 (±0.06) 4.04 (±0.05)* 3.99 (±0.05)** 4.03 (±0.05)* 3.92 (±0.06)*** <0.01 
HDL:LDL Unadjusted 0.43 (±0.02) 0.44 (±0.02) 0.43 (±0.01) 0.42 (±0.01) 0.42 (±0.01 0.25 
 Model 11 0.43 (±0.01) 0.44 (±0.01) 0.43 (±0.01) 0.42 (±0.01) 0.42 (±0.01) 0.21 
 Model 22 0.41 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.45 (±0.01) 0.14 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy 
3P value *≤0.05, **≤0.01 ***≤0.001 compared with Q1 
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Plant protein %en 
For plant protein %en and lipid levels significant inverse associations were identified with 
total cholesterol and LDL levels in men (Table 5.21) (P=0.01 for both). Significant 
differences of -0.21 mmol/L (P≤ 0.05) and -0.20 mmol/L (P≤0.05) were also identified 
between extreme quintiles for total cholesterol and LDL respectively.  A significant positive 
trend was identified for the ratio of HDL:LDL (P=0.02) and a significant difference of 0.03 
mmol/L (P≤0.05) was also noted between extreme quintiles. There was a strongly 
significant positive association between plant protein %en and HDL levels after adjusting 
for age, BMI, smoking status, education, baseline MI or DM, family history of stroke or MI 
and statin medication use (P trend <0.001). However, this association was attenuated with 
the addition of dietary factors including alcohol, total fat, total energy and animal protein 
intakes. There was no significant association between dietary plant protein %en and 
triglyceride levels in men, there was however, a non-significant difference of -0.11 mmol/L 
between the extreme quintiles. 
For women (Table 5.22) there was a significant inverse association between plant protein 
%en and total cholesterol (P trend = 0.01) and LDL (P trend <0.01) after full adjustment for 
confounding factors including age, BMI and dietary intakes such as total fat and protein 
from animal sources. There was also a strongly significant difference in LDL levels of -0.28 
mmol/L between the extreme quintiles of plant protein %en in women (P≤0.001) in the 
fully adjusted model. There were no significant associations between triglyceride levels or 
ratio HDL:LDL and plant protein intakes as a percentage of energy in women. In model 1 
after adjustment for anthropometric, lifestyle and medical history factors there was a 
significant inverse association between increasing plant protein intakes as a percentage of 
energy and HDL levels (P trend 0.01). However, this association was attenuated with the 
addition of dietary factors in model 2 (P trend 0.14). In addition the direction of effect 
changed towards a non-significant positive trend between HDL and plant protein %en in 
women.  
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Table 5.23 Association of quintiles of dietary animal protein intake (range and mean quintile intake) and cholesterol and sub fractions (means and SE) in 
1,888 men, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary animal protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  2.89-8.23% 
6.95% 
n=378 
8.24-9.41% 
8.86% 
n=378 
9.42-10.4% 
9.93% 
n=377 
10.5-11.8% 
11.2% 
n=378 
11.9-27.4% 
13.7% 
n=377 
P trend 
Total Cholesterol Unadjusted 5.96 (±0.06) 5.95 (±0.05) 5.99 (±0.05) 6.09 (±0.06) 6.09 (±0.05) 0.02 
 Model 11 5.96 (±0.06) 5.96 (±0.06) 5.99 (±0.05) 6.09 (±0.06) 6.09 (±0.06) 0.03 
 Model 22 6.00 (±0.06) 5.97 (±0.06) 6.00 (±0.05) 6.07 (±0.06) 6.05 (±0.06) 0.30 
Triglycerides Unadjusted 1.91 (±0.05) 1.84 (±0.05) 1.84 (±0.04) 1.97 (±0.04) 1.88 (±0.05) 0.70 
 Model 11 1.96 (±0.05) 1.88 (±0.05) 1.84 (±0.05) 1.97 (±0.05) 1.81 (±0.05)*3 0.16 
 Model 22 1.97 (±0.05) 1.87 (±0.05) 1.83 (±0.05)* 1.97 (±0.05) 1.81 (±0.05)* 0.21 
HDL Unadjusted 1.25 (±0.02) 1.23 (±0.02) 1.23 (±0.02) 1.22 (±0.02) 1.21 (±0.02) 0.05 
 Model 11 1.24 (±0.02) 1.22 (±0.02) 1.23 (±0.02) 1.22 (±0.02) 1.23 (±0.02) 0.66 
 Model 22 1.21 (±0.02) 1.22 (±0.02) 1.24 (±0.02) 1.22 (±0.02) 1.25 (±0.02) 0.16 
LDL Unadjusted 3.84 (±0.05) 3.89 (±0.05) 3.93 (±0.04) 3.98 (±0.05) 4.04 (±0.05) <0.01 
 Model 11 3.84 (±0.05) 3.89 (±0.05) 3.93 (±0.05) 3.98 (±0.05)* 4.04 (±0.05)** <0.01 
 Model 22 3.90 (±0.05) 3.90 (±0.05) 3.93 (±0.05) 3.95 (±0.05) 3.98 (±0.06) 0.23 
HDL:LDL Unadjusted 0.35 (±0.01) 0.34 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.32 (±0.01) 0.001 
 Model 11 0.35 (±0.01) 0.34 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.33 (±0.01)* 0.02 
 Model 22 0.34 (±0.01) 0.34 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.34 (±0.01) 0.98 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy, plant protein 
3P value *≤0.05, **≤0.01 compared with Q1 
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Table 5.24 Association of quintiles of dietary animal protein intake (range and mean quintile intake) and cholesterol and sub fractions (means and SE) in 
2,380 women, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary animal protein intake as %en  
  Q1 Q2 Q3 Q4 Q5  
  0.43-8.56% 
7.11% 
n=476 
8.57-9.97% 
9.35% 
n=476 
9.98-11.2% 
10.6% 
n=476 
11.3-12.7% 
1200% 
n=476 
12.8-26.0% 
14.8% 
n=476 
P trend 
Total Cholesterol Unadjusted 6.20 (±0.06) 6.38 (±0.05) 6.25 (±0.05) 6.34 (±0.06) 6.40 (±0.05) 0.03 
 Model 11 6.31 (±0.05) 6.41 (±0.05) 6.25 (±0.05) 6.28 (±0.05) 6.32 (±0.05) 0.49 
 Model 22 6.34 (±0.05) 6.42 (±0.05) 6.25 (±0.05) 6.27 (±0.05) 6.29 (±0.06) 0.13 
Triglycerides Unadjusted 1.57 (±0.04) 1.55 (±0.03) 1.50 (±0.03) 1.62 (±0.03) 1.64 (±0.04) 0.07 
 Model 11 1.67 (±0.03) 1.59 (±0.03) 1.53 (±0.03)**3 1.56 (±0.03)* 1.55 (±0.03)* 0.01 
 Model 22 1.67 (±0.03) 1.59 (±0.03) 1.52 (±0.03)** 1.57 (±0.03)* 1.55 (±0.04)* 0.03 
HDL Unadjusted 1.57 (±0.02) 1.57 (±0.02) 1.58 (±0.02) 1.56 (±0.02) 1.54 (±0.02) 0.32 
 Model 11 1.54 (±0.02) 1.56 (±0.02) 1.57 (±0.02) 1.57 (±0.02) 1.57 (±0.02) 0.31 
 Model 22 1.53 (±0.02) 1.55 (±0.02) 1.58 (±0.02) 1.58 (±0.02) 1.59 (±0.02)* 0.02 
LDL Unadjusted 3.92 (±0.05) 4.11 (±0.05) 3.99 (±0.05) 4.05 (±0.05) 4.12 (±0.05) 0.04 
 Model 11 4.01 (±0.05) 4.01 (±0.05) 4.00 (±0.05) 4.00 (±0.05) 4.05 (±0.05) 0.72 
 Model 22 4.06 (±0.05) 4.15 (±0.05) 3.99 (±0.05) 3.98 (±0.05) 4.00 (±0.05) 0.07 
HDL:LDL Unadjusted 0.45 (±0.01) 0.42 (±0.01) 0.44 (±0.01) 0.42 (±0.01) 0.42 (±0.02) 0.15 
 Model 11 0.43 (±0.01) 0.42 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.44 (±0.01) 0.44 
 Model 22 0.42 (±0.01) 0.41 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.45 (±0.01)* 0.02 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy, plant protein 
3P value *≤0.05, **≤0.01 compared with Q1 
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Animal protein %en  
There were no significant associations reported between dietary animal protein intake and 
total cholesterol or sub fractions in men after full adjustment for confounding variables 
(Table 5.23). A significant positive trend was identified in model 1 for total cholesterol and 
LDL (P trend 0.03 and <0.01 respectively) and an inverse trend with HDL:LDL levels (P trend 
0.02) and animal protein %en in men. However, these associations were attenuated with 
the addition of dietary factors to the model; alcohol, total fat, total energy and plant 
protein intake, but there remained a non-significant trend towards higher total cholesterol 
levels and increasing animal protein %en.  
In women there was no significant association between total cholesterol or LDL levels and 
animal protein %en (Table 5.24). A significant inverse association was seen between animal 
protein %en and triglyceride levels in women after adjusting for model 1 which included 
anthropometric, lifestyle and medical history factors (P trend 0.01). This relationship 
remained after additional adjustment for dietary alcohol, total fat, total energy and plant 
protein intakes (P trend = 0.03). Additionally there was a significant difference of -0.12 
mmol/L between the extreme quintiles (P≤0.05). A significant positive trend was identified 
between animal protein %en and HDL and ratio HDL:LDL levels in women after full 
adjustment for confounding variables (P trend 0.02 for both). There were also significant 
differences of 0.06 mmol/L (P≤0.05) and 0.03 mmol/L (P≤0.05) for HDL and ratio HDL:LDL 
between the extreme quintiles of animal protein %en in women. 
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Table 5.25 Association of quintiles of ratio plant:animal protein intake (range and mean quintile intake) and cholesterol and sub fractions (means and SE) in 
1,888 men, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary ratio plant:animal protein intake  
  Q1 Q2 Q3 Q4 Q5  
  0.07-0.33 
0.28 
n=376 
0.34-0.40 
0.38 
n=377 
0.41-0.48 
0.45 
n=378 
0.49-0.59 
0.54 
n=374 
0.60-2.71 
0.83 
n=383 
P trend 
Total Cholesterol Unadjusted 6.25 (±0.06) 6.00 (±0.06) 5.99 (±0.05) 6.01 (±0.05) 5.84 (±0.06) <0.001 
 Model 11 6.23 (±0.05) 5.99 (±0.05)**3 5.99 (±0.06)** 6.02 (±0.06)** 5.85 (±0.05)*** <0.001 
 Model 22 6.19 (±0.06) 5.98 (±0.05)** 6.00 (±0.05)* 6.03 (±0.05)* 5.89 (±0.06)*** <0.01 
Triglycerides Unadjusted 1.92 (±0.05) 1.86 (±0.05) 1.89 (±0.05) 1.92 (±0.05) 1.86 (±0.05) 0.61 
 Model 11 1.91 (±0.05) 1.85 (±0.05) 1.87 (±0.05)* 1.93 (±0.05) 1.89 (±0.05) 0.86 
 Model 22 1.93 (±0.05) 1.86 (±0.05) 1.86 (±0.05) 1.93 (±0.05) 1.88 (±0.05) 0.84 
HDL Unadjusted 1.26 (±0.02) 1.22 (±0.02) 1.21 (±0.02) 1.21 (±0.02) 1.24 (±0.02) 0.19 
 Model 11 1.27 (±0.02) 1.23 (±0.02) 1.22 (±0.02)* 1.20 (±0.02)** 1.22 (±0.02) 0.04 
 Model 22 1.25 (±0.02) 1.22 (±0.02) 1.22 (±0.02) 1.21 (±0.02) 1.25 (±0.02) 0.77 
LDL Unadjusted 4.11 (±0.05) 3.93 (±0.05) 3.93 (±0.05) 3.94 (±0.05) 3.77 (±0.05) <0.001 
 Model 11 4.10 (±0.05) 3.93 (±0.05)* 3.94 (±0.05)* 3.94 (±0.05)* 3.77 (±0.05)*** <0.001 
 Model 22 4.06 (±0.05) 3.92 (±0.05)* 3.94 (±0.05) 3.96 (±0.05) 3.80 (±0.05)*** <0.01 
HDL:LDL Unadjusted 0.33 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.36 (±0.01) 0.12 
 Model 11 0.33 (±0.01) 0.34 (±0.01) 0.33 (±0.01) 0.32 (±0.01) 0.35 (±0.01) 0.37 
 Model 22 0.33 (±0.01) 0.33 (±0.01) 0.33 (±0.01) 0.32 (±0.01) 0.36 (±0.01)* 0.08 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy 
3P value *≤0.05, **≤0.01 ***≤0.001 compared with Q1 
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Table 5.26 Association of quintiles of ratio dietary plant:animal protein intake (range and mean quintile intake) and cholesterol and sub fractions (means 
and SE) in 2,380 women, aged 40-75 years in EPIC-Norfolk cohort (1993-1997). 
  Dietary ratio of plant:animal protein intake  
  Q1 Q2 Q3 Q4 Q5  
  0.00-0.32 
0.27 
n=472 
0.33-0.38 
0.36 
n=474 
0.39-0.46 
0.43 
n=478 
0.47-0.57 
0.52 
n=478 
0.58-22.4 
0.90 
n=478 
P trend 
Total Cholesterol Unadjusted 6.46 (±0.06) 6.39 (±0.06) 6.30 (±0.05) 6.25 (±0.05) 6.17 (±0.06) <0.001 
 Model 11 6.38 (±0.05) 6.35 (±0.05) 6.25 (±0.05) 6.30 (±0.05) 6.28 (±0.05) 0.12 
 Model 22 6.35 (±0.05) 6.34 (±0.05) 6.25 (±0.05) 6.30 (±0.05) 6.31 (±0.05) 0.44 
Triglycerides Unadjusted 1.62 (±0.04) 1.61 (±0.04) 1.57 (±0.04) 1.55 (±0.04) 1.54 (±0.03) 0.05 
 Model 11 1.57 (±0.03) 1.56 (±0.03) 1.55 (±0.03) 1.59 (±0.03) 1.62 (±0.03) 0.24 
 Model 22 1.59 (±0.03) 1.57 (±0.03) 1.55 (±0.03) 1.58 (±0.03) 1.60 (±0.03) 0.67 
HDL Unadjusted 1.57 (±0.02) 1.57 (±0.02) 1.59 (±0.02) 1.57 (±0.02) 1.53 (±0.02) 0.23 
 Model 11 1.58 (±0.02) 1.58 (±0.02) 1.59 (±0.02) 1.56 (±0.02) 1.52 (±0.02)*3 0.03 
 Model 22 1.56 (±0.02) 1.57 (±0.02) 1.58 (±0.02) 1.57 (±0.02) 1.54 (±0.02) 0.37 
LDL Unadjusted 4.15 (±0.05) 4.10 (±0.05) 4.00 (±0.05) 3.99 (±0.05) 3.94 (±0.05) 0.001 
 Model 11 4.09 (±0.05) 4.07 (±0.05) 3.97 (±0.05) 4.02 (±0.05) 4.03 (±0.05) 0.25 
 Model 22 4.08 (±0.05) 4.06 (±0.05) 3.97 (±0.05) 4.03 (±0.05) 4.05 (±0.05) 0.56 
HDL:LDL Unadjusted 0.43 (±0.02) 0.42 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.53 
 Model 11 0.44 (±0.01) 0.43 (±0.01) 0.44 (±0.01) 0.43 (±0.01) 0.42 (±0.01) 0.32 
 Model 22 0.43 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.43 (±0.01) 0.42 (±0.01) 0.57 
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1Model 1: age, BMI, smoking status, physical activity, education level, baseline MI, baseline DM, family history stroke or MI and statin medication use 
2Model 2: model 1 + alcohol intake, total fat intake, total energy 
3P value *≤0.05, **≤0.01 compared with Q1 
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Ratio of plant:animal protein 
For lipid profiles in relation to ratio of plant:animal protein intakes in men, a significant 
inverse trend was identified with total cholesterol (P<0.01) and LDL (P<0.01) after full 
adjustment for confounding variables including age, BMI, smoking status, physical activity, 
education, MI or diabetes at baseline, family history of stroke or MI, use of statin 
medication, alcohol intake dietary total fat and total energy intake (Table 5.25). In addition 
significant differences of -0.30 mmol/L (P≤0.001) and -0.26 mmol/L (P≤0.001) between the 
extreme quintiles for total cholesterol and LDL were also seen. There were no significant 
associations between the ratio of plant:animal protein and triglyceride and ratio HDL:LDL 
after adjustment for relevant confounding variables. There was however, a significant 
inverse association between increasing ratio of plant:animal protein and HDL levels in men 
after adjustment for model 1 (P trend = 0.04). However, this association was attenuated 
with the addition of dietary factors including alcohol, total fat and total energy intakes. 
No significant associations between cholesterol or sub fractions and ratio of plant:animal 
protein was identified in women (Table 5.26) after fully adjusting for relevant confounding 
variables. A significant inverse trend (P trend 0.03) between ratio of plant:animal protein 
and HDL levels was identified in women after adjusting for model 1, including 
anthropometric and lifestyle factors, but this association was attenuated after adjusting for 
dietary factors (P trend 0.37). A significant difference of -0.06 mmol/L between the extreme 
quintiles was also noted in model 1 (P≤0.05).
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Table 5.27 Quintiles of dietary protein as percentage of energy (range and mean quintile intake) at baseline (1993-1997) and stroke risk (HR and 95%CI), 
follow-up March 2008, in 4443 men and women, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary total protein as %en  
Men Q1 Q2 Q3 Q4 Q5  
 7.18-12.93% 
11.8% 
n=400 
12.94-14.16% 
13.7% 
n=400 
14.17-15.26% 
14.7% 
n=400 
15.27-16.95% 
16.0% 
n=400 
16.96-32.16% 
18.8% 
n=400 
P trend 
Stroke Events 77 (19.3%) 83 (20.8%) 92 (23.0%) 100 (25.0%) 97 (24.3%) 0.03 
Model 11 1.00 1.01 (0.69-1.49) 1.11 (0.75-1.64) 1.24 (0.85-1.83) 1.25 (0.85-1.86) 0.14 
Model 22 1.00 1.01 (0.69-1.49) 1.03 (0.69-1.53) 1.15 (0.77-1.72) 1.04 (0.69-1.56) 0.65 
Model 33 1.00 1.04 (0.70-1.55) 1.01 (0.67-1.51) 1.03 (0.67-1.56) 0.91 (0.59-1.41) 0.67 
Women 8.13-13.33% 
12.1% 
n=489 
13.34-14.82% 
14.2% 
n=489 
14.83-16.16% 
15.5% 
n=488 
16.17-17.91% 
16.9% 
n=489 
17.92-30.79% 
20.0% 
n=488 
 
Stroke Events 92 (18.8%) 90 (18.4%) 93 (19.1%) 105 (21.5%) 99 (20.3%) 0.29 
Model 11 1.00 0.94 (0.65-1.37) 0.90 (0.62-1.31) 0.95 (0.66-1.36) 0.78 (0.53-1.14) 0.26 
Model 22 1.00 0.94 (0.64-1.37) 0.90 (0.62-1.31) 0.89 (0.62-1.30) 0.77 (0.53-1.13 0.19 
Model 33 1.00 0.89 (0.60-1.33) 0.87 (0.59-1.28) 0.91 (0.62-1.36) 0.74 (0.48-1.13) 0.25 
1model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI  
3model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, total energy 
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Total protein %en 
In men there was a significant trend towards a higher number of stroke events with 
increasing total protein %en (P trend 0.03) (Table 5.27). There was no significant 
association between dietary protein %en and stroke risk in men. In the fully adjusted model 
which included; age, BMI, smoking, education, physical activity, alcohol intake, serum total 
cholesterol, baseline MI or DM, family history stroke or MI, SBP, DBP, aspirin use, 
antihypertensive medication and total energy the HR in the highest quintile of protein %en 
compared with lowest quintile of intake was HR 0.91 (95%CI 0.59-1.41). There were similar 
results for women (Table 5.26), in that no significant association was reported between 
total protein %en and stroke risk. The HR for highest protein intakes compared with lowest 
quintile was 0.74 (95% CI 0.48-1.13).  
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Table 5.28 Quintiles of dietary plant protein intake as percentage of energy (range and mean quintile intake) at baseline (1993-1997) and stroke risk (HR and 
95%CI), follow-up March 2008, in 4443 men and women, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary plant protein as %en  
Men Q1 Q2 Q3 Q4 Q5  
 1.44-3.67% 
3.20% 
n=400 
3.68-4.23% 
3.98% 
n=400 
4.24-4.75% 
4.49% 
n=400 
4.76-5.51% 
5.11% 
n=400 
5.52-11.0% 
6.43% 
n=400 
P trend 
Stroke Events 113 (28.3%) 80 (20.0%) 75 (18.8%) 88 (22.0%) 93 (23.3%)  
Model 11 1.00 0.80 (0.55-1.15) 0.79 (0.55-1.13) 0.94 (0.65-1.36) 1.08 (0.75-1.55) 0.53 
Model 22 1.00 0.83 (0.57-1.20) 0.79 (0.54-1.14) 0.88 (0.60-1.29) 0.93 (0.63-1.37) 0.79 
Model 33 1.00 0.85 (0.58-1.24) 0.77 (0.52-1.12) 0.84 (0.56-1.25) 0.89 (0.60-1.33) 0.55 
Women 8.13-13.33% 
12.1% 
n=489 
13.34-14.82% 
14.2% 
n=489 
14.83-16.16% 
15.5% 
n=488 
16.17-17.91% 
16.9% 
n=489 
17.92-30.79% 
20.0% 
n=488 
 
Stroke Events 103 (21.1%) 110 (22.5%) 97 (19.9%) 81 (16.6%) 88 (18.0%)  
Model 11 1.00 1.17 (0.82-1.68) 1.21 (0.83-1.75) 0.73 (0.51-1.07) 0.99 (0.67-1.46) 0.25 
Model 22 1.00 1.17 (0.82-1.68) 1.21 (0.83-1.75) 0.73 (0.50-1.07) 0.94 (0.63-1.39) 0.16 
Model 33 1.00 1.08 (0.73-1.60) 1.10 (0.74-1.65) 0.68 (0.45-1.03) 0.91 (0.59-1.40) 0.15 
1model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI  
3model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, total energy 
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Plant protein %en  
For both men and women (Table 5.28) plant protein %en was not significantly associated 
with stroke risk. The lowest, non-significant, risk of stroke for men was in those with mean 
plant protein %en of 4.49% (quintile 3). The HR in the fully adjusted model was 0.77 (95% 
CI 0.52-1.12) compared with the lowest intakes, mean 3.20% of energy from plant protein. 
In women the lowest, non-significant, risk of stroke was in those with mean intakes of 
16.9% of energy from plant protein (quintile 4). HR for this intake of the fully adjusted 
model was 0.68 (95% CI 0.45-1.03) compared with the lowest intakes of plant protein %en 
(mean 12.1%). 
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Table 5.29 Quintiles of dietary animal protein intake as percentage of energy (range and mean quintile intake) at baseline (1993-1997) and stroke risk (HR 
and 95%CI), follow-up March 2008, in 4443 men and women, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary animal protein as %en  
Men Q1 Q2 Q3 Q4 Q5  
 2.71-8.23% 
6.96% 
n=400 
8.24-9.41% 
8.87% 
n=400 
9.42-10.4% 
9.94% 
n=400 
10.5-11.8% 
9.94% 
n=400 
11.9-27.4% 
13.7% 
n=400 
P trend 
Stroke Events 81 (20.3%) 78 (19.5%) 88 (22.0%) 102 (25.5%) 100 (25.0%)  
Model 11 1.00 0.70 (0.47-1.05) 0.88 (0.60-1.31) 0.93 (0.64-1.36) 1.04 (0.71-1.54) 0.32 
Model 22 1.00 0.70 (0.45-1.05) 0.92 (0.54-1.22) 0.90 (0.61-1.32) 0.96 (0.65-1.43) 0.58 
Model 33 1.00 0.66 (0.43-1.01) 0.81 (0.53-1.24) 0.80 (0.53-1.20) 0.84 (0.54-1.29) 0.90 
Women 0.43-8.58% 
7.14% 
n=489 
8.56-9.99% 
9.37% 
n=489 
10.0-11.2% 
10.6% 
n=488 
11.3-12.8% 
12.0% 
n=489 
12.9-26.0% 
14.9% 
n=488 
 
Stroke Events 86 (17.6 %) 88 (18.0%) 105 (21.5%) 97 (19.8%) 103 (21.1%)  
Model 11 1.00 0.83 (0.54-1.17) 1.11 (0.77-1.61) 0.85 (0.58-1.23) 0.78 (0.54-1.14) 0.36 
Model 22 1.00 0.80 (0.68-1.40) 1.10 (0.76-1.59) 0.75 (0.51-1.09) 0.99 (0.68-1.45) 0.33 
Model 33 1.00 0.70 (0.47-1.06) 1.07 (0.72-1.58) 0.78 (0.52-1.16) 0.70 (0.45-1.09) 0.29 
1model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI  
3model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, total energy 
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Animal protein %en  
As with total protein and plant protein %en, there was no significant association between 
animal protein %en and stroke risk in men or women (Table 5.29). In men, after adjustment 
for model 1 including age, BMI, education, physical activity, smoking, and alcohol intake 
the highest percentage of energy from animal protein (mean 13.7%) had a HR of 1.04 (95% 
CI 0.71-1.54) compared with those with the lowest mean intakes (6.96% energy from 
animal protein). The lowest risk of stroke in the fully adjusted model was in those with a 
mean of 8.87% of energy from animal protein (quintile 2) where the HR was 0.66 (95% CI 
0.43-1.01). In women (Table 5.28) intakes ranged from 0.43-26.0% of energy from animal 
protein sources. The HR for stroke risk in the highest quintile of animal protein %en in the 
fully adjusted model was 0.70 (95% CI 0.45-1.09) for women. This HR was similar to that of 
quintile 2 (mean intake 9.37% of energy from animal protein), where the HR was 0.70 (95% 
CI 0.47-1.06). 
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Table 5.30 Quintiles of ratio of plant:animal protein intake (range and mean quintile intake) at baseline (1993-1997) and stroke risk (HR and 95%CI), follow-
up March 2008, in 4443 men and women, aged 40-75 in EPIC-Norfolk cohort. 
 Dietary ratio of plant:animal protein intake  
Men Q1 Q2 Q3 Q4 Q5  
 0.07-0.33 
0.28 
n=400 
0.34-0.40 
0.38 
n=400 
0.41-0.48 
0.45 
n=400 
0.49-0.59 
0.54 
n=400 
0.60-2.71 
0.83 
n=400 
P trend 
Stroke Events 108 (27.0%) 95 (23.8%) 80 (20.0%) 76 (19.0%) 90 (22.5%)  
Model 11 1.00 0.94 (0.66-1.33) 0.78 (0.54-1.11) 0.78 (0.54-1.12) 1.11 (0.77-1.59) 0.93 
Model 22 1.00 0.98 (0.69-1.39) 0.80 (0.55-1.15)  0.74 (0.50-1.08) 1.07 (0.73-1.56) 0.66 
Model 33 1.00 1.00 (0.70-1.44) 0.81 (0.55-1.17) 0.76 (0.52-1.13) 1.10 (0.74-1.63) 0.77 
Women 0.00-0.32 
0.27 
n=489 
0.33-0.38 
0.36 
n=489 
0.39-0.46 
0.43 
n=488 
0.47-0.57 
0.52 
n=489 
0.58-22.4 
0.90 
n=488 
 
Stroke Events 100 (20.5%) 114 (23.3%) 93 (19.1%) 89 (18.2%) 83 (17.0%)  
Model 11 1.00 1.29 (0.90-1.84) 1.01 (0.70-1.46) 1.12 (0.77-1.62) 1.17 (0.80-1.71) 0.72 
Model 22 1.00 1.31 (0.91-1.88) 1.04 (0.72-1.50) 1.09 (0.75-1.59) 1.13 (0.77-1.67) 0.89 
Model 33 1.00 1.37 (0.94-1.99) 1.01 (0.69-1.49) 1.09 (0.73-1.62) 1.17 (0.79-1.75) 0.85 
1model 1: age, BMI, education status, physical activity, smoking status, alcohol intake 
2model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI  
3model 3: model 2 + SBP, DBP, aspirin use >3 months, antihypertensive medication, total energy 
Chapter Five   Dietary protein stroke risk and risk factors 
 
281 
 
Ratio of plant:animal protein 
There was no significant association between the ratio of plant:animal protein and stroke 
risk in men or women (Table 5.30). In the fully adjusted model the HR for highest ratio of 
plant:animal protein intake (mean 0.83) was 1.10 (95% CI 0.74-1.63) compared with lowest 
intakes (mean 0.28) for men. In women the HR was 1.17 (95% CI 0.79-1.75) for the highest 
intakes (mean 0.90) compared with lowest ratio of plant:animal protein (mean 0.27). 
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5.4 Discussion 
The main findings of this chapter, summarised in Tables 5.31 and 5.32, involving 2,000 men 
and 2,443 women aged 39-80 years, at the start of the study, indicated that dietary protein 
intake is more strongly associated with blood pressure and lipid profile in women than men. 
There was no significant association with protein intake or sources of protein and stroke 
risk in either men or women, but for women the beneficial associations identified with 
stroke risk factors may indicate a potentially protective effect. 
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Table 5.31 Summary of the results of associations between dietary protein intake and 
sources of dietary protein %en and stroke risk factors, blood pressure and cholesterol and 
stroke risk in men 
 Protein source as percentage of energy intake 
 Total protein Plant protein Animal protein Ratio plant:animal 
Blood Pressure     
SBP ↔ ↔ ↔ ↔ 
DBP ↔ ↓ ↔ ↔ 
Cholesterol     
Total cholesterol ↔ ↓ ↔ ↓ 
Triglycerides ↔ ↔ ↔ ↔ 
HDL ↑ ↔ ↔ ↔ 
LDL ↔ ↓ ↔ ↓ 
HDL:LDL ↔ ↑ ↔ ↔ 
Stroke risk     
Stroke risk ↔ ↔ ↔ ↔ 
↔ non-significant association 
↓ significant inverse association 
↑ significant positive association 
 
Table 5.32 Summary of the results of associations between dietary protein intake and 
sources of dietary protein %en and stroke risk factors, blood pressure and cholesterol and 
stroke risk in women 
 Protein source as percentage of energy intake 
 Total protein Plant protein Animal protein Ratio plant:animal 
Blood Pressure     
SBP ↓ ↔ ↓ ↔ 
DBP ↓ ↓ ↓ ↔ 
Cholesterol     
Total cholesterol ↔ ↓ ↔ ↔ 
Triglycerides ↓ ↔ ↓ ↔ 
HDL ↑ ↔ ↑ ↔ 
LDL ↓ ↓ ↔ ↔ 
HDL:LDL ↑ ↔ ↑ ↔ 
Stroke risk     
Stroke risk ↔ ↔ ↔ ↔ 
↔ non-significant association 
↓ significant inverse association 
↑ significant positive association 
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Blood pressure and protein intake 
Total protein 
The current null findings in relation to total protein %en and blood pressure in men (Table 
5.11), is similar to the results of the INTERMAP study (141). Two other observational studies 
also reported no significant association between total protein intake and blood pressure, 
however, the analyses were not sex stratified (123, 124). Elliot et al (141) did however, 
report no significant association in women, whereas our results (Table 5.12) indicated an 
inverse association between protein %en and SBP and DBP in women (P=0.02 and 0.01 
respectively). This difference in effects between sexes may be explained by differences in 
the source of protein consumed, as was identified in the previous chapter (Chapter Four). 
In these same observational studies the influence of different sources of protein was also 
assessed. Significant associations between plant protein and blood pressure were 
identified (123, 124, 141). Additionally a recent meta-analysis by Tielemans et al reported 
a non-significant inverse trend between SBP and plant protein intake (174). 
Animal studies including the work of Endoh et al (354) and a number of human 
observational and intervention trials indicate the potential for the total amount of protein 
and different sources of dietary protein to modify blood pressure (123, 124, 141, 251, 364, 
391). Endoh et al (2001) reported that in male Sprague-Dawley rats fed diets deficient in 
protein, in which 6% of energy came from casein protein, compared with high protein diet, 
with 23% energy from casein, SBP was significantly increased by 10-15 mmHg (P<0.05). 
They however, also reported a significant increase in SBP in rats fed the low protein diet 
with high sucrose content versus those on low protein and low sucrose diet suggesting that 
the CHO content or CHO:protein ratio of the diet is also an important and potentially 
contributory factor. This effect may be explained by the high sucrose content of the diet 
which has previously been associated with significant increases in blood pressure in animal 
models and humans (397, 398). 
Plant protein 
In this cohort there was no significant association between plant protein intake and SBP 
blood pressure in men or women (Table 5.13 and 5.14). However, a significant inverse trend 
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was identified in association with DBP for both men and women (Table 5.13 and 5.14), and 
a non-significant difference of -1.1 mmHg was seen between the extreme quintiles for DBP. 
The finding in relation to SBP is in contrast to a study by Altorf-van der Kuil (124), but the 
association with DBP is similar. They showed that higher intakes of plant protein were 
associated with modest reductions of -1.8 and -1.0 mmHg in SBP and DBP respectively in 
the highest quintiles of intake compared to people in the lowest quintile of intake (P trend 
<0.01).  
The range of mean intakes of plant protein intake in grams/d in our study was wider 15.7-
37.4 g/d and 12.4-28.3 g/d for men and women respectively than the previous study, 25-
39 g/d. Therefore it may be that the beneficial effect for SBP is seen only in the highest 
range of intakes as the participants were already consuming relatively high plant protein 
intakes. It may also be that due to this increase in plant protein intakes the proportion of 
animal protein intake decreases which may also translate to lower intakes of other 
nutritional components associated with animal products such as saturated fat intakes.  
Animal protein 
In women there was an inverse association between animal protein and blood pressure. A 
study by Masala et al (360) in 7,601 Italian women aged 35-64 reported no significant 
association between animal protein intake and SBP or DBP in women (360). Regression 
coefficients, although non-significant, indicated a positive association between animal 
protein intake and blood pressure; 0.99 mmHg for SBP and 0.58 mmHg for DBP (360). This 
difference in findings may be due to differences in the food sources contributing to animal 
protein intake. In the study by Masala et al (360) they reported participants as having high 
processed meat intake, although the mean processed meat intakes of women in the Italian 
study and this EPIC-Norfolk sub-cohort were similar (22.4 g/d vs 21.8 g/d respectively). 
However, the authors of the Italian study report that processed meat is especially high in 
salt in this particular Italian region which may have an influence on blood pressure (360). 
They did however, have higher red meat intake, mean intake of 72.7 g/d compared with 
64.4 g/d in the EPIC-Norfolk sub-cohort (which includes red meat, processed red meat and 
red meat in dishes). In men there was no significant association between animal protein 
%en and blood pressure. This finding, in men, concurs with that of a recent meta-analysis 
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(174) and also the individual results of several studies including the INTERMAP study which 
included UK population (141). Similarly in a Dutch population animal protein intake was not 
significantly associated with blood pressure or the risk of developing hypertension (123, 
124). This discrepancy between men and women may be due in part to differences in the 
composition of diets. Similarly the Dutch diet and the INTERMAP cohort which additionally 
includes populations from China, Japan and US may have different dietary compositions 
which could in part explain the differences in findings. 
The observed differences in associations between men and women may in part be 
attributable to differences in the contributing sources to protein intake as was highlighted 
in the previous chapter, Chapter Four – Dietary contributions to protein intake. There were 
small but significant differences in the mean intakes of all types of protein %en for men and 
women, P<0.001 for total protein, animal protein, animal-marine and animal-derived and 
P=0.01 for plant protein (Chapter Four; Table 4.0). There was no significant difference in 
mean intakes of animal-land %en (P0.11) and ratio of plant:animal protein (P=0.82). 
Despite this initial difference in reported mean intakes, on further inspection of 
contributing sources there were small but perhaps significant differences in patterns of 
consumption. For example men tended to have a higher contribution to protein intake 
from red meat than women, and when looking at specific nutrients and foods associated 
with risk of stroke and risk factors they also tended to have higher intakes of dietary sodium 
and fat. 
Lipid profile and protein intake 
Previous research has indicated the potential for dietary protein intake to beneficially 
influence lipid profile, a strong risk factor for stroke incidence. A large proportion of these 
studies have investigated the effect of soy protein sources on lipid profile in both humans 
and animals (27, 28, 347, 348). 
The present results report inconsistent effects of dietary protein and sources of protein on 
total cholesterol and cholesterol sub-fractions. Additionally associations between dietary 
protein intakes and serum lipid levels differed between sexes. In men increasing total 
protein was associated with higher HDL levels (P trend=0.03) whereas in women total 
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protein was inversely associated with triglycerides and LDL, and higher HDL levels and ratio 
of HDL:LDL. Plant protein was inversely associated with total cholesterol and LDL levels for 
both men (P trend=0.01 for both) and women (P trend=0.01 and <0.01 respectively) and a 
higher ratio of HDL:LDL in men only (P trend=0.02). Animal protein intake was not 
significantly associated with serum lipid levels in men, but an inverse association with 
triglyceride levels was seen for women (P trend=0.03) and higher HDL level and ratio of 
HDL:LDL were also noted (P trend=0.2 for both). In men the ratio of plant:animal protein 
intake was inversely associated with total cholesterol and LDL levels (P trend <0.01 for 
both), but there were no significant associations in women. Previous research has also 
presented differing effects of protein on the individual serum lipid levels (27-29, 173). 
Similar inconsistent effects on cholesterol sub-fractions have also been reported in 
randomised trials (127, 128).  
Plant protein 
Jenkins et al (396) investigated the effects of a high plant protein diet compared with a 
lacto-ovo vegetarian diet similar to a traditional cholesterol lowering. The intervention diet 
substituted 93% of animal protein for plant protein sources; legumes (including soy), and 
cereals. The test diet was also considerably higher in fibre than the control diet, however, 
fat and cholesterol content were similar between the two diets. They identified a significant 
decrease in total cholesterol and LDL levels for the test diet compared with control 
(P<0.001 for both). Additionally significant decreases in ratio of TC:HDL and LDL:HDL were 
also reported (P=0.002 and 0.004 respectively). There was also a small but non-significant 
decrease in HDL and triglyceride levels. I had some similar findings in relation to 
associations between plant protein intake and serum lipid levels, particularly in men. In 
men significant inverse associations were seen in relation to total cholesterol and LDL, and 
a direct relationship between higher percentage of energy from plant protein and ratio of 
HDL:LDL. I also noted no significant association with triglyceride or HDL levels.  However, 
the Jenkins study had a very small sample size n=19 men and n=12 women and did not 
stratify their analyses by sex. 
In animal models there tended to be a trend towards lower lipid levels with intakes of plant 
based proteins such as buckwheat protein and soy protein isolate when compared with an 
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animal based protein such as casein (346, 347). However this lowering of lipid levels, in 
some instances, also included reductions in HDL levels suggesting a negative effect. 
Animal protein 
In men animal protein %en was not associated with total cholesterol or sub-fractions, 
whereas in women there were significant inverse associations with triglyceride levels and 
direct relationship with HDL and ratio HDL:LDL. In men there was a range of 2.89-27.4% of 
energy from animal protein sources compared with a range of 0.00-13.2% of energy from 
animal protein sources for women. As detailed in Chapter Four – Dietary contribution to 
protein intake (Table 4.0) there were small but statistically significant differences in the 
animal protein intakes of men and women, with women tending to have a slightly greater 
percentage of energy from animal protein than men, despite crude protein intakes in g/d 
being lower. The differences in the type of animal protein consumed by men and women 
may explain the differences in associations presented. For example men consumed a higher 
percentage of protein energy from land based animal protein compared with women 
(5.08% compared with 4.96%) although this difference was not statistically significant 
(p=0.11). This category includes meat, poultry and processed products. Whereas women 
had a statistically higher percentage of energy and protein energy from marine based 
animal protein than men (P <0.001 for total energy and 0.001 for energy from protein) 1.36 
%en men and 1.54  %en women and 8.79 %protein for men and 9.56 %protein for women. 
Fish and other seafood that are included in the marine category are leaner sources of 
protein than land based animal protein, and may also contribute other beneficial nutrients 
such as omega-3 and -6 which increased intakes may be associated with beneficial effects 
on lipid levels. 
Despite the differences being modest they may still be clinically relevant as even slight 
increases in lipid levels can negatively influence stroke risk. For example increases of 0.55 
mmol/l of LDL or TG can increase stroke risk by approximately 11% and 5.5% respectively 
(284, 399). 
The mechanisms of action of dietary protein on lipid profile are not well established. 
Particular protein sources, such as soy, may exert beneficial effects such as reducing the 
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synthesis of cholesterol and an increase in activation of LDL receptors leading to increased 
clearance of LDL cholesterol from circulation (400). It also must not be ruled out that the 
potential beneficial effect is due to substitution of other macronutrients. For example a 
diet higher in protein but lower in fat or carbohydrates. 
Stroke risk and protein intake 
There were no significant associations between dietary protein intakes and risk of stroke in 
both men and women after adjusting for relevant confounding factors. This is in contrast 
to some previous work in animal models and human observational studies where 
significant effects were noted (176, 177, 324, 352, 356, 383). However, not all studies have 
provided conclusive findings and some like the current findings report no significant 
association (177, 382). 
Bernstein et al (175) indicated a benefit of substituting different meat protein sources 
during cross-sectional analyses. For example, swapping one serving of red meat for poultry 
or nuts may reduce stroke risk by 27% (95% CI, 12-39%) and 17% (95% CI 4-27%) 
respectively compared with red meat consumption. These sources of protein have very 
different fatty acid profiles. This may contribute to the beneficial effects reported for 
poultry and nut consumption compared with red meat consumption. Additionally there 
may be a difference in amino acid composition of these food products which could be 
influencing stroke risk. Future work could seek to elucidate whether the mechanism is due 
to macronutrient content, specific amino acid components or other factors.  
5.4.1 Strengths and limitations 
The limitations of the present analyses include those previously detailed earlier in Chapter 
Three, section: 3.4.1 Strengths and limitations. As with any epidemiological study it is 
possible that despite adjusting for a number of relevant confounding factors including 
lifestyle and dietary intakes residual confounding may have occurred. Self-reported dietary 
intakes are prone to bias in reporting by the individual, however the dietary data analysed 
in this thesis was derived from 7DD which are a more reliable and accurate method of 
determining dietary intakes, including protein as has been shown in validation studies (215, 
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362) and in particular FFQs may underestimate total energy and protein intake and over 
report percentage energy from protein (401).  In addition due to the high detail of 
information that could be entered into the specifically designed DINER programme it was 
possible to disaggregate total protein intake into sub-fractions of constituent sources 
(animal, plant and ratio plant:animal). The study cohort includes a large number of men 
and women, who are representative of the whole EPIC-Norfolk cohort which is in itself 
representative of the general UK population. Despite the limitations noted the strengths of 
the study provide confidence in the results presented.  
The analysis presented in this chapter could be further extended, future work could also 
investigate the potential role of specific amino acids in relation to stroke risk and risk 
factors. In addition it would be of interest to determine if the different sources of protein 
influenced sub-types of stroke differently. In the current analysis this was not possible due 
to the size of cohort and number of stroke cases.  
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5.5 Summary 
The current analyses indicate that in this particular cohort a higher percentage of energy 
from total protein may beneficially influence blood pressure in women. In part this may be 
mediated by percentage of energy from animal protein which was also inversely associated 
with blood pressure in women with approximate 2 mmHg difference of both SBP and DBP 
between those in the lowest vs highest quintiles of protein from animal sources as %en. In 
addition percentage energy from plant protein was inversely associated with DBP but not 
SBP in women. The effect of animal protein may be due to the composition of diet 
contributing to animal protein intakes. For example investigations detailed in Chapter Four 
– Dietary contributions to protein intake, showed women had higher intakes of marine 
protein sources compared with men, and slightly lower land based animal protein intakes. 
It therefore cannot be ruled out that the differences in the nutrient composition of these 
food groups may also influence blood pressure.  
There were inconsistent findings in relation to serum lipid levels, however, in both men and 
women a higher percentage of energy from plant protein was inversely associated with 
total cholesterol and LDL levels. No significance was seen in relation to percentage of 
energy from animal protein, therefore it may be postulated that higher intakes of plant 
protein may beneficially influence serum lipid levels and thus stroke risk. Despite this there 
was no significant association between total protein intake or subtypes of protein and 
stroke risk. However, the risk of stroke in highest quintile of protein %en was 0.91 (95%CI 
0.59-1.40) for men and 0.74 (95%CI 0.48-1.13) for women and therefore although not 
statistically significant higher protein intakes may beneficially influence stroke risk.   
To date there has been limited research investigating the influences of different protein 
sources on stroke risk and risk factors simultaneously in the same cohort. Therefore this is 
an area which required development and further research, to identify potential beneficial 
associations between dietary protein, including sources of protein, in relation to stroke risk, 
which this chapter sought to address.  
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6.0 Introduction 
The inherently subjective nature of reporting dietary intakes can lead to inaccuracies, for 
example if a 24hr recall were used, some participants, particularly the elderly, may have 
difficulties in recalling food and drink that was consumed during the previous day (37). The 
one-off nature of the recall also does not account for day-to-day variability in consumption 
and thus foods that are eaten frequently but not daily may be missed, this can be somewhat 
overcome by conducting repeated 24hr recalls at varied intervals including different 
seasons, weekdays and weekends (37). The use of FFQ may more accurately represent 
habitual intake, but FFQs tend to lack specific details of food items and cooking methods 
for example, and they also typically rely on standard portion sizes. FFQs are however, less 
burdensome to the participant and researcher, particularly in large studies, and can be the 
most cost effective method of determining habitual intake (179).  
In the preceding chapters, the associations between dietary intakes of magnesium and 
protein with blood pressure, a risk factor for stroke, were explored. As has been indicated 
above, and in Chapter One – Introduction, self-reported dietary intakes may be prone to 
bias, and it would be of interest to understand if biomarkers, namely serum magnesium 
and urinary nitrogen, which are objective measures of intake, were also related to blood 
pressure.  
The potential benefit of using recovery biomarkers of dietary intake is that they are an 
objective measure and are thus less prone to intentional or unintentional bias. A recovery 
biomarker correlates directly with total intake over a given period, usually 24 hours (37). 
There are several recovery biomarkers including urinary nitrogen (for protein intake), 
urinary sodium and total energy using doubly labelled water which are well correlated with 
dietary intakes in the general population (179). Urinary nitrogen is an established and valid 
measure of dietary protein intake, in the general population (215) as approximately 80% of 
the nitrogen from protein consumed daily will be present in a 24 hour urine sample (402). 
Urinary urea concentrations can be used to determine urinary total nitrogen (359). Some 
more recent evidence of potential biomarkers for specific types of protein have also been 
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investigated (403) for example biomarkers of animal protein intake, using isotopes from 
hair sample and compounds specific to red meat, such as creatinine, taurine 1-
methylhistidine and 3-methylhistidine, have been suggested as biomarkers for red meat 
intake (403). There is less evidence relating biomarkers of magnesium to dietary intake 
(404) this may in part be due to the way in which magnesium is stored. Approximately  60-
65% of magnesium is present in bones and a further 27% in muscle tissue (405). As a result 
extracellular levels only account for approximately 1% of total magnesium (406). 
Magnesium absorption occurs mainly in the intestine, and reabsorption in the long distal 
tube of the Loop of Henle in the kidneys. An increase in dietary intakes of magnesium would 
be reflected in increased concentrations in 24hr urine output.  
There is conflicting evidence whether serum magnesium levels are substantially influenced 
by dietary intakes (407).  Arnaud (407) reports that serum magnesium levels are in part 
dependent on dietary intakes as well as absorption of magnesium. Whereas Witkowski et 
al (406) indicates that increased dietary magnesium intakes, have been reported to have 
little effect on serum magnesium levels due to the tight homeostatic regulation (406). In 
two independent studies by Czernichow et al (404) and Galan et al (408), in the SUVIMAX 
cohort, no significant association between dietary magnesium intake and serum 
magnesium levels (mmol/L) was reported (404, 408). They indicated that few studies exist 
investigating the relationship of dietary magnesium intake with magnesium status (404). A 
recent systematic review of magnesium biomarkers indicated that in studies looking at 
supplementation or depletion of magnesium, plasma and serum magnesium may be used 
as a biomarker of status. Analysis was pooled for plasma and serum magnesium and for 
supplementation and depletion studies and comprised 22 studies and 322 participants 
(406). A pooled effect size of 0.03 (95% CI 0.01-0.06) was reported for the relationship 
between plasma and serum magnesium, but a high level of heterogeneity I2 96% was also 
shown.  
Although biomarkers are an objective measure of diet they are not without disadvantages. 
For example not all dietary intakes correlate well with a biomarker and in this instance it 
may not be accurate to rely on a biomarker to validate self-reported intakes. Other factors 
that may influence the efficacy of biomarkers include between-person variation in 
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absorption of nutrients (409), as some nutrients are absorbed at a dose-dependent rate 
which is strongly influenced by body status. There may also be differences in the storage 
and excretion of nutrients, although the specific mechanisms related to variation are 
unclear. In terms of excretion renal function is likely to play a key role and a number of 
medications and medical conditions can also influence renal function and excretion rate 
(409). It is worth being aware of these factors when utilising biomarkers of dietary intakes.  
There have been limited studies undertaken with the aim to ascertain the correlation 
between dietary intake and biomarkers of magnesium and protein in older populations. As 
the UK population becomes increasingly aged it is important to determine if biomarkers 
are still appropriate for use in older people. Differences in the reliability of these methods 
in older people compared with a younger general population may be due to physiological 
changes occurring as a natural part of the ageing process. For example a decline in kidney 
function may influence the absorption and excretion of some nutrients including both 
magnesium and protein/nitrogen as these are handled by the kidneys (407).  
In addition there is limited evidence on whether dietary intakes of magnesium and protein 
or their biomarkers serum magnesium and urinary nitrogen respectively are more highly 
correlated with blood pressure, a significant risk factor for stroke, in older populations. 
Understanding the difference in relationships of dietary derived intakes and biomarker 
measures may be important in determining a more appropriate method to use as a 
predictor of difference in blood pressure. A large study (INTERSALT), n=10,020, of 20-59 
year old men and women previously indicated an inverse association between urinary urea, 
and total nitrogen, from a 24-hour urine collection, with blood pressure (359). After 
adjustment for confounding factors; age, sex, BMI, alcohol intake, urinary sodium, 
potassium, magnesium and calcium, significant inverse associations were seen between 
SBP and DBP and urea nitrogen as well as total nitrogen. A pooled regression coefficient, 
after adjustment for regression dilution bias, of -0.570 mmHg SBP/g urea nitrogen and -
0.494 mmHg DBP/g urea nitrogen was reported (359). However, they did not concurrently 
assess the similarities/differences of biomarker and dietary intake with blood pressure. 
Although, dietary protein has in some instances been independently inversely associated 
with blood pressure (140) in analyses looking at the older age group in the INTERSALT 
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cohort, aged 40-50 years, stronger inverse associations were reported for SBP and urea 
nitrogen and total nitrogen thus indicating a potential importance of this measure in the 
older population (359). Research is also lacking specifically looking at the relationships in 
the older population. 
Therefore this chapter discusses analyses on data from the NU-AGE study, which assessed 
associations between dietary intakes and biomarkers of magnesium and protein intake 
with blood pressure. The NU-AGE study was chosen for several reasons including that the 
study participants had a smaller age range, of older participants, than the EPIC-Norfolk 
cohort. For urinary markers, such as urinary nitrogen, this may have importance as renal 
function decreases with increasing age. Thus establishing associations between biomarker 
and blood pressure in this older population, specifically, is important.  
This chapter will build upon previous findings in the EPIC-Norfolk cohort, with the premise 
that in the past two decades since the commencement of EPIC-Norfolk and the recording 
of food intakes that food consumption and dietary patterns have changed. There have been 
changes in the consumption of a number of foods including soft drinks, fruit juices and pre-
packaged meals and processed foods which may have had an impact on health in terms of 
stroke risk such as blood pressure. One nutrient which may be more prevalent in processed 
foods is salt which is a significant cause of hypertension, which itself is strongly linearly 
correlated with increase in blood pressure and stroke risk (410). Assessing the modern diet 
of the older population may provide an insight into whether dietary habits are influencing 
stroke risk via mechanisms relating to risk factors such as blood pressure.  
The aim of this chapter was to identify if dietary intakes of magnesium and protein were 
well correlated with biomarkers (serum and urine respectively) in an older population and 
to determine if one of these methods was more consistently and accurately associated with 
blood pressure than other measures in a cohort of 65-79 year old British men and women 
who were part of the NU-AGE study.  The primary aim of the NU-AGE study is to improve 
the health and quality of life of the ageing European population by assessing the effects of 
a whole diet intervention. This chapter is cross-sectional in design and is concerned with 
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the habitual dietary intakes recorded at baseline prior to commencement of the 
intervention.  
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6.1 Aims and hypotheses 
This chapter aims to address research question 4, outlined in the introductory Chapter, 
Chapter One. 
 
4. How do biomarkers of magnesium and protein intake compare with dietary reported 
intakes in relation to blood pressure in older men and women? 
4a. Firstly the aim was to confirm the correlation between biomarker and dietary intakes; 
serum magnesium with dietary magnesium and urinary urea with dietary protein intake. 
The hypothesis was that the biomarker would correlate well with dietary intake. 
4b. Secondly the aim was to assess the relationship between each of the biomarkers and 
dietary intake with blood pressure. This was to determine whether the biomarker and 
dietary intake had a similar relationship with blood pressure and which of the measures 
was most significantly associated with blood pressure and so if one could be recommended 
for future use. The hypothesis was that the biomarker and dietary intakes would have 
similar relationships with blood pressure. 
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6.2 Methods 
The methods of the NU-AGE study related to this thesis can be found in Chapter Two – 
Subjects and methods, section 2.2. Additionally more detailed information on the NU-AGE 
study can be found in the published study design (211).  
Briefly, before attending for a study day at the CRTU participants recorded their dietary 
intake over the preceding 7 day period using a food diary. During the same 7 day period 
physical activity levels were also monitored using an accelerometer. After this, in the 24 
hours prior to the study day, a 24hr urine collection was undertaken. At the study day a 
range of anthropometric, biological and cognitive assessments were undertaken including; 
height, weight, blood pressure and venous blood samples.  
This cohort consisted of 272 men and women aged 65-79 years at the start of the study. 
Participants with missing data for one or more variables of interest were excluded from the 
analysis (n=38). After this 234 men and women remained for analysis. 
The aim of this chapter was to determine the association between dietary intakes and 
biomarkers of magnesium and protein with blood pressure in older men and women. 
Statistical methods 
All analyses were conducted in Stata version 11.  
A pairwise Pearson’s correlation was used to assess correlations between dietary intake 
and each biomarker and each measurement independently with blood pressure.  
Regression, with adjustment for confounding variables, detailed below, was used to assess 
the relationship between dietary intake and biomarkers of magnesium and protein intake 
and blood pressure. Model 1 included age, BMI, smoking status, moderate physical activity, 
school years, use of antihypertensive medication, total energy intake and dietary sodium 
intake. Model 2 (magnesium analysis only) additionally adjusted for dietary potassium 
intake and calcium supplement use.  
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In addition sensitivity analysis was conducted excluding those taking antihypertensive 
medication and adjusting for confounding factors (model 1 for protein and model 2 for 
magnesium intake and biomarkers respectively).  
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6.3 Results 
In this cohort of 234 men and women aged 65-79 years at baseline 37% were men (Table 
6.0). The mean age was 70.1 years (70.6 for men and 69.7 for women). The mean BMI of 
26.9 (±4.13) was in the overweight range. BMI for men was slightly higher than the cohort 
average at 27.1 (±3.70) and women was 26.8 (±4.38). The mean SBP of the whole cohort 
152 (±19.3) mmHg and sex-specific 149 (±16.7) mmHg for men and 153 (±20.5) mmHg for 
women were in the hypertensive range (SBP>140) mmHg. The mean DBP and sex-specific 
means were in the prehypertensive range, 81.8 (±9.84) mmHg the whole cohort, 83.1 
(±9.68) mmHg for men and 81.1 (±9.88) mmHg for women. Years in education was similar 
across the cohort, 11.8 (±1.83), 11.9 (±2.03) and 11.8 (±1.72) for the whole cohort, men 
and women respectively.  
The cohort was sedentary for an average of 9.17 hours (9.72 for men and 8.83 hours for 
women). The average amount of time doing moderate physical activity was 27.4 (±21.3) 
minutes for the whole cohort, and 31.1 (±20.6) and 25.2 (±21.5) for men and women 
respectively. The majority of the cohort had never smoked 60.3%, 40.9% of men and 71.9% 
of women. There was similar distribution of use of antihypertensive medication between 
men and women 29.6% and 29.5% respectively and 29.5% for the whole cohort. 
Urinary urea nitrogen was 8.74 (±2.76) g/d for the whole cohort, 9.98 (±2.67) and 7.99 
(±2.37) g/d for men and women respectively. Serum magnesium values were all within the 
normal range of 0.7-1.0 mmol/L for the whole cohort, men and women 0.87 mmol/L for 
all. 
The mean dietary energy intake was 1927 (±396) kcal/d. Mean energy intake was lower the 
than the recommended intake for both men 2198 (±406) and women 1763 (±286) kcal/d. 
Total protein intake was 77.4 (±16.2) g/d for the whole cohort and 86.5 (±17.6) g/d for men 
and 72.0 (±12.6) g/d for women. Magnesium intakes were within the RNI for both men 364 
(±104) mg/d and women 307 (±72.5) mg/d. The RNI for men is 300 mg/d and 270 mg/d for 
women in the UK. Potassium intakes were higher in men with a mean of 3872 (±884) 
compared with women 3389 (±699) mg/d. Dietary sodium intakes were 2440 (±804) for the 
whole cohort and 2842 (±907) and 2198 (±623) for men and women respectively. Alcohol 
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intake was higher in men 12.9 (±11.2) g/d than women 8.38 (±8.60) g/d. Approximately 7% 
of the cohort were taking calcium supplements, a higher proportion of women (~10%) were 
taking calcium supplements than men (~2%). 
Table 6.0 Baseline characteristics of 234 men and women aged 65-79 in the NU-AGE cohort 
 Total 
n=234 
Men 
n=88 
Women 
n=146 
Age 70.1 (±4.04) 70.6 (±4.20) 69.7 (±3.91) 
BMI 26.9 (±4.13) 27.1 (±3.70) 26.8 (±4.38) 
SBP (mmHg) 152 (±19.3) 149 (±16.7) 153 (±20.5) 
DBP (mmHg) 81.8 (±9.84) 83.1 (±9.68) 81.1 (±9.88) 
Antihypertensive medication 69 (29.5%) 26 (29.6%) 43 (29.5%) 
School years 11.8 (±1.83) 11.9 (±2.03) 11.8 (±1.72) 
Physical activity    
Sedentary (time) 550 (±102) 583 (±118) 530 (±85.1) 
Moderate activity (time) 27.4 (±21.3) 31.1 (±20.6) 25.2 (±21.5) 
Vigorous activity (time) 0.83 (±3.04) 1.75 (±4.36) 0.28 (±1.61) 
Smoking    
Current 5 (2.14%) 3 (3.41%) 2 (1.37%) 
Former 88 (37.6%) 49 (55.7%) 39 (26.7%) 
Never 141 (60.3%) 36 (40.9%) 105 (71.9%) 
Biomarkers    
Urinary Urea (g/d) 8.74 (±2.76) 9.98 (±2.67) 7.99 (±2.37) 
Serum Magnesium 
(mmol/L) 
0.87 (±0.06) 0.87 (±0.06) 0.87 (±0.05) 
Dietary Intakes    
Total energy (kcal) 1927 (±396) 2198 (±406) 1763 (±286) 
Protein (g) 77.4 (±16.2) 86.5 (±17.6) 72.0 (±12.6) 
Magnesium (mg) 329 (±90.1) 364 (±104) 307 (±72.5) 
Potassium (mg) 3570 (±806) 3872 (±884) 3389 (±699) 
Sodium (mg) 2440 (±804) 2842 (±907) 2198 (±623) 
Alcohol (g) 10.1 (±9.89) 12.9 (±11.2) 8.38 (±8.60) 
Calcium supplement 16 (6.84%) 2 (2.27%) 14 (9.59%) 
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Correlations between dietary intakes and biomarkers 
Correlations of dietary intake with biomarker indicated a weak correlation between dietary 
and serum magnesium r=0.14 (P value=0.03), r=0.18 (P value=0.09) and r=0.13 (P 
value=0.12) for the whole cohort, men and women respectively. Dietary protein intake was 
more strongly correlated with urinary urea; r=0.60 (P value≤0.001), r=0.65 (P value=≤0.001) 
and r=0.42 (P value=≤0.001) for the whole cohort, men and women respectively. 
Table 6.1 Pearson’s correlation coefficients for dietary magnesium and protein and the 
biomarkers serum magnesium and urinary urea with blood pressure in 234 men and 
women aged 65-79 years. 
 Dietary Magnesium 
mg/d 
Serum magnesium 
mmol/L 
Dietary protein 
g/d 
Urinary urea 
g/d 
Whole cohort (n=234)     
SBP -0.24** -0.06 -0.15* -0.08 
DBP -0.13* -0.03 0.01 -0.13* 
Men (n=88)     
SBP -0.22* 0.14 -0.15 -0.07 
DBP -0.20 0.14 -0.07 -0.23* 
Women (n=146)     
SBP -0.22** -0.17* -0.09 -0.03 
DBP -0.15 -0.15 -0.02 -0.15 
P values*≤0.05, **≤0.01, ***≤0.001 
For the whole cohort, dietary magnesium intake was inversely correlated with both SBP -
0.24 (P value≤0.001) and DBP (-0.13 (P value=0.04) (Table 6.1). There was a weaker, and 
non-significant, inverse correlation between serum magnesium and blood pressure, -0.06 
and -0.03 for SBP and DBP respectively in the whole cohort. Dietary protein intake was 
inversely correlated with SBP -0.15 (P value=0.02) and only minimally correlated with DBP 
0.01 in the whole cohort and an inverse correlation with urinary urea of -0.08 for SBP and 
-0.13 (P value=0.05) for DBP was also present. 
In 87 men dietary magnesium was inversely correlated with both SBP and DBP -0.22 and -
0.20 respectively, this was significant for SBP P value=0.04. In 146 women there were 
similar inverse correlations -0.22 and -0.15 for SBP and DBP with dietary magnesium, the 
coefficient for SBP was significant, P value=0.01. There was a non-significant positive 
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correlation between serum magnesium and blood pressure in men 0.14 for both SBP and 
DBP, and an inverse correlation for women -0.17 and -0.15 for SBP and DBP which was 
significant for SBP (P value=0.04). Dietary protein intake was non-significantly inversely 
correlated with blood pressure in both men and women -0.15 and -0.09 for SBP and weaker 
inverse correlations of -0.07 and -0.02 for DBP for men and women respectively. Urinary 
urea was inversely correlated with both SBP and DBP in men and women -0.07 and -0.23 
SBP and DBP in men -0.03 and -0.15 in women respectively. In men the coefficient for 
urinary urea and DBP was significant (P value=0.03).
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Table 6.2 Regression coefficients for whole cohort, men and women in NU-AGE study aged 65-79 years for SBP and DBP with dietary intakes and biomarkers 
of magnesium and protein intake. 
 Dietary Magnesium 
mg/d 
Serum magnesium 
mmol/L 
Dietary protein 
g/d 
Urinary urea 
g/d 
 SBP DBP SBP DBP SBP DBP SBP DBP 
Whole cohort (n=234)         
Unadjusted -0.05*** -0.02* -20.5 -6.14 -0.17* 0.00 -0.59 -0.48* 
Model 1 -0.05** -0.03** -4.75 -4.74 -0.10 -0.07 -0.20 -0.78** 
Model 2 -0.07* -0.02 -1.74 -1.39 - - - - 
Sensitivity analysis (n=164) -0.08* -0.01 -16.2 -12.6 -0.07 -0.08 0.11 -0.77* 
Men (n=88)         
Unadjusted -0.04* -0.02 38.4 23.3 -0.15 -0.04 -0.45 -0.84*  
Model 1 -0.06** -0.04*** 53.4 23.8 -0.18 -0.17* -0.30 -1.54*** 
Model 2 -0.10* -0.02 58.0 30.1 - - - - 
Sensitivity analysis (n=61) -0.07 -0.02 34.2 30.3 -0.10 -0.22* -0.16 -1.78*** 
Women (n=146)         
Unadjusted -0.06* -0.02 -66.5* -28.3 -0.12 -0.03 -0.25 -0.61 
Model 1 -0.05 -0.02 -53.1 -20.6 -0.08 -0.05 -0.15 -0.66 
Model 2 -0.07 -0.01 -49.3 -17.6 - - - - 
Sensitivity analysis (n=103) -0.11 -0.00 -44.8 -21.9 -0.03 -0.02 -0.25 -0.56 
P values*≤0.05, **≤0.01, ***≤0.001 
Model 1: age, BMI, smoking status, physical activity, school years, antihypertensive medication, total energy, dietary sodium 
Model 2: model 1 + dietary potassium, calcium supplement use (Magnesium analysis only) 
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Sensitivity analysis: excluding those taking antihypertensive medication (model 1* for protein and urinary urea, model 2* for dietary and serum 
magnesium)*excluding use of antihypertensive medication. 
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Dietary magnesium 
In the whole cohort after adjusting for age, BMI, smoking status, physical activity levels, 
years in education, use of antihypertensive medication, dietary intakes of total energy, 
sodium, and potassium and calcium supplement use there was a significant correlation 
between dietary magnesium intake and SBP, regression coefficient -0.05 (P=0.01). In men 
this association maintained significance -0.06 (P=0.01), but was non-significant for women 
-0.05 (P=0.07). Sensitivity analysis excluding those using antihypertensive medication 
provided similar results in the whole cohort (n=163) -0.08 (P=0.02). However, in men the 
association was no longer significant -0.07 (P=0.10) and was non-significant in women -0.11 
(P=0.08). Similar associations were seen with DBP; -0.03 (P≤0.01) for whole cohort, -0.04 
(P≤0.001) for men and -0.02 (P=0.11) for women after adjustment for the above factors. 
Sensitivity analysis provided similar coefficients and yielded no significant association.  
Serum magnesium 
There was no significant association between serum magnesium and SBP or DBP with the 
exception of unadjusted SBP in women, coefficient of -66.5 (P=0.04). However, sensitivity 
analysis excluding those taking antihypertensive medication and adjusting for age, BMI, 
smoking status, moderate physical activity levels, education, total energy, dietary sodium, 
potassium and use of calcium supplements produced coefficients of -16.2 (P=0.57), 34.2 
(P=0.47) and -44.8 (P=0.26) for SBP in the whole cohort, men and women respectively. And 
-12.6 (P=0.39), 30.3 (P=0.21) and -21.9 (P=0.25) for DBP in the whole cohort, men and 
women respectively.   
Dietary protein 
After adjustment for age, BMI, smoking status, physical activity levels, years in education, 
use of antihypertensive medication, total energy and sodium intakes there was no 
significant relationship between SBP and dietary protein intake in the whole cohort, men 
or women. Regression coefficients were -0.10 (P=0.36), -0.18 (P=0.22) and -0.08 (P=0.63) 
for SBP in the whole cohort, men and women respectively. Sensitivity analysis (n=163) 
excluding those taking antihypertensive medication provided similar results -0.07 (P=0.54), 
-0.10 (P=0.60) and -0.03 (P=0.85) for whole cohort, men and women respectively for SBP. 
Coefficients of -0.07 (P=0.20), -0.17 (P=0.04) and -0.05 (P=0.52) were detected for DBP in 
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the whole cohort, men and women respectively after adjustment for the above 
confounding factors. Sensitivity analysis excluding those taking antihypertensive 
medication yielded similar results and the significance in association between DBP and 
dietary protein remained in men -0.22 (P=0.03). 
Urinary urea 
There was no significant relationship between urinary urea and SBP in the whole cohort, 
men or women. Regression coefficients of the adjusted model were -0.20 (P=0.69), -0.30 
(P=0.69) and -0.15 (P=0.83) for SBP for whole cohort, men and women respectively. 
Sensitivity analysis was similar, yielded some difference in direction but not in significance 
0.11 (P=0.86), -0.16 (P=0.87) and 0.25 (P=0.77) for SBP for whole cohort, men and women 
respectively. 
A significant inverse association was seen between DBP and urinary urea in the whole 
cohort -0.78 (P=<0.01) and in men -1.54 (P≤0.001) but not women -0.66 (P=0.06) after 
adjustment for confounding factors. Similar results were seen for sensitivity analysis -0.77 
(P=0.01) for whole cohort, -1.78 (P=0.001) for men and -0.56 (P=0.17) for women.  
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6.4 Discussion 
The findings of this study on 234 men and women aged 65-79 years, summarised in Table 
6.3, suggest that dietary magnesium intake was not well correlated with serum magnesium 
levels in this cohort of older men and women (r=0.14, r=0.18 and r=0.13 whole cohort, men 
and women respectively). This is however a slightly stronger relationship than has been 
previously reported in the ARIC study where a coefficient of r=0.053 was reported in a 
cohort of 7,731 men and women aged 45-64 (164) and ρ=0.04 in a larger sample of 13,560 
men and women, 45-64 years (167). This difference may in part be due to demographic 
differences in study populations, for example the NU-AGE cohort is fairly homogenous in 
its ethnicity, white Caucasian, whereas the ARIC study includes respondents from a range 
of ethnicities. As serum magnesium is in part influenced by dietary intake (407) it is possible 
that cultural related differences in dietary composition may have been a factor. There was 
also a wide range of dietary magnesium intakes reported in the ARIC study, 31-864 mg/d, 
which may also be a factor (164).  
Urinary urea was more strongly correlated with dietary protein intake in this cohort (r=0.60, 
r=0.65 and r=0.41 whole cohort, men and women respectively). This finding is generally in 
line with previous studies which have been conducted in general populations, rather than 
older cohorts specifically (215). Partial 24hr urine collections have been reported to 
correlate well with dietary intake in the order of 0.50-0.81 (215, 411, 412). Therefore, the 
reported correlations for the whole cohort and men are within this range (r=0.60 and 
r=0.65 respectively). Urinary urea nitrogen is reported to account for ~85% of total urinary 
nitrogen excretion and there is little variation in this amount between people (215). The 
correlation for dietary intake and urinary urea was lower in women (r=0.41) which may 
indicate an element of under-reporting, which would be plausible given the relatively low 
mean total energy intakes of women (1770 kcal/d). In addition the mean BMI for women 
of 26.7 would be indicative of higher habitual intakes than those reported.   
In the present study no measure of completeness, such as para-aminobenzoic acid (PABA), 
was used during the 24hr collection, thus it would be sensible to be cautious and estimate 
that not all urine collections would be complete, previous studies have reported 17% and 
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25% of urinary collections to be incomplete (362, 413). However, it is worth noting that a 
recent study investigating how urine samples without PABA provided estimates of  intakes 
of protein and potassium (414). They reported that there was little difference in the mean 
levels of urinary nitrogen and potassium between those who reported taking and not taking 
PABA (414). This would suggest that even in the absence of a measure of completeness, as 
in the NU-AGE study, the 24hr urine samples may still provide a good representation of 
daily protein intake.  In addition the ratio of protein intake estimated from total urinary 
nitrogen and reported dietary protein intakes for the whole population 0.85 (±0.23), men 
0.86 (±0.18) and women 0.84 (±0.26) were within the range of the anticipated ratio of 
estimated protein to reported intake if values were valid; ratio 0.81 ±0.05 (215). 
Table 6.3 Summary of the relationship (based on regression coefficients) of dietary intake 
and biomarkers of magnesium and protein with blood pressure in 234 men and women 
aged 65-79 
 Dietary 
magnesium 
mg/d 
Serum 
magnesium 
mmol/L 
Dietary 
protein 
g/d 
Urinary urea 
g/d 
Whole cohort     
SBP ↓ ↔ ↔ ↔ 
Sensitivity analysis ↓ ↔ ↔ ↔ 
DBP ↔ ↔ ↔ ↓ 
Sensitivity analysis ↔ ↔ ↔ ↓ 
Men     
SBP ↓ ↔ ↔ ↔ 
Sensitivity analysis ↔ ↔ ↔ ↔ 
DBP ↔ ↔ ↓ ↓ 
Sensitivity analysis ↔ ↔ ↓ ↓ 
Women     
SBP ↔ ↔ ↔ ↔ 
Sensitivity analysis ↔ ↔ ↔ ↔ 
DBP ↔ ↔ ↔ ↔ 
Sensitivity analysis ↔ ↔ ↔ ↔ 
↓ - significant inverse association (fully adjusted model) 
↔ - no significant association (fully adjusted model)  
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Correlations between dietary intakes and biomarkers of magnesium and protein with blood 
pressure were strongest in relation to dietary magnesium intake. Although the correlations 
were weak (mmHg/mg magnesium) at r= -0.23 SBP and r= -0.14 DBP for whole cohort, r= -
0.22 and r= -0.20 for SBP and DBP in men and r= -0.22 and r= -0.16 in women it may suggest 
that higher dietary magnesium intakes could lead to reductions in blood pressure of older 
men and women.  
A review of observational studies assessing the relationship between dietary magnesium 
intakes and blood pressure noted that other studies have also reported negative 
correlations between dietary magnesium intake and SBP and most also report negative 
correlations with DBP but not all (415). Studies were adjusted for classical covariates 
including age, BMI, total energy, sodium and potassium intakes. Only one paper included 
in the review was looking exclusively at an older population, aged 65-89. The study was 
small (n=40) and conducted in US men and women, dietary intake was recorded using 24hr 
recall and they did not adjust for confounding factors in analysis and reported a negative 
correlation with DBP only (416). The lack of adjustment in analysis makes it difficult to make 
any conclusions based on these results, as they may be influenced by a number of factors 
including total energy intake, BMI and smoking status. 
Joffres et al (165) reported on correlations between dietary magnesium intake and blood 
pressure in Japanese men in Hawaii aged 46 years and older (165). They reported 
correlation coefficients of -0.12 and -0.09 for SBP and DBP respectively, but did not 
investigate circulating magnesium levels (165). In a study by Kesteloot and Joossens  (417) 
in a Belgian population of men and women aged 25-74 years an inverse correlation was 
reported for dietary magnesium intake in g/d and SBP but not DBP in women (417). No 
data were reported for dietary magnesium and blood pressure in men. In women the 
regression coefficients for dietary magnesium and SBP were -14.43 and -0.07 for partial 
regression and standardised partial regression respectively. This was slightly weakened 
when those taking antihypertensive medication were excluded; -11.71 and -0.06 for partial 
regression and standardised partial regression respectively (417). In the NU-AGE analysis 
the relationship between dietary magnesium intake mg/d and SBP in women was -0.06 
(P=0.01) for the unadjusted model, and after adjusting for confounding factors including 
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age, BMI, dietary total energy, sodium and potassium intakes the association was non-
significant; -0.07 (0.12) but was slightly strengthened following exclusion of those taking 
antihypertensive medication -0.11 (P=0.08). This final finding is similar to that of Kesteloot 
and Joossens (1988) and suggests that dietary magnesium intake may be an important 
factor in reducing blood pressure in older women.  
Serum magnesium was not correlated with blood pressure in the whole cohort -1.74 
(P=0.94) and -1.39 (P=0.91) for SBP and DBP respectively. Sensitivity analysis, excluding 
those taking antihypertensive medication, was also non-significant -16.2 (P=0.57) and -12.6 
(P=0.39). This is similar to previous findings, including a small study of 26 subjects that 
included untreated hypertensives (n=11), treated hypertensives (n=8) and normotensive 
subjects (n=7). The authors reported no significant correlation between serum magnesium 
and blood pressure (418). In addition in a study of elderly men and women with type II 
diabetes, there was no significant difference in the serum magnesium levels of participants 
with SBP <130 and DBP <80 compared with those with SBP ≥130 and DBP ≥80 (254).  
In the present study there were differences in the relationship of serum magnesium and 
blood pressure in men and women. In men a non-significant positive relationship was seen 
between serum magnesium and SBP after full adjustment 58.0 (P=0.07) which was 
attenuated during sensitivity analysis, 34.2 (P=0.47). And a non-significant positive 
relationship with DBP 30.1 (P=0.08) and 30.3 (P=0.21) for fully adjusted and sensitivity 
analysis respectively. Whereas in women the relationship for SBP and DBP were negative, 
albeit non-significant after adjustment, -49.3 (P=0.14) and -44.8 (P=0.26) for SBP and -17.6 
(P=0.28) and -21.9 (P=0.25) for DBP for the fully adjusted model and sensitivity analysis 
respectively. These findings are important as although dietary magnesium was only weakly 
correlated with serum magnesium, it may have relevance for those taking supplements or 
medications containing magnesium as supplementation with magnesium, including bound 
to other medications, may be sufficient to increase circulating levels (405). A non-
significant association of higher blood pressure with higher serum magnesium levels was 
seen in men in this study, which warrants further investigation to determine whether high 
magnesium intakes in the form of supplements or in medication may lead to a detrimental 
increase in blood pressure in men which would require monitoring.  
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 There was a strong correlation between dietary protein and urinary urea for the whole 
cohort r=0.60, men r=0.65 and women r=0.41. In terms of their respective relationships 
with blood pressure, there were significant associations between dietary intake and DBP in 
men and urinary urea with DBP in whole cohort and men, but not women. The findings of 
other studies in younger populations have been somewhat inconsistent with some showing 
no significant association (141, 419), and others report a significant inverse association 
(359, 420). 
An Italian cohort (n=3705) which included older people, 25-74 years, reported a significant 
inverse relationship between overnight urinary urea nitrogen and SBP -5.2 mmHg/log(urea) 
mmol/h (P<0.001) after adjustment for a number of confounding factors including age, sex, 
BMI, antihypertensive medication and urinary sodium, potassium and calcium (420). 
However, they did not conduct any age stratified analysis and as the age range of the 
participants is very wide, a different relationship may be present in the older adults. This 
could be due to age related decline in kidney function, as the kidneys have an important 
role in processing nitrogen. In the INTER-SALT study which includes men and women from 
32 countries aged 20-59 years, they reported on differences in associations of total 
nitrogen and blood pressure between younger (20-39 years) and older (40-59 years) 
participants (359). They reported that inverse associations between total nitrogen and SBP 
and DBP blood pressure which were stronger in older participants -0.92 (P<0.001) and -
0.48 (P<0.05) than younger participants -0.20 (P not reported) and -0.38 (P<0.05) for SBP 
and DBP respectively (359). In addition Cirillo et al (420) in the Italian cohort used only an 
overnight urine collection, which may not provide as accurate a measure as 24hr collection, 
as urinary urea excretion is increased about 2 hours postprandially (420). Thus if protein 
intake is unevenly distributed throughout the day with higher intakes at the evening meal, 
this may lead to higher levels of urinary urea suggesting higher total intake than might 
otherwise be seen if a 24hr collection was completed. Additionally a Japanese study 
reported that higher protein intakes estimated from urinary urea was associated with 
lower SBP and DBP, reaching significance in men but not women, compared with lower 
protein intakes (421). A study by Kihara et al (419) also reported different directions of 
effect for men and women in association with urinary urea nitrogen in Japanese men and 
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women aged 30 years. In that study women had slightly lower blood pressure 129/75.6 
mmHg compared with 132/78.5 mmHg in men which was significantly different (P<0.05). 
This in conjunction with the women’s slightly higher urinary nitrogen/creatinine ratio, a 
potential marker of protein intake, may partially explain this inconsistency in direction of 
effects (419).  
6.4.1 Strengths and limitations 
Due to the cross sectional design of the current analysis it is not possible to infer causality, 
and despite adjusting for several confounding factors it may be that other factors not 
accounted for in analysis would influence the outcome. Despite using a more robust 
method of dietary assessment, 7DD, it is possible that bias in reporting may have occurred. 
In addition to dietary reported intakes, serum magnesium and urinary urea were also 
measured. Urinary urea is a recovery biomarker which has been reported to accurately 
represent absolute intakes, of protein. However, it is only reflective of the time period in 
which the collection was taken, in this study one 24 hour period. Thus if protein intake was 
particularly high or low on this particular day then this would be reflected in urinary 
nitrogen levels. To more accurately ascertain habitual intake the 24hr urine collection could 
be repeated on several occasions, although this becomes burdensome to the participant 
and increases costs of the study. 
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6.5 Summary 
In this study of older adults as has been found previously, dietary magnesium intake was 
not well correlated with serum magnesium levels. However, dietary protein was well 
correlated with urinary urea. The strongest relationship was seen between dietary 
magnesium intake and blood pressure, despite relatively weak correlation coefficients. This 
relationship was reflected in significant inverse associations between dietary magnesium 
intake and SBP in the whole cohort after adjustment and sensitivity analysis, and in men 
only after adjustment. There was also a similar strengthened correlation between urinary 
urea and DBP in men only. This was also reflected in significant inverse association with 
DBP in men only after adjustment and sensitivity analysis, and was also seen for dietary 
protein intake and DBP in men only, despite a much weaker correlation coefficient. These 
findings indicate that dietary magnesium intake may be correlated with blood pressure in 
older adults, however, as there was little significant correlation between serum magnesium 
and blood pressure in men, women or the whole population serum magnesium would not 
be recommended for predicting blood pressure in the older UK population. Dietary protein 
and urinary urea may be associated with DBP in older men and urinary urea in whole 
populations also. This finding would suggest a potential benefit of urinary urea in predicting 
DBP, although further research to confirm the association would be necessary, especially 
as the strongest correlations were seen between this biomarker and blood pressure 
outcome (in men only).
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7.0 Summary of research 
This thesis set out to answer five research questions which were: 
1. What is the relationship between dietary magnesium intake and stroke risk factors, 
blood pressure and serum lipid levels and the risk of stroke in middle and older aged 
men and women? 
2. What are the main contributing sources of dietary protein intake, and how do the 
types of protein (animal, plant and ratio of plant:animal) and food group sources of 
protein differ between men and women? 
3. What are the relationships between dietary protein intake, including that from 
different types (animal and plant) and stroke risk factors, blood pressure and serum 
lipid levels and the risk of stroke in middle and older aged men and women? 
4. How do biomarkers of magnesium and protein intake compare with dietary 
reported intakes in relation to blood pressure in older men and women? 
5. What are the implications of the findings of this thesis for public health nutrition 
In Chapter Three this thesis addressed research question 1 by determining the relationship 
between dietary magnesium intake and stroke risk and risk factors, through the use of 
linear regression analysis of 4,443 British men and women aged 39-80, part of the EPIC-
Norfolk cohort. In doing so a significant inverse association was shown between dietary 
magnesium intake and blood pressure in men, but not women. Dietary magnesium intake 
was also significantly associated with circulating lipid levels. In men higher magnesium 
intakes were inversely associated with total cholesterol and positively associated with the 
ratio of HDL:LDL. In women a significant inverse association was seen with triglyceride 
levels and positive associations with HDL and the ratio of HDL:LDL cholesterol. Both blood 
pressure and cholesterol levels are risk factors for stroke. In men we identified that having 
lower dietary magnesium intakes was associated with higher risk of stroke but that there 
was no significant association for women. 
In Chapter Four this thesis addressed research question 2 and identified that the primary 
contributing source to total protein intake was from animal and animal products in both 
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men and women. Women, compared to men, had small but significantly higher intakes of 
total protein as a percentage of energy and protein from animal-marine, animal-derived 
and plant sources as a percentage of energy than men. There was no significant difference, 
between men and women, for protein from total animal sources and the ratio of 
plant:animal protein intake. There were differences in the consumption of individual food 
items and food groups between men and women, with men consuming higher amounts of 
red and processed meat than women. Women tended to consume more fish and poultry. 
These differences in the makeup of protein intake may have implications on the effects of 
total protein intake on stroke risk and risk factors. 
In Chapter Five research question 3 was addressed and the findings indicated that there 
were differences in the effects of protein and types of protein (plant and animal) on risk 
factors for stroke between men and women. However, one consistency across total protein 
intake and types of protein was no significant association with stroke risk directly in either 
men or women. In men only protein from plant sources was significantly inversely 
associated with DBP exclusively. In men total protein intake was positively associated with 
HDL levels and protein from plant sources were inversely associated with total cholesterol 
and LDL and positively associated with ratio HDL:LDL. The ratio of plant:animal protein 
intake was inversely associated with total cholesterol and LDL cholesterol. There were no 
significant associations between protein from animal sources and blood pressure, lipid 
levels or stroke risk in men. In women total protein and protein from animal sources were 
inversely associated with SBP and DBP and plant protein with DBP only. Total protein and 
protein from animal sources also had similar associations for cholesterol levels both 
indicating an inverse association with triglycerides and positive associations with HDL and 
ratio HDL:LDL, total protein was additionally inversely associated with LDL levels in women. 
There was no significant association between the ratio of plant:animal protein intake and 
blood pressure, cholesterol levels or stroke risk in women after adjustment for confounding 
variables.  
In Chapter Six of this thesis research question 4 was addressed to determine if dietary 
intakes of magnesium and protein and biomarkers, serum magnesium and urinary urea, 
were correlated with blood pressure in an older population of men and women. In addition 
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to determine if one of the measures was more strongly associated with blood pressure than 
the others in an older population. In a cohort of 234 older men and women, aged 65-79 
years, in the NU-AGE study, a strong correlation between dietary protein and urinary urea 
was reported for the whole cohort r=0.61, men r=0.65 and women r=0.44 respectively. 
Dietary magnesium was less well correlated with serum magnesium (r=0.14, r=0.18 and 
r=0.13 whole cohort, men and women respectively). However, dietary magnesium had the 
strongest relationship with blood pressure, specifically SBP in the whole cohort and men. 
Dietary protein and urinary urea were also significantly inversely associated with DBP in 
men only.  
All together the chapters of this thesis combine to indicate that in middle aged and older 
adults dietary magnesium intake may be an important component in reducing the risk of 
stroke, particularly in men, whereby inverse associations were reported with both blood 
pressure and some lipid levels (total cholesterol and ratio HDL:LDL) in the EPIC-Norfolk 
cohort, and dietary magnesium intake was additionally associated with lower blood 
pressure in older population part of the NU-AGE study. Protein intake may have 
implications for stroke risk and risk factors for stroke, blood pressure and total cholesterol, 
and may be determined by the quality of protein rather than just quantity consumed. 
Public health perspective 
The findings of this study concur with the current UK guidelines in terms of increasing 
intakes of fruit and vegetables and wholegrains, as these are rich sources of magnesium. In 
addition other plant sources such as nuts and legumes also provide quality protein, as well 
as containing magnesium. In this study the difference in magnesium intake of the extreme 
quintiles was 250 mg/d for men and 198 mg/d for women. This is the equivalent to 
approximately 2 slices of wholemeal bread with peanut butter and 9 Brazil nuts (29) which 
could easily be incorporated as part of a healthy diet and could have significant effects on 
blood pressure. 
A more plant-based diet may have health benefits on a number of levels including on blood 
pressure, lipid levels and stroke risk and may also be more environmentally sustainable in 
the long term for the expanding population. As well as increased plant protein intakes, 
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quality animal protein sources could also be included in the diet. I believe the beneficial 
associations shown between animal protein intake and blood pressure and lipid levels in 
women were driven by women’s higher intakes of lean animal protein compared to men 
and their concurrently lower intake of red and processed meats, which negatively influence 
these outcomes (316-318). Therefore it would be recommended to provide education on 
improving the quality of protein sources, through increased consumption of fish (in line 
with the recommendation to consume at least two portions of fish per week), lean meats 
and vegetable protein sources such as legumes.  
Contribution to knowledge 
There is some evidence to suggest that dietary magnesium and protein intakes may 
beneficially affect stroke risk and risk factors including blood pressure and cholesterol 
levels. However, to the best of my knowledge no other study has previously assessed these 
associations in parallel in one cohort of men and women from the general population. In 
addition previous research has focused on recording dietary intakes through 24hr recall 
and FFQ whereas in this thesis magnesium and protein intakes were derived from 7 day 
food diaries. Finally, there has been a lack of research in the UK population specifically, and 
there is evidence to suggest that even within Europe there are significant differences in 
consumption patterns, both of specific items and frequency/portions consumed (309, 422).  
There is a current lack of knowledge surrounding the contributing factors to protein intake 
in the UK diet, specifically subtypes of protein (plant and animal). Little is known about how 
protein intake differs between men and women, and this may have implications for health 
outcomes due to the quality of protein consumed. Previous research on the correlation of 
urinary urea and dietary protein intake in an exclusively older population is lacking. Few 
studies have previously investigated the associations and correlations of magnesium and 
protein intakes and biomarkers in older population.  
Therefore this thesis aimed to fill these identified gaps in the existing literature.  
Chapter Seven  Discussion 
 
321 
 
7.1 Implications of findings 
The findings in relation to dietary magnesium intake and blood pressure may have 
significant health implications. In men in the EPIC-Norfolk cohort, a significant difference 
of -7 mmHg SBP and -4.3 mmHg DBP was reported between extreme quintiles of 
magnesium intake, the difference in magnesium intake between quintiles was 250 mg an 
amount that can be achieved through dietary modification. Independently reductions of 10 
mmHg SBP and 5 mmHg DBP have been associated with a ~33% and 34% reduction in 
stroke risk (423, 424), and also reduced risk of stroke death by 50-60% (425). Correlations 
between dietary magnesium intake and blood pressure were also seen in the older NU-AGE 
cohort of men and women aged 65-79 years. Dietary total protein and urinary urea were 
also related to lower DBP in men, only, in the NU-AGE cohort. 
There is some evidence to suggest that in a very old population, aged >80, treatment with 
antihypertensive medication may infer higher risk than the benefit gained from blood 
pressure reduction (426). The findings of the present study do not cover this age range, but 
may indicate a potential for, the increasingly ageing population, to increase their 
magnesium intake as a blood pressure lowering strategy (426). By 2037 it is predicted that 
1 in 12 of the UK population will be over 80, approximately 6 million people, double the 
current number (427). Therefore if the currently identified relationship remains the same 
in older age, there may be a potential benefit of dietary modification on blood pressure by 
increasing magnesium intake. 
In terms of effects on women, differences in blood pressure were smaller with dietary 
magnesium and protein intakes. However, even small reductions in blood pressure have 
been indicated to reduce the risk of hypertension and stroke itself. For example a -2 mmHg 
decrease in DBP was equated to a 17% reduction in prevalence of hypertension and a 15% 
reduction in stroke risk (428). The difference in effects of dietary intake on blood pressure 
between men and women are of interest, these differences are summarised in Table 7.0. 
Men tend to have higher blood pressure than their age-matched pre-menopausal women, 
so this may be one contributing factor to the larger effect seen in men. Previous studies 
have also highlighted that reduction in blood pressure associated with dietary intakes is 
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often greater in individuals with elevated blood pressure initially (108). The potential 
mechanisms of the difference in blood pressure regulation between men and women are 
unclear (197) but may be related to changes and differences in hormone levels of men and 
women.  
A study investigating the effects of different statin medications on LDL cholesterol indicated 
that on average LDL was reduced by 1.8 mmol/L and this equated to approximately 17% 
reduction in stroke risk (280). Differences of this magnitude were not identified during the 
current analyses, however modest differences of -0.21 mmol/L LDL were seen between 
extreme quintiles of magnesium intake in both men and women. For plant protein intake 
differences of -0.20 mmol/L and -0.28 mmol/L of LDL for men and women respectively were 
reported. In men animal protein, and total protein, was related to a slight increase in LDL 
levels between extreme quintiles of intake, whereas in women the difference was a 
consistently lower LDL in those with higher total and animal protein as percentage of 
energy. This finding may be influenced by the differences in the food items consumed that 
contribute to protein intake. Within this thesis it was identified that in terms of animal 
protein sources, men were higher consumers of red and processed meat, which are sources 
of saturated fat whereas women were on average consuming more fish and poultry which 
are leaner sources of more healthful fatty acids. Thus it may be of relevance to highlight 
the importance of the source of protein consumed in terms of health benefits. 
As with blood pressure, some differing effects of dietary magnesium and protein intakes 
were shown in relation to lipid profiles of men and women. This may have occurred for a 
number of reasons, including a difference in dietary intakes which influenced the 
associations. Mechanistic differences between men and women that may have led to these 
discrepancies could be related to the ways in which men and women deposit adipose tissue 
(429). For example central abdominal adipose tissue, which is more prevalent in men, 
provides a plentiful supply of free fatty acids and cytokines to the liver which may increase 
the risk of developing dyslipidaemia (429). This may also contribute to an increase in blood 
pressure in men. Although as women age distribution of fat changes and their central 
adiposity increases. 
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The combined implications of reduction in blood pressure and potential modest reductions 
in lipid levels that may be achieved through consuming a diet rich in both high quality 
protein and magnesium are not known but could potentially have a greater influence on 
stroke risk than the components individually.  
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Table 7.0 Summary of results highlighting similarities and differences in direction of effect between men and women. 
 Men significant1 Men non-
significant 
Both 
significant 
Both non-
significant 
Women 
significant 
Women non-
significant 
Dietary Intakes       
Magnesium SBP, DBP 
TC 
Stroke risk  
(intake groups) 
 
TG, HDL 
 
HDL:LDL 
 
LDL 
Stroke risk 
(quintiles) 
 
TG, HDL 
SBP, DBP 
TC 
Stroke risk  
(intake groups) 
Total protein  SBP, DBP 
TG, LDL, HDL:LDL 
 
HDL 
 
TC 
Stroke risk 
(quintiles) 
SBP, DBP 
TG, LDL, HDL:LDL 
 
Plant protein  
HDL:LDL 
 DBP 
TC, LDL 
SBP 
TG, HDL 
Stroke risk  
(quintiles) 
  
Animal protein  SBP, DBP 
TG, HDL, HDL:LDL 
  
TC, LDL 
Stroke risk  
(quintiles) 
SBP, DBP 
TG, HDL, HDL:LDL 
 
TC, LDL 
Ratio plant:animal 
protein 
 
TC, LDL 
  SBP, DBP 
TG, HDL, HDL:LDL 
Stroke risk 
(quintiles) 
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Abbreviations: DBP, diastolic blood pressure; HDL, high density lipoprotein; LDL, low density lipoprotein; TC, total cholesterol; TG, triglyceride; SBP, systolic 
blood pressure 
1significant inverse effect for SBP, DBP, TC, TG and LDL. Significant positive effect for HDL and HDL:LDL.
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The findings of the dietary intake and biomarker study, Chapter Six, indicated that dietary 
magnesium intake may be correlated with blood pressure in older adults, however, as there 
was little significant correlation between serum magnesium and blood pressure in men, 
women or the whole population serum magnesium would not be recommended for 
predicting blood pressure in an older UK population. Dietary protein and urinary urea may 
be associated with DBP in older men and urinary urea in whole populations also. This 
finding would suggest a potential benefit of urinary urea, due to its objectivity, in predicting 
DBP. Urinary urea is an objective measure, which relates to dietary protein intake, and may 
thus be less prone to bias than self-reported dietary intake. 
 
The findings in context of other dietary components 
The results of the current thesis are comparable to the established findings of other studies 
investigating the effects of different dietary nutrients and patterns on stroke risk and risk 
factors. For example the DASH combination diet comprising of low-fat dairy, modest 
saturated, total fat and cholesterol intakes and high in fruit and vegetables consumption 
has been associated with decreased blood pressure (108). This diet, consumed for 8 weeks, 
lead to reductions in SBP of 5.5 mmHg and 3.0 mmHg for DBP (P<0.001) compared to the 
control diet which was representative of typical dietary intake in US. In addition a diet high 
in fruit and vegetables, and lower in sweet and snack foods (108), resulted in reduced SBP 
of 2.8 mmHg (P<0.001) and DBP of 1.1 (P=0.07) compared with the control group. For those 
with existing hypertension the reductions in SBP and DBP were greater (108).  
Plasma vitamin C, a marker of fruit and vegetable intake, has been significantly inversely 
associated with both blood pressure and stroke risk (110, 111). With every 20 μmol/L 
increase in plasma vitamin C, approximately equivalent to 1 serving of fruit or vegetable/d,  
a decrease of -0.9 mmHg SBP and -0.5 mmHg DBP was seen (P<0.001 for both) (111). In 
addition a further study showed that plasma vitamin C was also inversely associated with 
stroke risk, after full adjustment for confounding factors and exclusion of those reporting 
stroke within 2 years of follow up the RR for stroke was 0.60 (95% CI 0.44-0.81) in the 
highest quartile of plasma vitamin C, levels ≥66 μmol/L (110). 
Chapter Seven  Discussion 
 
327 
 
A RCT on soy protein intake reported beneficial effects on serum lipid levels (127). A diet 
consisting of 24 g soy protein and 70-80 mg soy isoflavones lead to a reduction in total 
cholesterol and triglyceride levels after 6 weeks of consumption. Total cholesterol was -
0.17 mmol/L (P<0.05) and triglycerides were -0.14 mmol/L lower than the control diet 
which provided 24 g dairy protein (P<0.05). But no significant effect on LDL or HDL levels 
were shown (127). 
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7.2 Strengths and limitations of the study 
To the best of my knowledge this is the first study to investigate the associations of dietary 
magnesium and protein intakes on stroke risk and risk factors for stroke in one general 
population cohort of men and women. Additionally this study was also able to assess the 
associations of dietary magnesium and protein with blood pressure in an exclusively older 
population, whilst also exploring the potential correlations with biomarkers of intake, 
serum magnesium and urinary urea.  
The strengths of this study include the large cohort size and prospective design of EPIC-
Norfolk cohort. This design reduces the susceptibility of the study to selection bias and the 
prospective nature allows for risk of stroke to be investigated. The EPIC-Norfolk cohort used 
in this thesis was a sub-cohort of the larger EPIC-Norfolk cohort. The cohort was derived 
from a random sub-sample of 4,000 participants whom were representative of the larger 
cohort. To this sub-sample, those with an incident stroke were also included. Therefore 
there is potential for this sampling procedure to have skewed the cohort to be less 
representative of the original sample. The strengths of the NU-AGE cohort include its 
inclusion of potentially objective measures of dietary intake; urinary urea, and serum 
magnesium. It also allowed analysis in an exclusively older population, and as EPIC-Norfolk 
cohort is based on baseline food intakes, recorded between 1993 and 1997, there may be 
differences in dietary intake patterns and foods consumed in today’s modern diet that may 
influence the associations of magnesium and protein on blood pressure. 
Statistical analyses were adjusted for a number of relevant confounding factors, which 
enables identification of potential associations independent of other known associated 
components. However, despite the care taken to develop statistical models it is possible 
for residual confounding to occur. 
The 7-day food diary reduces the risk of recall bias, and is validated in the EPIC-Norfolk 
cohort to more accurately represent dietary intakes, including protein and some 
micronutrients, than 24hr recall and FFQs. The 7-day food diary was utilised in both the 
EPIC-Norfolk and NU-AGE cohorts. However, due to the nature of self-reported food 
intakes it is possible that there was response bias, in the form of either consuming a diet 
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perceived to be more healthful during the recording period, rather than habitual diet. Or 
the conscious and/or unconscious bias of foods and portion sizes. When compared with 
the UK population and dietary guidelines this EPIC-Norfolk cohort was generally 
representative of the UK population. Dietary intakes, and lifestyle factors, were only 
measured at one time-point, baseline, in these analyses. This means that changes in dietary 
habits, lifestyle or medical history which may have occurred during the following up period 
of the study (mean 9.58 years) cannot be accounted for. 
Some participants had missing data for variables of interest such as smoking status or 
medication use. In these cases participants were reclassified into an alternative category. 
For example those with missing smoking status were reported as current smokers, and 
those with missing aspirin or antihypertensive medication use were reclassified to ‘no’ 
category. Therefore it is possible that some individual observations were misclassified. In 
addition participants with missing values for certain variables including history of stroke at 
baseline, blood pressure and lipid levels were excluded from analysis, which may have 
introduced an element of bias. Selection bias is also possible, although the whole EPIC-
Norfolk cohort was representative of the UK population. Additionally, the sub-cohort in this 
thesis is primarily comprised of a further random sample of the EPIC-Norfolk cohort. 
However, truncation of the sample distribution would likely only attenuate the observed 
associations and therefore associations may actually be stronger than are presented. 
Due to the nature of the study design it is not possible to infer causality between exposure 
(magnesium and protein from diet and biomarkers) and outcome (blood pressure, lipid 
levels and stroke risk). 
It would also be beneficial to additionally investigate the association of urinary magnesium 
alongside serum and dietary intakes with risk factors for stroke. As urinary magnesium may 
correlate more strongly with dietary intakes, and may therefore be related to blood 
pressure and stroke risk. 
In terms of dietary protein intake, it would be of interest to further explore the differences 
in effects of subtypes of protein, to identify if the quality of protein is more important than 
the quantity. Further sub classification of protein into specific amino acids, may be relevant 
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to aid in hypothesis generating of potential mechanisms of action of dietary protein on 
stroke risk and risk factors. However, specific amino acid deficiencies and low intakes are 
rare, due to the widespread presence of amino acids in all food items. Therefore it would 
be difficult through diet alone to increase the intakes of only specific amino acids, and it 
would be preferred to obtain dietary needs through food intake as opposed to 
supplementation where possible. 
At present the current analyses allow for the understanding of the independent 
associations of dietary magnesium and protein intakes with stroke risk factors and stroke 
risk in one population. As the results of the analyses conducted in this thesis indicated that 
both nutrients were independently associated with stroke risk factors, blood pressure and 
lipid levels, it may be necessary to adjust for dietary intake of each variable in future 
analyses. Prior to this it would be of benefit to investigate the collinearity of the protein 
and magnesium in the respective regression models using variance inflation factor. If 
collinearity is identified a model incorporating an interaction term between dietary 
magnesium and protein intake may be necessary. 
The current analyses could be enhanced by assessing the associations by stroke subtypes. 
This would enable identification in differences in risk and prevention of subtypes, as the 
mechanisms of action may potentially be different.  
As these analyses were conducted at one time point, it would, be interesting to map 
changes in blood pressure, lipid profile and incidence of stroke over time. In this way it may 
be possible to determine if those with habitually low magnesium intakes across follow-up 
were at increased risk of stroke, or presented with hypertension or abnormal lipid profile 
at later follow-ups than those with adequate intakes. A similar approach could be taken in 
regard to dietary protein intake.  
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7.3 Future directions 
As has been mentioned in the previous section, one of the limitations of this study was that 
due to the design it is not possible to infer causality. Therefore, further research would be 
required to assess, using randomised controlled trial, whether increased dietary 
magnesium intake could lead to clinical reductions in blood pressure. Foods which 
commonly provide high proportions of UK magnesium intake include cereals and 
wholegrains, thus these could be encouraged and less commonly consumed but good 
sources of magnesium such as nuts which can be grown in the UK including cobnuts, and 
leafy green vegetables which can also be sourced in abundance locally could also be 
investigated and proposed for consumption. This would then also improve the 
sustainability of increasing dietary intake recommendations.  
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Background:Dietarymagnesium couldmodify themajor stroke risk factors, high blood pressure (BP) and choles-
terol, but has been understudied in both sexes in a single population. This study aimed to investigate if dietary
magnesium intake was associated with BP, total cholesterol (TC) and incident stroke risk in an adult population.
Methods:We conducted cross-sectional analyses in a case–cohort study of 4443, men and women aged 40–75,
representative of 25,639 participants years of the EPIC (European Prospective Investigation into Cancer)-Norfolk
cohort. The cohort included 928 stroke cases (42,556.5 person years). Dietary data from 7 day food diaries were
analysed using multivariate regression to assess associations between quintiles or data-derived categories of
dietary magnesium intake and BP, TC and stroke risk, adjusted for relevant confounders.
Results: We observed differences of−7 mm Hg systolic BP (P trend ≤ 0.01) and−3.8 mm Hg diastolic BP (P
trend= 0.01) between extreme intakes of magnesium inmen, a signiﬁcant inverse association with TC was ob-
served (P trend= 0.02 men and 0.04 women). Compared to the bottom 10%, the top 30% of magnesium intake
was associated with a 41% relative reduction in stroke risk (HR 0.59; 95% CI 0.38–0.93) in men.
Conclusions: Lower dietary magnesium intake was associated with higher BP and stroke risk, which may have
implications for primary prevention.© 2015 Published by Elsevier Ireland Ltd.1. Introduction
Stroke accounts for more than 5.5 million deaths annually and by
2020 predictions estimate that the global burden of stroke will account
for 61 million disability-adjusted life years [1].
Elevated BP2 is a signiﬁcant modiﬁable risk factor for stroke with an
approximate fourfold increase in stroke risk in hypertensive individuals
compared with the normotensive population [2]. Although established
evidence indicates that elevated BP, hypertension and circulatinga University of East Anglia FMH
the Medical Research Council
4/A8257).
on Health and Primary Care,
h NR4 7TJ, UK.
liability and freedom from bias
ssure, CVD— cardiovascular dis-
Nutrients for Epidemiological
ion into Cancer-Norfolk, FFQ —
tein, HLQ— Health and Lifestyle
ardial infarction, SBP — systolic
atio.cholesterol can be modiﬁed by dietary intake including: salt, alcohol,
saturated fat and cholesterol [2] other dietary components, including
magnesium, which is abundantly available in nuts, green leafy vegeta-
bles and whole grains, have been less extensively studied.
Magnesium has a number of metabolic roles in the body and may
inﬂuence BP and blood lipids through different mechanisms [3,4]. Mag-
nesium may serve as a natural calcium channel blocker, exhibit beneﬁ-
cial effects on platelet coagulation, have a potential role in vasodilation
and has been associatedwith reduced coronary artery calciﬁcation [4,5].
Other proposedmechanisms include increased peroxidation of lipopro-
teins with subsequent acceleration of atherosclerotic plaque formation
and low magnesium may facilitate an increase in inﬂammation which
is associated with negative changes in lipid proﬁle [3,4]. Higher magne-
sium intake has been associated with lower risk of Type II diabetes [6],
metabolic syndrome [7] and cardiovascular disease (CVD) [8].
Two recent meta-analyses have investigated the effects of dietary
magnesium on stroke risk and CVD risk respectively [8,9] showing
inconsistent ﬁndings. The reason for these inconsistencies may be due
to estimation of magnesium intakes from less precise methods of
recording diet such as Food Frequency Questionnaires (FFQs) and
24 hour recalls. However, it has been increasingly suggested that the
detailed 7-day diary represents dietary intakes more precisely [10].
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magnesium intake, estimated using a 7-day diary, was associated
with BP, lipid proﬁle and stroke risk in an adult general population of
4443 (representative of larger cohort 25,639) men and women.
2. Subjects and methods
2.1. Study population
The present study population is comprised of a randomly selected
representative sample (n = 4000) of the EPIC-Norfolk cohort
(n ~ 25,639), which will herein be referred to as EPIC-Norfolk sub-
cohort. EPIC-Norfolk has previously been described in detail and the
characteristics of the sample were comparable with other representa-
tive UK populations with the exception of a lower proportion of current
smokers [10]. Ethical approval for the study was obtained from the
Norwich Ethics Committee, and participants provided informed
consent.
Brieﬂy this sub-cohort (n = 4920) is comprised of a representative
random sample of 4000 men and women with complete data for food
diaries from the EPIC-Norfolk cohort (n = 25,369) and 1102 stroke
cases (n = 182 part of 4000 random sample previously mentioned)
giving a total of 4920. Participants were resident in the Norfolk area at
recruitment between 1993 and 1997 and recruited through participat-
ing General Practices (n = 35) [10]. Participants were excluded from
analyses if they had reported prevalent stroke at baseline or hadmissing
values for any variables included in the multivariate model (n = 477).
Participants with missing values for smoking status, aspirin medication
use for N3 months, and magnesium from supplements (including
medication) were recoded and classiﬁed as ‘current smoking’ (n =
37) and ‘no’ aspirin (n = 813) and ‘no’ supplements (n = 2) to reduce
the risk of bias due to under-reporting. Therefore 4443 participants
remained for analysis in this study.
2.2. Anthropometric measures
At baseline participants attended a health check, which took place
either at a clinic or the participant's GP surgery, where a number of
anthropometric measurements were taken by trained staff according
to standardised protocols [10]. This included height to the nearest
mm, using a free-standing stadiometer. Weight was recorded to the
nearest 0.2 kg with participants wearing light clothing and no shoes.
From this measurement BMI was calculated. Waist and hip
measurements were also recorded to the nearest mm [10].
2.3. Clinical and biological measures
BP was taken after participants had been seated for 3 min. Two
readings were taken using Accutorr Sphygmomanometer (Datascope,
UK) with the participants arm in the horizontal position in line with
the mid-sternum [10]. At the clinic visit, a non-fasting venous blood
(42 ml) sample was taken from which biochemical analysis for serum
cholesterol was conducted [10].
Stroke cases were deﬁned as ICD-9 430–448 or ICD-10 60–69. Fatal
and non-fatal stroke incidence was established using death certiﬁcate
data and linkagewith hospital records, using ICD-10 60–69 this method
of stroke ascertainment has been shown to have high sensitivity and
speciﬁcity [11]. The current study is based on follow-up to 31st March
2008. Numbers of stroke are given in the tables.
2.4. Lifestyle factors
Information was obtained from participants on a number of lifestyle
variables via a Health and Lifestyle Questionnaire (HLQ). This included
smoking status which was categorised as current, if participants
answered “yes” to the question “Do you smoke cigarettes now?”,never if they answered “no” to the question “Have you ever smoked
as much as one cigarette a day for as long as a year”. All other partici-
pants with valid data were classiﬁed as former smokers (missing data
were treated as ‘current’). Physical activity was assessed by the use of
a short physical activity questionnaire which assessed typical activity
over the previous 12 months. Physical activity status took account of
both work and leisure related activities and participants were ranked
into one of four categories (inactive, moderately inactive, moderately
active and active) [10]. The repeatability and validity of these was
conﬁrmed against heart-rate monitoring [12].
Education level was determined from the HLQ and was deﬁned at
the highest qualiﬁcation obtained at that time. Participantswere ranked
into one of four categories: ‘degree or equivalent’, ‘A-level or
equivalent’, ‘O-level or equivalent’, and ‘less than O-level or equivalent’.
2.5. Previous medical history
The presence of a number of existing underlyingmedical conditions
was ascertained using the HLQ. Conditions of interest included; stroke,
cancer, myocardial infarction and diabetes amongst others. In conjunc-
tionwith this, participantswere requested to detail anymedication that
they were currently taking.
2.6. Dietary assessment method
Participants were requested to record all food and drink items
consumed within the 7 day period in a food record diary. Included
in each food diary were colour photographs of 17 foods, each with
three incremental portion sizes. Participants were requested to
indicate which photograph best represented their portion size for
each of the items. They were also asked to record the weight of
food items or use household measures to describe the portion size.
The use of dietary supplements was also recorded within the diary,
and data was input into a speciﬁcally designed program ViMiS
(vitamin and mineral supplements) [13]. The 7-day diary was chosen
after validation studies showed its reproducibility and relative validity
and indicated that the diet diaries provide a more accurate represen-
tation of dietary intakes, over FFQs [10,14]. These studies indicate that
FFQs overestimate dietary intakes of a number of food groups
including fruit and vegetables, milk and cheese which inﬂuence the
magnesium intake estimates.
A speciﬁc program, DINER (Data Into Nutrients for Epidemiologi-
cal Research), was developed for entry of dietary information from
the 7-day food diaries [15]. DINER allows the detailed information
provided in diet diaries to be translated into structured data ﬁles for
nutritional analysis. The program is more ﬂexible than other software
which enables the detail of the diary, including cooking method, type
of fat used and commercial brand names of products, to be retained
[16]. Due to the classiﬁcation structure used to code food items
DINER is also able to adapt to changes in food items available on
the consumer market [15]. The input of items from the food diaries
requires a high level of detail, which reduces the risk of bias between
coders, and analysis of consistency has echoed this [15]. Nutritionists,
trained to use the DINERMO program, checked the entered data after
which nutrient quantities were calculated and checked for a ﬁnal
time [17].
The ratio of calcium tomagnesium intakewas calculated by dividing
dietary calcium intake by dietary magnesium intake.
2.7. Statistical methods
All statistical analyses were conducted using the statistical
software Stata; version 11 (StataCorp, College Station, TX, 2009).
Continuous data are presented as mean with standard error and
categorical data as number and percentage. A two-sided P-value of
≤0.05 was considered statistically signiﬁcant. Independent sample t
Table 1
Baseline characteristics by sex in 4443men andwomen, aged 40–75 years in EPIC-Norfolk
cohort (1993–1997).
Men
n = 2000
Women
n = 2443
P-valuea
Age (years) 61.1 (±9.53) 60.4 (±9.71) 0.02
BMI (kg/m2) 26.5 (±3.18) 26.2 (±4.24) b0.01
Family history stroke (%) 465 (23.3%) 601 (24.6%) 0.29
Family history MI (%) 720 (36.0%) 934 (38.2%) 0.13
Family history DM (%) 222 (11.1%) 305 (12.5%) 0.16
Blood pressure (mm Hg)
SBP 140 (±18.5) 136 (±19.5) b0.001
DBP 85.3 (±11.5) 81.8 (±11.4) b0.001
PP 54.2 (±11.2) 54.0 (±11.4) 0.66
Antihypertensive use (%) 417 (20.9%) 516 (21.1%) 0.83
Aspirin use (%) 271 (13.6%) 197 (8.06%) b0.001
Blood lipids (mmol/L)
Total cholesterol 6.07 (±1.10) 6.36 (±1.22) b0.001
Smoking (%)
Current 234 (11.7%) 314 (12.9%) b0.001
Former 1114 (55.7%) 774 (31.7%)
Never 652 (32.6%) 1355 (55.5%)
Physical activity (%)
Inactive 644 (32.2%) 800 (32.8%) b0.001
Moderately inactive 476 (23.8%) 790 (32.3%)
Moderately active 440 (22.0%) 514 (21.0%)
Active 440 (22.0%) 339 (13.9%)
Education level (%)
0 — No qualiﬁcations 667 (33.4%) 1086 (44.5%) b0.001
1 — O-level or equivalent 165 (8.3%) 249 (10.2%)
2 — A-level or equivalent 887 (44.4%) 822 (33.7%)
3 — Degree or equivalent 281 (14.1%) 286 (11.7%)
Dietary factors
Total energy (kcal/day) 2218 (±505) 1685 (±384) b0.001
Magnesium (mg/day) 318 (±92.0) 265 (±73.2) b0.001
Ca:Mg ratio 2.93 2.93 0.96
Potassium (mg/day) 3423 (±819) 2962 (±683) b0.001
Alcohol (g/day) 15.9 (±20.8) 7.70 (±11.7) b0.001
Sodium (mg/day) 3150 (±864) 2405 (±660) b0.001
Calcium supplement use (%) 34 (1.70%) 160 (6.55%) b0.001
Magnesium supplement use (%) 22 (1.10%) 53 (2.17%) b0.01
Values are mean and standard deviations were continuous and number and percentage
were categorical.
a P-value difference between males and females.
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between men and women.
To account for sex differences associated with a number of variables
of interest including BMI and WHR sex speciﬁc analyses were
conducted.
Multiple regression analysis with multivariate adjustment was
employed to assess differences in SBP, DBP and total cholesterol TC
with sex speciﬁc quintiles of dietary magnesium intake.
2.7.1. Statistical models
Model 1 comprised of age, BMI, smoking, physical activity (PA)
levels, education (all outcomes); use of antihypertensive medications
(BP only); baseline reported myocardial infarction (MI) or diabetes,
family history of stroke or MI, and use of statin medication (TC only)
[2,18,19]. Model 2, additionally adjusted for dietary factors, including
total energy intake in order to demonstrate the effect of magnesium
intake independent of total caloric intake, as well as previous incident
myocardial infarction (MI) or diabetes at baseline, family history of
stroke and MI (BP model only). Alcohol intake, dietary potassium and
sodium were included due to their associations with BP [2] and total
fat (TC model only). The use of calcium supplements and the ratio of
calcium tomagnesium intake were included; these two ions antagonise
each other, may compete during intestinal absorption and the Ca:Mg
ratio may be important for total mortality and coronary heart disease
[20].
For stroke risk, Model 1 comprised age, BMI, smoking, PA, educa-
tion and alcohol intake. Model 2 additionally adjusted for serum TC,
baseline reported MI or diabetes and family history of stroke or MI.
Model 3 included the addition of SBP and DBP, use of aspirin
medication N3 months, use of antihypertensive medication, the
ratio of dietary Ca:Mg and the use of calcium and magnesium
supplements.
A modiﬁed Prentice-weighted Cox regression analysis, for case–
cohort studies, was used to calculate hazard ratios with 95% CIs for
the risk of incident of stroke in association with dietary magnesium
intake [21]. This modiﬁed method accounts for the potential overlap
of participants with incident stroke and also randomly present in
the representative sub-cohort. Analyses were conducted by sex-
stratiﬁed data derived categories of magnesium intake with the
lowest 10% of intakes (b214 mg/day and b180 mg/day for men and
women), forming the reference category, and subsequent 30% groups
of magnesium intake. This approach was taken as we hypothesised
that the lowest risk of incident stroke would be in those with the
highest dietary magnesium intakes.
Sensitivity analysis was conducted excluding those taking antihy-
pertensive and statin medication respectively.
Total energy was not included as a covariate in cox regression
analysis. This was for a number of reasons, including that in the cox
regression we adjusted for classical risk factors for stroke and have
previously adjusted for total energy in early BP analyses, which
indicated that dietary magnesium intake has an effect on BP indepen-
dently of total energy, speciﬁcally for men, and BP was included in cox
regression analyses. Additionally with the inclusion of total energy
there is potential for collinearity, as a number of covariates included in
the model such as BMI, alcohol intake and physical activity are highly
correlated with total energy intake. There is also the potential for over
adjustment, and for these reasons we chose not to include total energy
in the cox regression models.
3. Results
In the 4443 participants included in these analyses 45.0%weremale,
with an age range of 39–78 years. Mean BP was 140/85 (SD 18.5/11.5)
and 136/82 (SD 19.5/11.4) mm Hg for males and females respectively
(Table 1). There was a total of 928 incident strokes during follow-up
(mean 9.58 years; total person years 42,556.5) between 1993 and 2008.Men had signiﬁcantly higher SBP, DBP and BMI and women had
signiﬁcantly higher TC levels (P for all b 0.001), and BMI (P = 0.01),
but not family history of stroke or MI (P = 0.35 and 0.17 respectively),
and antihypertensive or lipid lowering medication use (P = 0.89 and
0.34 respectively). This illustrates the need to conduct sex-stratiﬁed
analyses.
Bothmen andwomenwith the lowest 10% of dietarymagnesium in-
take, compared with the remaining 90% of intakes, tended to be older
(64 vs. 61 years, and 63 vs. 60 years for men and women respectively),
had a higher percentage of current smokers (18.6% vs. 10.9% and 21.1%
vs. 12.0% for men and women respectively), inactive people (42.7% vs.
31.0% and 47.4% vs. 31.2% for men andwomen respectively) and people
taking antihypertensivemedication (25.6% vs. 20.3% and 30.2% vs. 20.2%
for men and women respectively). There was no substantial difference
in BMI, use of statin or aspirinmedication andMI or diabetes at baseline
between lowest 10% ofmagnesium and remaining intakes. Across quin-
tiles of dietary magnesium intake a signiﬁcantly higher intake of fruit,
vegetables and bread and cereals was seen in men and women
(P b 0.001 for all).
In men but not women, there were inverse associations between
dietary magnesium intake and SBP and DBP that remained signiﬁcant
after analysis that accounted for age, dietary sodium intake and use of
aspirin or antihypertensive medication (Table 2). There were
differences of −7 mm Hg and −3.8 mm Hg between Quintile-1 and
111L.K.M. Bain et al. / International Journal of Cardiology 196 (2015) 108–114Quintile-5 in SBP and DBP (P ≤ 0.01 and P = 0.01 respectively). In
women there were no signiﬁcant associations between dietary magne-
sium intake and SBP or DBP (Table 2).
Signiﬁcant inverse associations between dietarymagnesium intakes
and TCwere identiﬁed for both genders (P= 0.02 in men and P= 0.04
in women) after adjustment for anthropometric and lifestyle factors
(Table 2). However, these associations were attenuated with the
addition of dietary factors; alcohol intake, total fat intake, ratio of
Ca:Mg, total energy and calcium supplement intake to the multivariate
model but remained signiﬁcant (P = 0.02 in men and P = 0.04 in
women) (Table 2).
Sensitivity analysis excluding those on antihypertensive medication
(n= 1583men and 1927women) or statinmedication (n= 1973men
and 2400 women) provided similar results.
Stroke risk showed anon-signiﬁcant inverse trend across quintiles of
dietary magnesium intakes in men and women after adjustment
(Table 3). In further analyses examining magnesium intake by catego-
ries there was a signiﬁcant trend across categories in men. In those in
the highest 30th percentile of dietary magnesium intake (Table 4), in
men, but not in women (Table 4), there was a 41% relative reduction
of stroke risk (HR 0.59; 95% CI 0.38–0.93 (P = 0.04)) compared to theTable 2
Association of quintiles of dietarymagnesium intake (range andmean quintile intake) and blood
in EPIC-Norfolk cohort (1993–1997).
Men Q1 Q2
85–242 mg
206 mg
n = 400
243–284 mg
266 mg
n = 400
SBP Unadjusted 143 (±0.98) 140 (±0.97)
Model 1a 140 (±0.87) 139 (±0.86)
Model 2b 143 (±1.16) 140 (±0.90)*c
DBP Unadjusted 86.1 (±0.58) 85.9 (±0.60)
Model 1 85.4 (±0.57) 85.4 (±0.56)
Model 2 87.15 (±0.76) 86.1 (±0.59)
Women Q1 Q2
48–204 mg
176 mg
n = 489
205–240 mg
223 mg
n = 489
SBP Unadjusted 140 (±0.90) 135 (±0.85)
Model 1 136 (±0.79) 135 (±0.77)
Model 2 137 (±1.07) 135 (±0.82)
DBP Unadjusted 83.5 (±0.51) 81.5 (±0.50)
Model 1 82.0 (±0.49) 81.3 (±0.48)
Model 2 82.5 (±0.67) 81.6 (±0.51)
Men Q1 Q2
85–242 mg
206 mg
n = 400
243–284 mg
266 mg
n = 400
Total cholesterol Unadjusted 6.21 (±0.06) 6.16 (±0.06)
Model 1d 6.17 (±0.06) 6.16 (±0.06)
Model 2e 6.18 (±0.07) 6.16 (±0.06)
Women Q1 Q2
48–204 mg
176 mg
n = 489
205–240 mg
223 mg
n = 489
Total cholesterol Unadjusted 6.67 (±0.06) 6.35 (±0.05)
Model 1c 6.51 (±0.05) 6.33 (±0.05)*
Model 2d 6.52 (±0.06) 6.34 (±0.05)*
a Model 1: age, BMI, smoking status, physical activity, education level, antihypertensive med
b Model 2: model 1+ baselineMI or diabetes, family history stroke, family historyMI, alcoho
(including contribution from medication).
c Model 1: age, BMI, smoking status, physical activity, education level, baseline MI or diabet
d Model 2: model 1 + alcohol, dietary total fat intake, ratio Ca:Mg, total energy and calcium
e P value for signiﬁcance compared with Q1: * = P value ≤ 0.05, ** = P value ≤ 0.005, *** =lowest 10% of magnesium intakes. Although stroke risk was also lower
in women this was not signiﬁcant.
Sensitivity analyses excluding those taking antihypertensive
medication attenuated the association of stroke risk in men to be non-
signiﬁcant and strengthened the association in women to be signiﬁcant
and separately excluding those taking statin medication attenuated the
association in men to be non-signiﬁcant.
4. Discussion
Themain ﬁndings of this case–cohort study of British adults suggest
that, after adjustment for several important confounding factors includ-
ing age, smoking status, history of CVD, medication use, total energy
intake and other dietary variables, there was a strongly signiﬁcant asso-
ciation (P ≤ 0.01) between dietary magnesium intake and SBP and DBP
inmen, but not inwomen. Therewas also an associationwith TC in both
men and women (P = 0.001 and P ≤ 0.01 respectively) which was
attenuated but remained signiﬁcant after adjustment for other dietary
factors (P = 0.02 and P = 0.04 for men and women respectively).
Furthermore in relation to stroke risk speciﬁcally, we identiﬁed a signif-
icant decrease in risk (HR 0.59; 95% CI 0.38–0.93 P= 0.04) inmen withpressure and total cholesterol (means and SE) in 4443men andwomen, aged40–75 years
Q3 Q4 Q5 P for trend
285–328 mg
307 mg
n = 400
329–385 mg
355 mg
n = 400
386–829
456 mg
n = 400
140 (±0.88) 139 (±0.90) 136 (±0.87) b0.001
140 (±0.86) 140 (±0.86) 139 (±0.87) 0.64
140 (±0.85)* 138 (±0.89)** 136 (±1.18)*** 0.002
85.4 (±0.57) 85.2 (±0.56) 84.1 (±0.56) 0.008
85.3 (±0.56) 85.5 (±0.56) 85.0 (±0.57) 0.68
85.1 (±0.55)* 84.9 (±0.58)* 83.4 (±0.77)** 0.01
Q3 Q4 Q5
241–274 mg
258 mg
n = 489
275–319 mg
295 mg
n = 489
320–692 mg
374 mg
n = 488
137 (±0.93) 135 (±0.89) 133 (±0.81) b0.001
137 (±0.77) 136 (±0.77) 135 (±0.78) 0.85
137 (±0.77) 135 (±0.81) 135 (±1.09) 0.45
82.4 (±0.55) 80.9 (±0.53) 80.7 (±0.48) b0.001
82.6 (±0.48) 81.4 (±0.48) 81.7 (±0.49) 0.71
82.5 (±0.48) 81.1 (±0.51) 81.2 (±0.68) 0.26
Q3 Q4 Q5
285–328 mg
307 mg
n = 400
329–385 mg
355 mg
n = 400
386–829
456 mg
n = 400
6.02 (±0.05) 6.05 (±0.06) 5.91 (±0.05) b0.001
6.03 (±0.05) 6.06 (±0.05) 5.93 (±0.06)** 0.001
6.03 (±0.05) 6.06 (±0.06) 5.94 (±0.07)* 0.02
Q3 Q4 Q5
241–274 mg
258 mg
n = 489
275–319 mg
295 mg
n = 489
320–692 mg
374 mg
n = 488
6.28 (±0.05) 6.32 (±0.05) 6.16 (±0.05) b0.001
6.31 (±0.05)* 6.36 (±0.05)* 6.26 (±0.05)** 0.005
6.31 (±0.05)* 6.35 (±0.05) 6.25 (±0.06)* 0.04
ication use.
l intake, dietary sodium, potassium, ratio Ca:Mg, total energy and calcium supplement use
es, family history stroke, family history MI, statin medication use.
supplement use (including contribution from medication).
P value ≤ 0.001.
Table 3
Quintiles of dietary magnesium intake (range andmean quintile intake) at baseline (1993–1997) and stroke risk (HR and 95% CI), follow-upMarch 2008, in 4443men and women, aged
40–75 in EPIC-Norfolk cohort.
Men Q1 Q2 Q3 Q4 Q5 P trend
85–242 mg
206 mg
n = 400
243–284 mg
266 mg
n = 400
285–328 mg
307 mg
n = 400
329–385 mg
355 mg
n = 400
386–829 mg
456 mg
n = 400
Stroke events 126 (30.6) 111 (26.9) 93 (22.6) 85 (20.6) 75 (18.3)
Model 1a 1.0 (reference) 0.85 (0.60–1.20) 0.70 (0.49–1.00) 0.86 (0.60–1.24) 0.80 (0.55–1.16) 0.22
Model 2b 1.0 (reference) 0.86 (0.60–1.20) 0.68 (0.47–0.99) 0.81 (0.56–1.17) 0.74 (0.50–1.09) 0.11
Model 3c 1.0 (reference) 0.87 (0.61–1.25) 0.73 (0.50–1.06) 0.80 (0.55–1.17) 0.81 (0.53–1.22) 0.21
Women Q1 Q2 Q3 Q4 Q5
48–204 mg
176 mg
n = 489
205–240 mg
223 mg
n = 489
241–274 mg
258 mg
n = 489
275–319 mg
295 mg
n = 489
320–692 mg
374 mg
n = 488
Stroke events 152 (30.5) 102 (20.5) 87 (17.5) 82 (16.5) 88 (17.7)
Model 1a 1.0 (reference) 0.74 (0.53–1.05) 0.74 (0.51–1.06) 0.84 (0.59–1.20) 0.83 (0.57–1.20) 0.39
Model 2b 1.0 (reference) 0.71 (0.50–1.01) 0.71 (0.49–1.03) 0.82 (0.57–1.17) 0.76 (0.52–1.11) 0.23
Model 3c 1.0 (reference) 0.72 (0.50–1.04) 0.73 (0.50–1.08) 0.86 (0.59–1.26) 0.82 (0.54–1.24) 0.45
a Model 1: age, BMI, education status, physical activity, smoking status, and alcohol intake.
b Model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke, or MI.
c Model 3: model 2 + SBP, DBP, aspirin use N3 months, antihypertensive medication, ratio Ca:Mg and magnesium and calcium supplement use (including contribution frommedication).
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to those with intakes ≤214 mg (the lowest 10%).
Compared with our ﬁndings, previous studies have shown a signiﬁ-
cant inverse association between dietary magnesium intake and SBP
and DBP in men has also been reported [22] with differences of
−6.4 mm Hg and−3.1 mm Hg for SBP and DBP respectively between
those with the highest and lowest intakes in 615 older Japanese men
(aged 63–82 years) using 24 hour recall. Using 7 day food diary data, a
more robustmeasure of dietary intakes, in a representative general pop-
ulation ofmiddle and older agewe identiﬁed slightly greater differences
in BP between extreme quintiles of magnesium intakes with a differ-
ence of−7 mm Hg (P b 0.001) and−3.8 mm Hg (P b 0.001) for SBP
and DBP respectively. We identiﬁed between quintiles differences
were 250 mg/day for men, and 198 mg/day for women, the equivalent
to approximately 2 slices of wholemeal bread with peanut butter and
9 Brazil nuts, therefore achievable through dietary intakes [23]. WeTable 4
Stroke risk (HR and95%CI) bymagnesium groups (range andmean intake), bottom10% (Group
75 in EPIC-Norfolk cohort.
Men Group 1 Group 2 Gro
85–214 mg
181 mg
n = 199
215–285 mg
254 mg
n = 605
28
31
n =
Stroke events 65 (32.7%) 157 (26.0%) 12
Model 1a 1.00 0.73 (0.50–1.07) 0.6
Model 2b 1.00 0.72 (0.48–1.07) 0.6
Model 3c 1.00 0.67 (0.45–1.01)⁎ 0.6
Women Group 1 Group 2 Gr
48–180 mg
156 mg
n = 232
181–240 mg
213 mg
n = 745
24
26
n =
Stroke events 73 (31.5%) 165 (22.2%) 12
Model 1a 1.00 0.73 (0.49–1.08) 0.7
Model 2b 1.00 0.67 (0.45–1.00)⁎ 0.6
Model 3c 1.00 0.65 (0.43–0.99)⁎ 0.6
a Model 1: age, BMI, education status, physical activity, smoking status, alcohol intake.
b Model 2: model 1 + serum total cholesterol, baseline MI or diabetes, family history stroke
c Model 3: model 2 + SBP, DBP, aspirin use N3 months, antihypertensive medication, ratio C
medication).
⁎ P value for signiﬁcance compared with reference (Group 1): P value ≤ 0.05.also noted a tendency towards lower fruit, vegetable and bread and
cereal intake in those with the lowest dietary magnesium intakes
which may be relevant for identifying individuals whom may beneﬁt
from increased intake.
In women a potential beneﬁt from increased consumption of
magnesium has previously been reported [24–26]. Witteman et al.
[24] and Song et al. [25] showed a reduction in relative risk, RR 0.77,
95% CI 12%–33% and RR 0.93, 95% CI 0.86–1.02 respectively for develop-
ing hypertension in prospective studies using FFQs. A meta-analysis of
RCTs using oral magnesium supplements also reported a dose depen-
dent effect of supplementation on blood pressure [27]. This is in contrast
to the current study where we did not ﬁnd any signiﬁcant trends
between magnesium intake and BP in women. This discrepancy may
be due to differences in the models used. For example Witteman et al.
[24] did not adjust for lifestyle factors including physical activity levels
and smoking status which are known to inﬂuence BP. We further1 reference category) and 3 groups of 30% intakes each, in 4443menandwomen, aged40–
up 3 Group 4 P trend
6–353 mg
8 mg
591
354–828 mg
427 mg
n = 605
3 (20.8%) 104 (17.2%)
3 (0.43–0.94)⁎ 0.67 (0.44–1.01)⁎ 0.07
1 (0.41–0.92)⁎ 0.61 (0.40–0.94)⁎ 0.03
0 (0.40–0.90)⁎ 0.59 (0.38–0.93)⁎ 0.04
oup 3 Group 4
1–294 mg
7 mg
740
295–691 mg
352 mg
n = 726
6 (17.0%) 115 (15.8%)
0 (0.46–1.06) 0.74 (0.48–1.12) 0.27
5 (0.43–0.98)⁎ 0.66 (0.43–1.02) 0.14
5 (0.42–1.01) 0.69 (0.44–1.09) 0.27
, or MI.
a:Mg and magnesium and calcium supplement use (including contribution from
113L.K.M. Bain et al. / International Journal of Cardiology 196 (2015) 108–114explored whywemight have identiﬁed differences between genders. It
may be due to the fact that older age, higher BMI, and higher levels of
physical inactivityweremore prevalent inwomenwith lowmagnesium
intakes,whichmay in part explainwhy a signiﬁcant effectwas shown in
men but not women. As highlighted in the results section differences
were identiﬁed between those with the lowest 10% of intakes and
those with higher intakes, however, we took these factors into account
during our analyses. It is also of note that differences identiﬁed were
largely the same for bothmen andwomen, although there was a higher
percentage of women, with the lowest 10% magnesium intakes, using
antihypertensive medication which may inﬂuence the ﬁndings due to
modifying effect of medication on future risk. In addition there was a
narrower range of magnesium intakes for women (644 mg/day) com-
pared with men (744 mg/day) which may attenuate the results. It
may also be that the cohort was insufﬁciently powered to detect an af-
fect in women.
A number of intervention trials, using oralmagnesium supplements,
have reported signiﬁcant reductions in BP ranging from 2.0–12.0 to 2.7–
8.0 mmHg for SBP and DBP respectively [28–32]. Although, the supple-
ment doses were comparable with dietary intake, ranging between
200 mg/day to 600 mg/day, the formulations used were inconsistent.
Limited studies have previously investigated associations between
dietarymagnesium intake and TC or subfractions and two previous stud-
ies found no association with TC unlike our study which found that TC
was≈4% lower inQuintile-5 comparedwithQuintile-1 [33–36]. Howev-
er, a highermagnesium intake has been related to beneﬁcial increases in
high density lipoprotein (HDL) concentrations [33,35].
Although several studies have previously investigated stroke risk
and dietary magnesium intakes, to our knowledge none have included
populations of both men and women simultaneously or included risk
factors as well as stroke risk [26,33–35,37–42]. Previous studies in
large populations of American, Taiwanese and Northern European co-
horts, which have mainly used FFQs, have reported no associations
[26,33,34,38,40–42]. However, several studies found signiﬁcant associa-
tions in men [35], women [43], and men and women [40]. Additionally,
a meta-analysis by Larsson et al. (2012) [9], in 241,378 people, reported
an inverse association between dietary magnesium intake, recorded by
FFQ, and risk of stroke. A more recent meta-analysis, of CVD, but not
stroke speciﬁcally, by Del Gobbo et al. [8] in 313,041 participants, con-
cluded that there was no signiﬁcant association between dietary mag-
nesium intake and CVD. However, a signiﬁcant inverse association
was identiﬁed in relation to circulating magnesium and CVD incidence
potentially indicating mechanisms that could also affect stroke risk. In
addition Guasch-Ferré et al. [44] recently reported that an increase in
magnesium intake was associated with a decrease in both CVD mortal-
ity and total mortality in individuals at high CVD risk. Our results indi-
cated a non-signiﬁcant trend across quintiles of dietary magnesium
intake and stroke risk in men and women (Table 3). However, when
we compared men with the lowest 10% of magnesium intake with the
remainder of the cohort, we identiﬁed a signiﬁcant inverse trend
(P= 0.04) across groups inmen only (Table 4). This ﬁndingwould sug-
gest that it is the very lowest magnesium intakes that may infer the
greatest risk of stroke incidence, and the current ﬁndings suggest an as-
sociation between lower dietary magnesium intake and higher stroke
risk.
4.1. Strengths and limitations
The strengths of the present analyses include; the size of the cohort,
the representativeness of the UK general population and prospective
design for the stroke analyses, which reduces the susceptibility of the
study to selection bias. The study design also reduces the likelihood of
measurement error, due to the recording of dietary intake at baseline
prior to the onset of stroke. Additionally robust and systematic adjust-
ment for a number of potential confounding factors allowed for the
identiﬁcation of dietary associations independent of known risk factors.It is possible that factors not included in the model may also inﬂuence
associations such as medication use; proton pump inhibitors, and
diuretics. The use of quantitative 7-day food diaries is likely to have
provided a more accurate representation of micronutrient intakes, in-
cluding magnesium intake, compared with FFQ and 24-hour recall
methods [45]. To our knowledge our study is the only one to use dietary
intake values from 7-day diaries as opposed to estimates from FFQs.
Seven day food diaries have been shown to more accurately represent
dietary intakes of a number of food groups that contribute to magne-
sium intake, including fruit and vegetables, and micronutrient intakes
including potassium, carotene and vitamin C in validation studies [14,
45,46]. Despite this, dietary intakes do not account for variation in
bioavailability and absorption of magnesium, potentially the use of a
biomarker would strengthen the ﬁndings [47] and wewere also unable
to take into account possible contributions ofmagnesium from drinking
water [48]. Furthermore in the same population we were able to
examine the complex relationship between magnesium intake, BP and
cholesterol and stroke risk taking into account potential relevant risk
speciﬁc confounders.
Selection bias may be possible although the whole EPIC-Norfolk
cohort was representative of the UK population, with comparable
cohort characteristics, and the sub-cohort for these analyses was
representative of the EPIC-Norfolk cohort. Furthermore, truncation of
the sample distribution due to potential healthy responder bias would
likely only attenuate the observed associations and therefore associa-
tions may actually be stronger than are presented. It should also be
noted that, as with other cross-sectional and observational longitudinal
studies, it is not possible to infer causation from these ﬁndings. Howev-
er, the prospective relationship observed with dietary magnesium
intake and stroke risk reduces the likelihood of reverse causality.
Furthermore the associations were in agreement with the existing
literature. Residual confounding is possible but, the likelihood is
reduced due to previous validation of dietary methods and results of
the EPIC-Norfolk cohort [46,49].
4.2. Summary
To our knowledge this is the ﬁrst study to investigate the association
of dietary magnesiumwith BP, TC and stroke risk in a UK general popu-
lation of both genders. The results suggest that increased dietary mag-
nesium could positively impact on BP and stroke risk in men and total
cholesterol levels in both genders. Our ﬁndings suggest that men with
the lowest magnesium intakes are at the greatest risk of stroke, lower
magnesium intake was also associated with higher blood pressure.
Therefore a higher dietary magnesium intake may be beneﬁcial for
prevention of stroke in men and warrants further investigation.
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